<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        25-415-12
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2012
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        TRANDATE TAB 200 MG.
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LABETALOL HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        200
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        18.3
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GLAXO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GLAXO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 411]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Saudi Import Company - BANAJA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            ASPEN
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07AG01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>1.&nbsp;What Trandate is and what it is used for</strong></p><p><strong>&nbsp;</strong>Trandate contains the active ingredient labetalol. It is used to treat mild, moderate or severe hypertension (high blood pressure), hypertension during pregnancy (high blood pressure triggered by pregnancy) and high blood pressure connected to angina pectoris (pain in chest).</p><p>Labetalol (Trandate) belongs to a group of medicinal products called alpha and beta blockers. These medicinal products lower the blood pressure by blocking receptors in the cardiovascular system (circulatory system) causing a reduction of the blood pressure in the blood vessels far away from the heart.</p><p>Please note that your doctor may have prescribed this medicine for another use and/or with another dose than what is described in the package leaflet. Always follow your doctor&rsquo;s instructions printed on the label on the glass from the pharmacy.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>2. What you need to know before you take Trandate</strong></p><p><strong>Do not take Trandate</strong></p><p>if you have certain heart diseases (e.g. heart block of 2nd or 3rd degree, unless you have a pacemaker, uncompensated heart failure) if you have persistently low blood pressure</p><p>if you have a very slow heart rate (severe bradycardia)</p><p>- if you have a disease called Prinzmetal&#39;s angina</p><p>if you have asthma or a similar lung disease (obstructive pulmonary disease)</p><p>-&nbsp; if you are allergic to labetalol or any of the other ingredients of this medicine (listed in section 6).</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking Trandate. if you have hepatic insufficiency or liver damage</p><p>-&nbsp;if you have renal insufficiency</p><p>if you have a vessel disease, e.g. Raynaud&rsquo;s syndrome, intermittent claudication</p><p>- if you have diabetes mellitus (type 1 or type 2)</p><p>if you have an overactive thyroid gland (thyrotoxicosis, hyperthyreosis)</p><p>- if you previously have had a serious allergic reaction (prophylaxis) to a substance</p><p>if you have heart failure or other problems with your heart (e.g. poor systolic function of left ventricle, 1st degree atrioventricular block)</p><p>if you know that you will have planned surgery</p><p>-if you have metabolic acidosis (when your body produces too much acid or when your kidneys do not remove enough acid from the body)</p><p>if you have phaeochromocytoma (a special kind of tumour in the adrenal gland)</p><p>- if you have a condition called ischaemic heart disease</p><p>if you get a low heart rate (bradycardia) due to the treatment with Trandate, your doctor might reduce the dose.</p><p>If you get skin rash and/or dry eyes or some kind of allergic reaction when taking Trandate, you must tell your doctor, as he/she might have to reduce or discontinue your treatment. Always follow your doctor&#39;s instructions.</p><p>Do not discontinue Trandate abruptly, especially if you have a heart disease (ischaemic heart disease or angina pectoris). Talk to your doctor if you think that you should stop taking Trandate.</p><p><strong>Surgery</strong></p><p>If you are planning to have surgery requiring general anaesthesia you must tell your surgeon that you are taking Trandate prior to your surgery.</p><p>Labetalol may affect your pupils during surgery for cataracts. Tell the surgeon that you are using this medicinal product prior to your surgery. You should not stop taking labetalol prior to surgery, unless the surgeon tells you so.</p><p><strong>Other medicines and Trandate</strong></p><p><strong>&nbsp;</strong>Tell your doctor if you are taking, have recently taken or might take any other medicines, before getting Trandate. It is especially important for the following medicinal products:</p><p>-&nbsp; NSAIDs (non-steroid anti-inflammatory drugs), e.g. sulindac or indomethacin used to treat pain and inflammation</p><p>digoxin (heart medicine)</p><p>adrenaline, used to treat serious anaphylaxis (allergic reactions)</p><p>- medicinal products for treatment of heart disease (Class I antiarrhythmics e.g. disopyramide and quinidine) and (Class II antiarrhythmics, e.g. amiodarone)</p><p>-&nbsp; other blood pressure lowering medicinal products (calcium blockers, such as verapamil) tricyclic antidepressants, e.g. imipramine (used for treating depression)</p><p>- cimetidine which may be used for treating stomach ulcers and heartburn</p><p>oral antidiabetics, e.g. biguanides (e.g. metformin), sulfonylureas (e.g. glimepiride), meglitinides (e.g. repaglinide) and o-glucosidase inhibitors (e.g. acarbose), used to reduce blood sugar levels in the blood</p><p>- derivatives of ergotamine, e.g. ergotamine or dihydroergotamine, used to treat migraine, cholinesterase inhibitors, e.g. donepezil, galantamine or rivastigmine, used to treat mild cognitive inhibition, Alzheimer&#39;s disease and Parkinson&rsquo;s disease</p><p>nitrates, antipsychotics (e.g. derivatives of phenothiazine, chlorpromazine) and other antipsychotics, antidepressants</p><p>-&nbsp;clonidine, used to treat high blood pressure</p><p><strong>Test</strong></p><p>The medicinal product can interact with certain medical laboratory tests and potentially give false test results. Ensure that all laboratory personnel and your doctors know that you are taking this medicine.</p><p><strong>Pregnancy, breast-feeding and fertility.</strong></p><p>If you are pregnant or a planning to have a baby, ask your doctor for advice before taking Trandate. The foetus may potentially be affected, but Trandate can be used during pregnancy if needed.</p><p>Trandate is excreted in breast milk in small amounts. If you are breast-feeding you must consult with your doctor prior to taking Trandate.</p><p><strong>Trandate contains lactose</strong></p><p><strong>&nbsp;</strong>If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p><p><strong>Trandate contains Sunset Yellow</strong></p><p><strong>&nbsp;</strong>Trandate tablets contain the colourant Sunset Yellow (El 10) which may cause allergic reactions.</p><p><strong>Driving and using machines</strong></p><p><strong>&nbsp;</strong>Translate will probably not affect the ability to drive or use machines. Some people may however at times experience dizziness and/or tiredness. You should be aware of the fact that this may reduce your ability to read, and you must therefore exercise caution until you know your reaction to this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>3.&nbsp;</strong><strong>How to take Trandate</strong></p><p><strong>&nbsp;</strong>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p>Trandate tablets should be taken with food.</p><p>The dose will be established by your doctor, who will adjust it to you personally. The usual start dose is 100 mg twice daily. Typical doses of up to 800 mg daily could control your blood pressure. Up to 2400 mg (divided into 3 or 4 doses) daily.</p><p>If you are older or you have hepatic insufficiency, your doctor may prescribe a lower dose.</p><p><strong>If you take more Trandate than you should</strong></p><p><strong>&nbsp;</strong>Symptoms of an overdose of labetalol (Trandate) include extreme dizziness when you try to get up (to a sitting or standing position), and sometimes a low heart rate which you will feel as a slow pulse (bradycardia).</p><p>Contact a doctor or a hospital or call the Poison Control Centre (+45 82 12 12 12) if you think that you have taken too much medicine, or if a child has accidentally taken the medicine. Please bring the medicine packs to the hospital/emergency clinic.</p><p><strong>If you forget to take Trandate</strong></p><p><strong>&nbsp;</strong>Do not take a double dose to make up for a forgotten tablet. Check with your doctor or pharmacist if you are not sure.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>4.&nbsp;Possible side effects</strong></p><p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>Please contact your doctor immediately if you get any of the following side effects: Very <strong>rare: </strong>may affect up to 1 <strong>in 10,000 </strong>people</p><p>-&nbsp;&nbsp;systemic lupus erythematosus, which may cause symptoms including joint pain, fever, skin rash and tiredness</p><p>lack of ability to urinate despite a full bladder (a medical emergency)</p><p>-&nbsp; angioedema, which may give symptoms including swollen lips, face and tongue and result in breathing difficulties</p><p><strong>Other side effects include:&nbsp;</strong></p><p>Very common: may affect more than 1 in 10 people antibodies not associated with a disease</p><p>Common: may affect 1 in 10 people</p><p>-right side heart failure</p><p>elevated liver function tests. It is usually reversible upon cessation of treatment with the medicinal product</p><p>dizziness, headache and a tingling sensation in the scalp, which is normally transient, and occurs during the first weeks of treatment</p><p>blurred vision</p><p>-&nbsp; difficulties urinating</p><p>dizziness if you stand up too quickly from lying down to sitting or from sitting to standing due to low blood pressure (orthostatic hypotension). More common at very high doses if the initial dose is too high or if doses are increased too rapidly. It is usually transient and occurs during the first few weeks of treatment</p><p>-&nbsp; nasal congestion. This is usually transient and occurs during the first few weeks of treatment</p><p>-&nbsp; nausea</p><p>- erectile dysfunction (impotence) and ejaculatory failure</p><p>tiredness or lack of energy, usually transient and occurring during the first few weeks of treatment</p><p>Allergic reactions (hypersensitivity) may also include rash (of varying severity), itching, dyspnoea and in very rare cases fever or rapid swelling of the skin.</p><p>&nbsp;</p><p>Uncommon: may affect up to 1 <strong>in 100 people&nbsp;</strong></p><p>- feeling depressed, usually transient and occurring during the first few weeks of treatment narrowing of the lower airways (bronchospasm)</p><p>- vomiting and stomach pain just underneath the ribs</p><p>hot flashes, usually transient and occurring during the first few weeks of treatment</p><p>- muscle cramps</p><p><strong>Rare: may affect up to 1 in 1,000 people</strong></p><p>-&nbsp; low heart rate, which may be felt as a low pules (bradycardia)</p><p><strong>Very rare: may affect up to 1 out of 10,000 people</strong></p><p>-disturbances of the electrical impulses controlling your heart beat (heart block)</p><p>inflammation of the liver (hepatitis), which is usually reversible when discontinuing treatment with Trandate</p><p>hepatocellular jaundice (the skin and whites in the eyes turn yellow), cholestatic jaundice (symptoms include tiredness and nausea followed by itching, dark urine and jaundice, and may include rash or fever) and liver necrosis (damaged liver tissue). These symptoms are usually reversible upon cessation of treatment with the medicinal product</p><p>-&nbsp; aggravation of the symptoms of Raynaud&rsquo;s disease (cold fingers due to circulation problems) swollen ankles. This is usually transient and occurs during the first few weeks of treatment</p><p>- muscle inflammation and weakness caused by the medicinal product (toxic myopathy)</p><p>- tremor when Trandate is used to treat high blood pressure in connection with pregnancy</p><p>- eye irritation</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>5.&nbsp;How to store Trandate</strong></p><p><strong>-&nbsp;</strong>Keep out of the sight and reach of children.</p><p>-Do not use this medicine after the expiry date which is stated on the pack. The expiry date refers to the last day of that month.</p><p>-Unused medicines should always be brought to the pharmacy. Do not throw away any medicines via wastewater or household waste.</p><p>-Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>a.&nbsp;&nbsp; </strong><strong>What Trandate 100 mg and 200 mg film-coated tablets contain:</strong></p><p><strong>&nbsp;The active substance is </strong>labetalol hydrochloride.</p><p><strong>The other ingredients are </strong>lactose, magnesium stearate, microcrystalline cellulose, Opadry Orange, hypromellose, sodium benzoate, titanium dioxide (E171), Sunset Yellow (E110).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                b.	What Trandate looks like and contents of the pack What Trandate looks like
Trandate 100 mg tablets are orange, round, biconvex, film-coated tablets engraved with TT01 on one side.
Trandate 200 mg tablets are orange, round, biconvex, film-coated tablets engraved with TT02 on one side.

Contents of the pack
100 mg film-coated tablets: Packs of 50 and 250 tablets. 200 mg film-coated tablets: Packs of 100 and 250 tablets. Not all pack sizes may be marketed.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>c.&nbsp; </strong><strong>Marketing Authorisation Holder</strong></p><p>Aspen Pharma Trading Limited 3016 Lake Drive,</p><p>Citywest Business Campus, Dublin 24, Ireland</p><p><strong>Manufacturer</strong></p><p>Aspen Bad Oldesloe GmbH, Bad Oldesloe, Germany.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                d.	This leaflet was revised in March 2019 version {002}
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p><strong>1. ما هو ترانديت وما هي دواعي &nbsp;استخدامه</strong></p><p>يحتوي ترانديت على المادة الفعالة لابيتالول، وهي مادة تستخدم في علاج ارتفاع ضغط الدم الطفيف، أو المتوسط أو الحاد (ضغط الدم المرتفع)، وارتفاع ضغط الدم خلال الحمل (ضغط الدم المرتفع الناتج عن الحمل) وارتفاع ضغط الدم المرتبط بالذبحة الصدرية (ألم الصدر).</p><p>تنتمي مادة لابيتالول (ترانديت) إلى مجموعة من الأدوية تُدعى حاصرات ألفا وبيتا. تقوم هذه المنتجات الدوائية بخفض ضغط الدم عن طريق حصر مستقبلات الجهاز القلبي الوعائي (الجهاز الدوري)، مما يؤدي إلى خفض ضغط الدم في الأوعية الدموية البعيدة عن القلب.</p><p>يُرجى ملاحظة أنه من المحتمل أن طبيبك قد وصف لك هذا الدواء لاستخدام آخر و/أو جرعة مختلفة عن تلك الموصوفة في نشرة العبوة. اتبع دائماً تعليمات الطبيب الموضحة على ملصق الزجاجة من الصيدلية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>2.&nbsp;ما الذي تحتاج لمعرفته قبل تناول ترانديت </strong></p><p><strong>لا تتناول ترانديت &nbsp;</strong></p><p>إذا كنت مصاباً بأمراض قلبية محددة (مثل انسداد القلب من الدرجة الثانية والثالثة، عدا في حالة وجود الناظمة القلبية الاصطناعية، أو فشل قلبي غير معالج) إذا كان ضغط الدم لديك منخفض باستمرار</p><p>إذا كانت ضربات القلب لديك متباطئة للغاية (بطء القلب الحاد)</p><p>-إذا كنت مصاباً بحالة تُدعى ذبحة برنزميتال</p><p>إذا كنت مصاباً بمرض الربو أو مرض رئوي مشابه (مرض انسدادي رئوي).</p><p>-&nbsp;إذا كنت مصاباً بحساسية من مادة لابيتالول أو أي من المكونات الأخرى لهذا الدواء (مدرجة في القسم 6).</p><p><strong>التحذيرات والاحتياطات&nbsp;</strong></p><p>تحدث إلى طبيبك أو الصيدلي قبل تناول ترانديت إذا كنت مصاباً بقصور كبدي أو تلف كبدي</p><p>- إذا كنت مصاباً بقصور كلوي &nbsp;</p><p>-إذا كنت مصاباً بمرض وعائي، مثل متلازمة رينود، العرج المتقطع</p><p>-إذا كنت مصاباً بداء السكري (النوع الأول أو الثاني)</p><p>-إذا كنت مصاباً بفرط نشاط الغدة الدرقية (التسمم الدرقي، فرط الدرقية)</p><p>- إذا حدث لك من قبل رد فعل تحسسي خطير (اتقاء) من إحدى المواد. &nbsp;</p><p>-إذا كنت مصاباً بفشل قلبي أو مشكلات قلبية أخرى (مثل قصور الوظيفة الانقباضية في البطين الأيسر أو إحصار أذيني بطيني من الدرجة الأولى)</p><p>-إذا كنت تعرف أنه من المقرر أن تخضع لجراحة &nbsp;</p><p>-إذا كنت مصاباً بالحماض الأيضي (عندما ينتج الجسم أحماضاً بكمية أكبر من اللازم أو عندما لا تطرح الكلى الأحماض بكمية كافية من الجسم).</p><p>-إذا كنت مصاباً بورم القواتم (نوع من الأورام يصيب الغدة الكظرية)</p><p>-إذا كنت مصاباً بحالة تدعى داء قلبي إقفاري</p><p>-إذا تعرضت لتباطؤ ضربات القلب (بطء القلب) نتيجة لاستخدام ترانديت، يمكن للطبيب تقليل الجرعة التي تتناولها.</p><p>-إذا أصبت بطفح جلدي و/أو جفاف العيون أو أي نوع من رد الفعل التحسسي عند تناول ترانديت، فينبغي عليك الاتصال بالطبيب/الطبيبة الذي يمكنه/يمكنها حينها خفض الجرعة التي تتناولها أو إيقاف العلاج. اتبع دائماً تعليمات الطبيب.</p><p>لا تنقطع عن تناول ترانديت بشكل مفاجئ، على الأخص إذا كنت مصاباً بمرض قلبي (داء قلبي إقفاري أو ذبجة صدرية). تحدث إلى طبيبك إذا كنت تعتقد أنه يجب عليك إيقاف العلاج بترانديت.</p><p><strong>الجراحة&nbsp;</strong></p><p>إذا كان من المقرر أن تخضع للجراحة تحت تخدير كلي، يجب أن تخبر الجراح أنك تستخدم ترانديت قبل الجراحة.</p><p>&nbsp;فمن الممكن أن تؤثر مادة اللابيتالول على حدقتي العينين أثناء جراحة إعتام عدسة العين. أخبر الجراح أنك تتناول هذا المنتج الدوائي قبل الجراحة. &nbsp;يجب ألا تنقطع عن تناول لابيتالول قبل الجراحة، عدا أخبرك الجراح بذلك .</p><p><strong>الأدوية الأخرى وترانديت</strong></p><p>أخبر طبيبك إن كنت تتناول أو تناولت مؤخراً أو قد تتناول أي أدوية أخرى، قبل البدء بتناول ترانديت. فهذا مهم بشكل خاص للمنتجات الدوائية التالية:</p><p>-مضادات الالتهاب اللاستيرويدية (NSAID) مثل سلينداك أو إندوميثاسين (يستخدم كمسكن للآلام أو مضاد للالتهابات)</p><p>-الديجوكسين (دواء للقلب)</p><p>-الأدرينالين، يُستخدم في علاج التأق الشديد (ردود الفعل التحسسية)</p><p>-منتجات دوائية لعلاج الأمراض القلبية &nbsp;(مضادات اضطراب النظم من الفئة الأولى مثل ديسوبيراميد وكوينيداين) مضادات اضطراب النظم من الفئة الثانية مثل أميودارون)</p><p>-منتجات دوائية أخرى لخفض ضغط الدم&nbsp;( حاصرات الكاليسيوم، &nbsp;مثل فيراباميل) مضادات الاكتئاب ثلاثية الحلقات، مثل إميبرامين (يستخدم في علاج الاكتئاب)</p><p>-سيميتدين الذي يمكن استخدامه في علاج قرحة المعدة و حرقة الفؤاد</p><p>-مضادات السكري التي تؤخذ عن طريق الفم، مثل مجموعة البيغوانيد (مثل ميتفورمين)، السلفونيل يوريا (مثل جليميبرايد)، ومجموعة ميجليتنايدز (مثل ريباجلينيد)، ومثبطات الجلوكوسيديز ألفا (مثل أكاربوز) التي تُستخدم في خفض مستوى سكر الدم</p><p>- مشتقات &nbsp;الإرجوتامين، مثل &nbsp;إرجوتامين أو ثنائي هيدرات الإرجوتامين التي تستخدم في علاج الشقيقة،مثبطات الكولينستيراز (مثل: دونيبيزيل، أو جالانتامين، أو ريفاستجمين)، التي تستخدم في علاج القصور الإدراكي الطفيف، ومرض ألزهايمر، ومرض باركنسون &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>النترات، مضادات الذهان (مثل مشتقات فينوثيازين، كلوربرومازين)، ومضادات ذهان ومضادات اكتئاب أخرى</p><p>-كلونيدين، يُستخدم في علاج ارتفاع &nbsp;ضغط الدم.</p><p><strong>الاختبارات</strong></p><p>يمكن للمنتج الدوائي أن يتفاعل مع اختبارات معملية محددةو يمكن أن يتسبب في ظهور نتائج اختبارات خاطئة. تأكد أن جميع العاملين بالمعمل و أطباءك يعرفون أنك تتناول هذا الدواء.</p><p><strong>الحمل والرضاعة الطبيعية والخصوبة</strong></p><p>&nbsp;إذا كنت حاملاً أو تخططين للإنجاب، اطلبي من طبيبك المشورة قبل تناول ترانديت. فمن الممكن أن يتأثر&nbsp;الجنين، إلا إنه يمكن استخدام ترانديت في مرحلة الحمل عند اللزوم.</p><p>ترانديت &nbsp;يُفرز في حليب الثدي&nbsp; بكميات صغيرة. إذا كنتِ &nbsp;ترضغين رضاعة طبيعية فيجب أن&nbsp;تستشيري طبيبك قبل تناول ترانديت&nbsp;.</p><p><strong>يحتوي ترانديت على اللاكتوز.</strong></p><p>إذا أخبرك الطبيب أنك مصاب بعدم القدرة على تحمل&nbsp;بعض أنواع السكر، اتصل بطبيبك قبل تناول هذا المنتج الدوائي.</p><p>يحتوي ترانديت على لون أصفر بدرجة غروب الشمس</p><p>تحتوي أقراص ترانديت على مادة ملونة صفراء بدرجة غروب الشمس (إي إل 10) التي قد تسبب ردود فعل تحسسية.</p><p><strong>القيادة واستخدام الآلات</strong></p><p>على الأرجح لن يؤثر ترانديت على قدرتك على القيادة &nbsp;أو استخدام الآلات. إلا أن بعض الأشخاص أحياناً يشعرون بالدوار أو الإجهاد. يجب أن تعيحقيقة أن هذا قد يحد من قدرتك على القراءة، و لذا يجب توخي الحذر إلى&nbsp;أن تعرف رد فعلك على هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>3.</strong><strong>كيفية تناول </strong>&nbsp;<strong>ترانديت&nbsp;</strong></p><p>تناول هذا الدواء دائماً على النحو الذي يصفه لك الطبيب. استشر طبيبك، أو الممرضة، أو الصيدلي إن لم تكن متأكداً. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>يجب تناول أقراص ترانديت مع الطعام.</p><p>سيحدد لك الطبيب الجرعة، وسيعدلها لك بما يناسبك. عادةً ما تكون &nbsp;الجرعة الأولية &nbsp;100 ملغ مرتين يومياً. &nbsp;يمكن للجرعات المنتظمة حتى800 ملغ يومياً &nbsp;أن تسيطر على ضغط الدم. حتى 2400 ملغ (مقسمة على 3 أو 4 جرعات) يومياً.</p><p>إذا كنت شخصاً مسناً أو كنت مصاباً بقصور كبدي، قد يصف لك الطبيب جرعة أقل.</p><p>في حالة تناولت جرعة أكبر من اللازم من ترانديت<strong>&nbsp;</strong></p><p>أعراض الجرعة المفرطة من لابيتالول(ترانديت) تتضمن الدوار الشديد عند &nbsp;محاولة النهوض (إلى وضعية الوقوف أو الجلوس)، وفي بعض الأحيان تباطؤ ضربات القلب الذي ستشعر به كنبض بطيء (بطء القلب).</p><p>اتصل بالطبيب أو المستشفى أو مركز مكافحة السموم &nbsp;(4582121212+) إذا كنت تظن أنك تناولت جرعة أكبر من اللازم من الدواء، أو تناوله طفل عن طريق الخطا. يُرجى إحضار عبوات الدواء إلى المستشفى/عيادة &nbsp;الطوارئ.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p><strong>4.&nbsp;الآثار الجانبية المحتملة</strong></p><p>مثل جميع الأدوية،يمكن أن يتسبب هذا الدواء بظهور آثار جانبية،رغم أنه ليس بالضرورة أن يعاني منها الجميع . أخبر طبيبك على الفور إذا لاحظت ظهور أي من الآثار الجانبية التالية: نادرة جدًا: قد تؤثر على 1 من &nbsp;<strong>10000 </strong>شخص</p><p>-الذئبة الحمامية المجموعية، والتي قد تسبب أعراضاً مثل آلام المفاصل، حمى، طفح جلدي، &nbsp;وإعياء</p><p>عدم القدرة على التبول رغم امتلاء المثانة (حالة طبية طارئة)</p><p>- الوذمة الوعائية، والتي قد تتسبب في ظهور أعراض مثل تورم الشفتين، والوجه &nbsp;واللسان وينتج عنها &nbsp;صعوبات &nbsp;تنفس</p><p><strong>من الآثار الجانبية الأخرى:</strong></p><p>شائعة جداً: قد تؤثر على أكثر من 1 من كل 10 أشخاص أجسام مضادة غير مرتبطة بالمرض</p><p>&nbsp;شائعة: قد تؤثر على 1 من كل 10 أشخاص</p><p>- فشل قلبي بالجانب الأيمن</p><p>ارتفاع نتائج اختبارات وظائف الكبد.&nbsp;والتي عادة ما تزول عند التوقف عن استخدام المنتج الدوائي &nbsp;</p><p>الدوار، &nbsp;والصداع شعور بالوخز&nbsp; في فروة الرأس، والذي عادة ما يكون مؤقتاً، &nbsp;ويحدث خلال الأسابيع الأولى من العلاج</p><p>تشوش الرؤية</p><p>- صعوبة التبول</p><p>الدوار &nbsp;إذا نهضت فجأة من وضعية الاستلقاء إلى الجلوس أو &nbsp;من &nbsp;الجلوس إلى الوقوف بسبب انخفاض ضغط الدم (هبوط ضغط الدم الانتصابي). أكثر شيوعاً &nbsp;&nbsp;&nbsp;مع &nbsp;الجرعات المرتفعة جداً إذا &nbsp;كانت الجرعة الأولية مرتفعة جداً &nbsp;تم رفع الجرعات بشكل أسرع من اللازم.عادة ما يزول هذا التأثير &nbsp;ويحدث خلال الأسابيع الأولى من العلاج</p><p>-احتقان الأنف. عادة ما يزول هذا العرض إذ&nbsp;يحدث خلال الأسابيع القليلة الأولى من العلاج</p><p>- غثيان</p><p>-ضعف الانتصاب (ضعف جنسي) وفشل القذف</p><p>الإجهاد أو انخفاض الطاقة، عادة ما يزول إذ يحدث خلال الأسابيع القليلة الأولى من العلاج</p><p>تفاعلات تحسسية (فرط حساسية) قد تتضمن أيضاً الطفح الجلدي (بدرجات متفاوتة)، والحكة، وصعوبة في التنفس، وقد يحدث في بعض الحالات النادرة للغاية حمى، أو تورم سريع في الجلد .</p><p>غير شائعة: قد تؤثر على <strong>1</strong><strong> من كل </strong><strong>100</strong><strong> شخص</strong></p><p>-&nbsp; &nbsp;شعور بالاكتئاب عادة ما يزول إذ يحدث خلال الأسابيع القليلة الأولى من العلاج تضيق المسالك التنفسية السفلية (تشنج قصبي)</p><p>- قيء وألم بالمعدة تحت الأضلع &nbsp;</p><p>هبات ساخنة عادة ما تكون مؤقتة إذ تحدث خلال الأسابيع القليلة الأولى من العلاج.</p><p>- تشنجات عضلية</p><p>نادرة: قد تؤثر على 1 من كل 1000 شخص<strong>&nbsp;</strong></p><p>-&nbsp; تباطؤ ضربات القلب، والذي يمكن الشعور به كنبض بطيء (بطء القلب)</p><p>نادرة جداً: قد تؤثر على 1 من كل 10000 شخص</p><p>- اضطرابات في النبضات الكهربائية التي تتحكم في نبضات القلب (انسداد القلب).</p><p>التهاب الكبد (التهاب كبدي)، والذي عادة ما يزول عند إيقاف العلاج بترانديت.</p><p>يرقان خلوي كبدي (اصفرار الجلد وبياض العينين)، يرقان ركود الصفراء (تتضمن الأعراض الشعور بالتعب والغثيان، متبوعة بحكة، ولون داكن للبول ويرقان، وقد يتضمن أيضاً طفحاً جلدياً أو حمى)، والنخر الكبدي (تضرر نسيج الكبد). عادة ما تزول هذه الأعراض عند إيقاف العلاج بالمنتج الدوائي</p><p>- تفاقم أعراض مرض رينود (برودة الأصابع بسبب &nbsp;مشاكل &nbsp;في الدورة الدموية) تورم الكاحلين. عادة ما يكون هذا التأثير مؤقت إذ يحدث خلال الأسابيع الأولى من العلاج.</p><p>-التهاب وضعف العضلات ناتج عن استخدام المنتج الدوائي (اعتلال عضلي تسممي)</p><p>-ارتجاف عند استخدام ترانديت لعلاج ارتفاع ضغط الدم المرتبط &nbsp;بالحمل</p><p>- تهيج العينين</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>5.كيفية تخزين ترانديت</strong></p><p><strong>&nbsp;</strong>-يُحفظ بعيداً عن مرأى ومتناول الأطفال.</p><p>-لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية الموضح على العبوة. يشير تاريخ انتهاء الصلاحية إلى آخر يوم من ذلك الشهر.</p><p>-يجب دائماً إحضار الأدوية غير المستخدمة إلى الصيدلية. لا تتخلص من أي أدوية في مياه الصرف الصحي أو المخلفات المنزلية.</p><p>-اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات في الحفاظ على البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>أ.&nbsp;&nbsp; محتويات ترانديت أقراص مغلفة 100 ملغ و200 ملغ :</strong></p><p><strong>&nbsp;</strong>المادة الفعالة هي لابيتالول هيدروكلوريد .</p><p>المكونات الأخرى هي: لاكتوز، ستيارات مغنيسيوم، سيليولوز دقيق التبلور، أوبادري برتقالي، هيبروميلوز، بنزوات صوديوم، ثاني أكسيد التيتانيوم (إي <strong>171</strong>)، أصفر بدرجة غروب الشمس (إي <strong>110</strong>) .</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p><strong>ب.&nbsp;&nbsp; كيف يبدو ترانديت ومحتويات العبوة &nbsp;</strong></p><p>ترانديت 100 ملغ أقراص برتقالية، مستديرة محدبة من الجانبين، ومغلفة، محفور على إحدى جانبيها &nbsp;TT01.</p><p>ترانديت 200ملغ أقراص برتقالية،مستديرة محدبة من الجانبين، ومغلفة،محفور على إحدى جانبيها &nbsp;TT02.</p><p><strong>محتويات العبوة</strong></p><p>أقراص 100 ملغ مغلقة: عبوات من 50 قرصاً و250 قرصاً أقراص مغلقة 200 ملغ: عبوات من 100 قرص و250 قرصاً قد لا تكون جميع أحجام العبوات مسوقة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>&nbsp;مالك حق التسويق</strong></p><p>أسبن فارما تريدينغ المحدودة، 3016 ليك درايف، &nbsp;</p><p>مجمع سيتي ويست للأعمال، دبلن 24، أيرلندا</p><p><strong>الشركة المصنعة</strong></p><p>شركة أسبن باد أولدسلو المحدودة المنطقة الصناعية، باد أولدسلو، ألمانيا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            ث.تمت آخر مراجعة لهذه النشرة في مارس 2019.{002}
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Trandate Tablet
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Labetalol hydrochloride 100 mg and 200 mg.
Excipients:
100 mg: Each film-coated tablet contains 14.625 mg lactose, anhydrous.
200 mg: Each film-coated tablet contains 29.25 mg lactose, anhydrous.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablets 
Trandate 100 mg tablets are orange, round, biconvex, film-coated tablets engraved with TT01 on one side. 
Trandate 200 mg tablets are orange, round, biconvex, film-coated tablets engraved with TT02 on one side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>&nbsp;Mild, moderate or severe hypertension</li><li>&nbsp;Hypertension in pregnancy</li><li>&nbsp;Angina pectoris with concomitant hypertension</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Posology</strong></u></p><p><u><strong>Populations</strong></u></p><ul><li><u><strong>&nbsp;Adults:</strong></u></li></ul><table border="1" cellspacing="1" cellpadding="1"><tbody><tr><td><strong>Indication</strong></td><td><strong>Dose</strong></td></tr><tr><td><strong>Mild, moderate or severe hypertension</strong></td><td><p>Treatment should start with 100 mg twice daily. If necessary the dose of 100 mg twice daily should be escalated periodically (with intervals of 2 to 14 days). The blood pressure is for many patients controlled with 200 mg twice daily, but&nbsp;up to 800 mg daily may be given, divided into two daily doses. In severe refractory hypertension, daily doses of up to 2400 mg have been given (divided in 3 or 4 doses). Hospital in-patients with severe hypertension may have daily increases in dose.</p><p>Additive hypotensive effects may be expected if labetalol tablets are administered together with other antihypertensives, e.g. diuretics, methyldopa etc. When transferring patients from such agents, the previous treatment should be gradually decreased.</p><p>For prolonged blood pressure control after the use of labetalol injection, oral treatment with labetalol tablets should start at 100 mg twice daily.</p></td></tr><tr><td><strong>Hypertension in pregnancy</strong></td><td><p>An initial dose of 100 mg twice daily may be increased if necessary, at weekly intervals by 100 mg twice daily. The severity of hypertension may necessitate a further dose titration to a three times daily dosing.</p><p>The total daily dose of 2400 mg must not be exceeded.</p></td></tr><tr><td><strong>Angina pectoris with concomitant hypertension</strong></td><td>The dose of labetalol is the dose required to control hypertension.</td></tr></tbody></table><ul><li>&nbsp;Paediatric population</li></ul><p>The safety and efficacy of labetalol in children aged 0-18 years have not yet been established. No data are available.</p><ul><li>&nbsp;Elderly people:</li></ul><p>When initiating blood pressure lowering treatment the normal dose start dose is 100 mg orally twice daily.</p><p>A satisfactory blood pressure control can be obtained with lower maintenance doses than doses required for younger patients. For patients with hepatic insufficiency it may be necessary to use lower doses of the oral formulation (see section 4.4 Special warnings and precautions for use)</p><p><u><strong>Administration:&nbsp;</strong></u><br />Labetalol tablets should be taken with food.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                - Non-selective beta blockers must not be used in patients with asthma or a medical history of obstructive pulmonary disease.
- Labetalol injection and tablets are contraindicated for 2nd and 3rd degree heart failure (unless an in situ pacemaker is present), cardiogenic shock and other conditions associated with severe and prolonged hypotension and severe bradycardia
- Uncompensated heart failure
 Unstable/uncontrolled heart failure
- Sick sinus syndrome (including sino-atrial block), unless an in situ pacemaker is present
- Prinzmetal's angina
- Sinus node disorders
- Labetalol injection and tablets are contraindicated in patients with known hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Liver disease</strong></p><p>Exercise caution in case of liver disease. Very rarely cases of serious hepatocellular injury have been reported in connection with labetalol treatment. The liver injury is usually reversible and occurred both after short term and long term treatment. However liver necrosis has been reported, in certain cases with a fatal outcome. Appropriate laboratory tests should be carried out at the first signs of liver dysfunction. If there is laboratory evidence of liver injury or the patient is jaundiced the treatment with labetalol should be stopped and not restarted.</p><p>Particular care should be taken when labetalol is used in patients with hepatic impairment as these patients metabolise labetalol more slowly than patients with normal hepatic function. It may be necessary to use lower doses (see section 4.2 Posology and administration and 5.2 Pharmacokinetic properties, Special patient populations).</p><p><strong>Renal impairment</strong></p><p>Caution should be exercised when using labetalol in patients with severe hepatic insufficiency (GFR = 15-29 ml/min/1.73 m<sup>2</sup>).</p><p><strong>Peripheral vascular disease</strong></p><p>Labetalol should be used with caution in patients with peripheral vascular disease, as it may lead to aggravation of their symptoms. It is recommended to exercise caution when treating patients with arterial diseases (Raynaud&#39;s syndrome, intermittent claudication), as labetalol may aggravate their symptoms. Alpha blockers may counteract the unwanted effect of beta blockers.</p><p><strong>Symptomatic bradycardia</strong></p><p>If the patient develops symptomatic bradycardia, the dosage of labetalol should be reduced.</p><p><strong>Atrioventricular block of 1st degree</strong></p><p>Considering the negative effects of beta-adrenoreceptor blocking medicinal products on atrioventricular overconduction time, labetalol should be administered with care to patients with atrioventricular block of 1st degree.</p><p><strong>Diabetes mellitus</strong></p><p>Care should be exercised in case of uncontrolled or hard to control diabetes mellitus. As for other beta-adrenoreceptor blocking medicinal products, labetalol may mask the symptoms of hypoglycaemia (tachycardia and shaking) in patients with diabetes. The hypoglycaemic effect of insulin and oral hypoglycaemic substances may be increased by beta blockers.</p><p><strong>Thyrotoxicosis</strong></p><p>Beta blockers may mask the symptoms of thyrotoxicosis, but the thyroid function is unchanged.</p><p><strong>Hypersensitivity to beta blockers</strong></p><p>Risk of anaphylaxis: During treatment with beta blockers patients with a history of serious anaphylaxis to a range of allergens could potentially be more reactive upon rechallenge, accidental, diagnostic or therapeutic. Such patients may not respond to the normal dose of adrenaline used for allergic reactions.</p><p><strong>Adrenaline</strong></p><p>If patients in treatment with labetalol require treatment with adrenaline, a smaller dose of adrenaline should be used, as concomitant administration of labetalol and adrenaline may cause bradycardia and hypertension (see section 4.5 Interaction with other medicinal products and other forms of interaction). After a potent adrenaline exposure, such as phaeochromocytoma, labetalol may cause a paradoxical blood pressure increase.</p><p><strong>Skin rash and/or dry eyes</strong></p><p>Skin rash and/or dry eyes in connection with the use of beta-adrenoceptor blocking medicinal products, has been reported. The number of reported cases is small, and in most cases the symptoms disappeared after treatment discontinuation. It should be considered to withdraw the medicinal product gradually, if such reactions cannot be otherwise explained.</p><p><strong>Intraoperative floppy iris syndrome</strong></p><p>The incidence of intraoperative floppy iris syndrome (IFIS, a variant of small pupil syndrome) has been observed during cataract surgery in certain patients in treatment with or previously treatment with tamsulosine. Isolated reports of other alpha-1 blockers, and the potential for a medicinal group effect cannot be excluded. As IFIS may cause an increased incidence of procedural complications during the cataract surgery, the ophthalmic surgeon should be informed about present or prior treatment with alpha-1 blockers prior to surgery.</p><p><strong>Heart failure or poor function of left ventricle</strong></p><p>Be especially careful when treating patients suffering from heart failure or with poor systolic function of left ventricle. Labetalol is contraindicated in uncontrolled heart failure, but it may be used with caution in patients responding well to treatment without symptoms. Heart failure should be controlled with suitable treatment prior to the use of labetalol.</p><p>The use of beta blockers includes a risk of inducing or aggravating heart failure or obstructive pulmonary disease. In case of heart failure heart contractility should be maintained and the deficit should be compensated for. Patients with reduced contractility, especially older patients, should be periodically monitored for the development of heart failure.</p><p>It is strongly recommended not to discontinue treatment with Trandate abruptly, especially in patients with heart failure and in patients with angina pectoris (risk of aggravating angina, myocardial infarction and ventricular fibrillation).</p><p><strong>Inhalation anaesthetics</strong></p><p>Exercise caution with concomitant treatment with inhalation anaesthetics (see section 4.5 Interaction with other medicinal products and other forms of interaction). Treatment with labetalol does not need to be interrupted prior to the use of anaesthetics, but the patients should receive intravenous atropine prior to induction. Labetalol could increase the hypotensive effects of volatile anaesthetics.</p><p><strong>Metabolic acidosis and phaeochromocytoma</strong></p><p>Exercise caution in case of metabolic acidosis and phaeochromocytoma. Labetalol should only be administered to patients with phaeochromocytoma after a suitable alpha block has been obtained.</p><p><strong>Calcium antagonists</strong></p><p>Care should be taken when using labetalol concomitantly with calcium agonists, especially &quot;calcium gate blockers&quot; which negatively impact contractility and AV overconduction.</p><p>Exercise caution with concomitant administration of adrenaline, verapamil or antiarrhythmics of Class 1 (see section 4.5 Interaction with other medicinal products and other forms of interaction).</p><p>Beta blockers have a negative inotropic effect, but they do not interact with the positive inotropic effect of digitalis.</p><p>Ischaemic heart disease</p><p>Treatment of patients with labetalol, especially those with ischaemic heart disease, should not be interrupted/discontinued abruptly. Discontinuation of treatment in patients with ischaemic heart disease should be gradual and performed over a period of 7-10 days if possible.</p><p><strong>Warnings about excipients: lactose and the colourant Sunset Yellow</strong></p><p>Patients with rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p><p>The medicinal product contains the colourant Sunset Yellow which may cause allergic reactions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The hypotensive effect of labetalol may be reduced with concomitant use of prostaglandin synthetase inhibitors (NSAIDs). It may therefore be necessary to adjust the dose. Additive synergy may occur with other agents reducing the blood pressure.</p><p>Labetalol is fluorescent in alkaline solutions at an excitation wavelength of 334 nanometer and a fluorescence wavelength of 412 nanometer, and may therefore interact with the results of analysis of certain fluorescent agents, including catecholamines.</p><p>The presence of metabolites from labetalol in urine may result is falsely elevated levels or urinary catecholamines, metanephrine, normetanephrine and vanillymandelic acid (VMA) when measuring with fluorimetric and photometric methods. When screening patients where there is a suspicion of a phaeochromocytoma, which is treated with labetalol hydrochloride, a specific method should be used, such as a highly efficient liquid chromatography analysis with extraction in solid phase, in order to determine the catecholamine levels.</p><p>Labetalol has been shown to reduce the absorption of the radio isotopes metaiodobenzyl guanidine (MIBG): There, caution should be exercised when interpreting results from MIBG scintigraphy.</p><p>Concomitant administration of labetalol and adrenaline may cause bradycardia and hypertension (see section 4.4 Special warnings and precautions for use).</p><p>Exercise caution if labetalol is used concomitantly with either antiarrhythmics of Class 1 or calcium antagonists of the type verapamil.</p><p>Increased risk of myocardial depression if combined with antiarrhythmics of Class 1 (e.g. disopyramide and quinidine) and amiodarone (antiarrhythmics of Class 2).</p><p>Risk of marked bradycardia and hypotension in combination with calcium antagonists with negative inotropic effect (e.g. verapamil, dilthiazem). Especially in patients with reduced ventricular function and/or overconduction disorder. In case of changing from a calcium antagonist to a beta blocker or vice versa the new intravenous treatment must not be started until at least 48 hours after discontinuation of the previous treatment.</p><p>Concomitant treatment with calcium antagonists that are dihydropyridine derivatives (e.g. nifedipine) may increase the risk of hypotension and cause heart failure in patients with latent heart failure. Digitalis glycosides in combination with beta blockers may increase the atrioventricular overconduction time. Labetalol may increase the effect of digoxin by reducing the ventricular frequency.</p><p>Beta blockers, especially non-selective beta blockers, may increase the risk of hypoglycaemia in patients with diabetes, and mask the symptoms of hypoglycaemia, i.e. tachycardia and shaking, and delay the normalisation of the blood sugar levels after insulin induced hypoglycaemia. It may be necessary to adjust the dose of the antidiabetic medicine and insulin.</p><p>Caution should be exercised when using general anaesthetics in patients treated with beta blockers. Beta blockers reduce the risk of arrhythmia during anaesthesia, but may cause a reduction of the reflex tachycardia and increase the risk of hypotension during anaesthesia. The negative inotropic effect of the used anaesthetic should be as low as possible. Cardiac function should be monitored carefully, and bradycardia caused by vagal dominance should be corrected with intravenous administration of atropine, 1-2 mg intravenously (discontinuation prior to surgery, see section 4.2 Posology and administration).</p><p>When treatment is discontinued in patients treated with both beta blockers and clonidine, the beta blockers should be discontinued gradually several days prior to discontinuing clonidine. This is to reduce the potential recurrent hypertensive crisis caused by the discontinuation of clonidine. It is therefore important to discontinue clonidine gradually when changing from clonidine to a beta blocker, and start treatment with the beta blocker several days after the discontinuation of clonidine.</p><p>Concomitant treatment with cholinesterase inhibitors may increase the risk of bradycardia.</p><p>Concomitant treatment with alpha stimulating adrenergic substances may increase the risk of elevated blood pressure (e.g. phenylpropanolamine and adrenaline) while concomitant treatment with beta-stimulating adrenergic substances cause a mutually reduced effect (antagonistic effect).</p><p>Concomitant use of ergotamine derivatives may increase the risk of vasospastic reactions in certain patients.</p><p>Labetalol has proven to increase the bioavailability of imipramine with more than 50% through inhibition of its 2-hydroxylation. Labetalol in combination with imipramine may increase the effect of imipramine. Concomitant use of tricyclic antidepressants may increase the incidence of shaking.</p><p>Cimetidine may increase the bioavailability of labetalol and caution is required with oral dosages of labetalol. An increased blood pressure reduction may occur with concomitant use of e.g. nitrates, antipsychotics (phenothiazine derivatives, e.g. chlorpromazine) and other antipsychotics as well as antidepressants.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Fertility</strong></u></p><p>No data is available for the effect of labetalol on fertility.</p><p><u><strong>Pregnancy</strong></u></p><p>Based on human data it is not expected that labetalol increases the risk of causing congenital malformations when used during pregnancy. Animal studies do not indicate teratogenicity. Toxicity associated with embryo-foetal development has been noticed (see section 5.3). Due to the pharmacological mechanism of action for alpha- and beta-adrenoceptor block one should be vigilant of the detrimental effects on the foetus and newborn when used during the later phases in pregnancy (bradycardia, hypertension, respiratory depression, hypoglycaemia), as labetalol crosses the placental barrier. Beta blockers may reduce the blood supply to the uterus. Labetalol should only be used during pregnancy if the benefits for the mother outweigh the risk to the foetus.</p><p><strong>Breast-feeding:</strong></p><p>Labetalol is excreted in human milk in small amounts (approximately 0.004-0.07% of the maternal dose). No adverse reactions have been reported until now. Caution should be exercised when labetalol is administered to breast-feeding women.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No labelling.</p><p>The use of labetalol is unlikely to affect the patients&#39; ability to drive and use machines. However, when driving and using machines, it should be taken into account that occasionally dizziness or fatigue may occur.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Summary of the safety profile</strong></p><p>The most common side effects observed when using labetalol tablets and reported after marketing include: heart failure, orthostatic hypotension, hypersensitivity, scaly rash, drug fever, elevated liver function tests, difficulty in micturition, dizziness, headache, tingling sensation in scalp, blurred vision, nasal congestion, nausea, erectile dysfunction and ejaculatory failure</p><p><strong>Table of side effects</strong></p><p>The following convention has been utilised for the classification of frequency:<br />Very common &ge;1/10<br />Common &ge;1/100 to &lt;1/10&nbsp;<br />Uncommon &ge;1/1.000 to &lt;1/100&nbsp;<br />Rare &ge;1/10.000 to &lt;1/1,000&nbsp;<br />Very rare &lt;1/10,000&nbsp;</p><p>Side effects marked with a hash tag (#) are usually transient and occur during the first weeks of treatment.</p><p><img alt="" width="500" height="473" src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAkACQAAD/4RD6RXhpZgAATU0AKgAAAAgABAE7AAIAAAAQAAAISodpAAQAAAABAAAIWpydAAEAAAAgAAAQ0uocAAcAAAgMAAAAPgAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEFobWFkIEFsWmFocmFuaQAABZADAAIAAAAUAAAQqJAEAAIAAAAUAAAQvJKRAAIAAAADOTcAAJKSAAIAAAADOTcAAOocAAcAAAgMAAAInAAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADIwMjA6MDU6MDQgMTU6MjY6MTEAMjAyMDowNTowNCAxNToyNjoxMQAAAEEAaABtAGEAZAAgAEEAbABaAGEAaAByAGEAbgBpAAAA/+ELImh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8APD94cGFja2V0IGJlZ2luPSfvu78nIGlkPSdXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQnPz4NCjx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iPjxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI+PHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9InV1aWQ6ZmFmNWJkZDUtYmEzZC0xMWRhLWFkMzEtZDMzZDc1MTgyZjFiIiB4bWxuczpkYz0iaHR0cDovL3B1cmwub3JnL2RjL2VsZW1lbnRzLzEuMS8iLz48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyI+PHhtcDpDcmVhdGVEYXRlPjIwMjAtMDUtMDRUMTU6MjY6MTEuOTcyPC94bXA6Q3JlYXRlRGF0ZT48L3JkZjpEZXNjcmlwdGlvbj48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOmRjPSJodHRwOi8vcHVybC5vcmcvZGMvZWxlbWVudHMvMS4xLyI+PGRjOmNyZWF0b3I+PHJkZjpTZXEgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj48cmRmOmxpPkFobWFkIEFsWmFocmFuaTwvcmRmOmxpPjwvcmRmOlNlcT4NCgkJCTwvZGM6Y3JlYXRvcj48L3JkZjpEZXNjcmlwdGlvbj48L3JkZjpSREY+PC94OnhtcG1ldGE+DQogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgIDw/eHBhY2tldCBlbmQ9J3cnPz7/2wBDAAcFBQYFBAcGBQYIBwcIChELCgkJChUPEAwRGBUaGRgVGBcbHichGx0lHRcYIi4iJSgpKywrGiAvMy8qMicqKyr/2wBDAQcICAoJChQLCxQqHBgcKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKir/wAARCALRAvoDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6RoorE1vxZYaBqtlYX0GoSy3sM00ZsrGW6wImjDbliVmH+tXBxjg5IOAQDborm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xigDpKK5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YoA6Siub/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GKAOkorm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xigDpKK5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YoA6Siub/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GKAOkorm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xigDpKK5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YoA6Siub/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GKAOkorm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xigDpKK5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YoA6Siub/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GKAOkorm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xigDpKK5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YoA6SiuWufiDpcFrLLFpniS5eNCywxeHL4PIQMhV3RBcnoMkD1IqX/hPNI/58/EH/hOah/8AGKAOkorm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABigDpKK5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYoA6Siub/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGKAOkorm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABigDpKK5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYoA6Siub/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGKAOkorm/wDhPNI/58/EH/hOah/8YqtqXxK0TTNKu7+ey8QGK1heZx/wj96mQqkn5niVR06sQB3IHNAHW0Vzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxQB0lFc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMUAdJRXN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFAHSUVzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxQB0lFc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMUAdJRXN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFAHSUVzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxQB0lFc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMUAdJRXN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFAHSUVzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxQB0lFc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMUAdJRXN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFAHSUVzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxQB0lFc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMUAdJRXN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFAHSUVzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxQB0lFc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMUAdJRXN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFAHSUVzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxQB0lFc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMUAdJRXN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFAHSUVzf/CeaR/z5+IP/Cc1D/4xUU3xC0eFrdTaa4DcXUFqhl0O7gQNLKsalnljVFGXGcn6ZOAQDqaKKKACiiigAooooAK5u+/5KnoX/YF1L/0fY10lc3ff8lT0L/sC6l/6PsaAOkooooAKKKKACiiigDlvHfixvCen2Ege3thfXi2pvrxWa3tMqx3yAEZGQBjcvJ6ioZvGbeGreW48ZyRLZDyUt9Q06znljuGfdztQPs5AAG5uo+Y7gK1fEkN7cQW8NvpsGqWUjMt/aTFB5sRQ8KGGCd23gkDrkiuP8N/D8Lp3iTTW0+40Xw7q0Ijt9HuJ1la2kO7zJF2O6oCSpCqx+7njpRsn/XyHpdf18/67HX33i/RtOu5La9muIpY7dLlgbKYjY7bUAITBctwEHzE8YrJ8Q/EbTtFi0tore/nOoXyWmBp1wWiyA7bkCbt208LjJPbg4yvD+lX+v/D15PFNi99e3ckcTi1uPKfZA21JY3yuCWVpRyPv9apvoHjG40rRZb6C5v20zxCl3DDdzwfa1tBGy/vHU+WzhmJ4J+XHU8VVlzW81911+hP2fOz++z/X9Dtp/GOhW2qxadcXrRzyuIlZoJBGJCMiNpduxXI/gJDe1U4fiV4RuEjkt9ailgkuTaC4jikaFZR/A0gXYpPbJGe2a5e38Cyf21fW+uaHqWpxTai2o213Frci2iMX8xQ8HnLhkbgFYyDgEkZOMltC8Vt4PvbIeEtQFzN4pGqon2q0/wBR9oEvXzsbsLjHqR25pR1aT/rVf5v7hy0vb+tH/kvvPU9H8Q6Zrr3cemzSNLZyCK4imgkhkjYjIyjqDgjkHGD2NVdX8Z6DoV00Gp3rRNGFMzpbySR24boZXVSsQPYuVBrH8MWerwfEjxVf32i3VpY6j9nNtcySwMr+UmwjakjMM5yMjoOcHiqV9oOtWV34ttLbSn1WDxMS8VyJokjtSYFiKyh2DbRtyCgY4PQVOtvl+PbyGrX1N+8+IHhax1eTS59YhN7EIzJBErStGHZVUttBwCXXk9MgninR+PfDD6gLNtXhhkaQwxPcK0MU7g7SkUjgJKwPBCEkGub8NeHtU0L4hxtNptw2lWnh630tdSeWHbI8RLFtofeAQccr1B7c1g+GbHUoJtCn1HTNSi0PTbuSbTWiittiecWRN8guDJJHiTjEKnkE5xVaX/rvp95Ouvy/K7/HQ9CtvHfhu71KSxh1ICVEkkDyQyRxSLH/AKwpKyhHC99pOO9N0z4geGNZnsotM1MXH29pEtZFgk8uV0zuUSFdu4bSduckcjI5ri9H0PxRa+IfD+rah4fui9gL2O6ht7m2WFfMGUMEQdVCEjGWw+T83rVPSNA8U2uieDbSfwrfLJpeuT3l3/pVqQkTmXBGJuf9cOB/db2yRV7J/wBajlon/XT/ADPU9X1zT9Ct45dSmdPNfZFHFC80srYzhI0BZjgE8A8AmuWvPF0974u8HN4f1O3n0PWHuUmVYMu5jiZh8xOVwwwV2ggjk9RVzxVpuqp4p0LxFpFi2prpyzwXFlHKiSMkoX50LlULAoOCwyCeay9X07VZPGXhC80zwrNDY2NxcT3Xky2yiHzkZfmXzBltzFm27h6FjxRHdXB7adjo7bxt4fvNcGkwX5N0zSIhaCRYpWj/ANYqSldjsvOQrEjBz0NLD4z0Kezku0upVt40LiWS1lRZFBUboyyjzAS6gFM7s8ZrhbTw74lPiPQ9QvtCmH2DUrxp44bmCO2EUqSBXjjVhkEsNxYeZkt1Bq1ZeFNUje80kaZqR8LSWyIdNvL+Jmil8xCDayK5dUQbjh2XlV2gUdAdrnoOm6ra6tC0tn5wCEK6T28kLqSoYAo6hhwwPI71crl/Atrr9pY3sevyXjQfaP8AiXpqMkUl0kO0cSvESrfNnByTjGTmuoodugteoUUUUhhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc38R/+SWeK/wDsC3n/AKIeukrm/iP/AMks8V/9gW8/9EPQB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV59onjfWfES391pTaVIbO8a2l0ZkkF3bqsuwyO27k7QWCbAO26vQa8s8ReEtU1+SzuP+Edax8Uwupi8R2lzEkcSh/8Alphlkf5OCmxlycBsc0L4kD+E7W38T6JJqmtKmupJ/ZUafboWKiKy+8cl9o5ODkFjjaOBnnndN8dNffE6+tDqKpoVvo323y7iye1aFvMClmMgDEYBIIAXB79ayNb8L+JNa1/xkINJltYtQismsrq4nh8q4e2fcUYK7Oqv0GV6ZzjoW694a8V+L/EF5ejQ/wCyIbzQfsLG6vk3pKJTIAPJLZU4AzuGA2eo20LdP1/J/r03BrRr0/Nfpc9D0fxPpOu3Nzb6bcO1xa7TNBPbyQSKG+622RVJU4OGAwccGmav4u0TQrpYNUvDC3yl2EMjpCGOFMjqpWME9C5ANY3g/wAPQ2mqS6vLoOp6ZqDW/wBmll1PV3vnkUEMAhM0nyZyedp9uTWRrfgl7zxfrDappGp6zpWtCM/6HrMltHCVQIyTRCZAyHaDuAY8kY4GX1QLZ3H634uvL/xxe+H9L1HVNJ/s+zjuRPb6HLdLM5Z8q4MRzHtTgoVLEkKxIxTfCPjC51q2k8SajrV5bWMc00MumzaQ6Rt+9ZIvJcoHeTCjcoL8nG1TxVuwg1nTfiRqV8PDF++nNpUFnBNFcWxDtCZG4DTBsNvCqWA5+9gc1hWfhbxDd/D6xs7rRb6zvNK1eS+NoNRSBryN5JTtjmglyjBZc8lRuXGcHNGiWn9a/wCQPV/12/zO8TxtoEmk/wBox3zND55t/KFvL5/nAZMXk7fM34527c47Vj3vxP0ePUvD8Gmi6vodYnkjM0NlM/lBEbcpCrkOGABUjKjJIAFY48H3Ol6jpfiPw54evI5oLySe90++1Pz7q4DxeWX8x5XTeAFwDJgjPIrS1fSNTudf8K6xpnh4QR2d3cS3Np50KOnmwld77SVJ3n5tpc9+elGgtbff+p1Gm+JNM1e4MOnzSyH5irtbSIkgUgMUdlCuMsOVJFalcH4V0TWtH8UhLK2v9P8ADxtmaeyvrqKeJJ2IIFsVZnVR84IbavTaK7yjoh9WFFFFIAooooAKKKKACiiigAooooAKKKKACiiigArm/Hn/ACLtr/2GtK/9OFvXSVzfjz/kXbX/ALDWlf8Apwt6AOkooooAKKKKACiiigArjfEek22s/EnQLe8kvI0XSdRcGzvZrV8+dZDl4mViOehOOhxwK7Kubvv+Sp6F/wBgXUv/AEfY0AUdV8O+E9CtVudb17VNNgZ9iy3niu9iUtjOAWuAM8Hj2qTTvC3hnV7FL3SdZ1i+tZM7J7bxTfSI2Dg4ZZyDyMUfFcZ+EnifPP8AxLpf/QawW1HxFJ4tvNDs9bXT7CDw7Fe2wtrKMyRPkryz7gw+Q/wjg44IzReyd/60b/Qdtv66pfqdR/wgekf8/niD/wAKPUP/AI/R/wAIHpH/AD+eIP8Awo9Q/wDj9cfpPivxLev4OuTqqE+JdKnlkgktUMNvKkSurqBhzyeQXwe22q+heJ/FN7pPga/u9d3P4illtrqJLOIInySOsicZDjZjklefu+tOLTt/XVfoSndXO4/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+uKi8U+JFhsFbWZpGtvF7aNO5t4c3dvngyYTCsOmU2/Sotd8VeK9LsfGP2HXFd9K1m0gt3urONykMwjyg2BBwZOCwY4GOpzUx95XX9fD/8AJIb0dv66r/21ndf8IHpH/P54g/8ACj1D/wCP0h8BaOQQbvxAQeoPiPUP/j9cjqvjHX9A8Ra1ov2mfVX86wFpJ5UCSRfaGcOig7EOPL+XeepGS1dR4HufFEn9p2/iq1uo4oplNhPetbfaJoivPmLbsUBDAjIxkY4zmmldf15f5g9HYkh+Huh28CQ28+uxRRqFSNPEV+qqB0AAm4FP/wCED0j/AJ/PEH/hR6h/8frFXWtUXxhcaTrmpano8l5cSRaayWkL2s0exivlybGIl6MRIcErgKRVTw7qfiC9VfD+oeIbptdsdYlS9nW3t1L2yLvUhfKwFZWiGQMhmPzcYpLXX+v6XUHp/Xr+dtDpf+ED0j/n88Qf+FHqH/x+mR+B9FmiWSG/16SNxlWXxLfkMPUHz65X+3tWn03WdK13VdW0rXPsF1Otu9rCsbBQMPbSqhDKPRiX+fJxgVn6Nq3iC18LeF9A0afWLuafQUvjcWiWJmj4RUQCcohjGTnhnOR83eha/h+v+TB6f16f5ne/8IHpH/P54g/8KPUP/j9H/CB6R/z+eIP/AAo9Q/8Aj9clpuseONR8UWOka5fx6LLNoEl1cQWlvFI8NwsqpuDkupz1xggAkcnkM8OeLvEF4PAepXup+dH4h82C7sxbxpEpSJ2EikDeGynPzFeeFFUo3/rza/QX9fgn+p1z+ANFkjZJLrXmRgQyt4j1Agj0P7+sDR/DPgC+0UN4futYudO0+5FtGtjrOovHDKCBhFSXoNw+ZRgcnIwa3PE2rXo8TaJ4d068bTn1QTyyXiRo7okSg7UDgruJYckEAA8V57pup654e8MatcafqUYm/wCE2NtdSPbKzTpJNGhxzhDzycH2x1CjrK3f/NL9Ry0jf+tm/wBD0f8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrFXxNqGm+MLi18R3GoWQluJPsEP2WNrO7iVGZVSVV3rKRyQ7DlSFGKy7bxP4m/sLwt4nXU/tEXiC5hgm0x7aPyrYTA7WjKgSEocE7mYHn7vZLW1vL8dl/XzB6X+f4HXf8IHpH/P54g/8KPUP/j9ZttofhO81670W11nW5tRskWS5t08SagTEG+7uPnYBPp1rmNO8WeLIPBsmvajrkFzI2py6SkP2FUiRzdiFJyQd3yjd8uSDxzkEmHUtR1LwZ498SXj3s+s3aaNYxwyzxQo+ZLl0GQvlocFif4RjGT1NNLb+ul/8vvDo/wCutjv/APhA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH64LXvEPxF0PQdTuC09lbxTWv2W61eCzkuH8yURyR7beTYACykMRnGR15rd1/UfEPha6STWtZ1KTRljlkbVLLToXEDljtW4TaW8tVK4ZAM4O40AdB/wAIHpH/AD+eIP8Awo9Q/wDj9H/CB6R/z+eIP/Cj1D/4/XQwyLLCkkbiRHUMrjowI60+kC1Rzf8Awgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9dJRQBzf8Awgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9dJRQB5/418J2WkeAfEGpafqHiCG7s9MuZ4JP+Eiv22OkTMpwZiDggcEYrXtvh9pcFpFFLqfiS5eNArTy+I74NIQMFm2yhcnqcAD0AqX4j/wDJLPFf/YFvP/RD10lAHC6ZpngjWryS00bxTe6hcxqWeG08X3kroAcElVuCQMkCpdO0PwfrFxcW+keItRv5rU4njtfFt7K0RyRhgtwSvII59Kp61qFp4B+IZ1e8KW+k+ILcx3Mp4CXUKlkJ93j3D6oKZqOo6l4d0LR4rOyuBqviS/d7k2Yg86NmjeUhPOYRllCqo3ZGB0J4ItVf+r/1+ncHo/62/rQ6D/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH64k638Qor7w/p2qXP9lfbtWmsi89tbyXM8HktIkreW7Row2kEAYJAPT5TcN/4l8L69f6Vr3im71RrzSfM0qY2ltDm5DBHACx43bnjKgkjDHIOM07f18rh1/rvY6r/hA9I/5/PEH/AIUeof8Ax+j/AIQPSP8An88Qf+FHqH/x+ovFGr3/AIQ+H5ujdfbr+LyYDd3CKAXkkWPzWVAowN2cDHTHvWTrd94n8JWuyfWU1OHUb+zs7K6nt0E1u0r7ZSwRVQqBgrxnJwc9y13Zd7fP+mHS5t/8IHpH/P54g/8ACj1D/wCP0f8ACB6R/wA/niD/AMKPUP8A4/XGeJvEvirwxB4s0y31gXkum6QmqWeo3dpGZEBZlaN1jCIT8hKttGO4bFaBv/EbeLv7FbxHOsd5of8AaIljtIA9vKrBSI8oRtbcDhw564I7Lpf+tL/5MOtv66f5o6P/AIQPSP8An88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8fri/D3inxT4l1HwpBJrEdlb6xoEt3P8AZrNDIsyMi7wz7l/jyBtwOeDkYXRPFviKaz8G6leaqZxqmpS6Zd232aNI3CCYeaMDcHzEDw23n7tU4tO39btfmhX0v/W1/wAjs/8AhA9I/wCfzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/x+uOk8X+IW8JQ+NrfUGMDan9lbRmt4/KaE3RgGG2+YJehzuK9ttVpfFXiu107WdSudbSU6V4mi09beGyjjjmgZ4lKtncw4kJBDA56kjgKKbdv63S/VDen9ev8Akd1/wgekf8/niD/wo9Q/+P1z/j7wVpdr8NvEtxFda4zw6TdOol1++kQkQsRuRpirD1BBB6EV6JXN/Ef/AJJZ4r/7At5/6IekAjeBdHVSzXuvgAZJPiTUOP8AyPWFZp8PNRvI7TT/ABpNdXMpxHDB40u3dz6BRc5NehV4td6fq3iTRPGvhrS/Dsly15rs3lalLNCkFq2EO8gv5m5cZG1DzjnrQtZW8v1S/UHtfz/Rv9D0X/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH65K81/xE2g+KNV07WGtj4Vle3jtGt42jvBDCjuZSwL5YlsFGXHHWr9x4q1O28QWtxrU2oaRpV6lr9jlitY5rUtJtLRzttMiOWyoOVXBHena+3l+O33i2Wv8AVt/uNZPCGgt55a98RxLbv5btNr+pRrnAOQWmAYcjkZGcjOQacvgzRWvHthdeJfMRBISde1IJgkgYfztpPB4ByOMjkV594i1PX9X8J6rFqOuSpLY+L7exSSygjiVovMhwCrBuhYtyTk9cjiuna58U3fizxN4btvETxva6VbT6fcraQiRJGMgJfKlXLFBnCqMHgL1pfZ5v62T/AFK62/rex0H/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9cgfGOq/8IRa+ILXVLuabTtLL6hbSRW4WW6LeWFk+Rdu11kJCsg+UZ61v+ELvxc3iG9g160vxpLwLLbXGpGzEyy5w8YW2cgpgggkZHIJPFVbWxN9Lmh/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP1yvjvxRrmk6pfT6Rqr+Xp0lops7a2SSMCRwH+0u65BIYbVjcNjkjBFQeIvEXiq11Dx75GupBFoFjDe2UcFlH3SRyjl924HaASMHpjbzmVqrlWd7f1qdcfBGiiTyzfa9v27tn/CSahux648+m2vgvRbu1juIrrxIqSKGUS69qUbAe6tMGU+xANclaNrF38SvEF/Z67cwSL4ftbmKCWKOWBGcSnaV2htoIyMMpJPJI4pNG8TeKdan8CQvraW8OvaRNcXbxWcZl81EU7lZsqOXGBswMc5zw+Vr+vX/Im6e39bf5nZ/8IHpH/P54g/8ACj1D/wCP0f8ACB6R/wA/niD/AMKPUP8A4/XGeGvFfiLU9W8Ipd6tK0V8+pWd4oghCzNbsypL9zKscZIB28dKdoXivX76303RbnWJPtV9rWoWTaoYIRKkVuW2hVCCPecDkqRweKLf187Dem/9b/5HQX2h+E9N1aw0y+1rW4b7UWZbW3PiTUC8pUZOAJugHfpWj/wgekf8/niD/wAKPUP/AI/XM63b6vaa34Cg8QXkN9dx65OBcxR7DJH9nm2FgAAHxjOABnpUGkeKPGesanYatZWF4dImvJYbtLhrJLSKAMyiRGEnn+YCFyGGD82FHFGlge/9ef8Akdb/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XE6X4q8T3GswQR619pTUdHurtLiWwT7KksTIAbcARyPHh+r5zwQSK6r4a3Wu6t4S07XNe1gXx1KxhlEAtUiEL4JYgr1yCvB6EHHBwDldr/11X6MHo7f10/zLn/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wAKPUP/AI/XKDxVrq+ONMSLVmu7G91e40+SKK1T7HGixuyBZCqyNKCnzEMyZDDgiqFr4r8Vx6Wmq3+tpO1v4q/siS2hs444poTMIuc7nBGdwIb2O6iKcml3/wA0v1QS929/63/yZ2c3g/QoIJ5WvfEUgtwTIsPiDUZHHGcbFmLE4xwBk5GKpafo/hHVdXvdL0/WdcnvdPVGuoV8RajmHfnaG/fYB4PHUdwK5CG617QvCfxK1nTPEFw93Y6nOY/tkEUqjZHGcgBVO7bhRklQAPlPOdKKLU734g+Kp9O1iTTLpNF0+bzkhjkDMBMcMHUjb1zjB9CKWnLzPsn96uO2tl3t9zS/U7H/AIQPSP8An88Qf+FHqH/x+myeB9FhiaSW+15EQFmZvEmoAKB1J/f1zWheKdc8dTW9pa6hJoEi6Ha6lJJbwRyGSWbd8v71WHljZnAAJz94U3w74x1vxidE0x7r+xbq40+e7u7m1iRmkaKbyQIxIrKFYgscgnBAB705Raduv+V/8ibq1/T8bf5mnpWk+Etc062v9H1XxFe2l1M8MU8Gu6myFlLAkkS/KuVI3HCnjB5Gdb/hA9I/5/PEH/hR6h/8frzrwRq2taTpPg61gvoRa6hruo217GLcbpiHnfIYn5RlegGffsdjSPE3jXWtU0/VNN0+8k0ye8lhuY5zZLaxwhmVXQiTz/MBC5DDB5wo4ptK+g3o2v66/wCR1v8Awgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9ZfgnX7+61NtL8S3moQ62sDTT6fe2sSRn5lG+3kjUB41PHJZvmG45qlrmq+JX8fa3pFprosbK30MahbfZ7OMyRyb2XlpNwYZQ5+UcNgYI3VMtPx/C/+Q0r3+X4tL9Tof8AhA9I/wCfzxB/4Ueof/H6a3gfRVkVGv8AXg752qfEt/lsdcfv65nQPE+u+OHtLO21N9ElXQbTUpJraCKQyzTbuCJFYbBt5AAJz94YrI8ParrHivx74P1K+1K6spJdKvGmtrYR+S7RTxoxAdCQr4yecgYwRzm+RqXK/P8AC/8AkTfS/p+Nv8zv/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+ofGmoX8E+mWWmapJYvdPJuWzgWa7lCrkCNXRkAzjcz4AGOQSK5O18ZeIZfCHh3XdVk1CHT5bOSTULzS7OKZo5VbaDLGQzCPAJPljII6gVncep2X/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P1hHxNfWniuIavqV7b6Xevbppd1DaRSWN0rBDh3Cl0kZtyjLKuCuATWXJ4v8Qt4Sh8bW9+zQNqn2VtGNvH5bQm6MAw23zBL0OdxXttqrMV9LnY/8IHpH/P54g/8ACj1D/wCP1FB4L0W48zy7rxIPLkMbeZr2pJkj03TDI9xkHsazPD9/4l8UMuuWGrxW9vHqc9rNpUsCGIQRSNGTuC+Z5vyhvvBecY71mad4o1+68IXhv9ahiv18Qy6aLmC0+do0fbtgi2uDIQCRu3AcknApdbf10/zG9P69f8jqJPA+ixKDLf68gLBQW8S34yScAf6/qScU/wD4QPSP+fzxB/4Ueof/AB+vNrzUte1/T/DqX2t6jazw+Ln05pEit0kdEDlHkUIyFxtHQbf9nOMbZ8UeMtQ1Sa80Gw1C4tLHVHs5onNktq8Eb7JHZjIJhJgFhgBeg2nrQtVf+rWT/UHdf11u1+jNzVNE8J6LdWNtqms63bz6hMILSJvEmolpnJAwAJs9xk9B3rS/4QPSP+fzxB/4Ueof/H68+1HUNT8R6V4J8SXWps1vqHiK3ZdOWFBHbrukCgNjeXAGGJYgnOAK9lp20172/Bf5g9JW8r/i1+hzf/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wAKPUP/AI/XSUUgOb/4QPSP+fzxB/4Ueof/AB+sPxZ4S07TNLsbu2udYeWPWtL2rc63eXEZzfwDmOSVlPXuDg89RXoFc348/wCRdtf+w1pX/pwt6AOkooooAKKKKACiiigArm77/kqehf8AYF1L/wBH2NdJXN33/JU9C/7Aupf+j7GgDQ8QeHdN8UaS+ma1HPLZyH95FFdSweYMYwxjZSy8/dPHtWPb/DPwza3MlxDFqYmktfsbSNrN4zeT/wA88mXgDPA7dq6yigDkv+FYeFvI06JLfUI00uNorLy9Yu0MCt94KRKDyOPpgdABTrb4Z+F7OLTIra1vY49JlM1ig1W62wMepA8z6jB4wSO5rq6Kd3uBy8fw58MxWN5ZraXTQ3tyt5Nv1G5ZvPU5EqsZCyPn+JSCcDPSo7v4YeEL1LoT6Swa8lSa5kiu5o5J2T7pd1cM2CAcE43fN15rrKKQbnMt8PfDUl9fXk9ncXE+oRLDctcX9xKJFUgpwzkAqRkEAEHOCMmtjStItNGtfIsvPZe73NzJcSH0BeRmYgZ4BPHar1FAGM3hfSU1OPVPss01zbs8sMbXUjRpIxYsyxs/lq53MN2AecZAqpomj+d4nv8AxPeaW+nXd5bRWghmaNpQiFiS5jZlyS2OGPCj6V0lFAPUxLfwfoltdPcLaSSu1ubUfaLmWZY4iACiK7EICAM7QM4Gc1X/AOEC8OjTbKxjs5oY7AYtZIL2eOaIYAwJlcSYwAMbsYAHYV0dFAHOTeAtAn1j+1WhvUvfs7Wvmxancx4iYcqAsgAyec4zu+brzUFt8NfDFpHpUdta3kaaPIZLFRql1iBj1wPM5HUYORgkdCa6qijbYNzM1vw5pfiKGCPVrdpDbyCWCWKZ4ZYX/vJIhDKcccEZFYs3wv8ACE1rLbnSmiSe6F5MYLyeJ5Zgch3dHDMQTkZJweRiutoo2AxovCWjxalb33kTSTWzM8Imu5pI43Yks4jZioc7m+bG7kjNR23gzQrO9N1bWkiPlmjT7VKYoGYEM0UZbZExBPKBTyfWt2igDn7HwL4e0/w9d6FDYvLpt47ST291cy3AZmOWOZGYgk88Ec89eahg+HXhWC4lnbSVup5rX7HJNezSXMjQ8/JukZjjkjr0wOgFdNRQBzF18O/Dl7ow0q8gvp7MSLIFk1W6ZgV5UbzJu2g8hc7QQDjIq9qXhTSdXjEeoRXEqeWkTqL2ZRMi5wsgVx5g+Zshsg55zWzRQAiIscapGoVFGFVRgAelLRRQAUUUUAFFFFAHN/Ef/klniv8A7At5/wCiHrpK5v4j/wDJLPFf/YFvP/RD10lAGfrWg6X4iso7TW7OO8gjmSdEfOA6HKnj37dD0PBpdY0XT9e082Wq2/nQ7g64dkZGHRlZSGVh2IIIq/RQBzs/gXQbm4064uIr2SbTZPNtpW1K53K+MbmPmZc44y2eOOnFR6npJ8ReJ9MkvdJkhg0S6N1FdTtGRO/llV8sKxYAFsncF5UYBrpqKdwK9/YWmqafNY6jbx3NrcIUlhlXcrqeoIrMg8H6JBpMmmG2muLWQAFbu7luGUAggK8jMygEAgAjBGRW3RSA52fwH4futDu9Juba6mtb3AuWk1C4aacDorzF/MZRk/KWxjjFRr8PvD66gt8I9Q+1JaGyWX+1rvcISMbP9b+OeucHOea6aigDkLD4XeFdLuLaewttQhktIXgtyNYvD5MbfeRQZcKD1wO4B6gU+H4Y+Fre1sLaG1vkh064a6tEGq3f7qVurD979ev95v7xz1lFO7DyMRPB+hpqp1BLRxKZfO8oXEnkebnPmeTu8vfnnft3Z71mSfC7wrLZ3NrJa37QXV0LydDq93+8mHRz+969D9Qp7DHXUUttg3GxoI41RdxCgAbmLH8SeT9TXO/Ef/klniv/ALAt5/6Ieukrm/iP/wAks8V/9gW8/wDRD0AdGw3KQc4IxwcVjaB4S0nwxJdvo6XaG8k82fz7+e43v3bEjthj3I5OBnpWvK7Rwu6RtKyqSI0I3MfQZIGT7kCuNi+J1lJY6Zdvoerww6hqTaYDJ9nBt5w5TEg87gEhumenuMi3sge2pt3vhDRNQ1J766tHMshBmRLiRIrjAwPNiVgkmABjeDjFOvfCukajfLdXtvLKyzCcxm5lELyKFCs0QbYxGxcZU4IyOayLzxvpw1Oxsr/TtXt2uNVNlaSpgRTSpnJLxyEbOvyvgnB+U4OOJ8TeONd1Lwv4muI4tT0QaPrcNtHLA8J8xN8SNE2xmck72b5QOqgMeRRHW1v62/zQ3dPX+t/8md7F8OfDEVlf2gs7l4dRuFubkS6hcSFplIYSAtISr5A+ZSDwPQVcsPB2i6Z4hm1yyguI7+eJYZHN7MyMi/dXyy5TA5xxxk+pp2i+JrfWdW1LTPsd3ZXmnFPNiulQF0cEpIpVmBU4PXBGOQK5TxB4t1e58SeJfDtrZ6hYRWGkC5j1G3eDKMRIQ/zMSAdm0AKTnJIXg0m3FX8v0/yBLmf9dzsLPwvothbalb2unQpDqszz3sZBZZ3cYYkH1A6dKdo3h3TtBjMempcBTwv2i7ln2D+6vmM2xeB8q4HtXK+C/HNu+g6FY6yl9Fcy6Gl99uvAClyqInmtu3FsgsCdwGc5Ga3NK8Z2ep64ulSWV9YXM1ubq1F4iKLqEEAum1iRjIyrbWGelXKLjLl/rS/+T+4lSurv+r/8OhNU8B+HNYur241CxkeS/VFugl1NGspTG1iquBvGBh8bgOM1Xufht4Zu5NTe5t76RtWjWO+zqt1+/QdFI83oOmB2JHQkVL4o8Rx2YuNJsotRuNQa0aZzpqxmS0jOQJT5hC9QcDDMcHCnBrmvBXjC2fw14Gttdm1S51TU7Rp47nMnluyxuXMrZCtwD8p3EHBwOCJWq/rz/wAinf8Ar5f5o6j/AIQLw9u3C0uBJ9jFiZVvpw5hGcAsHySMkBidwBIB5qrZ/DPwxYTWEtnb38T6bE0NnjV7siBG+8qgy4AP9B6CrVj40s7zRn1eWxvrPTRA1zHdzohSWIYwyhGYjdu4VgG4PAqo/wARtMtm1CHU7HUNPvLFIpDZ3EaGSZJH2Rsmx2Uhm+Xkgg/eApu99f6/rX8Rf1/X4fgSWvw48MWVhbWdtZ3UcVrdNdwH+0bkvFKwIYq5k3ANk5XODk5ByakX4eeFI9OksoNGht4pLo3haBmikWbn94sikOrckAgjA4HFQQ/EGyltJy2l6lFfwXw09tNkWITGdk3qobzPLOU+bO/Hvnir974pSzhhVdJ1G4vp/MaPTokjExWNgHf5nCbRkc7ucjGc0f1+T/yD+vz/AOD+JHdeBdBvZ9Omuobx5tMfzLaT+0rkMr4xvYiTLtjjLZOOOlTw+ENFt9TnvoLWRJLli8sQuZfIdzyXMO7y9xPO7bn3q1oOuWPiTRLfVdKkaS2uASpZdrKQSCpHYgggj1FaFDvswOUX4aeFo44Eis7qIW0UkMJi1K5Ro43xujUiQEJwMKOB2Arb0PQ7Dw5o0GlaRHJFZW67Yo5J3lKL6BnJOB2GcDtWhRRdgc0Ph94aFyk6WM0ckd4b6Py72dRFMc7mQB8LnccgAA55Bqqfhb4UNgbI2t+bc3f24p/a93zPnPmZ83O7POfXnrXX0UlpsH9f197ObvPh/wCG7+31OC5sZTFqz771Y7yaPzjgA/dcYyFXcBjdgZzTpfAXh2cwmWzmZooFty322fM8S9EmO/8AfKMniTcOTXRUUAZGp+FtI1aSCS6t5I5LdPLjktLmW2YJ/cLRMpKf7JyPao7/AMH6FqMdgs1j5X9mjbZvayvbvAuMFVaNlIUgDK5wccituigDk4vhh4Rt5LSS00t7VrO4a6h+zXk8IEzdXIRxubHGWzxx04rSg8I6LbanPfW9tLHJcMXliW6lELOeS/k7vL3553bc+9bVFAGTp/hnStL1Jr+1glN0YhCsk9zJMY4+PkTex2LwMhcAkAmql74F0HUNYvNVuYr03l7b/ZZ5I9SuYw0X9wKsgCjvwBySepNdDRQ9dwWmxzcXw/8ADsGn2Vlb2t1DFYx+VbtFqFwkix5z5ZkEm9k/2GJX2q7J4V0SS8026+wIkulxmK08pmRYkOPk2qQGX5VOCCMgHqK16Kd3e4GXq3hvS9bu7O61G3d7iyZjBLFPJEy7uGUlGG5TgZU5BxyKoReAfD0GlLpsFrcxWagr5Md/cKCpYsUOH5TLH5T8vOMYro6KQGK/hDRJLq3na0bFtIJYoBcSCBXUAK3k7vLJXaMErxjjFIng/RI9VOoJaOJTL5/lfaJPI83OfM8nd5e/PO/buz3rboouKyMWLwjosGrz6lb20kM9y3mTpFcypDK/99og3ll+B8xXPA5rPg+Gvhe2sJLOKzuxFJdi9y2pXLOs/P7xXMm5GOTkqRnPOa6qijYZzn/CAeG/s7wf2e4ja+GoYF1MNtwP41O7Kk9wMA5OQc1ZXwjosesvqkNrJDcS7TKsVzKkUpAwC8SsI3IAAyyk8D0raooDc5ab4a+EbiZnuNHWWNrn7X9neeRoFm5y6wlvLUnJzhRnqc11PTpRRR0sHW4UUUUAFc348/5F21/7DWlf+nC3rpK5vx5/yLtr/wBhrSv/AE4W9AHSUUUUAFFFFABRRRQAVzd9/wAlT0L/ALAupf8Ao+xrpK5u+/5KnoX/AGBdS/8AR9jQB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/5JZ4r/AOwLef8Aoh66Sub+I/8AySzxX/2Bbz/0Q9H/AAgekf8AP54g/wDCj1D/AOP0AdJRXA6lYeENK1D7Bcan4mmvAoZ7ey1jVbqSNTnDOsUjFAcHlsCr2meGfDOs2rXGl6trl1CsjRM8fiTUCA6/eX/XdQeD78UAdhRXN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P0AdJRXN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P0AdJRXN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P0AdJRXN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P0AdJRXN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P0AdJXN/Ef/AJJZ4r/7At5/6Iej/hA9I/5/PEH/AIUeof8Ax+uf8feCtLtfht4luIrrXGeHSbp1Euv30iEiFiNyNMVYeoIIPQigD0SvOta+Gd1qtx4iVL2GO1vWF7piYbda3uF3SntjdGpGOfnf1rffwLo6IzG78QkKMnHiLUCfyE3NYGlx+DdZt7+bTr3xhKunEi5DX2tIyMOqBWYFnH91QW5HFIZY1zwn4huLLwnFp39nXMuk36X99LdXLw+dIFbdsCxt95pGOTjGBwc8ZeueAfFFxpPiLTtMOkSQ6trKalG9xcyxsigxMVIEbc5ix3yGzxjB1/DmleFPFmmf2joWo+Jp7QsVWWXWdVgDkddvmSLuGeMjIyCO1a3/AAgekf8AP54g/wDCj1D/AOP1Wqd/66f5InovL/g/5sp6HoevW3xH1nXdSg02Oy1C0t4EW3u5JJEaLd1BiUYO89+MDrnirrvhTXpfE2vanox06WPVtISx2Xc0kZjdTJz8qNxiTOf9nGOcjW/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+k9VZlJtO/9aW/yOOHw88R3q+HrLVI9KjsbDQp9Iu3t76RpG81FQugMIHAQHBI+8R2yeh8F+Df7AkjkuvDvhmwurePyvt+k24WW6GMZYeWvl5wCQGfnvWh/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9U5Ntv+t2/1ZNtEu39foipqfh3W4PGlzrmgPYzR6lZJZ3kF7I8fl7CxSRCqtu++2UOM/3hXN6T4E8X6TD4JgL6Jdr4dWUTP580RcOhjwq+W27aDnJK7jxhetdf/wAIHpH/AD+eIP8Awo9Q/wDj9IfAekAH/S/EB9v+Ek1D/wCP1N7L+vP/ADHv/XyOYf4Y3V22sW6/YtF03ULIxNZWUzzwTXBZXExidVWPBBBVc7gxyan/AOEG1SHw/cpomjeGfDeqPsRpdI3Rfaow6s6tKsSvEGAI+UMRnIPFasfhTRNtmt3ceI7O4vMiO2m8SXxcEKWIOy4ZeADyCR71PB4J0ubzPMfxJBskKr5niS+O8D+Ibbg8H3wfUCnt/X9f8MBg2XgC9gh8QW15o2g3lhqt4l4tm9xKFUiEKRu8slW8xQfMAJOScA1Wb4ZagbPR7jUYdJ8Q3eni4iNhrTtPAsMrhlRZnjdy0e0AOUyRkEDt09z4J0uC3aSJ/Ely64xFF4kvgzc9t1wB78mmp4P0B76WyTUdeNzFGsskY8SahlVYsFJ/f9yrflRf+vlb8g6G3ommQ6RpMVnbWVlYRoSRbWMQjhjyScKAB69cDJ5wK0K5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH6HqB0lFc3/wgekf8/niD/wAKPUP/AI/R/wAIHpH/AD+eIP8Awo9Q/wDj9IDpKK4PxHpXhrwva2s+pXHil0urqO1j8jXdRfDu21dx8/CjJ6kj8+K2P+ED0j/n88Qf+FHqH/x+gDpKK5v/AIQPSP8An88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8foA6Siub/wCED0j/AJ/PEH/hR6h/8frG0XS/DWu6tq2n2Vx4qSbSZlhuPP13UYwWYZG3M+SMc5xg5BGRQB3tFc3/AMIHpH/P54g/8KPUP/j9VdT8J6FpOl3OoXNz4meG2jMjrBr+pSOQBk4VZiSaTaSuwWuh11FcZofhrQPEGgWOr2Vz4kS3voEuIll8RX4YKwyMgTkZ59av/wDCB6R/z+eIP/Cj1D/4/VNNOzDc6Siub/4QPSP+fzxB/wCFHqH/AMfqvf8AhHw/pem3F/fahr8NtbRNLLIfEeoYVVGSf9f6ClsNJt2R1lFcHoehaTrUlwjWnjLTjCFZWvdevgsyMMqyMlyynpyCQw7gZrY/4QPSP+fzxB/4Ueof/H6bVhXudJRXN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P0gOkorm/8AhA9I/wCfzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/x+gDpKK5v/AIQPSP8An88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8foA6Siub/wCED0j/AJ/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/H6AOkorm/8AhA9I/wCfzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/x+gDpK5vx5/wAi7a/9hrSv/Thb0f8ACB6R/wA/niD/AMKPUP8A4/WH4s8Jadpml2N3bXOsPLHrWl7VudbvLiM5v4BzHJKynr3BweeooA9AooooAKKKKACiiigArm77/kqehf8AYF1L/wBH2NdJXG+I7+5074k6BLZ6Teaq7aTqKmGzeFXUedZHcfNkRccY4OeRx1wAdlRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAB8R/wDklniv/sC3n/oh66SvO/H3iPVJ/ht4lil8F65bJJpN0rTSzWJSMGFgWbbclsDqcAn0BroP+Eo1f/oRPEH/AH/0/wD+SqAOd+FUyW+oeLbDUmCa7/bc89xHIfneJseS4HdNgAGOODVjVriC/wDHGl6HZ3E9tpGoJdz3M1lcPAbi5TywEEqEEYBYkKRkqc9CKn1WSLXmibXPhXqGpND/AKs3iaZMU+m65OKmv799V0/7Bqnwz1W9sxjFvcf2bJHx0+Vrkjijt5K34W/4IdX5u/4nEHUfEBXRLWTxDqItYvFz6XFOkihr21Ckje+CWKspTORnBzk80zVrvUNO8P8AjOe21rVd/h7WoU09n1CVvLV/JZlclsyr+8YYkLADpiuxvVtdSjtU1H4T3t2lmMWyzxaW4gHHCZufl6Dp6Cq7adpLpOj/AAcmZbhxJMpttKIlcZwzf6RyfmPJ9T6007f1/h/yf3g9X/X97/O3yOZ1671SOH4mXX/CRasZNEMNxp4W68tYG8kSY2oFDLk42tkEAZyean8R67rPhnVtbbSL69uHk8LrqPlzzNMI5/N2GVFbIQBSSVUBeOlbiaRokUUsUfwXdI5gBIi2mkgOAcjI+0c881atorOzv4r60+El5BdwxiKO4ih0tZEQLtChhcZA28Y9OKS0t/XS3+T+Qf1+Kf8AmvmZt7Hf6V4ptrHQtd1OSx1TRrq5upJLs3LW7oF2TxtLuCbixGB8vooxWb4N1HUY7z4cXFxq+oXcmuaXP9uW6unkSUrErqwQnaGBJG4DJB5Jrpofs1tZXdnb/Ci+itr0k3UEcelqk5PXeoucN+NQwWWm2txbT23wfuIZrTm2kjt9KVoeS3yEXGV5JPHcmqTt/Xr/AJ/gK2n9eX+R39Fc3/wlGr/9CJ4g/wC/+n//ACVR/wAJRq//AEIniD/v/p//AMlVIzpKK5v/AISjV/8AoRPEH/f/AE//AOSqP+Eo1f8A6ETxB/3/ANP/APkqgDpK5v4j/wDJLPFf/YFvP/RD0f8ACUav/wBCJ4g/7/6f/wDJVc/4+8R6pP8ADbxLFL4L1y2STSbpWmlmsSkYMLAs225LYHU4BPoDQB6JXm3hWDxHNf8AittE1fSbW2Gu3AMd1pklw+7amTuW4QY9tv410b+JtVkRkfwFr7KwwVM2nkEen/H1WPaWun6fb3MFh8Ibm1hu4/LuY4YNKRZk/uuBcYYexpW1fpb8v8geqXrf8H/mcfo9pdR/Avw94gs73UEfRZXubmCyvJYUurdbhjKrIjAN8uWGfTHQkHR1aee41/w/rth4j1WDTvEGufZvs8d83kSW4icKVBzt3NHuGwjIfpnBGvNPqmlaZJpvg/4VXGnW95vW5ZJdOgEeVwHEaTESH2JXp1rG8V2XiTUI/C2n6L8NbufStFuFkmgv76xQSRrE0QjCiVweGJ5x0xjnIu6vfzX/AAfyX4ie3yf/AAPz/Ibea1rGkNq2j6bfS3mlpr0FjHd3upSI0KSQ73ia62u64k2oG5Yb8ZBwRHfWni3SbvQrHVPEU1vDc+IY4EtbHUnuWW2eMt5ck8kayOQUODno3OTgjs0vmj0g6VH8MtUXTimw2a/2aIdv93Z9p249sVTe006SC1hk+EFy0VmSbaNoNKKwEkElB9o+XJAPHpSWjV/L8Lf5fj97eq07P8b/AOf4IoXxvPCOuRSandarqmixyWtnFfRasxmtHLINs8OQJNzFcvhnw+MY5qloMni/XtSs9civ7azjTUZbfUFk1iZyY97IIRaGHy45F+Uhs5OOSQa6ea7+0alFqNx8MNTlvoWLRXTjTGljJAGQxucg4AHHYU0zodUk1I/C3UTfyoY5Lorpnmuh4Kl/tOSPbNL1/r+v68xnEaPqOq22j+HtUn1/U7u6fxZNprtc3ZKSwGWVNrRrhD90EHGQemBxW5pl5qFpcXOj61dalb6peWFzc2uq2mo/aba7Qbf3iI+RCwBXChdvzHBOauDSdGESRD4MSCONzIiC00nCscZYD7RweBz7CrSi2VbpV+E96BeRiK5Ai0v9+g4Cv/pPzAehoesWv62S/PUf2r/1u3+Tt8ji9GjXWNY+F2o6vqF61xcaNcSTXB1CVCzqkZBOGA5JOf73RsgYq7BbaxrXwz8QSJresXOoaPrV0YZY794ZZ44ZBmJjEVGGQEYAABOQBXUQfZ7W3toLb4UX0MNpIZbeOOPS1WFz1ZALnCk9yKfpUyaDHKmh/CzUdNSYgyrZppkIkx03bbkZ6nrVSera8/zuJbJPy/Jo5jxbqL33g+78Z+HNd1O1gmuLKK38i+cxSx+YiP8AISQuS5BK7TmPryc2bXw5Zan8V/G1u+oanZzTW1mIpLbVbiFldkkJICuAcbcgYIAzgAE1uXZt7/TIdNvvhTfXNjbndDazR6Y8UZ55VDc4HU9B3pZNSvbEPeaN8LtQ/tGO3EEDNLp0OUX7sZkWdiqD0AIHpUu2v9f1sCv+X4MzPAU02stplhe3uoG+8MpNBqYa/mPnXG/apky53hgrSANnAZcYHFeiXhYWM5jmWBxG22V/uxnH3j7DrXDaVeaxb2+pS3vw/wBW+2atKZrpFlsJIs7AgTm5BcBVAyQM88DNW9K1C+0rRYtLh8A661vGpXy/M04JgkkqFF1gLzgL0AwKcveWv9N7grJ6bfocdd+JtV8NaNNpmpf2hp+rILVru9bUWvLd7aS4WOW5iZyTGQCflKqFzwCBmug1yy/4R6zFjD4n1WaDVL+3S1sxctJcYIbdGtw8gdVfaTvLZXB25yBWlbXf2JboWfwv1O3F4c3IiGmL55xj58XPzcetV1jtE0k6UnwlvF04v5hsxFpYhLZzu2facZ98UX/r7tP6+62grf18v6/zvqcdcX13c/DCSPUbqSdrPxfDbRGW6NwyRreR7V81vmfA7nmtrVEn8PeNNW0V9T1WRPE9qv8AZTS6jO32ebfslSPL/JgOsg24IAbnAxWpc2un3kbpefCG5uEkl851lg0pg0mMbzm45bHGeuKjGo+IL3X7S61H4c6lBa6U0n2BYLywkZiy7A5BnUR4UsNo3DnrxRF6JP8ArRL80N7tr+tW1+di/wDEdLnR/hHq7aTql9ZT2FiXiukn3THYONzvuY57nO73FYGtWklo2naamv65d3F9aT3zWx1FrflY4x5huFYNHGrc7FDZLn5cDjo9S1ObWrI2esfDXVr+1YhjBdHTZUJHQ7WuSKgeaOSGzik+FmoNHYY+yIyaYRbcY/dj7T8nHpik7u/n/X5jWlvI5SLWtZbwToPiXU5r3U9Pi0NJtQFhqRt7m3cg5uCgKrMMA8MeChIBNZ+tzyR/8LM13TtRvraaxayurVoLhoRuFuhG8LjeCDgq2R7ZrtfKs/Jgh/4VJeeVbsHhTydL2xMCSCo+0cEEk5Hqail0/SpmuWm+Ds8jXT77gvbaUTM2c5b/AEj5jk5ye9U5e82v61uJaW/r+v6+fewSebbRSHq6BuPcV534jujrPifxPpWo6ndafFpekpcWcVvdNB5m9ZN8rbSPMAIC7Wyo7jmrumST6Rqc95p/w61a0EsSQiK1GmwrsQYXdtuvmIHA9AAABzmxqF3/AGtPBNqvww1O9ltyTC9yNMkaLPXaWuTj8Kia5lZDj7u/kefeB4ZfEU/hnSYfFGqx6bN4SSRodOvREIZo3jQ7WQZDAgg5JOcjgZFPn1iXS/AttcXniG+glsPGJtPNuNVlDeQLrBSQs/zqI+z5wOa7iAW1rqcepW3wnvYb6Jdkd1HFpayouNuA4ucgY4xnpxT/ADo/t017/wAKs1D7VcMrzT7NM3yMv3SzfackjsT0rVzvNS87/wDk1/y0Jt7tv6+G3/BOZvbnxDqHiC+j0m+1sasNZSGGezDtYpYZXfyytbh1UtncDJuHAxius+KlnHc/CfxAs8k/7rT5ZA0c7RFmVDjdsIyD3U/Ke4rhl0bXLjUL3+1fhJb3clzPJKuulrAXibmyv7synDKMAMJR0Bx2ruNRv5dYsBZaz8NdX1G2BB8m8OmzKSOhIa5Iz71n9hL+tl/w/rqUnafN/W/9ei0OY1GDV31Ww8LaFLKsH9kLd2z3XiC6tpHmLEMwkCSPKE+X5CdoDDgjGFafUPCmt6LqvibVrm9/tXTnsZ1t9Rm+zNfqoKGNCQoMgVlGAPmxjBNbkkdnNplvp0vwlvHsbVt8Fq0OlmKJs5yqfacKeTyB3q/PrV5dRwpc/DrWZkgdZIlkfTmEbL91lBuuCOxHSqbV/wCvP9H+CJtp8v8AL9Vf5s4/UbHxI2sHwlpd7L5tppUVxb3N3r9zbyNOzPvl3BJDOqkL8jHaAQMcjFjw5a63qvxDvLPW/E+oSm10zT7wpYXOy384s+8KAozG2zowyQ3PQY6HUrw6z5P9sfDDU7/yH3w/ahpsvlt6ruuTg+4ptvOlpq8uq2vwt1GDUZhtkvI10xZnHHBcXO49B37ChPW7/r+v0B6q39dP8vxO1orm/wDhKNX/AOhE8Qf9/wDT/wD5Ko/4SjV/+hE8Qf8Af/T/AP5KqRnSUVzf/CUav/0IniD/AL/6f/8AJVH/AAlGr/8AQieIP+/+n/8AyVQB0lFc3/wlGr/9CJ4g/wC/+n//ACVR/wAJRq//AEIniD/v/p//AMlUAdJRXN/8JRq//QieIP8Av/p//wAlUf8ACUav/wBCJ4g/7/6f/wDJVAHSVzfjz/kXbX/sNaV/6cLej/hKNX/6ETxB/wB/9P8A/kqsPxZr2o3ul2Nvc+E9Y0+J9a0vdc3Mtm0aYv4DyI52bnGOFPJ7DmgD0CiiigAooooAKKKKACubvv8Akqehf9gXUv8A0fY10lc3ff8AJU9C/wCwLqX/AKPsaAIviVe6jpfw81fU9G1KbTrywt3uI5Yo433FQflYSKwwfYA+9c5L4sv/AAh4wsbHVddl1vS7vS59QuXngiE9mIlU7swogKNkgArnPeuo8f6PqfiHwPqWjaIlm1xqELW5a8naJI1YEFvlRySPTA+tJpHhWy0nw3LBYeHdC02+uYNlzDawjyJTjGGYRqXX6r3oXV/1sD6L+t1/wSrq/wAQBoejxajqHhjXFhd40YKLY+X5jbULN523BOMkE43DOM1e1HxlaaXf3VteWN8ot1hCzKsbLNLKcJCgD7i5PYgADnOOaw9J8BG00rxHp2peTZaHqUPlQ6Zb3ck8VqoDBpFZ1XZnKnYo2rt4Jqpp3hTWNZ+G+mS3F/CPEC3UGprcyxt5cjx4CBx1AMaqD3BJOO1PS/3fj/lqxa/n/X6EHi7xfPe2mlz2Daxo1xY+IbSzv9PZUDyK7A7WKFg6lcEbHwckH0rZ1T4haPH4X1q71Sx1i1TTLj7He20SEXEbFQwIeJyFUhgQ+8AZ5IqPxTo3i7xHp+kBbPRIZ7PUoL2aI6hMVxE24BX8jJ3e6jbj+LPGLrHgbxfqWn+NbaKHRE/4SO5ikgZtQm/coiKh3fuOSQgOB/ePPHLja1n3/wDkf+CPqv6/m/4B1Wo/EDTdM1VrKSy1CWGG4gtbm9ijQw28s2PLVsuHOdy8qrAZGSKxY/ig9lceLbnXdE1KDTdBuBEJII45uAiNyEcsCd27JG0LjLA5FVNc8DeK9eluJr06TNL9qs7uyEt7MVtPKZGeFV8rAyVf96BuO7BAHSXWvA3iO503xvZac2luniVw8TT3EiGItEkbBsRt02ZGM7s/w45Wy/ry/wCD/wAHqLp8v1/4Brw+PdK1DxNpemT6Zr1ldXErm0ee3khglAhLliwbY67T905IbqoIyLlj4807UNWs7SGzv1ttQeSOx1Fol+z3TICWCkMWHCsQWVQ2OCazNV8OeJL/AF7wjepbaUsOjq/2xWvpNxMkRjYR/ufmAByCduemB1q94M0TX/DGmw6DcHT59LsspbXiyv57x5yqPFs2ggHG4Oc4zt5p6XFrbX+v6/ruauueIYdHkt7RLa6vr+83fZ7OzCGVwo+ZvnZUAXI5YgcgckgVwHhDxfHb+EbX/hJbnW76W88RzWVvMd4kVhcbYxKybVUdMrwDggKeldb4i0HVpfFWleI/DzWkl1ZQy2s1reyNHHNFIVJw6qxVgUB+6QenHWuSbwB4wg0OCzhk0O6dPEZ1nDTTQhV80yCPdsfcTnrhdv8AtdaULXTfz/8AAl+mo5aqy/rR/qdzp/iqDUrifyLC9FnDPJAb9hH5LNHuD9HLqAUK5ZRk4xkHNZ0HxH0uSaz86x1K2tdRRn068kgDR3uF34jCMzhioJCsqluwNZ03gK8vPFTX6x2ej291HMmpNp11ITqHmKygPCUCBhlW8zJYkYxii18G64bHQNP1Aac9t4ZZZbKWK4kD3rxxNHGJFMeIR82TgyZpdP687/pYPT+u3/BLenfFDR9S0v8AtKPT9WhsmysM89ptE0nnGIRKM58wtjCkDg+xxjaD4suIfiD4tl1p9Wt7WC3sfJ0692M0MkjSKEjWMlDuO0AgkknBPHEmneAvEEXw2s9HuZ9PttX03Uv7QtJIZpJYJGExlCvlFYA7ipwDjg89Kg1X4c6/4k1bWL/WZdGgTUILPbZKj3SebbuXUOzBQ0ZyQRsyQe2Oa0T/AK20/wCCHf8ArqbN38VdG06KZdT0/VrS8t7qG1nsmtRJLE0v+rYmNmTa2eDu56deK0Y/G0c06W0WhawbvynmmtWhjSSCNWZAxDSDcGKHbs3E8Hoa5fVfAGqT+HYrfQvDfhTRbtr62uLiOylaKNxBIJB8624LE4wAV+XJOT0ra8ceEr3xMkbWVpp8V9HGFtdT+1ywXFi5zvdGRCXA+TCEqG5yaWn4/ov1Dr/X9f11O0ByoOCM9jRUcCPHbxpLIZZFQBpCMbzjk496kpMS2CiiigYUUUUAFFFFABRRRQBzfxH/AOSWeK/+wLef+iHrpK5v4j/8ks8V/wDYFvP/AEQ9dJQBxPguXWZvFXiiDVPEF5qNtpt4ttbQzQW6ABoo5NxMcSksC5HXGOxPNU7fxU/hS4u28R6rrOsrcawNNs0WxiYREhCMmKNMEl/4jyBwM5zpf2H4h0PxRq+p+HY9O1C21h45pra/upLYwSogTcrLHJuBVV4IGCOvNZ/iDwh4hvNL06PTzplzdrrUerXrzzyQISjAiNAsbk8ALk46Zwc8ONrxvtZJ/erv89Ql1t5v8Hb8bGvF8QNNa2vDNaX0F7aXq2DafIiGeSZlDIqbXKncpBzuwBkkjBwkXxA0+W1/48NRTUftjWI0p40Fw06pvKA7/Lxs+bdv2471zUvgLxPca/q2r7tJtrltXh1TTgtzJKrGOLyTHLmJdoZMncu7BPQ456DVtC13VrjRtbaPT4NW0iaSWKzFzI8EivGUZTL5YYHBBDeXxjGDmhWtr5fkv1v/AFuPfTz/AF/4H4/KOf4oaJaaW13dWupxSxX6afcWf2QvNbzORtDhSVAOQQwYg5+Uk8Ut38SbKyi1ZrjRdYV9GIa+i8qLMUJXcJs+ZtZSATgEvwfl4NYuueAvEF/YXtzZJpf9q6pq1pqF1HLdyLDCtvs2xowiJcnZyxVfvZxxik1jwb4s1O48bOlvoyL4isIrS3zqEuYiism5v3Ho5PHcAd8hdPP/AIC/W41a/l/wX+mv9WN27+JOmQX2p2lrpurX0umWkd7P5FqFUwuCdymRlDYAJ464IGSCBYtfH+lXGowW0sN3aw3Vi1/a3lwirFcQoFLsMMWXAYfeVc9s1zFt4S8aJfazdTWegq2oaJDpkaJqczBWjDjeT9nHB8wnHbAHOciFvh34ivofDtjqUelpZWGhz6RePBfyGQiVFQvGDCAcBAcEjliO2S31t/Xxf5L7xR6X/rb/AIP3HVWvxB06e+tbe50/UrFb+Fp9PmuIFK3qqu4iMIzMG287GVWPYGodI+Jelay2ktBYanBbatPLbW11cwLGhlj3ZQgtvBIRiDtx2JB4qvb+Ftdnk0P+1000jw2rNZG3uZM3knlGJTIDH+6XBJIBk5PXjnC0zwL4vstJ8LWcsOiE6Lq8t/O66hN+8RzJ8qjyOv71uv8AdHrxXu81v6t/X9dCdeW73/W3+Z6tRRRUFBXN/Ef/AJJZ4r/7At5/6Ieukrm/iP8A8ks8V/8AYFvP/RD0AdG5KoxClyBkKMZPtzXmreK9cu9VaL/hGtehS71eKGEi5tQI0hUNIp23BxkpJnHBHGSeK9KdVdGR1DKwwVIyCPSuD0r4U+H7K806efw7oJNuk7y7LGMlpndWTB2D5UG4DPTjFC+K7/rqD2siDR7bxJq3ifxPYt421WGPTLuOO1CWlkRteFZMPmDLYLEcEce/NTeHfHt2v9q6R4khW613S78WSx6egX7duQyRsiu2FJQEnc2BtPNGm6X440rX/EGoQab4flGr3KSx79VnHkhI1jGQLb5j8ueo6496oXXwoln0/wC2Xsun63rkmpnUrpdQtwLS5YxmPytmGKoqH5T8xBGeelC2+S+/T/gjlvp/Wj/WxsRfFLRprqys4rHVW1C7uZbT7GLYboZ41LNG77vLDYH94jBBzjmlm+KOjW1nBLc2Oqx3EmojTZLT7Jukt5yVAWQqSgyGBB3HcOma5rXtIl0HxB4Ij0fRND0y7k1S4kFjZnyrct9kcHMixgknH3vL444OObmp+BPElxCl1bLpMmo3WvQ6xerJdSRxxiIKqRRkRMW4XliF55xzgUkrq/l+av8Ahf7vvT8u3+f+S/rbdufiPY2enve3Wj6xFBbKG1AvAinTwTwZQXyeOfk38EHoQa1LPxTBqGpz21jY3lxBbyiGS+jEZhEhAYrjfv4BBJ27eeprnNT+Hsdx40vdWfQPDmt2+p+W0x1aIGa1dVCZjPlPvUgA7CV5B554luPBN43jCw1fToLDS5IZg11e2c8kb3cKjasMkAUI2Vx8zMduPlFSvP8Ar+v6vsEvL+v6/q25r2njWyutMl1R7K9t9MSJ5kvpEQxyouBlQjMwzngMAxweKrr8Q9Khl1CDVra90q6sYkma2u40Mk0cjbY2jEbMG3N8oGd2eCBXOXXwwvNRudSjAsNFsr+yeO5gsZpJYbu4YqwlaB1VE2sp6biwbkipZfhtJd+H5YrfRPDPhzVI5IpoLjSYMrM8UiyKZP3cZVSV5Qbuuc8U1bS/9f1/S7D8ix4Y1rUtR+Lmt294NVtLddLt5k06/aPEDM7glRGWUghQc7mOSQSMYGxqXj2ysNfvtFh0zVb6/sbMXskdvbAK0ecZV5GVW79D2IGSMVV0Xw/4kX4hXHiXWW0q3hudNis5LS0eSZtyO7ZEjKmB8390+nbJg1Dw94mf4g6prdlbaTJZ3OkDToVmvpUk3BmcMwEJAGWIwCeBn2pSukkvP9bfoNWbbfl+l/1NLTfH+l6nqOl20NtexQ6vbNc2F5NGqxXCqoZgBu3ggHPzKAexNMtviHpdxe2CPaX1vY6nJ5Vhqc0aC3un5wqkMXXODguqhscE8VzGmeA/FFrF4Jt7qLSDDoFpNaXbR38u6RZEEZZB5HUKN2CRycZ71o2PgTVDpOh+HdTayOj6DcRTQXUMzm4uRED5atGUCx8kZIds46DPFNK+m1/wu/0tbuSr213t+P8Aw5rL8RNLN1ab7S+j069uDa22rPGn2aWbcVCZ3bxkggMyhT2JyK5v4i+MZpNKVfDz6tBHbatbW02o2vlrbyP5ypJCzE+Z0JyVAXIxu6irll4B1OPQtN8K3b2TaFpd5Hcw3iTP9plWOXzEjaPZtU5wC4c5A+6M8UtR+H/idvD194c0u60r+z5NUXUbW7uXl82PNwJ2jaMLhsHOGDjPTA6gja69fwuv+D933t7P+u//AAP629QopsYcRIJmVpNo3Mq4BPcgZOB+Jp1SAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/kXbX/ALDWlf8Apwt66Sub8ef8i7a/9hrSv/Thb0AdJRRRQAUUUUAFFFFABXG+I9JttZ+JOgW95JeRouk6i4NnezWr586yHLxMrEc9CcdDjgV2Vc3ff8lT0L/sC6l/6PsaAMnxDpHhXwtppv8AWr/xRFarkvLDrGrTrGAMln8uRto9zgVHqVh4Q0vRLbV7jU/E0thdbfKntNZ1W5DBvun91IxAOQATxkgdTXSeMAjeEdQWUKUaMBg3QjcK861+1uvh5N/ZFvDJN4V1m+g+xbBn+zbkzqxix2ifkr/dOR3FC1dv6/rsB1lz8M/Cuu2ts+ox6zeRIy3EKXmtX5Mb44ba8uVYZ9ARV/8A4QPSP+fvxB/4Ueof/H64rUJfF2u+ItZl0e9tbGbR9TVEa41ieJY4AEJD2qwlJA6liGZifm4Ixil8P+G7/wAUr4ojvvFviIzWGr3NrayQ6i0AUeUm3cItoIVjkDAGe3Jybq67X/L/ADDrZ+n5/wCR2n/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P15+2vX0/wAOpNZ0y51A6r4a0yS2uk+3TSAXm7Y5kUsRIUCs/wA4PDqa1NSt7zT/ABHDp2j6tql5p+raLdXF0H1CWRoZECmOaOTduj3FiMKQvoBRL3b/AD/V/ikCu7f12/zOs/4QPSP+fzxB/wCFHqH/AMfo/wCED0j/AJ/PEH/hR6h/8frzvTtflSX4Zzz+JJoLjU9GmW5NzqDGOVxANjujNtZt5PJGSeM8V1ngS+urbVpNB16C/h1iK0Fw8kmoteW92pbBljZjlOf4CFAzgAgZqnG0nHtf8L/5E30v/Wpsf8IHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/WD4vvr3RvEsmragL250JEhgZ9O1JopNPdmwWeAELIG3Lz8zDsvOay47abS/Eur+C59V1iR9XngutNuJdUuGlS2zmZEcvuXZsbpjO9Qc1K1/r+umpT03/AK/rY7L/AIQPSP8An88Qf+FHqH/x+oLTwfoF9C0tnqOvSxrI8RZfEmoY3IxVh/r+xBH4VhxT3OmeMVs9ebUJ7XVb2S30/ULPVZHiICPiCSHcPLZQG+dQSWUEsDXH+FpbjTvA/h7TdHmcjVdSvI7oXOtXFuPleby0EqiRoixUn5ApYqeck0dLg9P69f8AI9T/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH64SC38UWPiXwjpHiDxHOwmvr2GSCxvmcPCIS8aySmNHd1BA3cdAfvc1Uh1DUrbw9BqC61qkk+n+L/7LiaW9kZWtjciMpIucSfKcbn3MOxFUldpd/wDNL9UD0V/66v8ARno3/CB6R/z+eIP/AAo9Q/8Aj9YNnYeHtS1LW9P08eLp7vRSizRHXr+IyswJAjMlwoPA6nCnIwTWr8QdWn0yx0mFLp7G21DVIbS7vI22tDE2ScN/CWIVN3bdxg4rzHXZxoM3xMg0bxFeW15aJYzRML3zLgoIwpUu+5yo3gbs7hkfNUx1f9eX+Y2tv67o9WHgPSMf8ffiAf8Acx6h/wDH6X/hA9I/5/PEH/hR6h/8frntd1C80bxV/aeqG8utGkmtbeKfT9RZTYyMU+SW3yFcMxU7vmbD4wBzWG2p6zP4Ph8WW+pX6+IBrf2RrD7S5hZPtZi+zmDOzITndgPxnOKaV7fd/X3k9L/1tf8AQ73/AIQPSP8An88Qf+FHqH/x+sZtL8NL40j8MGfxV9uks2vBIdd1ERbFZVIDmfk5YcDOO+OK5a6u9asLfx7rCeIdXuZ9A1BhaRvMDEiNbpu3RhQrKvmFgMcFAe7ZTVLm38NfEa2vNH1SbUrmbwreTWiXd61w0825HXZuJPzbSdi8YU4A5pLo32v/AOStoq13Zf1ql+p6H/wgekf8/niD/wAKPUP/AI/R/wAIHpH/AD+eIP8Awo9Q/wDj9ecXQ8XR+EtQ1+28QR2en3GiS3Ie11uS+lmnVQ6yRiWBViHBVlTAweMHmtx9M1q00LRdQsr/AFPXBNAl5fafJrDW80mIkG+JgRwDyYywUl+abVr36f8AB/y/4Yla2t1v+Fv8zq/+ED0j/n88Qf8AhR6h/wDH6P8AhA9I/wCfzxB/4Ueof/H6v+GNSttX8K6bqFhJcS21xbI8b3X+tIx/H/tetatDVnYa1Ob/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH66SikBzf/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wAKPUP/AI/XSUUAed+PvBWl2vw28S3EV1rjPDpN06iXX76RCRCxG5GmKsPUEEHoRXQf8IHpH/P54g/8KPUP/j9HxH/5JZ4r/wCwLef+iHrpKAOB1Kw8IaVqH2C41PxNNeBQz29lrGq3UkanOGdYpGKA4PLYFXtM8M+GdZtWuNL1bXLqFZGiZ4/EmoEB1+8v+u6g8H34rJ+FUyW+oeLbDUmCa7/bc89xHIfneJseS4HdNgAGOODVjVriC/8AHGl6HZ3E9tpGoJdz3M1lcPAbi5TywEEqEEYBYkKRkqc9CKFrbzV/wv8A5/MHu/J/8D+vI2v+ED0j/n88Qf8AhR6h/wDH6P8AhA9I/wCfzxB/4Ueof/H687Oo+ICuiWsniHURaxeLn0uKdJFDXtqFJG98EsVZSmcjODnJ5pmrXeoad4f8Zz22tarv8Pa1Cmns+oSt5av5LMrktmVf3jDEhYAdMU0r/wBf4f8A5JA9Hb+uq/8AbT0f/hA9I/5/PEH/AIUeof8Ax+j/AIQPSP8An88Qf+FHqH/x+vO9eu9Ujh+Jl1/wkWrGTRDDcaeFuvLWBvJEmNqBQy5ONrZBAGcnmp/Eeu6z4Z1bW20i+vbh5PC66j5c8zTCOfzdhlRWyEAUklVAXjpSWtvP/K/6MP6/FL9Ud7/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP1y17Hf6V4ptrHQtd1OSx1TRrq5upJLs3LW7oF2TxtLuCbixGB8vooxWb4N1HUY7z4cXFxq+oXcmuaXP9uW6unkSUrErqwQnaGBJG4DJB5JppX/r1/wAhX/r7v8zu/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+ukopDOb/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+ukooA5v/hA9I/5/PEH/hR6h/8AH65/x94K0u1+G3iW4iutcZ4dJunUS6/fSISIWI3I0xVh6ggg9CK9Erm/iP8A8ks8V/8AYFvP/RD0AH/CB6R/z+eIP/Cj1D/4/WVPofh6Ce4i8/xNI1vcw2rbPEV8cvLtwB/pHYOCfbpmu3lUtC6qMkqQBuK/qOR9RXimleHNYutZ01/7O2/aL6e9YN4y1Fi6RfugSDHzjKEN1YAA4BxQtZW/r+rA9Fc3hfeBDc3cC33jV5LJ/LutlxrrCBsZw5BwvBByexz0ratPD/hzVNIi1LQr/XtWtpWAR7PxResCN2CctcAfLySM54OATxR4Umij8beO5ZJESOO+ty7swAXFrHnJ7V50Lq6ht9f13w1qNzYaHeeLLL7H9lISO7DPHHOwOMlGbPKkAkHqMinFXaXe34tf5hL3df62b/Q9Ev8A4Q+DtVvre91Sz1G9urYgwT3GtXsjxYORtZpiV554rS/4QPSP+fzxB/4Ueof/AB+uV1rTU13x49jpOsaxaw2Egu9av01m5jihH3ltkQSCNSRy3y/KvPUg02LTI9a8eu+k61rMGk6PcF9RvX1q5MdzcE5FuiGTywiZ+bC/3V/vUlql/Xz/AK/VA9G/6+R08HgnS5vM8x/EkGyQqvmeJL47wP4htuDwffB9QKl/4QPSP+fzxB/4Ueof/H682XUdbfw3bZ8T6qZY/Gx055RMm+aHzgoVjt4AA6LgcnINWbvXdX0q617RrG8mntE8RW9mJb7UpUMEUtuHKm4w7oDJhQcEjfgEcYcVdXXl/wC2/wDyQPRtdr/hzf8AyJ6B/wAIHpH/AD+eIP8Awo9Q/wDj9H/CB6R/z+eIP/Cj1D/4/XHjS/GllYG1ubiLUUgvzcJpdrr0wuWtvL4j+1MqO5V/mAYgEEBmxTdR1+afR7LxPaHVbzw/DpzPcwQ6mbe9s23OGmZAwWYABhhmI+TK7qX9fh/S7eYLX+vOx2X/AAgekf8AP54g/wDCj1D/AOP1TuvC2g2l9BaS3fiIyTxySjHiO/wqoBuJ/f8A+0B+NdZbypPaxTREskiBlJGCQRkV5H450bVL7xLrU9pZkqtvFawzf8JTfW+HuGCjbEiFByFygO08E5JwB3vYI2aubej2/hfW9ebSLaTxbDdrYx3zC41zUEURyY2gN5+GPPO3IyCM5FdD/wAIHpH/AD+eIP8Awo9Q/wDj9cDNo0ieONSsp57vTntfCCHbZapM7IyzSFT9oYLI2Md8Z6EEVBa6v4q8ZWumWNpcpFcyeHrS9gnfV5rBmncNvlxHE/nBSFyjfKM8g54ejV1/Wsv/AJENnr5flH9Wei/8IHpH/P54g/8ACj1D/wCP1meItB8O+GPD93rOo3Pih7W0TzJBb69qMj4+gm6epOABySBXGeMtX1mPSL66GuXEuraRpVpLKbG8a2tbeYklnGD/AKR5mOFZNoA6jdU3jS8bX9D+IY1PU7q1l0a1MdpaRXTRIYmtw3mOgIEm9mZfmBAwMYPNKSsn5X/AcbOST6ndWvgvRbyzhuYrvxEEmjWRQ3iPUMgEZGf3/vU3/CB6R/z+eIP/AAo9Q/8Aj9eZ674hkn0p9T8Pa7dz/wBmR6aivbXxhtrYuU3LtViLhmU87lwo6HOa6uxF14m1zX55/EN5pV9omrCOKKKdlhitlVGG+HIRxIC3zMCRngjFU17zS/rb/MhN8qb8vy/4BY8OaX4a8Tpfvp0/iqMWF41nKLrXdRiYuqqThTPnHzDqAfatn/hA9I/5/PEH/hR6h/8AH681nmn0yz8Ua1Zahd289t4zjREiuGSNld4EdXQcOCrH72cY4xWtfy+Ltd8RaxLo97a2M2j6mqI1xrE8Sx24CEh7VYSkiupYhmYn5uCMUoq6j5pflH/5IqWjfq/zf+R2n/CB6R/z+eIP/Cj1D/4/WbqOgeHtMlmS4ufEh8izkvJGTxFfkKiEcf8AHx1POPoea7YdK8X8RaBq2peIdZaHTjIk99Dp6lvFt/HuBIkYeWEKhSknKjITB2g911t/Xb82Ppf+v6sd1H4T0GWeS3jvfEDXUUKTPbjxJf71Vt23P7/HJVh17VLb+CNLmtopZJfElu7oGaGXxJfFoyR907bgjI9iR7muCt9JXTvFfjqSPUL/AE3ULfSLVo3j1aacq/kyMwBmJ8zGzgsuQMkbSTVjR5NR1fXPBlte6/qxtNR8LNPcwRXZj3yKIhv3rh9x3k7t2eOCOcvvb+tJP9Cdt/62/wAzuv8AhA9I/wCfzxB/4Ueof/H6xta0rw1oOoaVZXtx4paXVbkW1uYtd1FkD9fmfz8Lxk4JycHAOK5bStev9T8J+Dm1rUNWuLK4t7pbs6U07XkjxuFjkbyP3pUYO4jjcy7uDVm6TXI9D8AP4rurmbUpfEcbOLoRK8a7JQi4jVR90AnOTknmi3vJeaX42G/hb8m/uTZ2cXgnTJJpkd/EsSxsFSR/El6VlGAcri4Jxk4+YA5B4xgmb/hA9I/5/PEH/hR6h/8AH68317Utct9B8beR4m1RJbDxFbRQSrKm5YpBCDGPlwqjzDjaAeBknnOrqeoavpGqeO9N0fVLpvs1lZ3Vv9quWleN5C4kEZcnaWCjaowAxGAOlLpf+tk/1H1/rvY7P/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH6x/BEepv4l1GSC511fDcdvELSDWFcSNOc+aczr55AwuMtt5OARjEPi6+vdE8TSavfi8utCjSGFn07UmiewdmwWkgyFlVsrz8zDsvOadtUu5N9Gze/wCED0j/AJ/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/H64lZ/F2v67fX2nXlrYvpmsNBL5+sTKEtlfGxrQQmMl0wyuW3EsCDjisy1v9WtNEXVZvEOq3d3a+Mv7ORp7ohHgM4iZGjTajDbzyvB6YoiuZpd7fi0v1HL3b+X+Tf6HpP8Awgekf8/niD/wo9Q/+P0h8CaOqktea+AOST4k1Dj/AMj1zel6tdaHr8tt4lkvBLeLdXNpqkOoNc2lxGgLf6kn90ypj5VXacfeJNcxZzXlzJd2VxqWqXFjqXhOe9drnUnL3EqsuJhGGItwQx+RGxg4IGKlvS67X/Bv9H/V7NLWz7/ql+p6Bb+FNEvIrOexuPEdza3aeYlzH4kvtirjKk5uA3OeMA++Kuf8IHpH/P54g/8ACj1D/wCP1574UnuNIu/h/BpmqX09tdaFNLNp73bSxmZII2X7xLD7/C52gY2gd7OnX2rNofgzxHaatfTatrF7FBqNpJcs8Lq4bzVWEnbGY9pOVAI2ndnmtJRtLl87fi1+hCd438r/AIXO5/4QPSP+fzxB/wCFHqH/AMfqG58E6ZBDvifxLctuVfLi8SXobBIBPzXAGADk85wOATxXnlrf6taaIuqzeIdVu7u18Z/2cjT3RCPAZxEyNGm1GBXnleD0xXcfFG6vbHw/p11p+pXNiy6vZxyCBwomR5lVlY4zjBPQj3yOKmKuovu0vvs/1Keja7X/AAbX6Gj/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XA+J5tTj1L4kSDxDqwGk6db3likd2Ylt5Ckj8BNuRkAYbOR97PGPWNLuHu9Hs7iUgvNAjsR0JKgmi2l/61B6O39dP8zF/wCED0j/AJ/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/H66SikBzf8Awgekf8/niD/wo9Q/+P1h+LPCWnaZpdjd21zrDyx61pe1bnW7y4jOb+AcxySsp69wcHnqK9Arm/Hn/Iu2v/Ya0r/04W9AHSUUUUAFFFFABRRRQAVzd9/yVPQv+wLqX/o+xrpK5u+/5KnoX/YF1L/0fY0Aa+q6LpWu2q22t6ZZ6lAr71ivLdZVDYxkBgRnk8+9SJp1jHp8VjHZ262cIVY7dYlEaBcbQFxgYwMemKs0UAULjQtIu9Uh1O60qynv7cYhu5LdGlj/AN1yMj8DTdK8PaNoTTNomkWGnG4IMxtLZIvMIzgttAz1PX1rRooAggsrW1877NbQw/aJDJN5cYXzHIwWbHUnA5PpUGm6HpOjCYaPpdlYCd98wtbdIvMb1baBk+5q9RQBmW3hnQrLP2PRNOt8l2PlWiLy+N54H8WBn1xzU9jo+maXJPJpmnWlm9w2+ZreBYzK3qxAGT7mrlFAFG50TSry+ivbvTLOe6hffFPLbozxtjGVYjIOOMiqNrpd5deI11jWbazgltYpLa0S3mab5HZSzszImCQijaAQOeTmtyihaAUI9C0mHVP7Ti0uyS/2lPta26CXaTkjfjOCSSeetNbw7oj2FxYvo9g1pdSGWe3NqhjlcnJZlxhiT3NaNFAGNJ4O8MyvaPL4d0l3slCWrNYxEwKDkBPl+UA88YqH/hAvB/2U23/CKaH5Bk8wxf2dDt34xuxtxnHGa36KAILmxtL2xeyvLWG4tJE2Pbyxho2X0Kngj2rNfwb4YlsTZS+HNJe1JUmBrGIoSowp27ccDgegrZooAy4/DOgxXFrPFomnJNZjFtItpGGgG0L8hxlflAHHYAVKNC0gawdWGl2Q1IrsN6LdPOK+m/G7Htmr9FAGdp/h3RNJmuZtL0ewspbs5uHtrVI2m5J+cqBu6nr6mk07w5oekSB9J0bT7FwGAa2tUjIzyfugde9aVFAGMfB/hkw3cJ8O6SYr1g90hsY9s7A5BcbfmOecnPNSy+GNBn0yLTZ9E02SxhXZHavaRmJFyDgIRgDIBxjsK1KKA63GoiRRrHGqoigBVUYAHoBTqKKACiiigAooooA5v4j/APJLPFf/AGBbz/0Q9dJXN/Ef/klniv8A7At5/wCiHrpKAM3VfDeh680Ta5o2n6k0P+rN5apMU+m4HFS3+jaZqun/AGDVNNtL2zGMW9xAskfHT5WBHFXaKAMq98K+HtSjtU1HQtMu0sxi2WezjcQDjhMj5eg6egqu3gbwk6To/hfRWW4cSTKdPiIlcZwzfLyfmPJ9T61u0UAc+ngDwbFFLFH4S0NI5gBIi6bCA4ByMjbzzzVm28JeHLO/ivrTw/pcF3DGIo7iKyjWREC7QoYDIG3jHpxWvRQBlQ+F/D9tZXdnb6HpsVtekm6gjtI1ScnrvUDDfjUMHgrwta3FtPbeGtHhmtObaSOwiVoeS3yELleSTx3JrbooAKKKKACiiigArm/iP/ySzxX/ANgW8/8ARD10lc38R/8Aklniv/sC3n/oh6AOkqCKytYDGYLaGLykMceyMDYpwSox0HA49hU/SubtvHFhNpM2rTWl5a6VHE8yX8qoY5UUgZUKzMMk8KwDHB4oGPb4feDHmMz+EdCaVm3lzpkJYtnOc7etaGpeHdF1q1ittY0ewv4IDmKK6tUlWM4xlQwIHHpWIfiHp8Ed/wD2lpmqafPZpFJ9nuIULzrK2yMpsdl+ZuMEgg/eArB8beLptU+GPiO50iTVNB1PR5Finify1mjb5Tt3KXXBVwco2fcU0ugbs6qXwB4NnuGnn8JaHJMzbmkfTYSxPqSVzmgeAfBy3QuV8J6GJw/mCUabDu3ZzuztznPOao3PxCsrbUdT0630nWL+50iGOa7EFsBhGB+ZTIy7wNp+7nPbODjpdO1C11bTLbUNPlE1rdRLLDIvRlYZB/Kgm5jj4feDAoUeEdCChtwH9mQ4B9fu9atQ+E/Dlv8AbPs+gaXF9vBF3sso1+0AnJEmB83JJ5zWvRSGZZ8L6AdLXTDoem/YEBC2n2SPylB5OExjnHpT7nw7ol6IBeaPYXH2baYPNtUbytudu3I4xk4x0zWjRQBm2Oi29jrF/qMSRJLfbPMEMQQNtBwzY5Z+cbj2CjjHNtrK1dnZraFmd1kcmMZZlxtY+pGBg9sCp6KAMe68IeG76+nvb3w9pVxdXK7J55bKN3lXAGGYrkjAAwfShvCHhtrG2sm8PaUbW0cyW8Bso9kLE5LIu3CnPORWxRQBm3nhzQ9RuGuNQ0bT7qZoTA0k9qjsYj1QkjO326U268L6BfSRPe6Hptw8ERhiaW0jcxxkYKKSOFxxgcVqUUAZVz4X8P3szy3mhabcSSQiB3ls42LRjkISRyvA46VJL4e0WbULe/m0iwkvLVdsFy9shkhHorYyo+laNFAHPnwD4PaF4j4U0MxyOJHQ6bDhnGcMRt5PJ59zV+Tw9os2oW9/NpFhJeWqhbe5a2QyQjphWxlR9K0aKAM3StFt9JnvpbdIo2vZzPIsEQjTd64HVj1LHkn8ALYsrUOHFtCGEpmDeWMhyMb/APewcZ64qeigDOvvD2i6nLNJqWkWF3JPEIZXuLVJDJGDkIxI5UHnB4zVGPwF4QiZWi8KaIjKjRqV06EEK2QVHy9DuOR7n1rfooA4PW/h/bC9szovhbwte6ZBG4/su9gFvGkjEEyqVikBYhQMFPxrUsPAPh9bJItS0DR5/LmaaCD7EjRWe7GViDL8o+UEkAZbJwM4rqKKFoG5z8ngHwdM0jS+E9Dcyv5khbTYTvbn5j8vJ5PPuao+IPAWmXWmXX9gaLodtf3GxZnmsUAuYgyloXZRu2sFAzzj0OK66igDlPC/hOLSb/7eugaJoEvlNE9vo3KzZIIZ38uPOMcDbxk881u3OiaVeX0V7d6ZZz3UL74p5bdGeNsYyrEZBxxkVeopgZ82gaPcasmqT6TYy6gi7FvHtkMyr6ByMgcnjNZ//CA+Dvs/2f8A4RPQ/J3+Z5f9mw7d2MbsbcZx3roKKQGfa6Bo9jdSXNjpNjbTyRiJ5YbZEZ0HRSQMke1RWvhfQLB4nsdD022aEOI2htI0KB/vgYHG7v6961aKAMaPwb4Yhura5h8OaTHcWgAtpVsYg8IBJGw7crgknj1qzBoGj22pT6jbaTYxX1yMT3Udsiyyj0ZwMn8a0KKAOf8A+EB8HfZ/I/4RPQ/J3+Z5f9mw7d2MbsbcZx3rQ1XQNG1y3ig1vSbHUYYTujju7ZJVQ4xkBgccVoUUAYT+BvCcrzvL4X0V2uRictp8RMvIPzfLzyAee4Fa9nZ22n2cVpYW0NrbQrtjhhjCIg9Ao4AqaigAooooAK5vx5/yLtr/ANhrSv8A04W9dJXN+PP+Rdtf+w1pX/pwt6AOkooooAKKKKACiiigArm77/kqehf9gXUv/R9jXSVzd9/yVPQv+wLqX/o+xoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/APJLPFf/AGBbz/0Q9dJXN/Ef/klniv8A7At5/wCiHo/4QPSP+fzxB/4Ueof/AB+gDpKK890S28HeIdVvNN0vUPFb3dj/AMfMc2p6xAIiegLSOoyQcgZyRyOKsaPpPhXXru9ttNvvFTSWMnlXHnatq0Kq/wDdDSSKGP0J4IPcUBsd1RXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJXN/Ef8A5JZ4r/7At5/6Iej/AIQPSP8An88Qf+FHqH/x+uf8feCtLtfht4luIrrXGeHSbp1Euv30iEiFiNyNMVYeoIIPQigD0Q9OK8wvfhffalPqSRNZaDa31myTxafPJLFc3JKuJmhZVWPayn7pJYHkiuqbwLo6IWa98QBVGSf+Ej1Dgf8Af+uRXU/ATz28KX3jZpbqMy26LNrxMyDGWTB+ZRkcjjkUdR9Do9UsPGur+FJbNpNL0/UA0Y32t5NtuFDKXHmeWrQ7lDL8ocjOQeK5m/8Ah34ibwz4t0rTLfRIBr9zFNEPtcqrBiNA+790Sx3J1/i3EnHSuo07wn4f1bTYL+xv/EUlvcIHjZvEGpISPdWmBB9iAatf8IHpH/P54g/8KPUP/j9PVN/12/yEuljj7YeIpvih4mg0y30tbybSLCO58+6kKQEiYbkIjzJjn5SEzxyK9C8OaLF4c8M6do1u5kjsbdIFdhgttGM/j1rm7f4Q+DrTWJdWtLPUYNRnBEt5HrV6s0meu5xNuOcDqe1aX/CB6R/z+eIP/Cj1D/4/RfT+vP8AzF1/rsv8jpKK5v8A4QPSP+fzxB/4Ueof/H6a/gTSVRiLrxC5AyFHiS/yfbmekM6aiuWt/BGlzW0UskviS3d0DNDL4kvi0ZI+6dtwRkexI9zUv/CB6R/z+eIP/Cj1D/4/QB0lFed6hb+EtPudJha88UT/ANr3ZtLaSDXdRaPzASDufzgo+6e+Tg4BxXQf8IHpH/P54g/8KPUP/j9HS4HSUVzf/CB6R/z+eIP/AAo9Q/8Aj9QW/g/QLtp1t9R16Q28hil2+I9Q+VwASP8AX+hFAHV0Vzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9AHSUVyieD9Ae+lsk1HXjcwxrLJGPEmoZVWLBSf3/AHKt+VT/APCB6R/z+eIP/Cj1D/4/QB0lFc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/QB0lFcpJ4P0CK7htZNR15Z5wxjj/AOEk1DLBcbj/AK/tkfmKn/4QPSP+fzxB/wCFHqH/AMfoA6SiuO1bwx4d0TSZ9R1C/wDEKW8C7nK+ItQJPOAABPySSAB71mJYaImh6jqepWfjfTl07PnQT61fvIwAB3J5Vw6uMHqpOOc4waV7K47X0PRKK47R/C+ha3odlqlpc+JEgvYEuI1k8RX4YK6hgCBORnB9au/8IHpH/P54g/8ACj1D/wCP1TTTsyU01dHSUVzf/CB6R/z+eIP/AAo9Q/8Aj9H/AAgekf8AP54g/wDCj1D/AOP0hnSUVylz4P0CzWNrrUdejEkixJnxHqHzOxwoH7/uan/4QPSP+fzxB/4Ueof/AB+gDpKK5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfoA6SiuVtvBOmTw75X8S2zbmHly+JL0tgEgH5bgjBAyOc4PIB4qb/AIQPSP8An88Qf+FHqH/x+gDpKK5v/hA9I/5/PEH/AIUeof8Ax+j/AIQPSP8An88Qf+FHqH/x+gDpKK881qw0HR782UUPjDVLmOJZ54tP16+kaCJmKhypuQWGVPCBm4PFbw8CaQVB+1+IBkd/Eeof/H6Olw62Olorm/8AhA9I/wCfzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/x+gDpKK5v/AIQPSP8An88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8foA6Sub8ef8AIu2v/Ya0r/04W9H/AAgekf8AP54g/wDCj1D/AOP1h+LPCWnaZpdjd21zrDyx61pe1bnW7y4jOb+AcxySsp69wcHnqKAPQKKKKACiiigAooooAK5u+/5KnoX/AGBdS/8AR9jXSVzd9/yVPQv+wLqX/o+xoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/8ks8V/wDYFvP/AEQ9dJXN/Ef/AJJZ4r/7At5/6IeukoA888Y6tH4A8ZW3iiVHOm6rAbC+Ealj56Bnt2wO5+dPxWmeIpNX0Lw54fsIvKE+rX5XUpWvHs1LyI8hXz0Rmjy+FBAzwACM5r0C6s7a+iEV7bw3EausgSZA4DKcq2D3BAIPYikvbG01KzktNRtYbu2lG2SGeMOjj0Kng0dLf1b+v0B7/wBb7XPIprLxZYat4a0vWvElxHHc61Nb/Z7DUXmItjbtIqSTNGkjupGAx7EHrg1cvLKfwP4lm0xtZ1u/t9e037Lpsl/qk8rR3YIUgHf8rMHV8qARsbBAr0BvCHhp/se7w9pTfYP+PTNlH/o/Ofk+X5eRnjFR3Gl3mq+ILW41O2s47PTJzPZtHM0kkrlCm5gUUJgM3ALZ4ORinp/Xa1v+CHn/AFe9/wDgehi/EKG60P4O6sNK1bULW40+wZ47sT75nKj+KR9xOe5zn0IrD1q0ktG07TU1/XLu4vrSe+a2Ootb8rHGPMNwrBo41bnYobJc/Lgcej6lpWna1ZGz1iwtb+1YhjBdQrKhI6HawIqF/DuiSQ2cUmj2DR2GPsiNaoRbcY/djHycemKT1v5/1+Y1pbyPKtNuNY8R3Hw+hvPEurRRazoc7XiWtwIizpGuJAyqG3ZfOc/wjgc5s6M/i/WNUj1O2vre3/s/V3tbz7VrM+Wt1lKCJrQQ+WHK7WD7txJBzg4HokHg3wxbXdtdW3hzSYbi14t5o7GJXh5J+VguV5JPHqatHQtIOsf2udLsjqW3Z9t+zp5230343Y9s1fMua/r+d/8Agf1Ym2lv62sX6KKKgYUUUUAFc38R/wDklniv/sC3n/oh66Sub+I//JLPFf8A2Bbz/wBEPQB0ZAZSrAEEYIPeuH1gJH8afCcaBVC6XfhUHGBmHHH4V3NZVx4V8PXesLq13oWmT6kjKy3klnG0ylfukORuyMDHPFC0kn/WzX6h0a/rc4gWV9cfFbxBZJrerLaWVlaX9tZW04jjWQySEptVRlW2YIOSdxyemMjQD4w1fTrDxB/bENjbXtnMt+0esS3EjS+WSPLt5IPLgkRgcqpxgHOSM16nB4f0a11iXVrbSLGHUpgRLex2yLNIDjIZwNx6Dqe1RN4V8PvNeSvoWmNJfrtu3NnGWuB6OcfMPrml9m3l/n/XyHf3rnl/h6e/ubf4cSXOu6tM+v2Mseobr9/3oEPmAgA/KwIxvXDYPJp/h/WNS1GfR/D9/qN//Z02rapayXQu3SZxAxEMJnB35xk53bjs69a9Gj8EeFIZLd4fDGjRvanNuy6fEDCc5+X5fl55470+Hwb4Yt9On0+Dw5pMVlcMGmtksYhHKR0LKFwSPerbTbdu/wCf6E2dkv66/wDA+48vv7zX4bVLJPEOppaWXi6DTba4WYF7q3coWR5CCz7CWXOecENur0bV9Pm0j4d6ha2er6isttZyvHfSzCS4UgFhl2Bz6ZIzjvnmrt34U8O39na2t9oOmXNtZjFtDNZxukA/2FIwvQdPSr19p9lqdjJZalZwXlpKAJILiJZI3AOQCpGDyBUSu4OPXv8AJL9L/MqLtNS/rdv9bHlOjyajq+ueDLa91/Vjaaj4Wae5giuzHvkURDfvXD7jvJ3bs8cEc56n4e3lx4h+EdhLqtzNcSzW8sUs/nMsjhWZMl1IbdgDkHOea1o/AXhCJlaLwpoiMqNGpXToQQrZBUfL0O45HufWtPS9H0zRLM2mi6daadbFi5htIFiTcep2qAM8daubUk13v+bf6/gTG8beX+SPENBsrdfhv8NY7e7uRJca7C8pN08jIdkwwocnYCB0UAdT15rVOuaxZm+0Gzu5ri1XxQ+n+dfapNEyQm3Eixm6CvImXOA3XooIzmvTJfBvhicRCbw5pMggkaWLfYxHy3Y5Zl+XgkgEkckinQ+EPDVvBeQ2/h7Soor7/j7RLKNVuOp+cBfm6nrnqaL6u/X/AO1/yf3jfS3T/wC2/wA/wM/wNZa7YaTeWXiW8guZI7p/s4hvJLl4YSAVjeV0RmYZPJGcYyc15TBbSaT4S1OfRtc1TT7k+MTbOsd+7+ZEbtU5Vy2OG5YYLcbiw4r3axsLPTLOO0021gs7aIYjht4xGiD0CjgVn3vg/wANai0jah4d0q7MsvnSGexjffJjG85XlscZ64pJ2mpen5p/oD1jbzv+D/z/AAPP9asvEUnia68K6LqNw4t7BbuyuL7XZ7WUSPJJl8pE/nqnyDY5wBjIOcjN8ZavrMekX10NcuJdW0jSrSWU2N41ta28xJLOMH/SPMxwrJtAHUbq9b1DQdH1ZYF1XSrG9W2YNALm2SQREdCu4HafpTLzw5oeo3DXGoaNp91M0JgaSe1R2MR6oSRnb7dKE7f1/X9fcHX+vL/I8d8VQf2frfxJ1TT9X1HTtQt9LtZ4JYL9xuYxyMRtYlSPl44yozt29a6T7PO/jldIfWtYe0vvDv26dRqMinzkdVDqykGPIbkIVBxyOtdzeeEvDmo/8hDw/pd1+7WL9/ZRv8i8qvI6DsOgqIeCPCglEg8MaMHEXkBhp8WfL27dmdv3dvGOmOKXS39bNf5P5Av6/D/J/eeaabrfiPxNofhLT/tHmyX+iNcNLJq82nPPOrKuRLFG7MyjkrwDuyc1esoPEM3jLw5o/iXxLdTtNod19uTTboxQySRyIodXVUfd83JyORxgZz6AfB/ho6Sulnw7pJ09ZPMW0+wx+UH/AL2zbjPvinXXhLw5e3gu73w/pdxcrF5Imlso3cR4K7NxGduCRjpgmm3d/f8Ajf8AK/4ISX9fd+dvxPI/BrjW/FvgbVNZv7yW5bRrwNMb+VPMaK4jRN2HAOf4h0Y9QeK9C8XXdxL4u8N6G89za6bqRuPtM1vO0DO6RgpEJFIZc5ZvlIJ2ema3LPwr4f077P8A2foWmWv2Z2kg8izjTynYYZlwPlJAwSOtXNQ02x1eyez1Wyt761fG6C5iWRGx6qwINDd0vn+Lb/X8AW7PHvEMV1e/DjxPY6rfX13aaRrcVvp9213IryR+ZDlXdWHm7S7Lls8rn7wzXpuuWkWn+AdUtoXmaKLT5gGuJ3mcjY3V3JZvqSas3fhfQNQ02306/wBD026sbY5gtprSN44uMfKpGF444qaTRNKm0YaRLplm+mBBGLJrdTCFHRdmNuBgcYqZrmg49/8AK1you0lL+tzybQbGaX/hDNGj1nVoINa8LsZvJv5I/LeNYTG8YUgIRuI+XG4fezzVvRJbzWvDi2L6vq1pqnhizuYtQmiv5C7XIJVGfezBwwRnAcHAZcYFd63hDQtPEd5onhbQxqNmhFmxtkg8s8nAkWNigyx6A9TxzUI0K+h0HW3t4bI6xrBaSRTKywhzGI1XeELEKqjnbyc8DPFVZcyk15/fd2/N/chQVrJ+X5K/5HC6BqOpW+n+ANTstWvtRvtXsyNQtp7x5kmRbdnMmwkhGVwo3KATuwck1FoX/CY6xpth4gGsxWFte2cov2j1iW4keXyyR5dvJB5cDoykFVOMZzkjNdz8PvCKeFfC9jb3mmaXb6vFbR291dWC7jcBBtVmcorHgZwRx6mtZvCvh95ryV9C0xpL9dt25s4y1wPRzj5h9c1VWzlLl63t+Io3srnjJ0X+0vC/w31vWdc1u7uNSvbRZ/N1SZEXMUrFlCsNrHgFgc8deTnoIJ/Fmva1d3+l3traf2Xq5gcz61OALVXACNaiIoxdMMHLFjuBBxxXpEfhrQotLj0yLRdOSwikEsdotogiRwchgmMA55zjrUkmg6RNq6arLpVi+oxrtS8a2QzKPQPjcBz60rrmbXdv8v8AL8QesbeSX5/5/geRXF9q1lpGv6m3iHVbi50zxbFa27S3RVPKZ4VZGRNqMpDngjA6jByT032u+07xoYNamvzFq99LDp2p2Gol4VIR8Qvbt8qMuG+YK2WQFj2rpj4B8HtC8R8KaGY5HEjodNhwzjOGI28nk8+5q4PDGgC4acaHpomeFoGk+yR7mjb7yE4ztOTkdDmp+yl/WyX5r8Snq3/XV/5/h93mPhfWNT1XSPB+l6pql/Ja6ncait3fC6aOWZopH8uLzUIZcjJwpXhMDjiq8t7r8Wp6fpo8Q6mLC38WjTYZRKC11bmHeVeQgs5RgUzn1zkjI9Si8I+G4NJl0uDw/pUenzP5ktollGIpG4+YoFwTwOSO1OuPCfh28is47vQNLnjsRi0WWzjYW44+4CPl6DpjoKq65r/1un/wPmJ7Nev5Nfrf5fdg/Du6nNx4o02W7uLqDTNZeC2a6neaRIzHG+0u5LMAWbGSeOK5bVtR1W78NeK/EMep39nrei6nLDY2kdy6xBUKiONoAdknmA5ywLHfwRxXpmmeHtG0WaeXRtIsNPkuSDO9pbJEZTycsVAz1PX1NOm0LSLjVotVuNKspdRhGIrx7dGmQegcjI69jS6p+SXz01/D8Q7+t/z0/H8DiNG0mB/jdqt3NJercrpFpO0f9oT7A7PMGBTftKjspBUHkAE5r0asuLwvoEOtHWIdD02PU2Ysb5LSMTEkYJ8zG7JHHWtSi+iQdb/1sFFFFIAooooAK5vx5/yLtr/2GtK/9OFvXSVzfjz/AJF21/7DWlf+nC3oA6SiiigAooooAKKKKACubvv+Sp6F/wBgXUv/AEfY10lc3ff8lT0L/sC6l/6PsaAOkooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I//JLPFf8A2Bbz/wBEPXSVzfxH/wCSWeK/+wLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACub+I/8AySzxX/2Bbz/0Q9dJXN/Ef/klniv/ALAt5/6IegDopXaOF3SNpGVSQikAsfQZIH5muBsPibdXWkWGtXfh42mk3WoNp8sjXqvNbyecYlJjC7SpYAEh8gnoRzXeyyxwQvLO6xxxqWd3OAoHJJPYV5D8MtLHi7wlEP7dtbjR7XWbi6eyt4QZDIty8kYeXeRsPyvt2Anj5scU46vXy/MH8P8AXZm9H8Up1g1W+1Dw5JYabpN5JZXVxPfxBkkCps+X7uGZwud2F4PTOGWXxf0+4t9VVobO5u9PNuFXS9QW7gn89/LjAlCrg7jhgV4681dsfh5cjSfENjrGsx3I1m+/tBJbSzNu9rNlSCN0jhsFEIB9DnOeIfGcGpWvgOeDxJrVrN9olige7j0147eGPeCzyqJGIGAcsGTGRjaeQuiv5ffpf8fkPS/zf3f8N8yHVvile6HZa0L/AMJ3Mt9oiRvdLaX0L24En3CJHKSEH/rlxg9a1k8b3Ueo61YXmhTfa9NsY7+C3s5ftElzG+4BcbRtfKEFRuHPBNcla+E5vEfhrU9D0TxFot5Z6oivc6zaWk9ySVYAI0kl1IZGwOPn+QLjHzDG7qHw81jVNW1a9uvElvF/aelR6cy2unNGY9hLBwxmOQWZsr/dIGeMl9P67f5i/r8V+lytd/Fe407SfEM134fjnvNCEDTwafqSTR7ZQcZkZUKkEYZdpIyMZrSuPiKNLvtWtdc0s20tjb29zAkFwJTcLM5jReVUI+8YIyRzndisvVPhZqmoWOrW0HiDT7RNWtLa1uFj0chIxCWI8tRMNoO7od2MHnni1qPw1vdc1rUb3WddgaO+0+C02Wdg0TwvC/mJKrtK4yHJOCDxgdsl6f16C1/r5f8ABH63468TaFo+pXd34OjL6aI5ZiupN5DwNnLpJ5OWZMfMm0YHIJ4rpLLWL288RSWS2VubKK0jme7S6LHzHziMJsAIwM7t3ccc1XLNpeiOnjrXtNmhnH2bzDALSOTcMbSHkfLnngEA9lqt8ONCl0DwZbW9zLNNLIS++dcSCP7sSsOxWJUU+4NJW1/r+u4P+v6/A6qiiikMKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/yLtr/2GtK/9OFvXSVzfjz/AJF21/7DWlf+nC3oA6SiiigAooooAKKKKACuN8R6LpWvfEnQLXXNMs9St00nUZFivLdZkVhNZAMAwIzgkZ9zXZVzd9/yVPQv+wLqX/o+xoAxfFfhzwJ4S8PXGs3Pw90u+trVS862el2m+NACS5DlcgY6Ak89Kg07QPCl/d2sU/wiisYbr7t1PpmnPGnylhu8qR2AOMZ24yQO9X/jDqFnYfCXxAL27htjcWUkMIlkC+bIVOEXPVjg8DnisvQdY8P3FxZWMnjxfFYv7b7GdHaWzm+8FLMVhRPlVVbO8HjOOeC463CWiX9djpv+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/ia4XQPDlpZ6rdeA10i3aHR759YtS9upR43U+TkkfeEjMuc5xFzxUPw8057vX9J1SXxFpsetW0TR6xpttpzR3k7lMEXTGds7WGVcoB2XAIFCSf9f110fYHp/X9bqzR30nw68EpEzL4K0GRlUkIulwZY+gyuPzrnvCegeEPFnhuDVrf4deHbQvdSwS289nAWjWORkJysZBb5c7enP3u5m8Z3Gmr4+0m38ZCEeHJbKURfbAPszXm9dofPy7tmdme+cc15xpGp6Pp/h3wQs989k9t4quFC3UskKtCZZW3YcgOBmP5+cE4yCSKI6282vzt/XkEtE/L/ACb/AK8z2T/hXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImvP557jSPEOpWfh+PS9b1TUVvLi0vLUlL+1k2SbBcL/FGCTGjEgD5QB3qCCDQJJPD9z4fu4baZbSRPFMkNyYZFh+zncbpgQyyCTGGYhwc4PWl0v/XX8rD62/rp+d9D0f8A4Vx4I/6E3w//AOCuD/4muf0TQPBOseJ9e0d/h5olo2jvEnmSafbN54kUsGAVTgYA6nPPIFcP4dg0u2+EXhrXIiZre4uYrfxDdxTvI32ZZJGKy4J+UOy7s/wkg8U83Fta6h45i8DBY7GSbTJRJZ2ry2y2wC+cU2FVKhWPyIwJXOPWnbVr5flr6Wf5k9F/Xlb+vI9V/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mvG9Z0/QNMh0y8XxdpNzp17rtk8NrpG6ysoAH/fFVE7qeApYfwnnjdz1niCw0rwd4gt5tMttJ1G1URWkWjzswvIMtuJs3JJOQ4JQADj7wAxTS/O34J/rYHp91zuP+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/ia6SipGc3/AMK48Ef9Cb4f/wDBXB/8TR/wrjwR/wBCb4f/APBXB/8AE10lFAHN/wDCuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNdJRQBzf8AwrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATXSUUAc3/AMK48Ef9Cb4f/wDBXB/8TR/wrjwR/wBCb4f/APBXB/8AE10lFAHN/wDCuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNdJRQBzf8AwrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATXSUUAc3/AMK48Ef9Cb4f/wDBXB/8TR/wrjwR/wBCb4f/APBXB/8AE10lFAHnfj7wD4Ps/ht4lurPwnocFxDpN1JFLFpsKvGwhYhlIXIIIyCK6D/hXHgj/oTfD/8A4K4P/iaPiP8A8ks8V/8AYFvP/RD10lAHnNzpPgAavcaZo/w60/W7qzKrdiw0q0C25IyAzylF3Y52qSwyOOa0tH8I/D/W7WWe18E6NGIZngdbjRoo2DrwflKZ/Hv1HHNYfgjV9P8AA154g0fxjeQaTd3GsXF7Bc3ziGO9ikIKskjYDED5SM5GBVjxVdaZdeKNHn8QwwR+EJIrn7TJqCBLaa5/diNpA3BGA20vwSOP4TQtl5r8bX/4HqD3fk/w/rX0Ok/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDia8mvvsWnQ+GotV1RoNM/4S2T+y0nvmjB0/B5xuG6MOAFY5wpUA4bmprN54YtPDnjo2N3psTaVrsDaUIpkH2Qt5RYwjPyZYS524zhvSmlf+v8P4+9+APR2/r7X+X4nsn/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E143repeFLuz+KF5Dq9leSx+RcabM2oecUl8oEPCSxwRISAV6fdHHFaGtapbweJNWg8D3tr/aGpeFEmCWNwpkuZ9+S4wcvL5RYg8sRzQle39dL/AKB/X4pfqeqf8K48Ef8AQm+H/wDwVwf/ABNH/CuPBH/Qm+H/APwVwf8AxNcDNF4dXXGu/CN5a22hHR7oa9JY3PkxLJhfLMjIRtmyWySQ+M5rH8DaloNlqnwvey1CyW/vdLngvWW4VpZfkXYjnOTiRWCg9CCB6U0r/wBev+X4ivpf+un+Z6t/wrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATXSUVIzm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mukooA5v/hXHgj/AKE3w/8A+CuD/wCJrn/H3gHwfZ/DbxLdWfhPQ4LiHSbqSKWLTYVeNhCxDKQuQQRkEV6JXN/Ef/klniv/ALAt5/6IegBr/DrwQqMR4L0ByBkKNLgyfbla4qKTwPJa392/wg8u102Z4b2Y6Vpz+QyAF8qkpdgAc/Kre2a9ad1jRndgqqMlicAD1rwiPWNC1PTfGaxfE1dIW81O58m1tri0YTqVUBlBQytu6fI4z2qbu79L/ih6aX72/BnWS2Hw/OueGrOw8BaFd2fiFHkg1BdPtxGqrGZPu7dxJAHYDnrkYrqP+FceCP8AoTfD/wD4K4P/AImvObTWbU3HwqttdtbPRLlo50fTJH2+WjQNGg2ucgMcABsnJxyaxYH0XT/DHhmykhjGoaL4ulSWG3t2eaziM0zYwgLIpUKR0yACOnGsopSsu9vxt+GhCb5eZ9r/AIN/jY9g/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mvDryy8JXHwj8WaqNRSW9tNXuoLK5/tWQvseRQqbt+XDImQGznBPvXZ+KdJ0i01DT4Eu9F0/wxqNpLcfaNVt2u7KW6dkO/PnIquVAZWJ67iOSTUdF5/5X/rzKej+/8Hb+vI7a/wDAPguz064uYvAuh3Twxs6wR6ZbhpCBnaCwABPuQKz/AAp4X8DeKfCena4ngXQLZb6ETCE6dAxQHtnYM1ykNtY6fqlvo3xA1JdVsYdHRNGvb6IpHcTh5A7ICW/fbfK2nJYjleprrvhL9n1H4NaFbzQNJCbIQTRXEDKHHIIwwG5SD15BqraNr+t/8hX1V/62NX/hXHgj/oTfD/8A4K4P/iahtvh14QaNjd+CPDUT72CiLT4XBTPykkxrgkYJHODxk9a4/wAN+HdHt9RvfA99pVqLLQ9Qk1ZZJIAF8iQFomDdmDMy5znENYPh6XS9Q+HMJtNb0SRNM1m+nNvrU3nWtwglfYJXLHacMjK7buxwaWlr/P8AIbvt5/5/8D7z0+T4deDxcRCLwR4baE58120+EMnHG1fLIbJ65Ix71L/wrjwR/wBCb4f/APBXB/8AE15tPr1tN4w8GXViF0rVLvR74R6bPekhJCuIcKxA+Zt+1toLD6YEmjQ6dI3g+40OaOLxFGVHiZo5dk4i8hvON3zuB3gbS/IP3aLf182vwtr2uLpf+tv16dz0X/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJrxjRdT8NafofhnULfVbL7dH4vniW5kvBJMLYyyBgXZi2woyE5ODuVjyc19F0W0v8A1sn+oPSVv63a/Q5v/hXHgj/oTfD/AP4K4P8A4mj/AIVx4I/6E3w//wCCuD/4mukopDOb/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mukooA5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/ia6SigDm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JrpKKAOb/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mukooA5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/ia6SigDm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JrpKKAOb/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mukooA5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/ia6SigDm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JrpKKAOb/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mukooA5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/ia6SigDm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JrpKKAOb/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mukooA5v/AIVx4I/6E3w//wCCuD/4msPxZ4K8K6RpdjfaV4a0exu4ta0vy7i2sIo5EzfwA4ZVBGQSPoa9Arm/Hn/Iu2v/AGGtK/8AThb0AdJRRRQAUUUUAFFFFABXN33/ACVPQv8AsC6l/wCj7Gukrm77/kqehf8AYF1L/wBH2NAHSUjhjGwjIV8fKWGQD7jjNLRQBl6RpVxaTz3uqXUN3qNyqJLNBAYYwiZ2qqFnIGWY8seSfpWpRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/wCSWeK/+wLef+iHo+3eN/8AoXvD/wD4Pp//AJDo+I//ACSzxX/2Bbz/ANEPXSUAc39u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdYej2o8LfFO9srzUtUntdUsvtGnC91KeeOIxn9/GA7EZ5RgeuCwzioLbXLHwfof9u3mozu/iC8b7DHrGryLbxIdzRgtKWES7F3EhSfmAAPAo6X/AK3t/XoHW39bXOj+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5Drl7L4wjVP7Oh0rQvt1xeahLprvBqEbW8cyRl/llAy6lRkMFHGe/ynRsPHeuG91ez8QeGrXSbrT9MGoJH/ahmEwOflysIAwVIYjdgkYBzmnZ/19/5B/X42/M1/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q6TxD4ovfDXgCfxFfaK01zbW/nT2NtcqRHxk/vGC5A7kLn0BrPvPGuu2lgJ5PC0cG9XmSW61IR26wqitueUI2xyWKhCOSp5xzSel79AWtrdTR+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5DrD/wCFm3d2/h+LRfDFxeSa9pz31qZbyOJAVTcYyeSDyozjHzDrziEfGLSv7fs7FxYeVc339nMqamj3cM+4p81uBny9wxv3Z6Hbg5p8rvy9f6Qr6X/rudF9u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IddJRSGc39u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIddJRQBzf27xv/0L3h//AMH0/wD8h1z/AI+vPGLfDbxKt5oWhxW50m6EskWtTO6r5LZKqbVQxA6AkZ9R1r0Sub+I/wDySzxX/wBgW8/9EPQAfbvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHXRuodGU5AYYOCQfzHSvF9Fm0iHUPEtrrt94yuDZ6xJbWr21/qrxxRbU2qZUfyxgseXbPrxihau3lf8l+oPRX/r+tD0X7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6qxeJb/TfGQ8MXunxLaR6c1za6nPqDO9yI9qsGXyuGBILHceDkZ5AxdT+La6NYQ/2paaVaal9jW+nsbnWViIiYttWIvGDJIQudu1QOm7pk0tf+uv8AkwSe39dP8zpPt3jf/oXvD/8A4Pp//kOj7d43/wChe8P/APg+n/8AkOp7jxJBN4DPiOws5dRtpLIXaW6lVaSMrux8xAHB5z+tcxbfEG8X+w9M8P8Ag5pG1DRRqNpCl5FDEqqqfuV44xvAyVUZx2yQ7O7XVf8AB/yYr6J9/wDgf5nQfbvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHXJXnxQ1C58J6vqlz4CmudLsXubW+ilvoCVMWAwdDwyHLA7Sx46EHNacviPXR8UtO0y0s7X+yDor3jRLcsHxvQZCiMgsvRVyAdxOR0oWtv66N/khvT+vNL82bX27xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh1zw+JOqTnULIaHbWepR6O+q20M1+WZEBxsuE8sNE/IO0bgeRu4qPw54tvJbbwJb+JNEiuLvVrYzQ6mLlZRERbli3zKGEjLnIAwAxG49KLf19/wDkwen9en+Z0v27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h1lJ8R3MOnatJpGPDupXYtIL9LrdKHZyiO8OzARmHBDk8jKjtWHxPuhDeXU3ht7eysNZTSrppr1PMUuUUOqIGDYMgyNw45BJyAJNuy/rb/NfeD0/r1/yZvfbvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFIDm/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ66SigDm/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ66SigDm/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ66SigDm/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ66SigDm/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ66SigDm/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ66SigDm/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ66SigDm/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ66SigDm/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ66SigDm/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ66SigDm/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ66SigDm/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ66SigDm/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ66SigDm/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ66SigDm/t3jf/AKF7w/8A+D6f/wCQ6w/Fl34ql0uxTVdG0e2tDrWl+ZLbavLNIv8Ap8GMI1sgPOB94YHPPQ+gVzfjz/kXbX/sNaV/6cLegDpKKKKACiiigAooooAK5u+/5KnoX/YF1L/0fY10lcb4j0XSte+JOgWuuaZZ6lbppOoyLFeW6zIrCayAYBgRnBIz7mgDsqK5efwB4CtbeSe58JeHIYYlLvJJpsCqqjqSSvArBgtPhNcFCvhnRY45JEjhnn8P+VDOzNtURyPEEkySMbSaN3YD0aiub/4Vx4I/6E3w/wD+CuD/AOJo/wCFceCP+hN8P/8Agrg/+JoA6SivPbfRfh7ea9rOjWfgHTZr3SIY5ZYzo1vGJd+7asZcKG+6eThffrjdX4deCGQE+C9AUkZKnS4Mj24WgDpaK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorz+00P4eX/iLV9EtPAmlveaTFHJMG0WCNZN+7aIywG77p54X3642Yvh34JkhR38E6DEzKCY30u3yp9DhSMj2JFAdbHT0Vzf8AwrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATQB0lFcFe6B8OrDxVpvh+bwTpJvNSSR4XXRYfKAQEtlyuM8dBk8jjBzWz/wAK48Ef9Cb4f/8ABXB/8TQHkdJRXN/8K48Ef9Cb4f8A/BXB/wDE0f8ACuPBH/Qm+H//AAVwf/E0AdJRXN/8K48Ef9Cb4f8A/BXB/wDE0f8ACuPBH/Qm+H//AAVwf/E0AdJRXN/8K48Ef9Cb4f8A/BXB/wDE0f8ACuPBH/Qm+H//AAVwf/E0AdJRXN/8K48Ef9Cb4f8A/BXB/wDE0f8ACuPBH/Qm+H//AAVwf/E0AdJRXN/8K48Ef9Cb4f8A/BXB/wDE0f8ACuPBH/Qm+H//AAVwf/E0AdJRXN/8K48Ef9Cb4f8A/BXB/wDE0f8ACuPBH/Qm+H//AAVwf/E0AdJRXN/8K48Ef9Cb4f8A/BXB/wDE0f8ACuPBH/Qm+H//AAVwf/E0AHxH/wCSWeK/+wLef+iHrpK878feAfB9n8NvEt1Z+E9DguIdJupIpYtNhV42ELEMpC5BBGQRXQf8K48Ef9Cb4f8A/BXB/wDE0AM8ceCoPG2nWdvJezWE1pcrNHcwD5wpBWRM5GA6My/iDzjFW/EHhs6vb2Dafd/2dfaZMJrK4EXmLG2woVZMjcpViCMg+hFc7qWi/C/S9Q+wXHhTRprwKGe3stAF1JGpzhnWKJigODy2BV7TPB3w51m1a40vwv4buoVkaJnj0yEgOv3l+51B4PvxQttPUH5+gar4R1zV9W0DULjXrMSaTdG6kQaa22ZihjIUedlBtZupY5Oc4GKreI9P0/xL450Qabfxve6XO66lHburlLcqH8qUDO3c6xEA4JGfetX/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iadwLHjPQLjxT4Q1DQ7W+jsDfRGF55LczbUP3sKHXnHQ549DWbqPgy91G70O6l1a383TLd4JUax3xSF1AMiIZP3cgxgMS2AxHOatf8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TSAxNG+HWqaTqPhaY+ILSeDw7aSWix/2aytOrgAkt5xCnCrjg8565wNrSPDGoaHezw2GsINGmuHuRZvalpondy7qs2/GwsScFCRk4I4wv/CuPBH/AEJvh/8A8FcH/wATR/wrjwR/0Jvh/wD8FcH/AMTTu27isdJRXN/8K48Ef9Cb4f8A/BXB/wDE0f8ACuPBH/Qm+H//AAVwf/E0hnSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJXN/Ef/AJJZ4r/7At5/6Iej/hXHgj/oTfD/AP4K4P8A4muf8feAfB9n8NvEt1Z+E9DguIdJupIpYtNhV42ELEMpC5BBGQRQB6G+4o2wgNjgkZAP0rhtG8H+LtDfVHs/E+jM2p3j3spk0KU7HZVUhcXQ4wo65+taj/DrwOiMx8G6BhRk40qEn8gnNYGl2Hwt1m3v5tO8HafKunEi5DeFnRkYdUCtACzj+6oLcjijq/T8A6DvFGi2utf2DoSa19q13T7mM3Lo6mYwOjCcyLklEkTcB2yVA7V0N94bvV8Tf23oGpw2E80CW93DcWpuI540LFMAOhRhuYA5I55BrH8OeH/hn4s0z+0dC8J6LPaFiqyy6CIA5HXb5kS7hnjIyMgjtWt/wrjwR/0Jvh//AMFcH/xNPVC3/I0NZ0y61Hwxd6Za3yQ3FxbmD7VPD5oG4YLFAy5OCe45/KuW0LwBrOk61oF7P4gsbmPRdNbTUiTS3jMsZ2/MW884b5E7Y68cjGz/AMK48Ef9Cb4f/wDBXB/8TUFv4E8AXbTrb+EvDsht5DFLt0uH5XABI+76EUlo7r+t1+v4je1n/X9WMhfhxqx8CeIPDsviGzZ9cuZp3uV0tgIhMcyKE8859jnjuDWlJ4JvptYsdTfXBFcw6U+mXDW9ps8xWZWDplz5ZBXvu68Y61ma1ovgDR782UXw8sNUuY4lnni0/RraRoImYqHKnBYZU8IGbg8Vun4d+CBGXXwXoLHGQo0uAE+3K0dP67W/LQOv9dXf/JmLpfwzubGS2M+s28iRaVPpciwad5XmpIVPmZ8w/vMrkk53E9BS2/w81eCXwn/xUVrJF4cjMYjfTDmdTH5RGRMNvyf73zEnkYUNbRPh5F4k0zQrnwHplvqGo27XEccmiwFIwoyytIAULDgEKW6jsQa3f+FceCP+hN8P/wDgrg/+Jp3f9er/AFbFp/Xov0sZ1n8PWtrOz0aXUo5vDthcrdWtl9lImVlfeitNvwyK3IGwHgZY85yrn4Y65c6Rqti3iawX+09XTVXkGkP8jKytsA+0dMxpz6bvUEdN/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNCbTv/XR/ovuG9f69f82dFGHEaiVlZ8DcVXAJ74GTj86dXN/8K48Ef9Cb4f8A/BXB/wDE0f8ACuPBH/Qm+H//AAVwf/E0gOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkrm/Hn/Iu2v/Ya0r/04W9H/CuPBH/Qm+H/APwVwf8AxNYfizwV4V0jS7G+0rw1o9jdxa1pfl3FtYRRyJm/gBwyqCMgkfQ0AegUUUUAFFFFABRRRQAVzd9/yVPQv+wLqX/o+xrpK5u+/wCSp6F/2BdS/wDR9jQBi/GeOZ/h4zBHksor62l1BEBJNqsoMnA5xgZPsDXVz3Wj32jwSyzW89jO0ZgZG3LI2QU2Y6nIBGPStMjIweRWXp/hnQdJvpb3S9E06yu5s+bPbWkccj5OTllAJ59aFored/6+4H3PMbDUb+58aaJNZa5qcltrF5qFvJdSXeFkVUkKeXakuiCMqAHwCSuSp3VW0jUNUsvhtp2v3fiTVpZb/Uf7Ou7me53JBA14ymUDGFbA2hhjAb2GPUpfB/hqfzPO8O6TJ5spmk32MZ3yEEFz8vLEEgnrg1PZ+HNE0/S5tN0/RtPtbCcky2sFqiRSZGDuQDByAByKadkvK39foD1/r+vL7jxnxC6eH9Y+I8GjeIb22vINDtLm2c33m3ACeYSoeTc5X5hk5yN4wRxWp4+1i+S01O70zWNQ+1aTplrOqxXjW0Nq7EsWbDf6Qzj+FlKgL1G6vSz4O8MmxayPhzSTaMFDW5sYvLIU5UFduOCePSlbwj4bZVVvD2lFUg+zKDZR/LD/AM8x8v3P9npTuH9fl/kcfD9s8U+IvEkc/iG80e90W6hFmIJ2WOODy0fzJIshZQ5Lgl8gAcYxW78QtZn0fw7ayW9y1pFdahbWtxeIQDbwySAM4J4HHGe27NbMvhzRJ7q0uZ9G0+S4sl22sr2qF4B6ISMqPpV25toLy1ktryGOeCVSkkUqBldT1BB4IpPZeVvn/wAP1Ev6/ryPFdSMeheIviPbaR4gu7e7h0C2ubaRr3zrhfLWViA8m5mGSuSckB+COK27vVNQ0xNO13VXvr7RvsFnHJPYamySWUjgbnkgyBKG3Kdx3MOy85rvB4Q8NjT5LEeHtK+ySKqvb/Yo/LYKcqCu3BAPI9KdD4U8O2/2X7PoOmRfY23W2yzjXyD6pgfKfpQn+n6/5hLX8f0/y/E841bUdVvPDXivxDHqeoWet6LqcsNjaR3LrFtQqI42gB2yeYDnLAsd/BHFLbS62NY8cahJrOr3dxoLR3NlYicCPebUuYmRQAybmxg8/Kpznk+mzaFpFxq0Wq3GlWUuowjEV49ujTIPQORkdexptj4e0XS764vdM0iws7u6JNxcW9skckxJydzAAtzzz3qfs28vx01+dir+9fz/AKXy2PI7y9ttO8R+A9ct9bm1K5vrC8mU3V6ZFnnMC7dik4Qs3y7EAGeMZqayXxfd6CniCPXo7OyvNJle4kg1mS7llmEe9XjjkgCQEFWDKvGCe4Br1Sz8NaFp90bmw0XTrW4LtIZYLREcs33myBnJwMnvio28JeHH+2b/AA/pbfb8fa82UZ+0YOR5nHzc885py1Tt1/Df/P8ABCjo1f8A4f8Ar9Wef2Gma6/gfw7qllqWp6zNeW1vdX2nzaw9vJOBCMmGQYKncVJXcFbuRk57/wAJ6rba34VsdQsTdGGdCR9rOZVIJBDHnJBBGQSOOpqQ+GNBOkppZ0TTTp8YIS0NpH5SgnJATGBk89K0YYY7eFIYI0iijUKiIoCqB0AA6CrlJNt92TFWSH0UUVBQUUUUAFFFFABRRRQAUUUUAFFFFAHN/Ef/AJJZ4r/7At5/6Ieukrm/iP8A8ks8V/8AYFvP/RD0fbvG/wD0L3h//wAH0/8A8h0Ac78Kpkt9Q8W2GpME13+2557iOQ/O8TY8lwO6bAAMccGrGrXEF/440vQ7O4nttI1BLue5msrh4DcXKeWAglQgjALEhSMlTnoRU+q6TrevNE2ueBPB+pND/qzeao8xT6brI4qa/tPEmq6f9g1TwZ4UvbMYxb3GrySR8dPlNkRxR28lb8Lf8EOr83f8TiDqPiArolrJ4h1EWsXi59LinSRQ17ahSRvfBLFWUpnIzg5yeaZq13qGneH/ABnPba1qu/w9rUKaez6hK3lq/ksyuS2ZV/eMMSFgB0xXY3uh6vqUdqmo+APBl2lmMWyz6k7iAccJmy+XoOnoKrt4Uu3SdH+GvgVluHEkym+JErjOGb/QeT8x5PqfWmnb+v8AD/k/vB6v+v73+dvkczr13qkcPxMuv+Ei1YyaIYbjTwt15awN5IkxtQKGXJxtbIIAzk81P4j13WfDOra22kX17cPJ4XXUfLnmaYRz+bsMqK2QgCkkqoC8dK3E8HTRRSxR/DHwGkcwAkRbwgOAcjI+w8881attA1Szv4r60+H3guC7hjEUdxFqLLIiBdoUMLLIG3jHpxSWlv66W/yfyD+vxT/zXzM29jv9K8U21joWu6nJY6po11c3Ukl2blrd0C7J42l3BNxYjA+X0UYrN8G6jqMd58OLi41fULuTXNLn+3LdXTyJKViV1YITtDAkjcBkg8k100Oi6xbWV3Z2/gHwbFbXpJuoI9TdUnJ671FlhvxqGDwxfWtxbT23w48DwzWnNtJHfsrQ8lvkIscrySeO5NUnb+vX/P8AAVtP68v8jv6K5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOpGdJRXN/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh0AdJXN/Ef/klniv8A7At5/wCiHo+3eN/+he8P/wDg+n/+Q65/x9eeMW+G3iVbzQtDitzpN0JZItamd1XyWyVU2qhiB0BIz6jrQB6JXm3hWDxHNf8AittE1fSbW2Gu3AMd1pklw+7amTuW4QY9tv410b3njWRGR/Dnh5lYYKnXZiCPT/jzrHtPDeoafb3MFh8OvBNrDdx+Xcxw6gyLMn91wLLDD2NK2r9Lfl/kD1S9b/g/8zkfDmo6nD8L/BOnWDReXqNxcxXDtfyWKuQZCqCaNHdCTyMYJ24zV6VdetrWz8Pa/rc1zqCC9mjt9O1OWP8AcqFMbTXmI3zHuAOFYtuBIODXRQaBqltpc2mW3w+8Fw2Fw26a0j1FlikPqyCywTwOoqVtJ1tobOJvAng8x2BzaIdUfbbn/YH2L5fwxTlrfz/r8P6sC0t/X9f1ucdokmr+KdQ8H22oeJ9Zii1bwzLNcrZ3IhPmqYgJAyqDuyxOST09CQeh+D+nWlhZ+IFhuLqSUa3eRFbi9lm+RJMA7XYjPPLYye5NWbTw3qFhfQ3tj8OvBFtdQcRTw6gySR9fusLLI6np61o2yeKrKe4ns/CPhe3lun8y4ki1mVWmbGNzEWfzHHc1Tavdef4u/wDwBW0t5r8Fb/gnOXdlY6d8V/FOqy399aG00KG7M32yd0iO6fLGLftZQACEI2g9ACc1k6beatFda3aR6zqtvHJ4YXUY5Z78XEwm3NmUB96w7gB8ikqAeMV1Y0LVRq0mqD4f+CxqEm7fd/2k/mtuGGy/2LJyCQeeRUf/AAjF8bdYD8OPA/krGYhH9vbaELbiuPsOMFucevNQ1eNvL/P/ADX3ehd1e/p+Fv8AJ/f63w7CV9U1v4ZNe3E0st1oF0ZZvOYSOWghy28Hdu6nIOc81l6frU8Phj4dXGoeI72C6m1WazupJdSfMqfvhiQMxVyGVACwODgd8V18Hhi+tbi2uLb4ceB4ZrT/AI95I79laHkt8hFjleSTx3Jqwmj6zHLLJH4D8HLJNKZpXXU3BeQgguT9i5YgkZPPJrSUk5X8/wBW/wBSEmo28v0scZp97rlj8O7nxCNf1O+vE1WbTma8vNsKwG9CGRtqEIVUH5wvyhjxgADuvA2n+INMvtTh1q6t5LGURTWNsuqTahLACCGzNLGrFSQCM5xz2qLTtL13SLGaz0nwN4QsbWckywW2qPGkhIwSyrZAHjjmpdMtfEuiWn2XRvBvhTT7fJbybTV5Ikz64WyApXt/X9evzB6/1/XodjRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h1IzpKK5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOgDpKK5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOgDpKK5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOgDpKK5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOgDpKK5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOgDpKK5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOgDpKK5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOgDpKK5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOgDpKK5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOgDpKK5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOgDpKK5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOgDpKK5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOgDpKK5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOgDpKK5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOgDpK5vx5/yLtr/wBhrSv/AE4W9H27xv8A9C94f/8AB9P/APIdYfiy78VS6XYpqujaPbWh1rS/MlttXlmkX/T4MYRrZAecD7wwOeehAPQKKKKACiiigAooooAK5u+/5KnoX/YF1L/0fY10lc3ff8lT0L/sC6l/6PsaAOkooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I/8AySzxX/2Bbz/0Q9dJXN/Ef/klniv/ALAt5/6IeukoA8c1LxNqWn614rsJPiDdRahpsqf2VpzW1nJJdboVk2eUsIkkG4lflIOO+ea7f/hMrnTdC0Y6zo15Nrl/ZmeXTrFULIUVTKcyOqgKWHG7POBmsVfAus6vqXiX/hIIdOtbfVbiO7s7qxvpJJ7OaKNUjYBoVGfl3Z3e2CDmn3GgeOtaksI/Ef8AYc9pBFJDdQQ3k6x3TMAFmZPKGcYP7okqd2cggUa8tuun5f57/LzZTtzX6f1/X9IvP8U9GaawisNO1nUJdQ086jbpa2JPmRDGQCxALDd0BPp1IBvSePdNi1O2t5bW9S0urr7FFqRRPs5uMkeV97eDkEZ27cjGc1zXhTwV4o0bXPC0t/Fo5tNE0mTTZXgvZWeTcUO9VMIHHlgYLdzzxza0f4cQ6Tr07yaB4bvYGvXvIdVnt1N9EWkMm0jyiGIJIV94IGODirtHm021/P8Ay/roRrb+u3+f9dT0KiiioGFFFFABRRRQAUUUUAFc38R/+SWeK/8AsC3n/oh66Sub+I//ACSzxX/2Bbz/ANEPQB0bgsjAMUJGAwxke/NeMS+L59Ms/Ep1P4oG21PSb2aK0srtLHM6IoKBolhWRtxJHyEe1ezuWCNsALY4BOAT9a85sfD/AI1ttO12yuNH8M3CazeTXLebqczpEJABtKG2+fGPVc+1Trd27fjdf8Eeml+/4Wf/AAC+vxHFhbaLZ61omqtrupad9sNlZWhcblTc6KzEKWH93ORkZ6jNy0+IenXms2tithqUcV3cyWcN7LEiwtOilnixu3gja3JULkHmsHQ/AGveH9X8GrFc2d/Y+H7Oe3nuLi5kSaQy4zsTy2G1doABfkccY5R/AniO48RWGp38mm3k1jrEt0LqW6l8x7V0dBGq7CsW0Mo2qcNtySDWsrOWnn+f+RC0jrv/AMD/ADI/FnjGa/1Tww+hPq1vYS67FatdRiNLa+XLB1znzCAU4JCq3PLV0Fp8QobvTdYuhoGrxS6RdJaTWcotxNJI23AQCYg/fU5JGc8ZrnR4A8WRaJomhW15o4s9B1SO7tL2UyvJJEm8qjxAABhuAyH568Vs3mgyv8XLe5tJlFncWa3GpQY+9JC2IG9iS7fXyh6VMbbd2/yX+T07lS3uuiX5v/NF+Xx/p8WoJAbDUGtjdrYy36RI0ENyxAETENuJ3EKWVSoPBamWvxD0271qGxWw1JIrmWeG1vTCphuJIM+YihWL5G1sbkAO04J4pug6Fr3hvU9RtbM6fcaPe3st7HNLK6z27SHc6eWEKyDdnB3qeehxWHb+CPEyeI9J1m9Ol3t7p19cyvcy3cvmXEMiOqqMxkRbdyjYuV+XOc0K2l/6/wCGf9PcH1t/W/56GpYfFPRtQszeR6frEVpveFJ5rIorzLKI/JAznzGZhgEDv0IIGBZeMJbLxZ44vPEI16LTrGwtJTp8oDyWobzN3liAkAYAO8MSMctxxasPAXiFfAp066l0211W11ptWs3hnkmhZjMZQj5RCB8xXIB9fam6p4L8YalceKb0tocUuvaTHp4tPPmZYmUOu/zdg4AkY48vngZXGSnpF97fp/ndFRtzWe3/AAf8tTd1H4haXolhE62GqXkUenx39w0Kq7Wts3AkkLuCx4OQu9uCcV10UizQpLGco6hlOOoNeX6z4B8Va5oL6ZfPpUkD6ItjHA95MYrW4UEeaF8sCTd8nLAFMcZ5z6Tpsc8Ol2sV4sazxxKsgicsoYDBwSASPwFXK2tu/wDmZxvZen6L/glmiiioKCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/yLtr/2GtK/9OFvXSVzfjz/AJF21/7DWlf+nC3oA6SiiigAooooAKKKKACubvv+Sp6F/wBgXUv/AEfY10lc3ff8lT0L/sC6l/6PsaAOkooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I//JLPFf8A2Bbz/wBEPR/wrnwP/wBCb4f/APBXB/8AE0fEf/klniv/ALAt5/6IeukoA890TS/hd4h1W803S/COlvd2P/HzHN4bMAiJ6AtJCoyQcgZyRyOKsaP4e+GuvXd7bab4P0lpLGTyrjzvD3kqr/3Q0kShj9CeCD3FVvGOrR+APGVt4olRzpuqwGwvhGpY+egZ7dsDufnT8VpniKTV9C8OeH7CLyhPq1+V1KVrx7NS8iPIV89EZo8vhQQM8AAjOaFqvw+f9fmgej/H5HRf8K48Ef8AQm+H/wDwVwf/ABNH/CuPBH/Qm+H/APwVwf8AxNefzWXiyw1bw1peteJLiOO51qa3+z2GovMRbG3aRUkmaNJHdSMBj2IPXBq5eWU/gfxLNpjazrd/b69pv2XTZL/VJ5WjuwQpAO/5WYOr5UAjY2CBTt/XyuH9fjY7T/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJrN+IUN1ofwd1YaVq2oWtxp9gzx3Yn3zOVH8Uj7ic9znPoRWHrVpJaNp2mpr+uXdxfWk981sdRa35WOMeYbhWDRxq3OxQ2S5+XA4T0v5f1+g0r28/6/U67/hXHgj/oTfD/AP4K4P8A4mj/AIVx4I/6E3w//wCCuD/4mvPdNuNY8R3Hw+hvPEurRRazoc7XiWtwIizpGuJAyqG3ZfOc/wAI4HObOjP4v1jVI9Ttr63t/wCz9Xe1vPtWsz5a3WUoImtBD5YcrtYPu3EkHODgVy2ly/1vYm+l/wCtrnc/8K48Ef8AQm+H/wDwVwf/ABNH/CuPBH/Qm+H/APwVwf8AxNdJRUjOb/4Vx4I/6E3w/wD+CuD/AOJo/wCFceCP+hN8P/8Agrg/+JrpKKAOb/4Vx4I/6E3w/wD+CuD/AOJrn/H3gHwfZ/DbxLdWfhPQ4LiHSbqSKWLTYVeNhCxDKQuQQRkEV6JXN/Ef/klniv8A7At5/wCiHoAa/wAOvA6IzHwboGFGTjSoSfyCc1gaXYfC3Wbe/m07wdp8q6cSLkN4WdGRh1QK0ALOP7qgtyOK9FrzbwrB4jmv/FbaJq+k2tsNduAY7rTJLh921Mnctwgx7bfxpX1fpf8AFf5g9EvW34P/ACL/AIc8P/DPxZpn9o6F4T0We0LFVll0EQByOu3zIl3DPGRkZBHatb/hXHgj/oTfD/8A4K4P/ia838OajqcPwv8ABOnWDReXqNxcxXDtfyWKuQZCqCaNHdCTyMYJ24zV6VdetrWz8Pa/rc1zqCC9mjt9O1OWP9yoUxtNeYjfMe4A4Vi24Eg4NVKybt0/TcFrY7r/AIVx4I/6E3w//wCCuD/4moLfwJ4Au2nW38JeHZDbyGKXbpcPyuACR930IrgtEk1fxTqHg+21DxPrMUWreGZZrlbO5EJ81TEBIGVQd2WJySenoSD0Pwf060sLPxAsNxdSSjW7yIrcXss3yJJgHa7EZ55bGT3Jp8tpNPz/AAdhX91PzX4q5a0PQPh14gv9VtLHwTpKSaVcC2uPtGiRRZcqG+UFckYI5wM9Rkc0tl4f+HN/4p1HQIPBWkLeadFHLMZNFiRCr527SV+b7p5HHvXL6lF5d38TdRi1S80+9sLqK4tWtrp4v3gtU2BkBxIGOF2sCD6Zo1fW9W0vXPGOrWsZTVovC9hKVVcmJy0u5sf7OSfwpLVL0X4q5TWtvP8AVL9T0D/hXHgj/oTfD/8A4K4P/iazfEPhX4e+GtAu9X1HwVo721onmSC20WKV8dztVOg6k9AOSQKwtZvNW8J62reF7691WG60K7vpYLu5e6CyxqpjlUsSVDFiNqkKewFM1SwH/Cr9U1y18T3l/baj4bnaW3ubkzJPMY93mpuP7vHzAogC8jgYqZXUW+3/AAf8v61s6aUpRT6/8D/M6qw8CeBNQ062vYfBmgrHcxLKgfSoAQGAIz8vXmrH/CuPBH/Qm+H/APwVwf8AxNc18NrxNYvA+py31nqun2cEUelm7lEP2cphJxGG2Sb+fmx8pAXqMn0mtJpKWhlBtxVzm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JrpKKgs5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJrpKKAOb/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDia6SigDm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mukooA5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJrpKKAOb/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDia6SigDm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mukooA5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJrpKKAOb/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDia6SigDm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mukooA5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJrpKKAOb/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDia6SigDm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mukooA5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJrpKKAOb/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDia6SigDm/+FceCP8AoTfD/wD4K4P/AImsPxZ4K8K6RpdjfaV4a0exu4ta0vy7i2sIo5EzfwA4ZVBGQSPoa9Arm/Hn/Iu2v/Ya0r/04W9AHSUUUUAFFFFABRRRQAVxviO/udO+JOgS2ek3mqu2k6iphs3hV1HnWR3HzZEXHGODnkcdcdlXN33/ACVPQv8AsC6l/wCj7GgA/wCEo1f/AKETxB/3/wBP/wDkqj/hKNX/AOhE8Qf9/wDT/wD5Kqx4vstavfDd0PDGrS6ZqcaNJbvHFFIsjAHCMJEYbSfTB9+1c8NXvtb+HmgSaH4hu4NT1KWKNbtoYGkZuTMroY9g2qr9FHKgZ9Ra/h+If8H8DZ/4SjV/+hE8Qf8Af/T/AP5Ko/4SjV/+hE8Qf9/9P/8Akqqr+O7HTdUj0meDU7xYbuLTZ9VMUXlC5dQVVwCrZO5clY9oLdR2vWvjC0ujdTCzu4tOtZZYn1GQR+RmLd5h4cuoUoRllGTjGQc0+l+geRH/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVWbd/FDT7Kyurm50TWkSCxOoxK0MQNzbAgNImZOMbgSr7Xwfu1fl8VwX+sjw9FDqNlc3ultfW18oi2hPlB25ZiHUuOGTH1pO6X9ef+T+4Fr/Xp/mh/wDwlGr/APQieIP+/wDp/wD8lUf8JRq//QieIP8Av/p//wAlVzfg3xvLafDfw5JqMOpa5q2oWss+y32NLIqMS7kyMq4GRxnPIAFab/FPRmmsIrDTtZ1CXUNPOo26WtiT5kQxkAsQCw3dAT6dSAW1rb+v60YdLmj/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVWjrOvWuiWUM1xHNLLcyLDbWsKgyzyEEhFBIGcAkkkAAEkgCvONN8ZjTrXx1e+Kn1+SytdQjiW3/5eLVXhVigMJCoAzEBwwHQ7jnJEru39dP8w/r8/wDI7b/hKNX/AOhE8Qf9/wDT/wD5Ko/4SjV/+hE8Qf8Af/T/AP5KqxD4niuNZudPs9OvrhbSSOG4uoxGY4pHCkKQX3nCuGJClQM85GKz5fiJpUNxG0lrfDTJLo2S6t5afZvPDlNh+bePmG3cU25/iosHS5Y/4SjV/wDoRPEH/f8A0/8A+SqP+Eo1f/oRPEH/AH/0/wD+Sqo2fxP0a8e+cWOrQWenyzRXd7cWZjigaNA53ZO4ZBwMryRjuM4i+Lbj/hbUU2oNq2l6SmgXF3JaX+xYsLJHiYLGTkkZ4Y7h0wucESu0vn+Df6D/AK/Gx1P/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lVnah8UtI0eG/bWNN1eyls7YXgge2DyTwZx5qCNmAXPXcVK5+YCrsPjmC4kt4YdF1f7TdSlbeCSGOJpYwqs0yl3ClAHHfdnI25GKQiT/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KrftZ/tVpFP5UsPmIG8uZdrpkdGHY1LQBzf/CUav/0IniD/AL/6f/8AJVH/AAlGr/8AQieIP+/+n/8AyVXSUUAc3/wlGr/9CJ4g/wC/+n//ACVR/wAJRq//AEIniD/v/p//AMlV0lFAHN/8JRq//QieIP8Av/p//wAlUf8ACUav/wBCJ4g/7/6f/wDJVdJRQBzf/CUav/0IniD/AL/6f/8AJVH/AAlGr/8AQieIP+/+n/8AyVXSUUAc3/wlGr/9CJ4g/wC/+n//ACVR/wAJRq//AEIniD/v/p//AMlV0lFAHnfj7xHqk/w28SxS+C9ctkk0m6VppZrEpGDCwLNtuS2B1OAT6A10H/CUav8A9CJ4g/7/AOn/APyVR8R/+SWeK/8AsC3n/oh66SgDlLrXL2+iEV78PNauI1dZAk0mnOAynKtg3XUEAg9iKS91q81KzktNR+HWtXdtKNskM76c6OPQqbrBqhomq6x47v8AVrmx1efRdJ0+/extxaQwvLctHw7u0qOAu44CgA8ZzzWkNev9CAsdZjk1jVbmeU2Vvp8UaPNAu07sO4VdoYAlmGT06gUdPxDr+BltBYv9j3fCO7b7B/x6Zh0v/R+c/J/pHy8jPGKjuNU8R6r4gtbjU/h3qkdnpk5ns2jvbGSSVyhTcwM6hMBm4BbPByMVof8ACz9C+y6bKsOovJqF82nrAloxeC4X70cvZCPryORkc0yT4m6dBZ3Vzc6Tq0CWF4LPUN8cX+hMxUKz4kIZTvU/u95wRkCmr3/ry/zX3i2/r1/yZLqWpza1ZGz1j4a6tf2rEMYLo6bKhI6Ha1yRUDzRyQ2cUnws1Bo7DH2RGTTCLbjH7sfafk49MU+9+J+k2b60P7O1aaPQpUTUJVtQiwqwz5nzspZQOflBJBBAI5q3/wAJ/pUN7qFvqUN3pwsbIagZLmNds1vkjzECsT1GNrBW9qX9f18hmTBa6fbXdtdW3whuobi14t5o4NLV4eSflYXGV5JPHqatm7zrH9rn4YamdS27PtuNM87b6b/tO7HtmrKfECwju57XU9N1TTbmO1e8hhntw73UK9WjETPkjIypwwzyBTdD+Iem69eaTDBY6hbR6zatc2M9zEiJMFALLgMWDAEHkAEdCaev9fP/ACYtP6/rzLH/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lV0lFIZzf8AwlGr/wDQieIP+/8Ap/8A8lUf8JRq/wD0IniD/v8A6f8A/JVdJRQBzf8AwlGr/wDQieIP+/8Ap/8A8lVz/j7xHqk/w28SxS+C9ctkk0m6VppZrEpGDCwLNtuS2B1OAT6A16JXN/Ef/klniv8A7At5/wCiHoAa/ibVZEZH8Ba+ysMFTNp5BHp/x9Vj2lrp+n29zBYfCG5tYbuPy7mOGDSkWZP7rgXGGHsa71yVRiFLkDIUYyfbmvNW8V65d6q0X/CNa9Cl3q8UMJFzagRpCoaRTtuDjJSTOOCOMk8ULV2B6K5fgis7bS5tMtvhJeQ2Fw26a0jh0tYpD6sguME8DqKlaSJobOJvhXqBjsDm0Qppm23P+wPtPy/hiotD1XV/H02rXVhrFxoem2N/JY2otIIXlnaPh3cyo42luiqAcDrzVKx+K0emXV7pHii3uJ9TsdVTTfM0+1Zkm8zBic9o8huQW6g4z0oWvzs/yt+aB6fj+t/yZbtLXT7C+hvbH4Q3NtdQcRTwwaUkkfX7rC4yOp6etaNtq9zZT3E9n8ONYt5bp/MuJIm05WmbGNzEXPzHHc1hv471bXPEt3odvomtaLF/Y73P2iQW6TQMXZRIVZ2wBsIGAxO7OMYNP8A+PYj4U8N2uvi/W4vNIN3/AGldgGOcxqDL8xbfkA5yVAI5BNC2v/XX/IHvb+un+Zp3F4bvVINSuvhhqc9/b/6m6kGmtLF/uubnI/A0yKWODWJdWg+FmoR6lMCJbxE0wTSA9QXFzuPQdTV2x8fadd6lZ2lzZX+nLqMRm0+4vI0WO8ULuOzaxKnbztcK2O1Z+t/ESW28Aah4j0rQdQkjjs3ubWWXyRHKgxiTIkJC/NnaQHwD8tDukNasm028OjCYaP8ADDU7Dz33y/ZRpsXmN6ttuRk+5qqbewMN3CfhFdGK9YPdIYNL2zsDkFx9o+Y55yc81YuviPBpOmRy6no2rGeKxW9vo40gZrSEkr5j4k2kHaThCzY7Coj4/uE8darpsujX7aXp+mxXZuLdUkLB9537FbzCCF2gKpOckgDBptW/rt/wwk7q/wDWv/DiWkdpYXlvd2PwlvLa5tU8uCaGLS0eFOflVhc5UfMeB6n1rX/4SjV/+hE8Qf8Af/T/AP5KqnZ+ONMTw9pMuj2Oq6m99Y/a7ezjYSXPkDGXdpZAO4HLkk8DJrWk1KLX/BMmo6Rd3FtHd2bSwXCIEljypIOHUgEe4pTbim30CKTaS6lX/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KrnfAXjp5fCfhuz1Kz1W71G+0j7TDcSBD9teNQXRWZwd/IOXCqc5BxWrbfEe1u/C8OtwaDrLpLePZi0WOFrhWTdvJjEh6FG4GW4+7iqkuVtdv8AOwk7q/8AW1y7/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVUtM+JelaomlXEdhqcGn6tKYLW/uIVSJpQzARkbt6k7TglcHpnPFSy/ETSobiNpLW+GmSXZsl1by0+zeeHKbD828fMNu4ptz/ABUrO9hlj/hKNX/6ETxB/wB/9P8A/kqj/hKNX/6ETxB/3/0//wCSqyNJ+IVxPrniODVNHvLe202+js7cqYX8yRlTamFcsXYvkcbQvVgQRUsvxT0a2AjvbDVre9GoR6dNZG1EkkEr4KbyjMm0hgQQxzzjJBFJK9rdf1/4dfeg2NL/AISjV/8AoRPEH/f/AE//AOSqP+Eo1f8A6ETxB/3/ANP/APkqoE+IFg8F0Dp2oJf21+NPOnMIhM8zJvUA+Z5eCnzAlwPx4qW/8U6fFrGhWOoWerW13qF1JHbLsZEV0V8+YytsIIBIUls8EDjIdrhsO/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqry/ETSobiNpLW+GmSXZsl1by0+zeeHKbD828fMNu4ptz/FVeb4o6RE2oN/Z+rG30y+SxvbhrURpAz7QHIdlYplhyATznGCDSWu39bf5r7wen9f12ND/hKNX/AOhE8Qf9/wDT/wD5Ko/4SjV/+hE8Qf8Af/T/AP5KrpKKAOb/AOEo1f8A6ETxB/3/ANP/APkqj/hKNX/6ETxB/wB/9P8A/kqukooA5v8A4SjV/wDoRPEH/f8A0/8A+SqP+Eo1f/oRPEH/AH/0/wD+Sq6SigDm/wDhKNX/AOhE8Qf9/wDT/wD5Ko/4SjV/+hE8Qf8Af/T/AP5KrpKKAOb/AOEo1f8A6ETxB/3/ANP/APkqj/hKNX/6ETxB/wB/9P8A/kqukooA5v8A4SjV/wDoRPEH/f8A0/8A+SqP+Eo1f/oRPEH/AH/0/wD+Sq6SigDm/wDhKNX/AOhE8Qf9/wDT/wD5Ko/4SjV/+hE8Qf8Af/T/AP5KrpKKAOb/AOEo1f8A6ETxB/3/ANP/APkqj/hKNX/6ETxB/wB/9P8A/kqukooA5v8A4SjV/wDoRPEH/f8A0/8A+SqP+Eo1f/oRPEH/AH/0/wD+Sq6SigDm/wDhKNX/AOhE8Qf9/wDT/wD5Ko/4SjV/+hE8Qf8Af/T/AP5KrpKKAOb/AOEo1f8A6ETxB/3/ANP/APkqsPxZr2o3ul2Nvc+E9Y0+J9a0vdc3Mtm0aYv4DyI52bnGOFPJ7DmvQK5vx5/yLtr/ANhrSv8A04W9AHSUUUUAFFFFABRRRQAVzd9/yVPQv+wLqX/o+xrpK5u+/wCSp6F/2BdS/wDR9jQB0lcX4c8D3Oh+N9W1N71JNJmd5tPsgDm2lmwZyc+rKCMdNzdM89pRQtHcN1Y8313wP4j1fWpbuV9Nu/I1e2v7CW5uZQ0UMbKTCECFYzgN865LZ5xTtU+HN3rGuXMyrZ6NbX0FxFqMmn3MhN/5iMg3wFQgZcq3mZLEjHSvRqKOlv62t+gX1uv66nGDw/4j1XwHe+GdebTI/MsHskvLWWRzNlCodoyi+X2JAZ+/NZ9t4V8XDxBpWtztoqS6fo8mntZpLK6zMdpBEpUbASin7jYGRhuCPQ6Kbbbb7/5NfqwWiSX9bf5I8t0fwF4qtPDOgaNqL6VPZ6fBPb3dot5N5U+/7kp/djftyw8phtOc5zjE3hTwV4o0bXPC0t/Fo5tNE0mTTZXgvZWeTcUO9VMIHHlgYLdzzxz6ZRT5ne/9df8AN/1YW6t/X9aHNeMPD9/q7aTf6JNbpqOj3n2qCO6LCKYFGRkYqCVyrnDAHB7GuP1fwF4w1HSvGESSaGJPEk0MiwmaYC32oisTJsO77mANgznOR92vVaKlaf16f5Ff1/X3nBX3g7V9R8Rabq8dtpuk38U0T3d/Y3spkkiXGYGTy1WYH5l3ORtGCBnioI/h/qY8PjwlK9m2gLffaxeec/2kr9o8/wAox7NvXjfv6fw16JRTvbb+v6/rdk2/r+vU86tPAmtXvhvxhpWtvY2Z129e8tprK4efyiwXAYNGnQxqeDzk9Mcwat4D8T+LNUjuPEFxpNlE2j3Gl3K2hknaTzCp3qWVAvKg4IbAyOc5HplFLt5K34W/IfW/9b3/ADPLr34c383grVdN07w14Q0rVLy0ey+12IMQlVsZdisG5Omdg3AnHzDFdD4g8M3eu+GrG0vNI0q8ubeHO2W9liME4CgPFOkZdcDdyFBPHTmuwopt33BaWM7w9YXml+HLCx1O+bULu3gWOa6ccysByxzz+J5rRooobu7iSsrBRRRSGFFFFABRRRQAUUUUAFFFFAHN/Ef/AJJZ4r/7At5/6Ieukrm/iP8A8ks8V/8AYFvP/RD0f8K58D/9Cb4f/wDBXB/8TQBmab4Z1/whqmp/8Iuum6hpWpXb3ptL64e2e1lf7+x0jk3qTzggY9TVnUvDutN4g07xJZS2d3qlnDNbtaTu0EDRSlThXVXYFSg5KnOTwOMZeiaX8LvEOq3mm6X4R0t7ux/4+Y5vDZgERPQFpIVGSDkDOSORxVjR/D3w1167vbbTfB+ktJYyeVced4e8lVf+6GkiUMfoTwQe4oV9Ldvw2/4APrf+nuZt74B16OTTLjTF0ya4Gvtrl/591JEu8qUEUeImyNp+8ccrnHPFbVfAvi7UNI8YWiQ6Kj69qMN3Ax1CXESIEBDfuOv7odP7x9Oex/4Vx4I/6E3w/wD+CuD/AOJo/wCFceCP+hN8P/8Agrg/+JoWm39bf5IN3d/1v/mzjr7wV4z1Gw8bRS2ugwyeJo40jC6lMwgKxiM5P2cZ4Geg5496l1r4feIPEmsTHURptpZXWgrpcjwXkkkscgbzA4UwqGXeAMFhkc8dK6z/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaNv68rfqH9fin+iMy58N+INV1GLV9Tg0uO+06xuLWxggu5DHM0oUGSRzECgwv3Qr4z1NZGheCvFWm3HgUXMOjmHw3bSW9y0d9KWl3oE3IDCBwFBwSOSR2yeq/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaadv69f82K2lv66f5HSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0hnSUVzf8AwrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATQB0lc38R/wDklniv/sC3n/oh6P8AhXHgj/oTfD//AIK4P/ia5/x94B8H2fw28S3Vn4T0OC4h0m6kili02FXjYQsQykLkEEZBFAHobqroyOoZWGCpGQR6VwelfCnw/ZXmnTz+HdBP2dJ3m2WMZLTO6smDsHyoNwGenGK13+HXgdEZj4N0DCjJxpUJP5BOa5S3l+El35/2XwZBP9mkMU/l+DLhvKcDJVsW/BAI4PrQtHcOhuaf4a1zwhfap/wiiaffafqV2959lv7l7c2sr/f2skb71J52kDHPNY2o/DrW0t4ptPk0++1O612LWNSnup3t0JiI2RRhY3O0KMZJ7Z5zgdLbeAfAV5aQ3Nv4P8PvDMiyRt/ZUIypGQcFMjg1L/wrjwR/0Jvh/wD8FcH/AMTTV4teVvwt/khaNev6/wDDlDWPDWuN42vNd0f+z5UutG/s9obqZ4yrh2YHKo3B3EZ6jHQ5rlh8NPEt3pHhXSNRTSUs9J0240+8lgv5TI6yx+UWjBgAyFAbBIyTjtk9x/wrjwR/0Jvh/wD8FcH/AMTR/wAK48Ef9Cb4f/8ABXB/8TS6W6f8P/myru/N1/4ZfojMs/CmtXNxoI13+z0i8OgtayWszu12/lGJWdWQeWMEkqGfJ78c4938M9SubbxBa2H2DRLTVNMktvsdpcSywTXD4PnGNlUQ4O4YTOd2ScitfxH4X+Hnhfw/d6zqXgrR3tbRN8gttFilfHrgJ09ScAdSQKvWvgHwLeWcNzF4M0EJNGsihtKgyARkZ+X3p3bbf9aiS5bJf1Y53xL4G8U+JNPurO8l0ua3uNH+yRQSXMwjs7gZ/eBQmJc/L87AFduQOSK0E8LeI7XX77VbZdLka+0WGxeGS5kUJLHv6MIzlTv+9jIx905yNaT4eeBYo2kk8H+HlRAWZjpcAAA7/dqvF4G8DXC2klp4I0Oe3uk8xbhNLtwqLjKkggNznjAPvih+8mv61uC0t/Xb/JGF4d8FeKPDdr4fvLYaTNqOmaYdKurV7qRYZ4gwZZFl8osrAjkbCDnGe9d3fx6jN4fuYoUtZL+SF1RHkaOLcQQAW2scDPXbz6DpWX/wrjwR/wBCb4f/APBXB/8AE0f8K48Ef9Cb4f8A/BXB/wDE0pe+mn/Vwj7rujldC8FeKtNuPAouYdHMPhu2kt7lo76UtLvQJuQGEDgKDgkckjtk6uj6FLa/E3XJoZlbSlVbxYcf6q8lTbJ9PkQNj/pqT3rV/wCFceCP+hN8P/8Agrg/+Jqpqvgz4e6LpN1qWo+EvD8VraxNLK/9lQnCgZPATJ+lOTbu/X8QS6LyOP8Ah3omq+I/h/4ZguvsMWjWV4b3zEldp5mjmcqmzaFQBsEtuOQMYGa24/h/qQ8PjwlK9m2gLffaxeec/wBpK/aPP8ox7Nuc8b9/T+Grei+E/BWr/aVl+G9hpj27AFb7RrYCQEZDIyblYfQ5HQgVUl0v4ZR65o2lx+DdHnk1kSG1ni0WIwkIpYkuVA6L0GTyDjHNO7vp6/19wt03/XX/ADf9WItU+G+oaldeIRI2lz2t/qcOqW0d1GZVd0REMUqFcbCEPIJPzdBjlmpeBNVfTNNTQPDvhbRpYdTt766gs52ijbyWyAHW3BYtnuo2/wC1muo/4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJpLS1ulvwtb8kN67+f4/8OznY/BetXOoeJ21rSNA1Cx1m8S5jtpbyU4CRbFBbyfkbKo24ZxkgdAaiTwT4rt08KKJ7G9XR9QlvJvteoTFkjdXRYUcxMZAivw7bSdoGBnjp/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImhO34fgD1/rv8A1/Whz8fw/wBSHh8eEpXs20Bb77WLzzn+0lftHn+UY9m3OeN+/p/DWbq3gXxfqGk+LrOGHREbXtSiuoXbUJsRIgQYYeR1/dL0/vH057L/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaLtf16f5IP6/P/ADOgtzKbaM3KIk2weYsbllVscgEgEjPfA+gqSuUuPAngC0aEXHhLw7GZ5BFEDpcPzuQTgfL6An8Kn/4Vx4I/6E3w/wD+CuD/AOJpbhtodJRXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQB0lFc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAHSUV55rWi+ANHvzZRfDyw1S5jiWeeLT9GtpGgiZiocqcFhlTwgZuDxS61pnwv8AD9/a2WqeDtOW4vB/o6QeGGuPNOCSoMcLAsApJXOQBnGKAPQqK4fQ/Dnwy8RwTS6P4X8PzfZ5DFPG+jRxSwv/AHXjeMMp9iBWp/wrjwR/0Jvh/wD8FcH/AMTQB0lFc3/wrjwR/wBCb4f/APBXB/8AE0f8K48Ef9Cb4f8A/BXB/wDE0AdJRXN/8K48Ef8AQm+H/wDwVwf/ABNH/CuPBH/Qm+H/APwVwf8AxNAHSUV5vf2fwu0vXL/TNQ8HaTA+nWB1C5nfQ4/KWEEDKnZlzz/CD0I68V0MXw98CzwpLF4P8PskihlP9lw8g8j+GjpcOtv6/rU6eiub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkrm/Hn/ACLtr/2GtK/9OFvR/wAK48Ef9Cb4f/8ABXB/8TWH4s8FeFdI0uxvtK8NaPY3cWtaX5dxbWEUciZv4AcMqgjIJH0NAHoFFFFABRRRQAUUUUAFc3ff8lT0L/sC6l/6Psa6Subvv+Sp6F/2BdS/9H2NAHSUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD10lAHnnjHVo/AHjK28USo503VYDYXwjUsfPQM9u2B3Pzp+K0zxFJq+heHPD9hF5Qn1a/K6lK149mpeRHkK+eiM0eXwoIGeAARnNegXVnbX0QivbeG4jV1kCTIHAZTlWwe4IBB7EUl7Y2mpWclpqNrDd20o2yQzxh0cehU8Gjpb+rf1+gPf+t9rnkU1l4ssNW8NaXrXiS4jjudamt/s9hqLzEWxt2kVJJmjSR3UjAY9iD1wauXllP4H8SzaY2s63f2+vab9l02S/wBUnlaO7BCkA7/lZg6vlQCNjYIFegN4Q8NP9j3eHtKb7B/x6Zso/wDR+c/J8vy8jPGKjuNLvNV8QWtxqdtZx2emTmezaOZpJJXKFNzAooTAZuAWzwcjFPT+u1rf8EPP+r3v/wAD0MX4hQ3Wh/B3VhpWraha3Gn2DPHdiffM5UfxSPuJz3Oc+hFYetWklo2naamv65d3F9aT3zWx1FrflY4x5huFYNHGrc7FDZLn5cDj0fUtK07WrI2esWFrf2rEMYLqFZUJHQ7WBFQv4d0SSGzik0ewaOwx9kRrVCLbjH7sY+Tj0xSet/P+vzGtLeR5VptxrHiO4+H0N54l1aKLWdDna8S1uBEWdI1xIGVQ27L5zn+EcDnNnRn8X6xqkep219b2/wDZ+rva3n2rWZ8tbrKUETWgh8sOV2sH3biSDnBwPRIPBvhi2u7a6tvDmkw3FrxbzR2MSvDyT8rBcrySePU1aOhaQdY/tc6XZHUtuz7b9nTztvpvxux7Zq+Zc1/X87/8D+rE20t/W1i/RRRUDCiiigArm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh6AOkry3wpB4jl1PxlJoeraZaWy+IZt6XNi8jkhI9xEolCrx6xtj3r1F1WRGR1DKwwVIyCPSuc/4Vx4I/6E3w/wD+CuD/AOJoWjv5W/FP9Aeqt5/o/wDM4bx5czR6omt+G9X1a40+8sz/AGtHa3k5WytWIAvIl8wBGG04Cg5G5gDhsyeNrxFsHtvD+ualOLDQHvoPJ1OSIL18u4kn3lpicEBCGB744r0RvCvh5vtO7QdMP2qJYbjNnH++jUAKjcfMowMA8DApieEPDUUdukfh7SkS2V0gVbKMCJXzvC/L8obJyB1zzSa92y/rf8v8/K1Jq93/AFt/lb7vO/DWM994y1a70y916+0y5ttIsrqwe0uGiy8iEvOyqQJQGAUq2V46c5qnqU/i7X9c1qPRNRtLe40eaH7Lcz6xNbIIvKRzI9skTJKjkv8AMzcdBjGT6RL4W8Pzw2cM+habJFY4+yI9nGVt8dNgI+X8MVNd6FpF/qFvf32lWVzeW3+ouJrdHki/3WIyv4Vd1zXX9f1sZxTUbM8f1az1DUfDfxKl1DxDq90NKedIITcARFWswSjIFAKgvkDAwVB65zt/bX8O6tpsllrV4LK68PT3WoiWZ7mO18uNPLnVCSE5JG1cBvTivQ9P8O6LpM1zNpWj2FlLdnNw9tapG03JPzlQN3JPX1NOsNB0fS4biLTNKsbOO5YtOlvbJGspPUsABuJ96npbyS/Br/g/1cvqr9/1T/Q8XvZLyXSfFGn3V9qclpN4S/tAJdam8sjzZb97gMfKDcZjVimOMdq2be6u9B1TwdDoupX9zby6FdStp73bTJJNHCjryxLE5fG0sQABgCvSbXwt4fsShstC023McTQp5NnGm2NjlkGBwpPJHQ0xPCHhqO6tblPD2lLPZKq2sosYw0ABJAQ7cqASSMetD6+f/wBt+V19wu3l/wDa/wCT+88/0251RLXwLrFhrOoXV5r7pHqcMly0sbK0DO7rExKxGNl/gAHYg1maPqGq22j+HdUn1/VLy6k8WTabI1xdkpLAZZU2tGuEP3QQcZB6YHFetW/h7RbW8uru10iwhubwYuZo7ZFecejsBlvxqivgLwesUca+FNDEcbmRFGnQ4RjjLAbeDwOfYVV1zXt1/Vaen+Ymrxt5fo9fx/Ao+Or+6guPD9hDNNbWep6kLa9uIZDGyR+W7BQ45QswVcgg88EE1wXi22uT4S+IOj3V/f3elaSsMljNLeymRHdMvC8m7dKq5Bw5b7wznAx7HeWVrqFnJaX9tDdW0q7ZIZ4w6OPQqeCKoTeFPDtxpMWlXGg6ZLp0Lb4rN7ONoY255VCMA8nkDvUrT+vT/L8fvq+q/r+r7EdzpNtD4LudOSS7aD7LIN8l7M8uCpP+tZi//j3tXkvhjT7V9L+E9vDd3QM8c8k2LyRnUm05VSWJjGMcJtxnIx1r22zsbTTrGOy0+1htbWJdscEEYREHoFHAFZZ8F+FjLBKfDWjmS3JML/YIsxHJb5Tt45JPHc5p31b72/X/ADJS91L1/E8w0/XddvLDS9CjuXuoZdU1Kz8+71ea0kl8mXEUZuUR5N20k9i2zk9QfR/B0Gt2fhQWviS/trrUIHlQ3EMzShVySgZ2VSzKpAJwM4qzH4N8MQ6ZNpsPhzSY7Gdw8tqtjEIpGHRmTbgkepFasFpb2tolra28UNvGuxIY0Coq+gUcAe1J7ND63PK7Oy1HU7W68J6rfa1p/iCbT5Lu21Oz1mWSC7IKjzkIYGP5iv7vCrhjjPWq0mq3OvfDvUNb0/VNU0y60HQ3hlEN/I228QEyLIHLB2XYBuYFsSZyDgj1Wx0XStLnnn0zTLOzluMedJb26xtLgYG4gDOB61StvCumDSLrT9Ts7XUYby6kuriOe2Vo5HZ93KHI4+UD/dBolqml/T1/R/gthxdpJvv/AF+K/FnCWENzN4s8O6dNrery2+seHXuLwf2hIC8ieVtdSpBjPznJj254znnOR4U1LVNdvvBVvq3iLU2ttS0y+WeFLvyfMaGQKrb0xJv2nk7s/LnjnPqCeCPCkckcieGNGV4ozFGw0+IFEIIKg7eAQzcdOT61kXPww8PTa/p13BpelwabaQTxyaWunR+TO0uz5yOFyPLH8Jz6jFU2nL7/AP2635r7iEmo+en6f5Hn8kZ1eXwe2saje3MFt4jvbO3vRfyxNNbJHLtcujLlvlxv6kA84Jzpf2nrE/g2DxZbalfrr41r7IbD7S5hZPtRi8gwZ2ZEfO7G/jO7Feqz6RptzbQW1zp1pNBbOrwRSQKyxMv3SoIwpHYjpTBoWkDWDqw0uyGpFdhvRbp5xX0343Y9s0J2t/Xb87ajev8AXr+V/wADyPWbzVbbRviDqH/CRas9xomrRtYn7XsWIFIm2bVAVl+cjawI74zknavP7Yh8X+I9D0bWJ1M2k2l3CL6+cgTPM6sFc5MW8AKNgABIIFdm/gXwjIJxJ4W0VxcP5kwbToj5rcnc3y8nk8n1NSx+DvDEV2LqLw5pKXARYxMtjEH2qAFXdtzgBQAO2B6VK2S/ra356j6/13v/AMD5md4F1RL221Cze21CzvNPuFgurW+vDdGJvLUjZKWJdSMNknOScgVxN/qWsXHhHVfFEGpX0HiCw1iS2t7EXLiEqtx5aQNb52NvQg7iN3zZB6V6tp2l6fo9mLTSLG2sLZSWENrCsSAnknaoA5qJtC0h9YXVn0qybUlXYt6bdDMF9A+N2Pxp396/9dP6+YdLf11/r5HF6Zo9r/wvTWLky3vnJpVrNs/tCfZuaSYEFN+0rwMKRtB5ABOam+IovX8SeCk0q4tre9OqS+VJdQtLGD9ll6orqT6cMOvfpXUxeF9Ah1o6xDoemx6mzFjfJaRiYkjBPmY3ZI460mpeFvD+tXsd5rGhaZqF1GoVJ7qzjldADkAMwJAySaL6JB1b/rax574bvbbS9A8Z6prOoyab4r2s+sP5Yf7OY49sckMXG6PbypPJ6E5HFXS9O1XXNS8R+HU1jWbDfpFreWjnWJZZ4Z28wbywc7MlVzGGZMdOvHp954b0PUNRTUL/AEbT7q9RPLW5ntUeRUwRtDEZA5PHuaWw8O6Jpc0c2maPYWcscXko9vapGyR5zsBAGFyScdM0aPftYd7bf1qv+GPLZdUudf8Ah3f63p+q6rpl1oOhvDKIb9223iAmRJA5YOy7ANzAtiTOQcEPfWLrw/qFu0/iHUIobzwhJfXVxcytc+VMnlhZkjJ2hsOchQA2Oeea9GtvCumDSLrT9Ts7XUYby6kuriOe2Vo5HZ93KHI4+UD/AHQaSPwX4Whnjni8NaOksUflRyLYRBkTBG0HbwMEjHTBNF7tt9f8n+r/AAErK3l/mrfgvxPI9WvNXtdF8Z20OpaxbC10O11G2D6vLLPFKS+5y4clMhRmNWZPzq74z8XT+HPGl8dO1yZGuPD8Epie8MiQu06o8yRMxUMsWX4GOCT3r1a28L6BZY+x6HptviA248q0jX90SSY+B93JPy9OafZ+HtF06IR6fpFhaoI/JCwWyINmSduAPu5JOOnJp31T/rqv8g6W9P8A23/J/eearo+iy/F660KbVZrq21bwuYgtzfmeRw8pLbGcknK5bHIHYAVr6jeXWgeNPtOrfbZ9Jury3tLO6sNRYJZsdgEMttkKdz/xgM2HwcCuz03w7oujEHR9HsLAhdgNrapFhck4+UDjJJ/GnvoekyapHqT6XZNfx5KXRt0MqZGDh8ZGQB3oTtby/wA7/wDA/qwnrfz/AMkv0uXqKKKkYUUUUAFc348/5F21/wCw1pX/AKcLeukrm/Hn/Iu2v/Ya0r/04W9AHSUUUUAFFFFABRRRQAVzd9/yVPQv+wLqX/o+xrpK5u+/5KnoX/YF1L/0fY0AdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/wDklniv/sC3n/oh66Sub+I//JLPFf8A2Bbz/wBEPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc38R/+SWeK/wDsC3n/AKIeukrm/iP/AMks8V/9gW8/9EPQB0leP2+tz2euTaX4w1PV9B8RXF6RaXctzJ/Z95D5uUjjHMSkoAvKh/fJr2CuL1DwJfapoqaDf65HcaISpmjksf8ASWw+4KsocKqjgD5CwH8WeaF8SB6xsC+N9Uj1HxNY3uh2sFxo0C3Fso1Bm+2o+7YR+5GwErt/iIbjHQnPu/iXq1l/wkCT+FRHL4etYbq8Daku10dWZvLIQlsBTjcFz328ZtavpuneI/iLo1xpWoRyy6X5sWpx27q48tSrpFLjO1hKEYA4OA3vUOr/AA81jVLvxZIviGyhj8SWqWrIdLZjbogKjB88bjtZucDnBxgYJ0v/AF/THpfX+u5D448TS6z4V8RWGh6e91DZ6b515ci9a2aIvEZEWPaCXYDaxBKjBAyckVFofjXUrK30Pw5pvhqW9mGgQXqTvexwpIgEasF6nI3H72MkY6HIuP8ADjUkg1CKz8RQ241fT1tNSX+z9yyOsXlrLEDJ+7O3AIJcHHbrU+h+ANR0bxNpuoy+II761sNK/ssQTWAWV48hsmRXCggqP4PujByfmpqyk+3+Sl+tvkS7tJ9V+vL/AJManxIcwadq0uj7fDupXQtIL9brdKrs5RGeHZgIzDghyeRlR2rSfFC7isdTv5PDMkVnperLpt15l6nm/MUUOqgFT80gyCw45yeQL1n8PWtrOz0aXUo5vDthcrdWtl9lImVlfeitNvwyK3IGwHgZY85yrr4Y65d6LrWnP4nsAur6ompSONIfMbKytsA+0cjMac/73qMCtfX+tV+nN+A3/X4/8A0rn4kx6RPrdv4jsYdPm0v7Oyst4HilWdisZLsqBDkHdnIA5yat+CfH1p4wu9Tso/sX2vTWTzW0++F5byK4JVklCrnoQQVBBH41n3vw5vtT8Rarqd/rsIF/FaiNbaxaN7eW3bfFIGMrA/MSSpXkYHbnrdJttUt4P+J3qMF9cYC7ra1NvHgd9pdzk9zuxxwBQrW1B+RoUUUUgCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACub8ef8i7a/9hrSv/Thb10lc348/wCRdtf+w1pX/pwt6AOkooooAKKKKACiiigArjfEei6Vr3xJ0C11zTLPUrdNJ1GRYry3WZFYTWQDAMCM4JGfc12Vc3ff8lT0L/sC6l/6PsaAMbxX4c8CeE/D9xrFx8PdLvra2UvOtnpdpvjQAkuQ5XIGOgJPPSqOnWPw/uvEFtoupfDex0a+vIWmtEvtKsytyq8ttaJnXIBBIJB5rV+MGoWdh8JtfF9dw2xuLOSGHzZApkkKnCrnqxweB6VzGnajpegeLrDXPFuupq+m3lt5eh6/cSxiK2YqBJA3lhYlJ25D4BIBUnjlxt/Xp/X/AA9gltp/W39f0zuf+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mvN/D9i+qeJLW+vfEum2Gv2V7NJd20Ont/aE8JdhsaQznfDtZSrBNoAUjpVG9+z2fg/xPoUS2F69rok92Nb0aZ4ZGYbWAu1U5EzYVuWO4K2QBkUulxpXlY9VPw48EYOPBvh/Pb/AIlcP/xNR2vw68Hvaxte+CPDcVwVHmRxafDIqnuAxjUke+B9K4BR4ekv7W60C6hgsxoE6+Ibm2nMSghE8oTSKQRMG3YydwGe1YXhxvDPiG9+Gun3+pW94LjQ57a8tDqBKs2xVVWjDYDElx0BJHfaMVy62/r7X+X4kp6Xf9bf5nsP/CuPBH/Qm+H/APwVwf8AxNUdL8H/AA81m3ln07wl4fliinkgLjS4MFkba2Pl6Agj8K87v5tFXxtaXVv9nt5rXxMlldPeSb7wRFGQIx48u3bHyq24NnOck1HoFppuneHYIUsrS102PxNdJ4h2QBFW2DzeSs+AP3YJThuApGflNKOqv/XT/McrrR/18X+R6t/wrjwR/wBCb4f/APBXB/8AE0f8K48Ef9Cb4f8A/BXB/wDE15D4vi0uz8K+JH0/UUtvDEmpWB0cW94YoDISPtAh2sA0e0k4GVBDEAEZHWeJPDPhvwLqmkePNA0e28mC4cXz28fmtJHcDAlU8kkOVwR/CzDoaP6/Bf5gdl/wrjwR/wBCb4f/APBXB/8AE1R1Hwh8PNMnsoLrwj4fE19P5FvGNLg3SPtLHHy9gpNaPhm00vw1p1lpANjZajeK91JaxlUaaQ/NKyp1IBOM9hiuY+Kdho8viDwXea9ZWc1rHqjxzy3UCuoQwSYU5B4LhcDuQO+KLapAtU36kng/QPBPivTbu6f4e6Jpz2t9NZtBLp9s7BozgklVI656Ej3roP8AhXHgj/oTfD//AIK4P/ia8Zi1jwzBoZ1qHUtOF9H45Z4Lk3K70gecbypz8qGPJOOCOTW3qEUV5o+pea8SfEVdWd9PIYfa/L+0futn8Rg8s84+TG7PeiKuk/T8o/5hLRv1f5y/yPS/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mvM4IPDdx4i+JF3LPcahPpbrcQCyv2kuYW+zlZDFljtIZ3XpgHjHAFUrGd7MeK4fCD2ccl14ftbq3t9FYsHO91ldCMebLtGC6qpJxxkUlqr+V/wuP8Ar8Uv1PVLj4deDltZWtPBPhuWcKTGkunQorNjgFhGSB74P0NSL8OfBJQb/Bnh4NjkDTISAfrsrzvxdB4Fj+FvijU/C2pxQR3NgFeCyuzFELheV3qpGJmLAFWOWxyDg1blfw5r/iGe28Y3sAsLzTbQ6BePMqoGwQ7W8h+UTB8cr82Mdqdib7f12/zO6/4Vx4I/6E3w/wD+CuD/AOJo/wCFceCP+hN8P/8Agrg/+JqDx3dW1h8Nb6W5a9e3ECIzxSGKXaWUZZypKDnLHbwN3FeM67c6HYeH/FlgupadYwHUdNuLG2026a2gKuE3mNQwDqV3kkDBxuwMZC62/rcetrntv/CuPBH/AEJvh/8A8FcH/wATXP2WgeCbvx3qPhp/h5okBsrSK6W5fT7YiZXYj5VCkgAqRzg8dMYJ43VtWsrDxN4ysPCV1D9kePTbm7g0yQFzEZCLqRQnJbyyu5hzyD1rofBU3huL4x6knhBLf+zrnRLdom0+Im23CWTdhlGxT+Iyc981UVez/rb+vxCWify/Nf5nY/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TXSUVIHN/wDCuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNdJRQBzf8AwrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATXSUUAed+PvAPg+z+G3iW6s/CehwXEOk3UkUsWmwq8bCFiGUhcggjIIroP+FceCP+hN8P/wDgrg/+Jo+I/wDySzxX/wBgW8/9EPXSUAec3Ok+ABq9xpmj/DrT9burMqt2LDSrQLbkjIDPKUXdjnapLDI45rS0fwj8P9btZZ7XwTo0YhmeB1uNGijYOvB+Upn8e/Ucc1h+CNX0/wADXniDR/GN5BpN3caxcXsFzfOIY72KQgqySNgMQPlIzkYFWPFV1pl14o0efxDDBH4QkiuftMmoIEtprn92I2kDcEYDbS/BI4/hNC2Xmvxtf/geoPd+T/D+tfQ6T/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJrya++xadD4ai1XVGg0z/hLZP7LSe+aMHT8HnG4bow4AVjnClQDhuams3nhi08OeOjY3emxNpWuwNpQimQfZC3lFjCM/JlhLnbjOG9KaV/6/w/j734A9Hb+vtf5fieyf8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TXjet6l4Uu7P4oXkOr2V5LH5Fxpszah5xSXygQ8JLHBEhIBXp90ccVoa1qlvB4k1aDwPe2v9oal4USYJY3CmS5n35LjBy8vlFiDyxHNCV7f10v8AoH9fil+p6p/wrjwR/wBCb4f/APBXB/8AE0f8K48Ef9Cb4f8A/BXB/wDE1wM0Xh1dca78I3lrbaEdHuhr0ljc+TEsmF8syMhG2bJbJJD4zmsfwNqWg2WqfC97LULJb+90ueC9ZbhWll+RdiOc5OJFYKD0IIHpTSv/AF6/5fiK+l/66f5nq3/CuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNdJRUjOb/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDia6SigDm/+FceCP8AoTfD/wD4K4P/AImuf8feAfB9n8NvEt1Z+E9DguIdJupIpYtNhV42ELEMpC5BBGQRXolc38R/+SWeK/8AsC3n/oh6AD/hXHgj/oTfD/8A4K4P/iaw7nw54IiubqGHwF4fma3vYLMD+z4FLtIFZv8Aln/Cr598dq72VPMhdPlO5SPnXcv4juPavFdE+H/2nVtHlFl4OXzZrnUAY/DOP3aNsUZE/Qh1ZR/CQD82KFrKz/r+lcHoro6HQbT4ca34iv8AQJfAGmaXq9iod7O+0u03SKQDuRoy6sBuXODxkZq74f8ADfgrX5b5G+GdhphspvIc3umWRDvjJC+Wz9ARycDnjPOM+ex0rxzea4/hnW7IeIdJ1MXNhdW86yNC3kRKQwU5MbFWRh04PcVjNrK6h4Yik8XaZ9hlvfEjRXNpeTBLRJFiAInJUhoyRlV43EpyOtNa/cvxa/zCWn3/AJJv9D0T/hXHgj/oTfD/AP4K4P8A4mj/AIVx4I/6E3w//wCCuD/4mvLdJa2XwPaNJquhbtD1PUP+JfrClLN1WfCqNxPksuU2Z3EBuAag8a6hp2saDKW00abfQ+GEurS31Ny5tiNx/wBFTAbzRj5pNw2jZkHmi39fK40ru39b2O5ttA8EXHj688MN8PdEhNtZJeC6fT7YrKrNtG1QpI5DDnB46YOa6D/hXHgj/oTfD/8A4K4P/ia5Tw9r+l33xuZLfVLS4ml8M26gJOrM7+YzkdeTtIbHXBzT/FMejXvxEu9P8fSRQ6VcadEukS3biOJJyziUxueFm5jwfvYHHeizSS9fwb/yJTTbfTT8Uv8AM6j/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/ia4TU7fRZNX12z8bzB1Fnbp4emv2ImcCLl4CcHz/M67AHzt4xisiA6Y3jTTrbx9f20l+PB5/tO3v7wFFmBQkNGzbQ20biMdt3bNL+vwb/TXtca8/wCtUv1PUv8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+Jrxqz8QaRc+F/CsuvXNnrETaA0McF1f28P2W5V9omDTOo3jG0lSXXAIHNbmoWZTSvDNl4g8Q6RPpE2ksJdT1fzNRs57ssu5hI06ANjJRicDnaBVNWdvO35/5fihJ/wBfd/n+DPSf+FceCP8AoTfD/wD4K4P/AIms+38IeAL+41G103wh4cnudPcRSqdNgVRIUDBSwQ44IzwcZ71xGp2q+FrPTbu/1LTvFk1pYpZfZdRjaG7nBZ8PZsSx8xlOCBksFU7hVPUbTw9punfFd54LbS77czwyIPs8qq0EbIN64O1pf4c4ZsjB5qZaJtdE/wAGv8yo+80u9j1CL4c+CzChm8F+HUkKjeqabCwB7gHYMj3wPpT/APhXHgj/AKE3w/8A+CuD/wCJrgbW58P6nd2DeNJ9Pm8Oy6Bappct1Ipt2uBuEuwk4EwwoGPmGOO9Yujrp6eLPDFp481COSY6BeC6t9UvDjyvMUw+bG7YBMQJORk7STkrkVJWbXr+F/8AIiLvFP0/G3+Z6x/wrjwR/wBCb4f/APBXB/8AE0f8K48Ef9Cb4f8A/BXB/wDE1lfBrUotS+FOkNFdpdGBXgYq4Yptdgqn6Lt69sV3NKSs7DTujm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/ia6SikM5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/ia6SigDm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JrpKKAOb/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mukooA5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/ia6SigDm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JrpKKAOb/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mukooA5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/ia6SigDm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JrpKKAOb/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mukooA5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/ia6SigDm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JrpKKAOb/wCFceCP+hN8P/8Agrg/+JrD8WeCvCukaXY32leGtHsbuLWtL8u4trCKORM38AOGVQRkEj6GvQK5vx5/yLtr/wBhrSv/AE4W9AHSUUUUAFFFFABRRRQAVzd9/wAlT0L/ALAupf8Ao+xrpK5u+/5KnoX/AGBdS/8AR9jQB0lFc9428VP4O8OHVl0ybUgJo4mjilSPbvYKGJY9MkDjJ59MkY194+1WxutetG8PQNdaNarfup1HCSWzBjnd5ZIk+RhtwV4+/wA0r6XHZndVi+L9DuPE3hHUdFtL2Oxa/haBp5LczBUYYbChl5xnBzx6GuT1/wCMWlaPbrNCLFyllDfTQXmpR20zRyKWCwoQfNkAGdvyjkDdk1Q+IPixvEvw98Sx+H7FrmwtLDfc3v21rd43aISqEVRl8BkLAsowcfNyKck7PyCDu1Z7npGj2lxp+i2lne3EdzPbxLG80UJiV8DGQpZsce5q7XB6V4qjt9Xl08+Hp3u9O8PxXiXMQR5buMjiONVy33gRgkcjpzmo4/ie0Ca4mraXBb3OkW8Fy6W9+JkCysVAkbYpjZSMsCpwOcmqlu/66v8AyIhsreX5L/NHoFFec+J/F3iWO28NvpVnpRXU9VhgMkWqM8UylN+EkWLOwlWUsVzx90huJLv4grpVr4y1H/hFZBdaA0YuljniD3Q2bg5b+6FIIzlsH7oPFT0f9dv8yuqXf/g/5HoVZOp6Vd6peRxz3kC6UpR3tRbnzZHVwwzLvxs4GV2ZP97tWEnj27j1G/srzw/N9oh0pdUtYLOb7RLcxklSm0KNrhgBgFgc5zWFr3iuTxL4I8caVf2sdjfaPp3nM2nak0y5aNnT94qowYFPmUjH1BoleKcu2v3DguZqPfT7/wDhz0e4sY7m8t55mc/ZmLxx5AXeQRuPckAkdcc9M4qzXP6fqtrofw4s9U1BylrZ6XHNKwGSFWIE4Hc1xjX2q3Hxi0C/v9He0eXR7ySG3i1Azeao8sqpVgqRyfMQcZHI+c44pxtJx7X/AFf6ERfNBS72/T/M9TorzvRfiJbzaZoa6fotlpbavNdFbe6vFt40McxVwGVCHlYkttAGfm+bjJ2L7xfqIv7nT9G0OO+vtPtIrq/hlvRF5QkDERowRg7/ACHg7V6fMM0npqUdZRXntp8UbjWdTs7Tw34ZuL5b3TRqMMs93HAHTeqsoHJBBZhzjJXjg7qxPHWvXHiPT9DvrTTmXSE8R2kMN4L1leRluAjFoQApjJUgEsTnB2jrTUW5Jd3b8bCurN/1tc9dorzm5+MWkweIYbGL7DcQTXx04LFqUZvBOGKAm2xxGWGAxbPIJAHNFt8U76bw7ca5P4YNnp8M0ls01xqEYEcyziICTaDtTkkuNwXa3B4Jlaq5TVnb+v60PRqKo6Re3GoWInuobeItjaba58+OQbQdyvtXIySOQOme9Xqb0EncKKKKQBRRRQAUUUUAFFFFAHN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN/Ef/klniv8A7At5/wCiHrpK5v4j/wDJLPFf/YFvP/RD0AdJRRRQAUUUUAFFFFABRRRQAUUUUAc/f6HrJ8Rtqui61b24mhSGW2vbE3CBVJOYyskZQncc5LA8ccVrabYJp1n5COZCztI7sAC7sxZjgcDkmrVFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN+PP+Rdtf+w1pX/pwt66Sub8ef8i7a/8AYa0r/wBOFvQB0lFFFABRRRQAUUUUAFc3ff8AJU9C/wCwLqX/AKPsa6Subvv+Sp6F/wBgXUv/AEfY0AHjrwxd+L/DR0my1KHTt88UskstqZ8hHDgAB0x8yjnJ4zx3GPe+AtbvtV1++k8QWCtrWlppzKNKfEQXd84/f8/ffj3X0Oe8opWVmv67DTaaf9dzitF8E6xoDWsuneILUTfZYbW9EmnM0dwsQKo6r52Y32nBO5gcZ29qh1f4c3d4uv2+ma/9jsvEMBS+imsxM3m+WI/NRg67SQBuBDA4429a7uiqbbbbFFctkjzxvhpqz6ldzP4rJiudFGkblsNlwqDJEnmLIF3bmPRAMYHX5qu6P4E1DSNVkvodYsVMun29k8EGlCOICJ2b5V8w4DKzKRz1yCOldtRRd/18/wDNit/X3f5I89i+FrQQRyW+qW9reJrKavi1sPLtVdUKFVh8wlcqSSd5+bn2pmofDbWr+HxbE3iWzVPEyokhOlMWgVUCDB88BjsHJwOecAcV6LRS/r8v8kV1v/XV/qzzzUfhvrOq6nPd3Hie3h87RxpRFtprIwAIbeGM56t1GPunGc/NTpvhvqUlnrsMOuWMB1rTYrCQR6UVjhCB1LIgmGAVc4BJwcHJ6V6DRQ9VZ/1v/mJaO6/q1v8AJGAPDAvPAP8AwjGuXC3aPZfY5p4IjDuXbtBClmwcY7nn8qxIPAmu/wBt6Rqt54rWa50i1mtoNmmqgmVwuDLlzuPyDO3Zntt5z3VFNttt/wBf1qJJJKK6f1+h59YfDjU7XwO/hm81jStQt2aU/wClaKWT94+8naZvvAs2DnAyODjm9a+ArnRZlm8N619nklsoLK8e+tjctOkKlVcEOm2TBIydw6fLXZ0UhnE6L8PpNA8V6dqGnalAumafpn9mx2LWbGRkJDFjL5mNxcZ+5jGRjvVG5+F97JpY0a08TNa6RDqK6haRrYq09uwk8zYJGYqy7iSMpkdyRxXolFO7un2/zv8AmH9fhb8jl9K8Lanoc9xBpmtxrpM0z3CW01mXlikdi7ASiQDYWJO0pnkgMOMReF/COp+HfDNxpcmsWt1JNeS3XnDTyiYkcu6MhlbIJYjII4x9a62ikBz3g3wonhLTrq3SaKRru6a6dLa38i3iZgBtii3NsX5c43Hkk966Giim3cAooopAFFFFABRRRQAUUUUAc38R/wDklniv/sC3n/oh6P8AhY/gj/ocvD//AINIP/iqPiP/AMks8V/9gW8/9EPXSUAc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VS+HvGH/CQ6xqWnLoWqWD6ZJ5VxLd+RsEhVWCjZKxJKsDnGMd88VZ0DxG+vXF9E2i6hp32KbyHe8MBDuACQvlyOeAQcnA5+uD/hwehV/wCFj+CP+hy8P/8Ag0g/+Ko/4WP4I/6HLw//AODSD/4qukooA5v/AIWP4I/6HLw//wCDSD/4qj/hY/gj/ocvD/8A4NIP/iq6SigDm/8AhY/gj/ocvD//AINIP/iqP+Fj+CP+hy8P/wDg0g/+KrpKKAOb/wCFj+CP+hy8P/8Ag0g/+Ko/4WP4I/6HLw//AODSD/4qukooA5v/AIWP4I/6HLw//wCDSD/4qj/hY/gj/ocvD/8A4NIP/iq6SigDm/8AhY/gj/ocvD//AINIP/iq5/x94+8H3nw28S2tn4s0Oe4m0m6jiii1KFnkYwsAqgNkkk4AFeiVzfxH/wCSWeK/+wLef+iHoAP+Fj+CP+hy8P8A/g0g/wDiqP8AhY/gj/ocvD//AINIP/iq6NyVRiFLkDIUYyfbmuJi+JYktb+7fwl4gjtdNmeG9mItX8hkAL5VJy7AA5+VW9s0Aaf/AAsfwR/0OXh//wAGkH/xVH/Cx/BH/Q5eH/8AwaQf/FVt6dqFrq2mW2oafMs9rdRLLDIvR1YZB/KrNNpp2YJ3V0c3/wALH8Ef9Dl4f/8ABpB/8VR/wsfwR/0OXh//AMGkH/xVdJRSA5v/AIWP4I/6HLw//wCDSD/4qj/hY/gj/ocvD/8A4NIP/iqk8M+KG8RX+uWsmnS2D6Re/ZCJZVcyfIrh/lyACGHGT74PFdBQBzf/AAsfwR/0OXh//wAGkH/xVH/Cx/BH/Q5eH/8AwaQf/FV0lFAHN/8ACx/BH/Q5eH//AAaQf/FUf8LH8Ef9Dl4f/wDBpB/8VXSUUAc3/wALH8Ef9Dl4f/8ABpB/8VR/wsfwR/0OXh//AMGkH/xVdJRQBzf/AAsfwR/0OXh//wAGkH/xVH/Cx/BH/Q5eH/8AwaQf/FV0lFAHN/8ACx/BH/Q5eH//AAaQf/FUf8LH8Ef9Dl4f/wDBpB/8VXSUUAc3/wALH8Ef9Dl4f/8ABpB/8VR/wsfwR/0OXh//AMGkH/xVdJRQBzf/AAsfwR/0OXh//wAGkH/xVH/Cx/BH/Q5eH/8AwaQf/FV0lFAHN/8ACx/BH/Q5eH//AAaQf/FUf8LH8Ef9Dl4f/wDBpB/8VXSUUAc3/wALH8Ef9Dl4f/8ABpB/8VR/wsfwR/0OXh//AMGkH/xVdJRQBzf/AAsfwR/0OXh//wAGkH/xVH/Cx/BH/Q5eH/8AwaQf/FV0lFAHN/8ACx/BH/Q5eH//AAaQf/FUf8LH8Ef9Dl4f/wDBpB/8VXSUUAc3/wALH8Ef9Dl4f/8ABpB/8VR/wsfwR/0OXh//AMGkH/xVdJRQBzf/AAsfwR/0OXh//wAGkH/xVH/Cx/BH/Q5eH/8AwaQf/FV0lFAHN/8ACx/BH/Q5eH//AAaQf/FUf8LH8Ef9Dl4f/wDBpB/8VXSUUAc3/wALH8Ef9Dl4f/8ABpB/8VR/wsfwR/0OXh//AMGkH/xVdJRQBzf/AAsfwR/0OXh//wAGkH/xVH/Cx/BH/Q5eH/8AwaQf/FV0lFAHN/8ACx/BH/Q5eH//AAaQf/FUf8LH8Ef9Dl4f/wDBpB/8VXSUUAc3/wALH8Ef9Dl4f/8ABpB/8VWH4s8a+FdX0uxsdK8S6PfXcutaX5dvbX8Ukj4v4CcKrEnABP0FegVzfjz/AJF21/7DWlf+nC3oA6SiiigAooooAKKKKACubvv+Sp6F/wBgXUv/AEfY10lcb4jl1WH4k6A2h2dneXH9k6iGjvLtrdAvnWWSGWOQk5xxgdTzxggHZUVzf27xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh0AdJRXN/bvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHQB0lFc39u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdAHSUVzf27xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh0AdJRXN/bvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHQB0lFc39u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdAHSUVzf27xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh0AdJRXN/bvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHQB0lFc39u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdAHSUVzf27xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh0AdJRXN/bvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHQB0lFc39u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdAHSUVzf27xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh0AdJRXN/bvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHQAfEf/klniv8A7At5/wCiHrpK878fXnjFvht4lW80LQ4rc6TdCWSLWpndV8lslVNqoYgdASM+o610H27xv/0L3h//AMH0/wD8h0AYOma9pnhPx14sh8UX1vpCX93Dd2c17KsUdwnkIh2M2ASGQgjOeRxzXNeN59MGmaXfaleNZRX3iyGe3E1y9t5kAZFdyu4ZX5M5I4BB4zXof27xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh007NPtb7k1/kD1v8/wAU1+p5V/ammW+reItO02e3bw3a+JLd9RtbNgY4rVoAJCVTpH5wG/tw2e9dBqNl4e09dG/sm6huPBFzqU0+pASq9hCDAwRBj5BDvGSvKhjzjOK7X7d43/6F7w//AOD6f/5Do+3eN/8AoXvD/wD4Pp//AJDoTsren5JfoD1f3/jf/M8k8SDTtP8ADl+V1Fbbw23iWxfRdl60URjzGZ/KwwDRDLEYyowSMYzS+Ip/CaSfEy2tbjShFa2MN3ZRJOm2K6KMGkjXOBJv8sbl+bcRzk8+tfbvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0ulv62S/Qa0d/63b/Wx5I2p+ENZ1zxZPfaxYahFJ4ZtpQZ9QEqCcB8lQWIDq3l8DBUnjBPLrfWbaO78LXPhu/sjr+q+FbkSMlwpku7rZGIhIc5Zg6uF3cgqwHQ16z9u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdNu9/P/wC2/wA/wFHS3l/wP8vxPP8ATItEbUvDN14auYYLlLd18UPDP5ciw+QdxumyGWQSYwz4cHODwa5zwrqfh2w0vwBe22p2a6g+vXUEs7XYeYwsZvkZmJbaS0RweMsp6nJ9j+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5Dqub3rk29239bW+/wD4B0lFc39u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdQUdJXN/Ef/AJJZ4r/7At5/6Iej7d43/wChe8P/APg+n/8AkOuf8fXnjFvht4lW80LQ4rc6TdCWSLWpndV8lslVNqoYgdASM+o60Aehu6xozuwVVGSxOAB614RHrGhanpvjNYviaukLeanc+Ta21xaMJ1KqAygoZW3dPkcZ7V6p9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHSte/pb8v8h328nf8/8AM8qso9K1vxB8PNP8TWcWly3ejXMFxorXboiptCRDymb5dw3EfxH1JXie7s4H0PUIGMcPxDg1Rv7OG/8A0xYhPiIIT8xg8rGeqY3E85r077d43/6F7w//AOD6f/5Do+3eN/8AoXvD/wD4Pp//AJDq+b3ub+t7kpWVv62seOeJrnw6kXxRnfUrWa9tJ7eSxaa9814ZwgJMW5iVYSFh8vTleAMV1Nu3h7xH4k1VPF2oJHfyzQXGgXiyhZGt/KRgbR+ckuH3BMk5wcjFd19u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdKLsv68vx0G9Tx3xFqvhw2XxA1P+0LB9QttftZLGU3Cl43VYQWjGeD8sgJHUKwPTjb1xtO1O28WPq8sLeJZJ2l8MyLIDcNH5KGE2hHJBbO7Zx13V6P9u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdJbW8rfgtfXQfW/wDXp6anDXRGl+MraTUxput3uqTW1tcQKxj1KzcLGGMLDloVYByBtC5Y5Nc/4cj0qXw5pEGjSpJ4ut/EEnlESGS6S2F44kLkkt5Xl7sk/KT/ALVerS3vjtoXEGgeHUkKnYz65OwB7Ej7IMj2yPrXPeBtG+InhLw++mX1h4Z1HNzLOksWp3EGPMcuwINu+fmY4PHGPrVRlr6a/loS17tv62Zykd9pZ+ImkanbSQWs/wDwklzaXctxJuvWDRy7UlYBQkRKjZGd2RtIPUVV1a803SPDviHS5rjS7wPpNxcprenXDW9yrttMaXYBz5jnYFJbL4I24yK9Z+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5DqGrx5fK34f0y1K0+b+t2/1seZabL4Nfxh4Zt2utKktL7wxIdQSS5RkuWQR7POycOVAlxuzgKfTjt/gzqcOpfCvSjDeJdtb+ZA5WUOY9rttU+mF24Hpitb7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6tyvf+urf62M4xsl/XRL9DpKK5v7d43/6F7w//AOD6f/5Do+3eN/8AoXvD/wD4Pp//AJDqSjpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AOkorm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoA6Siub+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgDpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AOkorm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoA6Siub+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgDpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AOkorm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoA6Siub+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgDpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AOkorm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoA6Siub+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgDpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AOkrm/Hn/ACLtr/2GtK/9OFvR9u8b/wDQveH/APwfT/8AyHWH4su/FUul2Karo2j21oda0vzJbbV5ZpF/0+DGEa2QHnA+8MDnnoQD0CiiigAooooAKKKKACubvv8Akqehf9gXUv8A0fY10lc3ff8AJU9C/wCwLqX/AKPsaAKvxK8T3fhfwqkul7Fv768hsLaWRcpC8rY3kewyee+KzPEtvYeCdHi1C98S+IILl5Y1e9ke6u45TuXKtEqvHEH+6CqL14rq/E/hrT/F3h640fV1c28+Duiba8bA5V1PYggEVz2oeCde1rSU0bW/FEN3piyROzLpuy7k8tg67pfN2dVGSIxn2oj+v4af8H1B/wBeomo/EWbT9ctIJdFaLTrq/hsIp7qcwXEryqCHjt3QFkBYAncCCG+Xiprbxrfaqmsf2NYafI2nyzQhJdRKyo0YbmWIRkopZRjBYkMDxVTUPhxeXmp3l1HrcKefqkGpRmWw8yVDEynyjJ5g3R/LwAF25PJq9deBX1HxVa61qN9bGS1jlRHtrHyZ5Q6su2SXed6ANwu0cgHND1h56/kv1uP7X9d3+ljmvDvxF8Rr4f8ACcN74dXUL/X7Z5ILmPUFWNysRkw+5NyMccgAqARhm6VtXnxEvbew1LUYPD/nWOisE1U/bQJYXCK8giQKVk2BuSWXocZqDTfhxqumzeFAviO2ltvDQZI430w7plZPLI3Cbg7O+D82T0+UX73wHLK+s2thqiWuk69I0uo2rWu+Qs6BHMUm8BNwUZyr98YqpWu7ef56fKwl0v8AP9fn/wAEo3nxCtrPUPEd3b+GpZ5NK0qC9+0pJEsl5bvvYYJOQi4Y4Y564XpmxB481K5ufsZ0SC1urrRjqtgJb0srgbQyS7Y/kILDpuyPTpVXVfhvql7qGuyWGvWNnaavpiaWLdtLeQ28KBgMN54y2HbnAHTjjmzaeAtVi8QaXqN3rtpLFY6S2ltBFprRmRGC5cMZm2nKL2I6+uRLs07f1pL9eUF0v/Xw/wD2xg6N8U7mw8D6HLrx0ddW1Cx+2ob3WBbRyx/LyXePiQliAgDDj7wrcsPidb63/ZH9iWlu76pYm8jjvr0W7vglfLj+VhI4ZcEZAAIOaNJ+H2paBY6T/ZPiGJb/AEy0Niss9hvhmt8gqrRiRTuBGdwcck8YOBf8VeDbnxVo76Zd6haPbzKFkNzp4leM5Ys8Lb18t+V2k7tu0cGrdr6d/wANf+AKN+v9bf8AB+Rzmo+M9d0/xR40/tDRrfUdH0fT4JDaxXnzlGWRidroFbIzu+bgKAA5NbH/AAm92mr6RomkeGwz3+km+t3e7SGBAoT93wrMAN4GdnpgHnEesfDq8vZtfOm68tqmuafFYzC4s/PZQiMm7d5i5yrn/gQByRlStv4G1631vR9SHiHT2k0rS5NORTpL4k3bfnP+keqJx/veoxH9fg/1sN9H/X2f+CRSfEy4m8JWGuaboavHcWct3cPe3n2eC38s7Wj87YwLk52jABAJyKrWt/FrHxZ8K6za/aI49T8Oz3HkySsQoLQlflyVBAc5IHPfPFN0n4Vahptjp1rN4it7pbG2uLYb9M42ytu3oDKQkgJI3c5XjA61f0bwBqula54dvn1+0nh0TTDpvkjTWVpkO3LbvOO0/IvYjr1zxcbc13/Wkv8AgEu9rL+tV/wTb13XpoNUh0LSbFb/AFG6t3nZJLk28cUKkKWMiqxBJbCgDk9xjNee+A9ej0fwT4Xs7zRJLxdR166t0mnmV/scv2iUqSWJZnwGwR6HLDPPf634XurzxLZa/ouppp2oW0LWsnnW3nxTwsQxUqGUggjIYNxzkGuah+FuqWen6RaWfilGTTdXfVQbrTQ+52LHYNkiYX53JzuOSMEAYqY9L91f7/8AL8SpbNL5fc/1/A2bHx4l22rXElvaxafpMsyXLi9DXEKxBtzSQ7BtBKjbhjkMDx0qsPiDfW9xpw1Lw68cOswNJpZt7xZJJXEfmCKRWVVjcqOPmZeDlhT9V+HUfiDX47/XLq2mjjgmgYW1l5M86SqyFJJQ53IFbhQo5AOadD4I1HZYLfa1b3f9jRsuklrAr5TmMxh5sS/vSFJHy+WOT7YXT+vP/gD6/wBeVv1v+BS0n4mXmp6BYas/huSCHVjHFpqG9RmnmZ3Uowx8gCpvLc8Z4yMHE0PxEvhXxR4+1PxFEtmyT2CtE1+ZYw8iEDbLIF2pufPIUKM8DFb9n8N7i28A6ToD62v27Rbhbiw1GGz2BHUnG+Mu24YZgRuGQeMdaQ/DW5u7/Wb/AFTxFLJdao1tKPstosMdvNBtMciglmOCv3S2MEg5609Lv+tNPx3/AAJ6L+tf6/X0MsfGmE21yLfSYdSurS9trWY6VqcdxbgTttR1lIUtzkbduQRzgc1vR+NtTOvpolzolnaal9na4a2n1VVaVd7qnkYQiTOwE527dy5yab4h8H+IfEeg21le+I7FLiG7huWlTSm8tvKcOoCefkEkDJ3HIHAHWrXjDwbN4vsvsV3e2iWzFCWew3zQkdXgk3jy3PGGIbGOlNW/H8LL9bgdXRSKuxFXJOBjJOSaWpGFFFFABRRRQBzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9dJQB534Xef4hXWtanquoX8FjaanLY2NnY3stqEWI7S7mJlZ2Y54JKgAcVqNqeo+Hb6HQYHOu6tfyT3Nr9tufJVLdNud7qjYwWCjCHPU9zTovBuoaLrF/e+ENZg0+DUpzc3Vle2RuYfNP3nj2yRshbuMkE9hU+oeErmbUbLWLDVvK1u0SSMXN1b+dE8chUshiVkwPlXGGBGOc5ORbL01+7/P8AAHu/X+vw/Exv+FpFodNWPw9dNd3WrNo91D9ojC2lwoyQWP3wR8wIHI64OBSXHxLvrLTtUu7zw/Eo0TUEs9SCahu2hym14v3Y8ziRSQwT6mpL74cXkv8AZj6drVvbz22rNrF3LNYGX7VcEEcASrsQKSMcnAXng5q6h8M9Y1DTfEtm/iSyQa/fR3buNKfMOzaNo/f88Rpz/veow1br/Xw/h8QPfT+vi/TlJ9R+Jl5ZHxM8fhuQweGpE+1vNeojSRMu4vGFDZO3DBSRkHkg8VauviOmk32pQ67pv2WK00sapC8NwJWmhLbdrDaoV92BgFhz96s26+Guv31n4qhuvE+nlvE0aJO0ejuoh2oI/lBuD1Udz159qn1D4Z3et6s8+ta1azWk+jjSp7eDT2jYgHeJFczNtYOAQCpGOOetC6X/AK0/zsH9fiv0uXn8dX+n6o2m614fMN3PZS3tglneLMLlY8FoyzqgSQAg4OV9GNReHfiJPrV54dW70UWNt4isnubST7X5jqyKGZGUIAAVOQ249OQKtP4P1O7uPt2p6zaXOpW1pLaWEy6eyRwLJtDO6eaS7kKBkMg9hWZpHw51fS7jwizeIbOWHwzA8CoNLZWuFddpy3nnadoHY85PQ4DVuv8AW/8AwBa2/ry/4J6DRRRUjCiiigArm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh6AOhnhW4t5IZC4WRSrGORkYAjHDKQQfcEEV5Xp2p6h4L1a4GtX95e+E9Uv5rNLi5u5JJdLlDlEBlZi/luABuzlW+terPuKNsIDY4JGQD9K5zS/DF1/YmpaV4pu7HV7W/kkdkhsGt1AkYs6kNK+Rk8dMY79aXW/8ATH0t5/duYGhahd+HvDIbToL3WLi71W7h83UtTmeG3jjllCtJM/mGNAqBRgHLEZ5Oam0T4ly65deG0t9IiWDXYrrbL9u3eVLASGUAJh0JAw4I4P3aW2+GjafoWhaZp+r7o9HvJbhRe232hJ1dmIDrvGWXdw+eozjtSWXw5vdNg0ZrPXYftekXt1cQzS2G5XiuCxeNlEg5+bhgR0Hy1btd/wBf1/wBPy/rci034nzX5sbebS7Gyvbq8urVkudTKw5t3CMEk8rLuc5VNq5APIxTvFfxWs/C0ssFzFp4u7O2juby1udVjglwwJKQqQfOcYPHyg5HOTiiD4aXVv4e1LSG1u31C21C5muHi1PS0mjjaV9xKqrIdwycEkjPIA6Vo2Hgq90K7t5vDuueUv2WC1vFv7Y3P2gRDargh0KyYOM8jp8vFLoHX+u/+RT134lNpCQ3sOkCXSGFsTdz3XkPN55AXyEKESlQwLDcuPeu7rgde+G13rN1q0ia6iLqUduA1xYiaWBoSpAV96/uyVyUAHJJyOld5GHEaiRlZwBuKrgE+wycfnRpYWo6iiikMKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACub8ef8i7a/wDYa0r/ANOFvXSVzfjz/kXbX/sNaV/6cLegDpKKKKACiiigAooooAK5u+/5KnoX/YF1L/0fY10lc3ff8lT0L/sC6l/6PsaAOkooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I/wDySzxX/wBgW8/9EPR/wrjwR/0Jvh//AMFcH/xNHxH/AOSWeK/+wLef+iHrpKAPOPD2keB/EOsalpy/DCzsH0yTyriW70ux2CQqrBRsdiSVYHOMY754qxoHhvwVr1xfRN8NLDTvsU3kO95plkQ7gAkL5bOeAQcnA5+uGaZr2meE/HXiyHxRfW+kJf3cN3ZzXsqxR3CeQiHYzYBIZCCM55HHNc143n0waZpd9qV41lFfeLIZ7cTXL23mQBkV3K7hlfkzkjgEHjNOOriu6X3tr/N/cEtL/P7km/0X3nof/CuPBH/Qm+H/APwVwf8AxNH/AArjwR/0Jvh//wAFcH/xNeVf2pplvq3iLTtNnt28N2viS3fUbWzYGOK1aACQlU6R+cBv7cNnvXQajZeHtPXRv7JuobjwRc6lNPqQEqvYQgwMEQY+QQ7xkryoY84zihaq/p+Sf6/gD0dvX8L/AOX4na/8K48Ef9Cb4f8A/BXB/wDE0f8ACuPBH/Qm+H//AAVwf/E15J4kGnaf4cvyuorbeG28S2L6LsvWiiMeYzP5WGAaIZYjGVGCRjGaXxFP4TST4mW1rcaUIrWxhu7KJJ02xXRRg0ka5wJN/ljcvzbiOcnldL/1sn+o0ru39btHrX/CuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNeSNqfhDWdc8WT32sWGoRSeGbaUGfUBKgnAfJUFiA6t5fAwVJ4wTy631m2ju/C1z4bv7I6/qvhW5EjJcKZLu62RiISHOWYOrhd3IKsB0NNq1/L/wC2/wDkRR1t5/8AA/z/AAPWf+FceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8Aia8/0yLRG1LwzdeGrmGC5S3dfFDwz+XIsPkHcbpshlkEmMM+HBzg8Guc8K6n4dsNL8AXttqdmuoPr11BLO12HmMLGb5GZiW2ktEcHjLKepya5fesTf3eb+tr/f8A8A9j/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mukoqCjm/+FceCP8AoTfD/wD4K4P/AImuf8feAfB9n8NvEt1Z+E9DguIdJupIpYtNhV42ELEMpC5BBGQRXolc38R/+SWeK/8AsC3n/oh6AGyfDrwSkbMvgrQZCoJCLpcGW9hlQPzrnvDGkeBfE82pwx/DOy06TTJvs8632lWQJkwG2jYzdipycA5GCa9Hrzbxlc6j4R8bRaho1vJMniaEacyxrkRXq/6mVh6bSwY+iD0oW9u/5/1p62H0/r+vMt+GfDfgjxLYzXS/DfT9NjjmaEC+0qzzIVYqxXyy/AIIycZ7Zra/4Vx4I/6E3w//AOCuD/4msPxjZw6VH4UsdQ2nwvbzNHqj3BzEVEDCPzs8FC/J3cZxmvPddOladHHnU0tvDbeKrN9HUXxihMG1DOY8MAYlbofurzjFUknKy8l+KX63J1Sv8/zf6Hr3/CuPBH/Qm+H/APwVwf8AxNU7zwN4I09Z7q98HeGIdOggMslw9hCGUjk5Xy8bcc53fh3ryrxDceF49L+Jsdnc6Yv9mzwz6YkcyYtpzGu54RnCP5gIJXB3ZFXfEt9oWt+KPFkFnf2uqve+DxLHCLkXAecbmHlqSQGCqjYUDs3vUO/Lddv0uWkm7Pv+qX6npFr4F8F39vY3dn4I8OG0uohKzSadCroCoK4URkHrzyMe9XP+FceCP+hN8P8A/grg/wDia8ytL7wjp3ivwEttqNlp9rLolyLhIrv7PEN0a4cAMFVmYyfOMEkHk44yfCup+HbDS/AF7banZrqD69dQSztdh5jCxm+RmYltpLRHB4yynqcnRx96y7/q0ZKXucz7fpc9j/4Vx4I/6E3w/wD+CuD/AOJo/wCFceCP+hN8P/8Agrg/+JryvSZdN1HxfZ2K6jaW+qxa5cPfaoNYjt59Qg3vtt9iSi4JBKAIyhQE4yCAfcLHULLU7b7Rpt5BeQ7mTzbeVZF3A4IyDjIPBFT0uW9JNGH/AMK48Ef9Cb4f/wDBXB/8TR/wrjwR/wBCb4f/APBXB/8AE15xZaVNrXi1jqniHTtM8QWmrSu9ulg41Ka281gsYlE43QtGRyqbV69QTWb4cj0qXw5pEGjSpJ4ut/EEnlESGS6S2F44kLkkt5Xl7sk/KT/tURV7eYS0vbp/wf8AI9Ti+HXhBpphP4I8NJGrAQsmnwszrgZLAxjac5GAW4AOecCb/hXHgj/oTfD/AP4K4P8A4mvLzqemrpHxIh03WoisWtwysGvd5kjIhDoXZjtRmDpuJCryCQBxCl14efS9bv7eaC20Se7s4YdHtNaia3tFLDzGuEheSGOJ2XnAJI3DI3EUlrb5fjb/ADG9Px/A9W/4Vx4I/wChN8P/APgrg/8Aiao3vhD4d6fqGn2Vz4S8Pi41CVoreMaXBliqM5P3egCnn3HrXBaRbWc/hfxBpQ1XRbKGz8QtLFbXMJ/s9ovIWTynjLfLERvbOQuRkDtTb2TQNaufA2ra7oen2Nl9sv4ZmIEsDARuVaKQqCUZhvTAHbb0FO36fir/APAF0+/8L/5XPSpfhz4MELmDwX4deQKdivpsKqT2BIQ4Hvg/SiL4c+CzChm8F+HUkKjeqabCwB7gHYMj3wPpXk+kWXhd/gf4o1pL5WurdtRt4rxdSk3gGYtEhcPk7isZAOd27vuOdbT5PDev3SWnjG+txY3OkWS6FdvMqojhSsht5D8onEmOnzcDtxRb9PxuD0/H8Gl+p6L/AMK48Ef9Cb4f/wDBXB/8TR/wrjwR/wBCb4f/APBXB/8AE1kfFiBJPgvrREtz+5sfMR/NeNyQBjdjBPuDwe4rl7mfR4NW1HUfCLSyaanh64GtNo7Dc042+X83I+0AeZyfmA+92pd/66XGle3n/mv8zvJfhz4MELmDwX4deQKdivpsKqT2BIQ4Hvg/SiL4c+CzChm8F+HUkKjeqabCwB7gHYMj3wPpXj8tzotlpXjOKG+02ws7rw1b3VtHpl20UbzAyDcHBXzXLBAzADccKR1zo2994P1Pxnp39o6rp93aN4PIninvw8IddnBQttBCqTjH8O7qM02rX/rpJ/oLt/X8v/yR6l/wrjwR/wBCb4f/APBXB/8AE0f8K48Ef9Cb4f8A/BXB/wDE1R+EmpLqnwn8Pzi7W6dbNYpHD7yGXgqT6jHfmuypyjyyaFF3Vzm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mukoqRnN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TXSUUAc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNdJRQBzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E10lFAHN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TXSUUAc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNdJRQBzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E10lFAHN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TXSUUAc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNdJRQBzf/AArjwR/0Jvh//wAFcH/xNYfizwV4V0jS7G+0rw1o9jdxa1pfl3FtYRRyJm/gBwyqCMgkfQ16BXN+PP8AkXbX/sNaV/6cLegDpKKKKACiiigAooooAK43xHLqsPxJ0BtDs7O8uP7J1ENHeXbW6BfOsskMschJzjjA6nnjB7Kubvv+Sp6F/wBgXUv/AEfY0AH27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdU/iqsifDHW7u3u7y0ubK1e4gms7uSB1dVOOY2BI9jke1cd4v1iwn8PeHrLSbrxbaTDUrS3M0q6pa+ZHJKokDzOFDkgnBZiR/Dimk20l1aX3g9Ff1/A737d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOud1r4t6P4c1V9P3Wc1vY3UdjciTVF+2BjtG5ICC0ijcNzFgeGODipF+J95/ZV/rEvhp4NM0vUGsr9pb1fPiClQZFRVZWALcjeOBkZ6ULXb+tv8ANBtv/W/+TN77d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6zdW+IM+keIrezn0ZUsJ9Qi06O5mu/LmmeQAh4oSmJIwWALBweG44rI0Tx5rUN7r39tWVrMza9/ZenQwXjEmXYmE+aMAIBly+Sc7vl6ZEr/wBen+aB6f16/wCTOp+3eN/+he8P/wDg+n/+Q6Pt3jf/AKF7w/8A+D6f/wCQ64X4ieIpNZ8D+ItJ1exk03WNHe1maK2vHkiljklCqyuAm9SNwKuowR06GuquvG15p91qunav4ezc2untf28VtdrKt3ADtbl1QKwyMqcjngmpeiv/AFtcdtbf1/WxofbvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h1yGn3kVz8QfCWrabYyW8d54WnmTToZv3aAGEpGikhFIDFcgLnjPTjV0rxvJN4M0/UtD8MRWwvJ7ndDNciC3tfLkfe8syIwUsQT905ZuverkuVa/wBatfoSnfb+tLm19u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHXPQfFO71JdBTRfC011NrljNdW/mX0Uce6MHdHu5PXA3bQPmHvi1p/jzW7rT9aF54btbPVtMu4bVbBtTZxM0u3afMEPAO/ggNkg5xjNKzvb+t7fmO5r/AG7xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh1e17Xl0DSIrq4gaa4nljt4baJs+ZNIQqqGIHGT1I4AJxXmlvq93oXjD4harrGhtcSW+l2c1xYQ332iORMS7iryhcJtzldo6HCnPK6N9hpX2/rWx3v27xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh1RsfGv2jVrTR9M0+yjf+z4Lv7PLfCGTZIOBDHsw6rjBOVxwMVDqnxEksbbUtVtdHF3oWkXTWt/drdbZkK4DukW0h1UnBy6ng4B7tqzt/W9iYu6uv66mp9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHWRB8R7i41fWIf8AhHpYdP0SVft17NeRjZC0TSCVUGdwwF+XIOG9QRWFf6xd3XxO8G6zqunNplpJaXs8eb5pcxCHcPMjwFSQBj93dwcbuMUvX+tLj6af1/X9bnafbvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHXKwfGqxuLow2tla37TWMl7aRadqkM8pVAGZJl+UQuFOcbmB2kZyMVfT4kXw8P6bql7oNvp8WrNbrYyXmpqkJ8yIufMcITHjG0fKdxK9MnDs/689P0A2/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ63bKaa4tEluYVgkYn5EkEgxk4IYYyCMH8anpAc39u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIddJRQBzf27xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh10lFAHN/bvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHXSUUAed+Przxi3w28SreaFocVudJuhLJFrUzuq+S2Sqm1UMQOgJGfUda6D7d43/6F7w//AOD6f/5Do+I//JLPFf8A2Bbz/wBEPXSUAc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/Idc/wCF3n+IV1rWp6rqF/BY2mpy2NjZ2N7LahFiO0u5iZWdmOeCSoAHFajanqPh2+h0GBzrurX8k9za/bbnyVS3Tbne6o2MFgowhz1Pc0dvNX/X8g6/gXPt3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ6w/8AhaRaHTVj8PXTXd1qzaPdQ/aIwtpcKMkFj98EfMCByOuDgUlx8S76y07VLu88PxKNE1BLPUgmobtocpteL92PM4kUkME+pppX2/rb/NfeD03/AK3/AMmbv27xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh1h6j8TLyyPiZ4/Dchg8NSJ9rea9RGkiZdxeMKGyduGCkjIPJB4q1dfEdNJvtSh13TfssVppY1SF4bgStNCW27WG1Qr7sDALDn71Lf+vK/wCQf1+NjS+3eN/+he8P/wDg+n/+Q6Pt3jf/AKF7w/8A+D6f/wCQ6oP46v8AT9UbTda8PmG7nspb2wSzvFmFyseC0ZZ1QJIAQcHK+jGovDvxEn1q88Ord6KLG28RWT3NpJ9r8x1ZFDMjKEAAKnIbcenIFO1/69f8mK6/r+vM1Pt3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DrpKKQzm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Drn/AB9eeMW+G3iVbzQtDitzpN0JZItamd1XyWyVU2qhiB0BIz6jrXolc38R/wDklniv/sC3n/oh6AD7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q66N1DoynIDDBwSD+Y6V4vos2kQ6h4ltddvvGVwbPWJLa1e2v8AVXjii2ptUyo/ljBY8u2fXjFC1dvK/wCS/UHor/1/Wh6L9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHXN3T23h34wLeXV1ctb2vhaWWeSedpMiOVAWwTgEheSAMnrTLb4vDUbm5s9GsNM1O+Fi1/aQWesrKJEQjdHIyRnypcHIXDA9N1Glr+v4Nr9A1vb0/FL/ADOn+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOqlv4z1C60vS9RtdGhu4LzTH1GdLW8aSWMBQVSNPKHmFiwAyV5B9K53XPiXrC+G/FcVrpllaavo+nJd/JqBmREkDfexGCsq7SdhGOnzYptNXQR963n/X6nW/bvG//AEL3h/8A8H0//wAh0jXvjgqR/wAI/oAyOo16bj/yTrndW+KK+GbCC21VNJXVIbFLu6t59ZEW6M7gBCzxgyyEKTt2qOcbuRmDxV4yHirwLraeGrCS7tItJFzc3P2xrZ4vMiMiKm0Es4G1mBKjBxk5IqZ+7FvsOC5ml3/r9Q03Q/iba2I0rUIvDF7pKYwpv50uX+bd+8l+zlWyc5IjUnOcg810Nl/wmdisvl6BoUjzSGWWSTX5iztgDJxZgdABwOgq34bgS6+GWlW8pcJLpMKMY5GRsGIDhlIIPuCDXDeAfEP2Twv4A0yfRvt0+oQ3D2+oTyriGVVkY8nc+4jgnHRjyelaSVpOPb/g/wCREXzRU++v9fedpLe+O2hcQaB4dSQqdjPrk7AHsSPsgyPbI+tc94G0b4ieEvD76ZfWHhnUc3Ms6SxancQY8xy7Ag275+Zjg8cY+taWl+Nda1PR5Zv7AsYdSi1Y6a9i2qMcbT8z7/J9PmA28rzntWfcfGLSYPEENjH9huIJr46cFh1KM3gnDFATb4yIywwGLZ5BIA5qVfp1/wCA/wBUU9ten/BX6MueIrb4gazpqQ2Wm6BYTwzpPHIdZllQshyA6G0G5c4OAQeBgijTYfiLHdLfa3pfhe8vkiaFWtdUuLeNULAnCm2dsnaucsRxwBzm54M8Zaj4uBuG8OSafYrJcQtNLeI7JLFJs2lF9eeQSAVI9CeY8WwaprvxKudKvNB0rVtOtdIFxBBd6nLDtJkIMwKwNsl+XAIOQOQwyRSvyted3+H+SHvfy0/H/NnY/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHWJp/xFuZ7DwfPDoINv4ihfYq326WB0iaQIAyAPkJjcWXk80mjfE2fU4tCu7vQTY2Os3k1kkj3geSKWPzMZRVwVIjPO7IPYjk04tOxPS5ufbvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h1T0zxpqesSWVxYeHWk0jUhILK+FySQVBKtMgT90j7ThgzHkZUE4rl9B8capN4O0a98VaDbaiNS137NFNHch1gY3LBWZXQEbCMLt3fdBJWkk27en4uw3or/ANbXNXxtpfxA8WeD77Q7XTfDdh9tTypJ5NWnm2oeuFFsvPvn8K17C48f2+nW8N5onhueeONVkli1qeNXIHUKbViB7ZP1qlffEh7SzuNZTSBN4ctLxrO5vluv3yMsnltIIdmGjDcZ3huCdvrW1H4n3dkfEkieG3+zeHJYhdyT3qI0kTjdvjVQ2TtIYKSMg8kHihbadf6/UHvb+v60N77d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOmfEHW9Q0T4caxq+hrC1zb2jSo0zlQgx94YByQOQOMnuK5rVviwnhiwWHVotKGoWdnHc3lu+sqjujA4EAeMNNJtGSpCDkDcaQdrdf+B/mdR9u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHVW08dDVfEB03R7a0nCwQT4nvfJnkSUKwdIth3IFY5bcOQRg1z2i/EDWbTw/r2r+IrXT1SHWpLGBjqDLFGwcR4dmi/dxjAO/knJ+UU7a2/rdL9Q6XX9aX/JHV/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh1s6ZdT3lks11DDEzHjyJ/ORh/eVsDIP0FW6QbnN/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFAHN/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFAHN/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFAHN/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFAHN/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFAHN/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFAHN/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFAHN/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFAHN/bvG//AEL3h/8A8H0//wAh1h+LLvxVLpdimq6No9taHWtL8yW21eWaRf8AT4MYRrZAecD7wwOeeh9Arm/Hn/Iu2v8A2GtK/wDThb0AdJRRRQAUUUUAFFFFABXN33/JU9C/7Aupf+j7Gukrm77/AJKnoX/YF1L/ANH2NAEvjXw/eeKvCd5oljqEGni9jMM00tqZ/wB2QQQoDphunJJHtWZ4l8Ia54i0DSrA67YW81jcxXUsw0t2WZ4nDJhfPGwccjLZ7EV2VFG35/cH9fecxZ+GdU0zVbqew1uGKxv5PtF5bPZlmEpUB3hfzP3YJGcMHxzXB+CrGPxtH4rsLXxFZyaPL4hnlu7W3jWSWWMspXEofCxvtIPyHIBwRXsdFNaO/lb8V/kD1VvO/wCD/wAzgtQ+HF3d6leXUWtwoJ9Tt9RjMth5kiGJlIiL+YN0fy8ABduTyafJ8Ni11qFwurlXl1YaxZH7MD9muNqqd3zfvFIBGPl4Y85wR3VFJaKy/rb/ACX3B/X5/wCbOMvfh6utadrA17UBNqWrxwxTXdpb+SkaRNujVI2Z8AMSTliTk9OMPn8Galew6hdahrVtNrN3YHTorpbArBbwsctiLzSxY9yX6gYAAwewooaurMFo7nn2lfD7X9L1LQrweJNPlOi6W+mxKdIceYjbcM3+kdRsTp79M8R6T8MtT0yx0a3l8Q2t1/ZVzcTKH0s+XIsx3HKGU4kUltr54BxtPOfRaKbbe/8AXX9RJWVl/WlvyPPdD+G+q6Nqvh24PiG0nttBinhjiOmMrypM2Wy/nYBAAAO3HXjniymn6frvxTt9b0W/jube0tXi1AWzq8bzIxEKsRn503ynHUfLntXc0UJ2afb9RvVPzMTxX4cXxPo6WounsrmC4jurW6RQxhmjbKttPDDsR3BPIrmL74caxqMmv3U/iiMXeu6cmnzhNMAgVV3DeE8zfnDNj58AnJ3cAehUVNtLDTad/wCu5wt98PbzV9B03StX1WxnSxMRFwml7Jo/LAwYXMp8pjt5Y7upxipbj4fPJDqmmW2ppFoGsTvcXtk1qWmLPgyCObeAqsRyCjHk4I4x2tFVd3v/AF/WhKSSsjjdP8BSxX/ik6rqFvd2HiJQj2sNm0LQosflABzI2fk9hzzx0qivw21G6udEOs+J2urfRo5oIkisVjeeGRAhWVizAnaMFlC5zxg816BRSGcfH4T16LwvcaEPElvJbfZjbWkkunEyRoVK/vSJQJCFPGAnIBOelWbPwtf2ngaw8PtqFhctaWwtne500yQXCKu1d0Rkz0wTh+SD0BxXT0UPW9+v9fqG1rdP6/QxvCfh2Pwp4ZttHhnadIC53FdoG5ixVVydqDOFXJwABk1s0UU223diSsFFFFIYUUUUAFFFFAHN/Ef/AJJZ4r/7At5/6Ieukrm/iP8A8ks8V/8AYFvP/RD0f8K48Ef9Cb4f/wDBXB/8TQBVi8G6housX974Q1mDT4NSnNzdWV7ZG5h80/eePbJGyFu4yQT2FT6h4SuZtRstYsNW8rW7RJIxc3Vv50TxyFSyGJWTA+VcYYEY5zk557QNK8Da94g1LRz8MbPTp9NC+e95pdkE+blduxmJyMnIGODznirWheG/BOu3WoQj4a6fYrYzmAzXel2eyZwedmwsSBxyQOvrkAXS3b8NgfW4t98OLyX+zH07Wre3nttWbWLuWawMv2q4II4AlXYgUkY5OAvPBzV1D4Z6xqGm+JbN/Elkg1++ju3caU+Ydm0bR+/54jTn/e9Rjo/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaNv69P8l9wdb/ANdf82c3dfDXX76z8VQ3XifTy3iaNEnaPR3UQ7UEfyg3B6qO568+1T6h8M7vW9WefWtatZrSfRxpU9vBp7RsQDvEiuZm2sHAIBUjHHPWt3/hXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImj+vwt+Qf1+T/RFV/B+p3dx9u1PWbS51K2tJbSwmXT2SOBZNoZ3TzSXchQMhkHsKzNI+HOr6XceEWbxDZyw+GYHgVBpbK1wrrtOW887TtA7HnJ6HA3f+FceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaabX9ev+bFbS39f1odJRXN/8K48Ef8AQm+H/wDwVwf/ABNH/CuPBH/Qm+H/APwVwf8AxNIZ0lFc3/wrjwR/0Jvh/wD8FcH/AMTR/wAK48Ef9Cb4f/8ABXB/8TQB0lc38R/+SWeK/wDsC3n/AKIej/hXHgj/AKE3w/8A+CuD/wCJrn/H3gHwfZ/DbxLdWfhPQ4LiHSbqSKWLTYVeNhCxDKQuQQRkEUAehvuKNsIDY4JGQD9K4bRvB/i7Q31R7PxPozNqd497KZNClOx2VVIXF0OMKOufrXcuSqMQpcgZCjGT7c1zOieNG12DVXt/DerwPpkjQSRTtbBpZVAJjTExGeRySF560ur9Pw/qwdF6/iZkvw9vr3xFHfarrsV7ZtpD6Vc272TCWdHwXfzRLhWLDIwuAOPet7w/pGsaXbx22ra1HqUFuuyArZ+TIygYHmtvYOcd1VB3xSeEPFUPjHQU1e0069sbaVmWIXojDSAHBYBHbAyCOcHjpjmt2qd1p/Xf9WG/9fL9DjbD4fDT/Deu6RBrFyq6mZUtpkQK1jE5ZhGmDyFZ3IPH3sdqzj8LpprXVLe51e1SHU9FTSpI7PTfJWLYXKug8w4HznKnP1HSvQ6pXWr2dpqtjps0n+lXxfyYx1IRdzN9BwPqRSC/9fO/6HPxeEtWstTt9T03XYI75rWO1v8AzrAyQ3KISVKoJFMbDcwB3NweQaq6n4Avbi71iTStf+yQ67afZ9RjnsxMXcRmMSoQ67GxgEEMDjoOtdJfa1HpFususeVAJrxLW3EchcymRwqdQMHJyQM4A6mryNcG7lWSKJbcKpjkWUl2bncCu0AAcYO45yeBjkfvLX+v67BH3Xp/VjM0vRbrR/B8GjW2pGe4trXyIry6gDdBhSyIVBA44BBIHXPNcfo3wz1vSP8AhFY/+ElsZofDbyGNf7JdWnWQFWDHzzg7WOCB15welekVz/i/xQ3hSws7oadLepc3sNoxSVUEPmOEDNnkjJ6AH8BzTu3K/V/1+okko26Iba+EY7Xx1eeIY7x/Ku4k3WPljYJwNvnbuu4phcelRaZ4X1PRLm6h0vWok0maaS4S1lsy8sMjsXYLL5gGwsSdpUnkgMOMdPRSGc34H8M3nhPRZ7C+1KDUWku5roSQ2hg2mVy7AgyPn5mOORxj61EfC+qt8QpfELavZmzlsxZNY/2e2/ygxb/W+bjduJ52YxxjvXU1S1LV7PSfsovJNrXdwltAg6u7HgAfTJPsDRu1936B0f3/AK/8E4i1+GOpWtpoFvF4o8tfDs0j6f5enryrKVCy7nO/AYgldmQeMH5qisvhjrFppnh+xbxJYyR6LqMl+D/ZLgzFy2UP7/j/AFj8/wC76HPpNFO7B66HM+F/C+oeGIF02DWUn0WBmNrbvaYniUnIjMu/DKMkD5AcY5rn5Phlqsfh7T9IsPElvHBp+q/2jCZ9MMhJErSqhxKvdiCe4AwF5z6NXA33xQax0/Wrl/D10f7I1SPTpENxGCd4TbKcE4X514G488gc4Fe676fmv1sD2f8AXR/pcsN8PHNndaMupxjw7eXLXU9j9kJlLtJ5josu/AjZuxQnBIDelDVPhpq+pw+LYf8AhIrKKPxM0e/GlMTboihAAfP+Y7QOcDnJx2r0WsAeJz/wsEeF206VM6e18t40i7XAdU2hRk9W5Jx04z1pLdJf11/QNtf6/rUfrPh19e8C3Xh7ULxRJd2RtpbqGHaMlcFghY4HfG4/Ws618JaxpupJqGna/AlxPBFDqCzWBeOfy8hWjUSKY2wcclxgDINdbRTvrcVlaxyXiHwTL4iu7I3moW5gs7qO4jkaxBu4ym0gRzBxsyyksdpyGIGKXSvB15o0OqwWmrQyQX+oTXqw3FiHVfNyWR/mG8buRjbxx710ts90zTfa4YYgshEJimL70wMM2VXac54GR71PS6f15f5If9fn/mzB8HeFo/COiPYRSxyCS4kuGWCHyYY2c5KxR5OxB2XJ6nmt6iim3cAormtN8VXWra74i0i10nybnRjEqG6uQq3JdSwOUDbFwBzgnnkCulHTnrSAKKKKACiiuf8ADPihvEV/rlrJp0tg+kXv2QiWVXMnyK4f5cgAhhxk++DxRuB0FFFYGn+KDfeN9V8Ovp8tu2nW8M4uHkUidZCwBVRnABU9cH270buwdLm/RRVLUtXs9J+yi8k2td3CW0CDq7seAB9Mk+wNAF2iisyDWo9S/tGPRvKup9PuPs0qySFE8zarEbgG6Bx268UAadFFFABRRRQAVzfjz/kXbX/sNaV/6cLeukrm/Hn/ACLtr/2GtK/9OFvQB0lFFFABRRRQAUUUUAFc3ff8lT0L/sC6l/6Psa6Subvv+Sp6F/2BdS/9H2NAHSUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Ef/klniv/ALAt5/6Ieukrm/iP/wAks8V/9gW8/wDRD10lAHnnj+8uvB3iLTvF2nWkt2lwh0u9t4RlpC+Tbt+Eny/SSoPGtleaP4R0C0lurZLAXedZur21a4tyGRyzTRq6ExmVgT82BkE8A16VRR0t/X9b/wBIfW54HcaTomm6t4Osr3xPZapZ3etTNBHbSNb2iW7wN+6jj851aPeQoOT97YPSt7U/CWkeBPFIs/D+i28Nj4qsP7JVUh3iKdehOQSVaMszZOCYsnJr16sk6TdXOuJealdwTW9q5ksreK2KGNiu0s7F23nBYDAXG48Gnf8Ar5W/rzF5/wBXve/3nKfFSy0rRvgjq9lGyada21kY7RIpjAN4HyINpGcn+HkHuDXOa7pvhWKPQrO2gtJYdXtZrpZL2YzWM8vlRrv2c+bMcAqFZf42znr7JRSet79f6/r0GtLW6Hz/AKM2geItU+G1lrOpR3r3mhzwXltLqDESHYFVWTfwxJkHTJI77RjU0fSZb3xZH9t8Qabpmv6bqrsLX+z3bUZrUSkJF5pn+eBoyvIQqOp5BNe2UVfN73N/W9ybaW/rawUUUVAwooooAK5v4j/8ks8V/wDYFvP/AEQ9dJXN/Ef/AJJZ4r/7At5/6IegDo3dY0Z3YKqjJYnAA9a8j8I31hq0/i++0/4gyafaw6tPPIllLYtEsW1cSlpYnIU4PzbtvHFeu1Ba31pfLI1lcw3KxSNFIYZA4R1OGU46EHqOopW1fpb8v8gey9f0Z4ToWpRXfwl8JRR6ppp0mG6uItWlvYPtVvEx8wxi4jSRMKc5+YhQSpI6VMuk6PoOv+EF1zxBb6rosz6gfOctFYLAYgyRqjSOhjXewDEkYO3OAK93rmNb8L6jqnjbQtdttVtraDSBIPsr2TSNN5g2v84kXb8oGPlODyc9Kq/vX7itoeaRrpgtrLTL6KJ9Du9XvDosepEix8gIoUFCD5nzljEgK5HIPAFVPDcOjXd18NL3WorS78u0vraS4niDkTRkeWmTkhlwxUZyOcV77VSTVtOijupJb+1RLP8A4+WaZQIOM/Oc/LxzzQv6+636j/r73c8Bi/4R3U/BGHkstTtLHxwN8lxILny7Z5toLOxY7GUAZJww9a6GF9DvfGHj3R9M1y3sftFvYCIPIZVjIJDIYy2RGGZUZBtChsfLXtAORkciihaR5f62S/QN3zf1u3+tjgvh94i0w6dPbSRaNpuL0WlvLptwPseoOI1wbfOOgGCi5wVPJ5qL40Xtha+DbKPUbyG2WbV7LHmTCMkLOjMQcg8KCSR0AzXc3tjHfrGk7P5aSLIY1IAcqcrnvgEA4GM45yOKfBeW11LNHbXMM0lu+yZY3DGNsZwwHQ4IODRe7T7NP7rBbRr1PD7vUrSDWvGml+FbyxisI9SsJ7mK3Tzo44ioFw5ijdSy7gvmAEdTnvUN/o+m6VZaRfxeI7PUNHuPElq6R6Qj21hbKQ3mKqrM6kEoGIz8pz0ya98rmPGfhfUfEzaQdP1W208abfJfYmsmn810+6OJEwOTnqTxyMcqOjXqvuVv8geqfo/yf+Z5veS6HZjV/wCz1h/4Q681SyjtQkoi04zbWMxZtpUwHCBgo2s3GRkmslLPRptF0mDVINOubXTfGslvIjW4MNvA4crGEfOyMkrhTwePavoUdOetRXV1b2NrJc3s8dvbxKWkllcIiD1JPAFNaO/p+Fv8vxB6r7/xTX6/geLaxFa3Wl+I0vvLh8cpqEj6Cudt2sY2/Z/IB+by9o+YL8v3t3etZrbSNT8X61Y+Prr7JrK3MMmjXBcRzCERIf8ARW7nzA+4ICTnBB4r1gHIyORRRF2t/XbX10B6/wBfh6djxb7BNq/ja6Gp+IdM0nXrTVzNbRPpztqEtsHyiRSGcbomTghUwDuzyCaxvEniXQ/7J+IUX9sWHmSeI7No0+0pucL9n3EDPIGx846bT6V9BUUR921v61T/AEB6tv8Arr/meK+KP7Bg8Q+Plu0smi1rw9BdWi7FcXrosxMiAA72U7DkZI4PvUGm+JNKh8SaSr3UqzweCHie2i/d3QkUoxRUYBg+1WYDHIGeRzXuNFL+vwkv1/Ad7tN/18P/AMj+J833F1oNlpev+RqGn2FpfeExPCLG9aPz7lXYAvKCvnTbsBiAMk7SD0r2j4e6ZpFn4QsbzRBGwv7WCWeaOYyCZ1jVNxOSM/LgkenNdRVO7uGm8+y02+tIdSWISKsyeb5YJIDNGHVipII6jODzxTvo/P8Azb/X8Cbary/yS/T8Tx+c6ZYLq1hqYaWzm8YNHi/uj9l5t0OLhnDFk54Q9W2DIFUNLfT7PQPCmo3s1okeh+K7q2muiuxLKFmmVU+YkxR58vCk4Hy17J4e0L+xLe6Ms63F5fXLXV3Mkflq8jAD5UydqgKABknjkmtemna3lb8Ev8n943rf5/jf/P8AA+ctQufDtpfX9u039mwHxvbzQpvktIZISsfmMPuqwBUknnbkHjcCdQ6vptpqXiXTtMuYB4ctvEls+owWLjZDatCPMO1OkZmAD44+8D3r3milF2SXp+HL/wDI/iD1d/66/wCf4Hzj4mufDFppvxGi0qeO2sJVsJLBrR3itpGEYBRHXCMMMTsBIIycYHHZ3J8OeIfFmrW3i+/ij+1R20nh29EwU+UYwS1pJyPM8zOduWPy5yMV63RQnb+v67AeLeItPm1rxlq1nqviHTtEvlnik0Wa8055LzyhGhzbP5yclg4ZApJOd2civX7LULS9M0VreQXMtq/lXCxSKzRPjO1gCdp9jVqq1vYx295cXW55JrjaGdyOFXO1RjsMn35NF9LB1ueZ3NtomqeONfsfG9z9j1RbyKTQ52fy5lgEaEfZWPU7w+4JknOCDxXHeItV8OGy+IGp/wBoWD6hba/ayWMpuFLxuqwgtGM8H5ZASOoVgenH0NRQna39dVr66A7P+vX/ADPD9Vaz1TSPEMl1NAfGzX8k2gOkgNy0Xym3Nuc5MRXrt+X727vVrW9Wmbxx42tdHv4pNbHh60QR28gaXejSGUKqkEsqtnAIPI6ZFezUUulv62t/w/cOt/63v/w3Y8b0rQbG507WrnSPGGjLZ6jbxQywaVprRWsM4kXDTJ574d92xwdpKk56ZrJ1BtF1jT9BfUdB0NbKw8TQ2013YIs2n3EZgIzGSMKhIRSnI3KBkmveqKd9b+n4O/8AwA6Nd7/irHhd7e6OfHVnqVobe0uLfxOltcSXTf6YsRRlCHhfKgJxtRtwbrweKyPEEHhrRdC8Z71s9M1KPxPH5XlnyHaItCdp243IVMjBTkcMwHGR9F0Uo+7/AF/h/wDkfxCVm/68/wDP8Dydl8P674w1uDxffJDfPcwz6BdrKElNt5aMptH5yS4fcEyTnnIxXrAOQP60UU+iX9f13DrcKKKKQBXN+PP+Rdtf+w1pX/pwt66Sub8ef8i7a/8AYa0r/wBOFvQB0lFFFABRRRQAUUUUAFc3ff8AJU9C/wCwLqX/AKPsa6SuN8R63pWg/EnQLrXNTs9Nt30nUY1lvLhYUZjNZEKCxAzgE49jQB2VFc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFUAdJRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lFc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFUAdJRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lFc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFUAdJRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lFc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFUAdJRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lFc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFUAdJRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAB8R/+SWeK/8AsC3n/oh66SvO/H3j7wfefDbxLa2fizQ57ibSbqOKKLUoWeRjCwCqA2SSTgAV0H/Cx/BH/Q5eH/8AwaQf/FUAdJRXN/8ACx/BH/Q5eH//AAaQf/FUf8LH8Ef9Dl4f/wDBpB/8VQB0lFc3/wALH8Ef9Dl4f/8ABpB/8VR/wsfwR/0OXh//AMGkH/xVAHSUVzf/AAsfwR/0OXh//wAGkH/xVH/Cx/BH/Q5eH/8AwaQf/FUAdJRXN/8ACx/BH/Q5eH//AAaQf/FUf8LH8Ef9Dl4f/wDBpB/8VQB0lFc3/wALH8Ef9Dl4f/8ABpB/8VR/wsfwR/0OXh//AMGkH/xVAHSUVzf/AAsfwR/0OXh//wAGkH/xVH/Cx/BH/Q5eH/8AwaQf/FUAdJXN/Ef/AJJZ4r/7At5/6Iej/hY/gj/ocvD/AP4NIP8A4quf8fePvB958NvEtrZ+LNDnuJtJuo4ootShZ5GMLAKoDZJJOABQB6IenHWvPoPG2vXHh64uJodJsLqLWpNNkmlkLw26IcB9pZGlYtgBV2k7hxxWpf8AxV8BabYyXdx4v0d448blt7xJ3POOEjLMfwBrh9D1PwTqenNeX3jfTdMuBrtzqtjJFqdukqK5ZRuSTcBuQnKsuRu7GktZeX/BX6XG/h87/o/1sbOi/ELXNTuPC3mx2CxapqF5p92BbSo26ASFZEDPlAfL5RgSM9agh+IXioPa28lro9xJJ4ll0SSdRLCAqjKuI8vyQGz83HAwc5DUX4cQ2kEVt8R7OGS11KXUra4XV7MyQSSbt6jcCCp3twwY89aq/wBm/DRLyK5tfiZHbvHqbaqVGu2sivcHPzESBsDDEYGMg85IBF6XV9v+Cn/mhS2dvP8A9ut/7abVr4+1d3l0WaOxfXP7bfSYbhYnS3IEPneaYy5bhONu/k9xnI5qz1fV/BNj8R9TsrTSpr201OGSVUR4IG3Qx7nVBk5JbcVLdSfm7m+tr8N919LL8S7aS5u79dSS5Or2SyWtwF274yqgcrhSrBgQOnXLL3T/AIbX1lrME3xNjD648b38w1y0zLsUAAKQUXO0ElVB4wCBxQmlr5L/ANtv+Kf9bN7+V/8AP9Gv636m88S+I9Q1TV7fwna2Ex0UxJNBdht95I6ByiOGCxYVhhmDZJ6ADJy9W+I+rw6zcJo+k3F7BY362c9pFpF3M8w+Xe63CDyk27j8pzkL1GRSR6l4Dg1gapZ/EyztruWKOK9eLVrPF+EGFaRSpAbHG6MIf0xKmr+ALfWZ76w+IlhZxXbb7uyh1i1MNw+0Lubdl1YgDJRlzjnNJWTX9dvw3+/5k62/r+rnoteNW2q33gy68d6lotvp0VhaeIIDcW7QtmRZI4Q+zaVCNl92SGyc5A611+k/EHwxFPfG/wDHWiTQvOWtln1O03xp6fuyBtz0zlsdTk4HLXtl8PL+z1q1n+KsQi1u7S7uwuq6eDvXGAp8vgfKn/fA9TlR0lfy/VP9BvVW8/0Zr+IfiPqtnrGoQ6DpdxfrpVykE1pFpF3cPdEqjNsnjHlxlQ/Rt2cfw5BqKTx74qGk+J9V+x6TFD4bvWjmtMSyPcQrGjtiTKhXwxPKEZ4wMZMyar4Ch1Z9QtPiTY2r3KqL6OHVrMJesqhd7gj5XwAC0ZQ9PQVxfhjxH4G8R694vi1Pxmlnp1zq3nGyluY7eC+i8uNQS0ihiNyMCEYZGMgginG17eX43X/BDpd/1udpqvxA1ew8S20SJpwsZtRtrNbQo8lw0cwGJ2kR9sWGbAR1ydvXkVixeKfFmgaF471z7Rpuptp+sPEsU0EkWwBIlyCHbIAKjZgc5O/nFXbv/hXFzcXUi/Eazt47jUItSEEWsWmyO4QqQy5BODtGQxI9AKj1SH4b6nYa1Zf8LItbW31u5+03UcGsWeN2FDBdynAOxSepGOCASCRaWv8AX2f8pf1ojrr/AFv/AMD+t+m1LxF4hvda1TTvCUFg82kQQyzJeqx+1PICwiQhlEfA++dwyfu8Zq9421/U/Dnw/wBR1zT7O2kvLO2M7QXMpCLgZYZUHcR6cZ9RXNNqfgNdXi1W1+Jdlaah5EdvdXEOq2f+mon3fNVlKZ5PzIqnk4Iq54l8ReAfE3he50G48f6Xa211H5Uslvq1sZGTuu6Td1HU4z70ntp/X9f15kd1f+v6/ryqX/xF1Tw/qN5b63b2lwDpdvfWq2UMuVeSUQ+W3LF/mZSCqgkZG3NMh+JGs2kN+mo6VLMyzWsFhevpdzp8M8k8nlhWSfLDYSCSCcjpiqNxb/Di+1Rr3VPiVaX2/T109oZdWslQxqQwPyIrBw4DhgQQfbitGbU/h9f6BNpWu/EWx1eOQLtnutYtUli2kMpUxbAGDAHcQTkck1WnX+lf87C1/r0X63JfEXijxx4X0xpLzT9GvD/aNrbRXiNJCk0czhTiLLsrKxxy+McjPSrS694su9bufD1q+ixarYWou7idoJZIZFeRxFGq71ZSVTLMSwB6A1j6tdeCNc0a30/UvizFL5FxHcC4/tWwDs0bbkBHl7OGAOQoJxySOKv6lrngK+1RdTtfiJpumX/ki3mubPVLTdcRAkhHDhl6kkEAEZOCKnp/XbT8R/1+Ov4f0ipB8Ubi9s9IvJvseg217buWn1GCSWBrlZGjMPmqyrHhlB3NncDgDNad34z1u28Q+J9PTTLa4GlabDeWa2xeSSfeXB3DA6bPuqCfc5wM69vfhzc6CNEt/iBptlpZgW3ltLfV7UrLGN24EvuILbjuZSGOByKbb3ngC18TXetW3xLtIpLq3itjbpq1mI444zlFX5d3GT1Y53HOabtr8w/r8v8Ag/1t1ng/xAviLS3uU1XT9TEbBHezgeAxvj5leJ2Zo2H90nNdDXB6J4j8AaLd394PHmkXt7qDq1xc3OqWoZwowq4TaoAHHAz6k1sf8LH8Ef8AQ5eH/wDwaQf/ABVDEjpKK5v/AIWP4I/6HLw//wCDSD/4qj/hY/gj/ocvD/8A4NIP/iqQzpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkrm/Hn/Iu2v/AGGtK/8AThb0f8LH8Ef9Dl4f/wDBpB/8VWH4s8a+FdX0uxsdK8S6PfXcutaX5dvbX8Ukj4v4CcKrEnABP0FAHoFFFFABRRRQAUUUUAFc3ff8lT0L/sC6l/6Psa6Subvv+Sp6F/2BdS/9H2NAGrrWtWegaW9/qDMIlZUCou5ndmCqqjuSxAH1rntV8fnStHvrqfw5qsd5ZWb3r2M3kqxiUgFvMV2jPXOAxIA6ZIBv+OLfS7zwvJaa9ZS3ljcTRRSJCGLx5cASLtG4FThsjpjNeV6lq8uleHfE+ljxVb+KdBTQ7lYtUmeNprGUgIts8ynEjOTkA/NkDI6VLbs/n+Cv/X3blxSckn5fi7HtemXp1HR7S+Eflm5gSYR7s7dyg4zj364qW1a4e1ja9ijiuCo8yOKQyKp7gMVUke+B9K8S8Ma14VvbK9XxbPpcGvLpC/ZL+O6RA9l5ZC+TKpDKww4cZ3Zz/DgDO8Nah4Y1G9+GkWo6tZ3Cf2HcRXttNf5iyI1AWSMttySZAQRzg5zjjWSXM7f1v/lZ+ZjBtxTf9bf56H0HRXAfBrUrW++G6LZ3cdzFZ3l1AgicP5cazP5a8dBsK49iK4bw9f6GPGWh6lHc21hb30WpQ30slyVu2YAMFuphtAcDJC4ygHB71EtHYvp87HvFYHifxQ3hu60aL+zpbpNUv47LzllVVgLdCc8ngHAA7ckV4t4Y1Pw/YaR4BvbPUrIak+u3cEk73YaUwsZvkZmJbaS0RweMsp6nJsSXujNp/ha8v0LeLrfxFEdZVYnku1O6QkOqguYwPuDG3H3apR95eqX4r/P5CekZej/X/I+gKK474kWkF5otobi/0y2W3uPtHk6ymbO5Co2Um5AA53AnOCoODiuH0y80afxpoOs6tpFrpFrq+i31lJHKA8d1J56kIrEfvFcbmQY5U8CpWv8AXk3+NrD0/r1/pnpV14oa18e6f4abTpdt9aS3KXpkXZ+7IBUKMtn5hycDnjPON+vnzwkdGGm+B5vEkEcGhwWOpW1w+pQGK3DPIhRGMgCkMvTsccciti0jTTrXQ4PFkZTwU1/frGl+p8hIyw+yCbdwI8b9u/jlPanbp6/m/wBLW7h/X4f1c9rqldavZ2mq2OmzSf6VfF/JjHUhF3M30HA+pFeXvp3hrw3468J3MVxE+kT2N9Ype3bh1mDsjxwCQjDrguEHPHAzXKeC7HQv7e8GSXukwpFFdatChutPKfN5vmQKu5fmIByuM4OcYINNK7/rz/4H3g9rn0RRXgtnfaGnjTR9V+1W1hFPqOo2+o3E9yVvCDHIQtxMNuwDaNiHJUBSG4ql4V1Pw7YaX4AvbbU7NdQfXrqCWdrsPMYWM3yMzEttJaI4PGWU9TkpK9vl+IS0v5f8H/I+h6K8T0TTrvUfEcN5L4g0yz8UWN7O89iunsL+4QuwEckhnO+DDKQQm1QFIxik0m0tLy08KHTzD/wmq3kS6+gINy0RDfaFuR1KY+7v4+7t7ULW39b/AKd+wPS/9f0+x7bRXz5avo+n+G/C9iYIzqWi+L5UeC3tjJNaRGeVsbUUsqlQpAxyAMZxXZ+EpoNM8ff2bEmlaub3z7v+07LKXkAPIF2nOcg7VckdAAooSv8A15J/r+ApaO39btfp+J6hRRRSGFFFFABRRRQAUUUUAc38R/8Aklniv/sC3n/oh66Sub+I/wDySzxX/wBgW8/9EPXSUAc54e8Yf8JDrGpacuhapYPpknlXEt35GwSFVYKNkrEkqwOcYx3zxVnQPEb69cX0TaLqGnfYpvId7wwEO4AJC+XI54BBycDn645fTNe0zwn468WQ+KL630hL+7hu7Oa9lWKO4TyEQ7GbAJDIQRnPI45rmvG8+mDTNLvtSvGsor7xZDPbia5e28yAMiu5XcMr8mckcAg8Zpx1cV3S+9tf5v7glpf5/ck3+i+89norwb+1NMt9W8Radps9u3hu18SW76ja2bAxxWrQASEqnSPzgN/bhs966DUbLw9p66N/ZN1DceCLnUpp9SAlV7CEGBgiDHyCHeMleVDHnGcULVX9PyT/AF/AHo7ev4X/AMvxPWaK8A8SDTtP8OX5XUVtvDbeJbF9F2XrRRGPMZn8rDANEMsRjKjBIxjNL4in8JpJ8TLa1uNKEVrYw3dlEk6bYroowaSNc4Em/wAsbl+bcRzk8rpf+tk/1Gld2/rdo9+orwBtT8Iazrniye+1iw1CKTwzbSgz6gJUE4D5KgsQHVvL4GCpPGCeXW+s20d34WufDd/ZHX9V8K3IkZLhTJd3WyMRCQ5yzB1cLu5BVgOhptWv5f8A23/yIo628/8Agf5/ge+0V43pkWiNqXhm68NXMMFylu6+KHhn8uRYfIO43TZDLIJMYZ8ODnB4Nc54V1Pw7YaX4AvbbU7NdQfXrqCWdrsPMYWM3yMzEttJaI4PGWU9Tk1y+9Ym/u839bX+/wD4B9D0UUVBQVzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9AHSViT+I/LurmCK2EhgvoLIEyY3NIFZj0/hV8++O1bEqeZC6fKdykfOu5fxHce1eK6J8P/tOraPKLLwcvmzXOoDy/DOP3aNsUZE/Qh1ZR/CQD82KI6ys/6/pXB/Dpuei3Pjyyt21GSPTtSurDTGdLvULeJHijkQZZMb/MYjuVQqO5GDjp1bcoYdCM14z4iay0i51XW/Cet/2LrM1xOJ/Dt4vmw6y6MUOyFsEs+B80eeuD3p/iPwray+IL3SBoVrA/jbTUY/6KrLbXcRzI5YDhgsm4HuyepoXwr+ul/wCvlcbSvb+t7fh/wx7JRXikAvdR+HUviC30yOx1W1W10i6mFnuZIIJQLnCoVdkzvBUMMhOKabTSdI8JandJr2m6poWpXlpi20eH7Hp1s2/Db2LyhY2wPMUfkN1U0r2v/Wn+f6ErbX+u56/qusWejW8Mt/JsE9xFbRDu8kjhVAH1P5A1ZRrg3cqyRRLbhVMciykuzc7gV2gADjB3HOTwMc/P01lo7+H7m1vodLns9O8a2/7pIAILa2kEZIVGzsibJ9FbnjnFO8V6l4ahb4n2ltq8UG7TbU20A1Bo28xVfMaruBADMoMY4GcFe1K3u3/raL/Ue7t/W7X6H0JRXh7anolr4s1a18N63Z2LXvg/zZJ7WYSM065KynaSzuEOc8sVwfStH4ayaRqfjKK60SWy02CDTQs2mWesxSG5uc4a4aK3lZWG043SDcSQcAjNO2tv60v/AJfiK+l/61Sf6/gev0UUVIwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm/Hn/Iu2v/Ya0r/04W9dJXN+PP8AkXbX/sNaV/6cLegDpKKKKACiiigAooooAK5u+/5KnoX/AGBdS/8AR9jXSVzd9/yVPQv+wLqX/o+xoA6Sqkuq6dA9ys1/axtZxia5DzKDAhzhn5+VeDyeODWf4r19/D+mQSW8STXd5dxWVskjbU8yRsAsfQDJOOTjFeYzalrfg3xP8RNYjttIutStdMsrmRoont4ZseblymXbdgYwW5wPmHYWv9f13Hb+vnY9oVldAyMGVhkEHIIpa4e+8a3Vp4otNOu7qw0qG5t4Xt3vraXZeyv1RJgwRGXH3CGZs8YqhffEDWYtBvfFdnBYy6Dp989rNaNG/wBpkjSXynlWTdtBzkhChyB94Z4dne39diU7q/8AXc9HqF7y2jvI7WS4iW5lUtHCzgO4HUhepArzu4+IHiK11DxTNdWWlR6X4akV51R5HmnhaEyDacAB+U6gjlhngGqFxLqFj8WtC1rxEmm+Y2h30zNYQMjqi+W3lszMTJtycN8oO4/KO683t/wGx+n9apfqes0V5XB8SvE06me10P7Vbz6dJeRvLpl5ZxWboofy5JpEKyhlzhkC5IxjBzU8fjvxLbaHomr68dI0/TNVhina+jtJ50tMxqzJKA427iTiQttXGCD1Ls/6+f8AkxXX9fL/ADPTaKrabcNd6Xa3DzW87SxK5ltW3RPkZyh7qe1WaHo7D3CiiikAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Ef/AJJZ4r/7At5/6Ieukrm/iP8A8ks8V/8AYFvP/RD10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN/Ef/klniv/ALAt5/6Ieukrm/iP/wAks8V/9gW8/wDRD0AdJRRRQAUUUUAFFFFABRRRQBQ1zSzrWh3WnLdS2huE2edEAWX8CCCD0IPUE1T07SNU8+2n8Q6laX0loxaD7HYm2UErt3MGkkJOCw4IHPTpjboo2AKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACub8ef8i7a/8AYa0r/wBOFvXSVzfjz/kXbX/sNaV/6cLegDpKKKKACiiigAooooAK43xHrelaD8SdAutc1Oz023fSdRjWW8uFhRmM1kQoLEDOATj2NdlXN33/ACVPQv8AsC6l/wCj7GgDL8Q+Jvh34m0htP1HxloiJvWWOWDV4UkhkU7ldG3cMCM+nrmuZv7D4camuqPe/FBJLnVrRLO8uf7ctAZIlzxsC+XnkjO3IycYyc+g+Mdc1Dw54an1XStLj1WS3wXtXuTCzr0+QhHy2SODj60mneL9O1HwNF4piLCze2+0MmMspA5TH94EFcetLo2PW6OSvNQ8BalpcOm6j8S7O6sl8vzoJNWssXATGAxCgryoJ2Fcmka6+GzTzIvj3S00ye4+1TaSurWv2aSXdvLH+MZYAlQ4UnqOTW14J+IMPijSbS61eKx0S61B5RZ6e+oiSeVY2ZXO0qvIKnhd3HetxPFfh2TTP7Sj17TGsfN8n7Ut5GYvM/ub843cjjOat3TJ0scRa3Xw5hvvEM958QNN1GLxCMXlrdapZ+XgLsAXYFYYX5eSfXrzVe1T4bxalp17e/Ei31J9Mhkt7ZLrXbfaInABRtm0yDC/xk575wMeiXniHRtOgt5tQ1ewtYrltkEk9yiLK3opJ+Y+wpsviXQoJL2OfWtOjewUPeK90gNsp6GQE/IDkYJxU7f1/Xce5wcd34Dh0O40eH4owJYSRGGCH+17JvsiEEFUYqSRtJHzl8Dpg4NWLbWPBFl4ZstFs/ihaQR2dsbWOddUsTI0fy4DAoUJAXaDtzgnuc1uf8JZcTfELS9Hs1srjSNR0yW9hvYZjI0hRkHGPl2kOCCCc+3fctde0i+1KfT7LVbK4vbf/XW0NwjyRf7yg5H409ba9f0uv8wvZ+n62/4BzmjeMPh5oOi2mlab4u0CO1tIhFEratCxAHqS3NXv+Fj+CP8AocvD/wD4NIP/AIqo/EnjKCz8J6zqPhm70vVL3S4ZJXgN2CF8vlw2zcQQO3HJAJGc1e0nxPp17Hp1rdalYx6veWcdz9hE6iUhk3ErGTu29efajWV3/Wt/8gelv62t/mVf+Fj+CP8AocvD/wD4NIP/AIqj/hY/gj/ocvD/AP4NIP8A4qma/wCMbe38H63q3hi603V7nSYXklhW7BVCgyysU3ENgHg454461eh8SWFt4d03Ude1Cy077bDEwM8yxIzsoO1dx568DJNL/gfiD0t8/wALX/Mqf8LH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFU4+ONC/4TZfC41G1/tA23nlDOoOcjagHdiuWwOQBnvTr7xZZS+H9WvPDF/pmrXemxO7wpeKyoygna5TcVPB4xSbSjzdBpXfKR/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FVf8L6pNrfhHSdVukjSa9s4riRYwQqs6BiBkk45p9n4j0TUJLqOw1nT7p7P/j5WG6RzB/vgH5eh6+lVJOLafQlO6ujN/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KrVste0jUrprbTtVsrudYlmMUFwjsI25V8A52nsehrnLvxyD8RtH8PaVPpd5a3YuFu3iufMmgkjTdsKLwvUckk9eB1pdbD6XL3/AAsfwR/0OXh//wAGkH/xVH/Cx/BH/Q5eH/8AwaQf/FVs6lqunaNZm71i/tbC2UgGa6mWJAT0G5iBUV94g0bS7CO+1PVrGztJceXcXFykcb56YYkA5oAy/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqti51jTLOOJ7vUbSBJlLRNLOqiQBSxIyeQFBPHYZqNdf0d7O3u11axa2us/Z5hcpsmwCTtbOGwATx6GgDL/wCFj+CP+hy8P/8Ag0g/+Ko/4WP4I/6HLw//AODSD/4qtMeINGbRf7YXV7A6Zgn7aLlPJxnGfMzt6+9LceINGtNITVbrV7GDTpACl5JcosLA9MOTtOfrQBl/8LH8Ef8AQ5eH/wDwaQf/ABVH/Cx/BH/Q5eH/APwaQf8AxVF3488P2finTdBk1Sz+16jCZos3CgFcgIBzyXJ+UDrg4qzJ4p0XTlLav4j0eIS3DxQFrhIeRj938znc4yM4x1HAoArf8LH8Ef8AQ5eH/wDwaQf/ABVH/Cx/BH/Q5eH/APwaQf8AxVajeINGS4vIG1exWawQPdxm5QNbKRkGQZygx3OKsWGo2Wq2SXmmXkF7bScpPbyrIjfRgSDQBwfj7x94PvPht4ltbPxZoc9xNpN1HFFFqULPIxhYBVAbJJJwAK6D/hY/gj/ocvD/AP4NIP8A4qj4j/8AJLPFf/YFvP8A0Q9dJQBzf/Cx/BH/AEOXh/8A8GkH/wAVR/wsfwR/0OXh/wD8GkH/AMVUXhjxPrGua9rWn6jo1nYx6TMLd5odRacyOUVxhTCmF2uOSc54wetSaL4nu7ia/HiK103SIrW7FnFIupGXzpODjDRJjO5cDJJORj1P8r/194PT8hf+Fj+CP+hy8P8A/g0g/wDiqP8AhY/gj/ocvD//AINIP/iq1YNe0i602XUbbVbGaxhLCW6juUaKMr97c4OBjvnpSL4g0Z9GOrpq9i2mAEm9FyhhAHU787f1oAy/+Fj+CP8AocvD/wD4NIP/AIqj/hY/gj/ocvD/AP4NIP8A4qtZNc0mXTYtQj1OzeymYLFcrcIY5CTgANnBJPAxVdvFnh1bcztr+liET/ZjIbyPb5v/ADzzn73+z1oAo/8ACx/BH/Q5eH//AAaQf/FUf8LH8Ef9Dl4f/wDBpB/8VWnfeING0xpF1LV7C0MQUyC4uUj2Bjhc5PGSMD1qS31nTLvUZtPtdStJ72BQ8ttHOrSRqehZQcgH1NAGR/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VWrZ69o+o3lxaafqtjdXNr/AMfEMFyjvD/vKDlfxptv4h0W6vYrO11ewmuZlZo4I7lGdwpIYhQckAgg+hBoAzP+Fj+CP+hy8P8A/g0g/wDiqP8AhY/gj/ocvD//AINIP/iq6SigDm/+Fj+CP+hy8P8A/g0g/wDiq5/x94+8H3nw28S2tn4s0Oe4m0m6jiii1KFnkYwsAqgNkkk4AFeiVzfxH/5JZ4r/AOwLef8Aoh6AD/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKrpK5Oy8X6hr9xcP4U0eC+061uHt5by7vTb+a6HD+Sojffg5GWKAkcHHNHWwFj/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qp7Pxbpz6Sl7rMsOiOzShoL+5jRkEbspJOcfw5OCQPXvVyLxBo02rf2XDq9hJqGzf9kS5Qy7eu7ZnOPfFAGZ/wALH8Ef9Dl4f/8ABpB/8VR/wsfwR/0OXh//AMGkH/xVaS+I9De6itk1nT2nmLiOIXSFnKHD4Gcnbjn070tv4h0W70839rq9hPZh/LNxHco0e/ONu4HGc9qAMz/hY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqtKHxFolzY3V7b6xp8trZsVuZ47pGSAjqHYHCkd81astQs9SthcaddwXcDYxLBIHU5AI5HHQg/jQBh/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVdJRQBzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVXSUUAc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFV0lFAHN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVdJRQBzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVXSUUAc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFV0lFAHN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVdJRQBzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVXSUUAc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFV0lFAHN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVdJRQBzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVXSUUAc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFV0lFAHN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVdJRQBzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVXSUUAc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFV0lFAHN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVdJRQBzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVXSUUAc3/AMLH8Ef9Dl4f/wDBpB/8VWH4s8a+FdX0uxsdK8S6PfXcutaX5dvbX8Ukj4v4CcKrEnABP0FegVzfjz/kXbX/ALDWlf8Apwt6AOkooooAKKKKACiiigArm77/AJKnoX/YF1L/ANH2NdJXN33/ACVPQv8AsC6l/wCj7GgB/je9Fl4YkP2W9umeWMLHZWctw5w4Y/LGpIGFPJwPzFcfY6FqFh4nvoRBP/whkki6+gFvJ5omOSbcQ7d/+sAl24yCMY5r0+SRIYmkmdY40GWdjgKPUmmLco149sFl8xEEhJiYJgkgYfG0njoDkcZHIoWjv/X9Xsweqt/X9W0+Z4t4chvbfQvBd7Po2sRjR9avGvIm0ucSxpMJtjhNm5l+dclQcZ56Vb03TdRWHV7ua11zQLu31+81Cwu0037UsiuNmGhTc7Kw9AD3DV7HRTb6/wBdH+gPXf8Arf8AzPKNKTUBrZu/HXh2drTWdGisjHZWMk8du4eTzEaNAzRCQMrc8DGCcirN/ZS6N4y1BrbRdRezvvDMdlZpBbNMFkjMn7p3GQp2suC7AH1zXp1FKXvK3r+N/wDMadnf0/C3+SPE9BttYS+8IWT6Rq2nXlr4XuNPeaaxkMcE7CMJukQFAD5ZPJyOM4JxWnp+j3F9Y+CNPh0q+stR8OMv9oyyWjxKsYgZZESUgLLvbH3C3qcV6Pe+IdJ07WrDSby+ji1DUSwtbbkvLtUsxwOgAB5OB2q7BcJceZ5ayDy5DG3mRMmSPTcBke4yD2NVKTlq+uv4t/m3cm1tP62t+mh4/ex6vp3hXXtBs7TU9W0iPQpbezkm0aVLu2kcBUtgVX9+pB5ZRhdnzHvTdEOvT+FNY8NzafqX9q6hpX/Ev1Z9PnhQr5ZUW8hZMQshUgA4DZDdW59nopX38/8Ag/5/1qO708v+B/l/Wh4zfaKknhfXdXhPiy81OTQpdLNpd6Use0kYRFSG3TzMMeHXcoGeQKsXFheXM2jXV9J4istJutBj09hY6UJpIZQT5iSwyQSSIGGPmCgfLyelem654g0rw1p327Xb6Oytt4jDyZ+Zj0UAckn0FaPWjf8Ar1/+SDZJf10/+RR5NBol14a8STQ2mj6rqlkPCa2VqJuWmaORz5ckqgKjFWX0PPGSKzbKO7tru/vJNL1Yw3HhIWcKRaJOgjkVmAgVNpfjcMbySRkg45r2uipl7y18/wAeb/5Ia0f3fhy//I/1ocn4NaZfhNpcbWF0LmDSkhezuIXt5DIke0oQ4BGSMZ/EcV5mthIUilvvD+pyWT+FZ7BbJdCnZLeUOhSEKUaRiD/G5IO3cMc17xRVTfPKUu/6pr9f61FH3Ukun+af6HhsFnqUkPhGy0XS9UsLyPwrdWLzNpdxClvcuiBFdygCnejHJPoe4J1tPE0/ij4fy2PhTVbUaTb3FpfB7Ewrakxov33wrrnJypYHnGTxXrlFU5Xlf+t3/mybaW/rZf5I4nxUtzYePdD1u5sbu/0iC1ubaZbW3e4a3lkKbZPKQFiCFZcqCRu9CazIdOt/DPi61v49GvR4b/sl7K0gt7GW4e3kaYu4MShnVXBHUYG3B28CvSaKjt5X/G/+bKev9drf5HieneHH0LXfAi6hol3I9nd30zSRabLcCyt5PM8iJpERgu0sPlz8vXgc1n6TbrLrHhx7nw1rHmWnie+uWlm0C5HlW0plMZ3GLhSzIcZ4PJAxmvfKKpSad/63uJq6t/XX/M8PsbbVZZJr2G28Q6fZWviW8u2+z6UwnWKZCI5Y4poW3jO7IVSw3ZxWrp2gr4S13R9Vgt9d1XQCLwyGeyLzwTTmNvM+zRxqyqcOuBHldxyADXrdFJaW9LfhYb1b83f8W/1POF0mLR/iB4Ym0jRL2HRYtNvLZFS3dhEzyRuAwOSgIDEBsemM4FYnh7QJNR+G/iOw07SbrTru01qfUtKiudOktVysvmQbFdV+U7dpA6A4OK9ioou1t/Wt/wAw/wA7/hb8jzPXbTWdY8J6fryWupWM82ow317aW8CPdwwKhVVEciMGZTtcqVJzuxziuh8CaLa6Xb6jdWVzq9yupXP2qSTVbdbdzIVCsREIo9g4GcqMnmuroova9v62/wAkLe1+n/B/zZzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9H2Hxv/wBDD4f/APBDP/8AJlIZj2d5N4R8aeJX1bTtRlstWuIru0ubCwmuwcQpGyMIlYoQUzyACD1rn/GWmGfTtKu73w/eXE9x4mivxEmnPdSW1uGUOX8tW2ZVQSvU5xzg13H2Hxv/ANDD4f8A/BDP/wDJlH2Hxv8A9DD4f/8ABDP/APJlNOzT7W/Bp/oget/n+Ka/U85nh1GbxRrt7baLqs2n2/iS11CW3bT5Y/tUCQCNmjDqBIVkAbaMk7QRniui1PT7ddX0XxFomj3y6XHqkt9qcX2KZZpJGgMazC3YeYSpAyAuecgHk10n2Hxv/wBDD4f/APBDP/8AJlH2Hxv/ANDD4f8A/BDP/wDJlCbSSX9aJfoger/rz/zZ5l4n8Pl9N1TUF0G+uLPUvEdnfWNoulSyyRInl+fKYghaLcA+QwBPQjnFWfEKvc3nxL+y6Hqzf2hpUMNmy6Ncfv5BGyMEPl88lPwGegJHon2Hxv8A9DD4f/8ABDP/APJlH2Hxv/0MPh//AMEM/wD8mUvs8v8AWyX6DTtLm/re55rZrbtrfii9Xw3qyi98NQWyu2gXKtPOFdXXmLJbmMe4HcDhotdTuofCNppmnapZ3o8L3Vi876XcRpb3MiIqiRjHhfnRjk+x6EE+mfYfG/8A0MPh/wD8EM//AMmUfYfG/wD0MPh//wAEM/8A8mU273v1/wDtv/khR921un/A/wAjjodNXU5fCPl6Le2f/CPW0keqifTpEUw/ZyjQL8uJwz4OE3g4z3Gee8OwSaf4f8CW8Xh/V7WWz8QXE9yi6LcJ5MTeaAzfu+ARJGPp/unHqX2Hxv8A9DD4f/8ABDP/APJlH2Hxv/0MPh//AMEM/wD8mU+Z81/n+NyeX3eVen4WOkorm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MqSjpK5v4j/8ks8V/wDYFvP/AEQ9H2Hxv/0MPh//AMEM/wD8mVz/AI+s/GK/DbxK15ruhy240m6MscWizI7L5LZCsbpgpI6Eg49D0oA9DZdyFemRivN/AEtx4B0FfCmvaZqbPa3MwtLy0sZbqK6ieQsrFolbyz82CH29M9K6X7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoWgdLHLa9Ywan8XvCt5feG52/0O6iupm055kRXAESSyqhT+/wWIXceecnDNrcx6/pEz+H9QsrKw8RXLzWVvpUsqJG8UqiYvtYyb+D+7wihtpGQK9F+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkyhaf153B6/wBeVjyiwtFtPAmlWcPhnVYXh8Wm7aBdBuBstvPZt+3yvu+WwH047EUeL4YpY/GU15o14UPiHTri0kutNkRZAGhicxtIoBJIZeDyD3BzXqMqeL4JoIZ/FPhqOW4YpCj6JMGlYAsQoN5ycAnjsDWP4u8D+MvGGkR6ddeM9NsIUnSctZaEwZ2Rgygl7luAwB4x09OKpOzXr/8AI/8AyImr3/rv/mUL7Rl8SeJNX1aK11fTdNmtLS3SaOxaOZ7mKYyLKIXXcQnyjJUgjOMiup8CXmsXuk3cmu24WQXTLDdGya0e8jCriV4X+ZG6rg9doOAMUsWneOY4UR/EugysqgGR9Alyx9Ti7AyfYAU/7D43/wChh8P/APghn/8AkyktFb+v6/rsD1d/62sdJRXN/YfG/wD0MPh//wAEM/8A8mUfYfG//Qw+H/8AwQz/APyZSGdJRXN/YfG//Qw+H/8AwQz/APyZR9h8b/8AQw+H/wDwQz//ACZQB0lFcrdr4usLV7m+8VeGra3jGXlm0SVEUepJvMCpRZeNyMjxF4fI/wCwDP8A/JlAHS0Vzf2Hxv8A9DD4f/8ABDP/APJlH2Hxv/0MPh//AMEM/wD8mUAdJRXN/YfG/wD0MPh//wAEM/8A8mUfYfG//Qw+H/8AwQz/APyZQB0lFc39h8b/APQw+H//AAQz/wDyZR9h8b/9DD4f/wDBDP8A/JlAHSUVzf2Hxv8A9DD4f/8ABDP/APJlRXUfjCxtZLm98UeG7e3iUtJLLokyIg9STeYAoA6miuaFl43IyPEXh8j/ALAM/wD8mVHcReMbS3e4u/E/huCGMbnkl0OZVUepJvMCgDqaK5pbPxs6Bk8R+HmVhkEaFMQR/wCBlL9h8b/9DD4f/wDBDP8A/JlAHSUVzf2Hxv8A9DD4f/8ABDP/APJlH2Hxv/0MPh//AMEM/wD8mUAdJRXN/YfG/wD0MPh//wAEM/8A8mUfYfG//Qw+H/8AwQz/APyZQB0lFc39h8b/APQw+H//AAQz/wDyZR9h8b/9DD4f/wDBDP8A/JlAHSUVyluvi67aYWnirwzOYJPLlEWiSt5b4B2ti84OCDg+oqf7D43/AOhh8P8A/ghn/wDkygDpKK5v7D43/wChh8P/APghn/8Akyj7D43/AOhh8P8A/ghn/wDkygDpKK5v7D43/wChh8P/APghn/8Akyj7D43/AOhh8P8A/ghn/wDkygDpKK5v7D43/wChh8P/APghn/8Akyj7D43/AOhh8P8A/ghn/wDkygDpKK5v7D43/wChh8P/APghn/8Akyj7D43/AOhh8P8A/ghn/wDkygDpK5vx5/yLtr/2GtK/9OFvR9h8b/8AQw+H/wDwQz//ACZWH4stPFUWl2L6rrOj3NoNa0vzIrbSJYZG/wBPgxh2uXA5wfunI446gA9AooooAKKKKACiiigArm77/kqehf8AYF1L/wBH2NdJXG+I9b0rQfiToF1rmp2em276TqMay3lwsKMxmsiFBYgZwCcexoArfGRbn/hXFw1pf3FmwurZWMG351aZFKncp4+bPHpzkZBq/wBq+LbbxN4o0S0vxqstjpNvcaeslvHHI0jmQHcRhWY7PRV6cDnOnrPi74ceINJm0zV/FXh+4tJ8b4/7XiU8EEEMrggggEEEEYrKguvhPb6vcanF4p0kXdzGsUrnxIWDKpyo2mbbweRx1JPc0Lr/AF0G/wCvvIj4m1e70EjR7vXriezuo49VhksLdNStIyjHKxlBHJltvKqwK7tuTU1h4lvNU8Z+H4tL8Q3F1pWq6fes4NrFGUkidQpwU3K67ypB4yv3etSR6p8LYo5lj8WaSsk7l5LkeIz57EqV/wBd53mcAkAbuO2KR7/4TvBp0Q8R6DENNdntWh1xYnQv9/LrIGfd/EGJ3d807r+vS3/BRP8AX4/1cwNI8aeJ9S0nS9KSbUr3ULltQeS9sIrJbgrBc+UgCzFIsYI3YUnjgDJI77QtW1uDwB/aXi2wFvqtrBK9zbxsjbtm7B+RmUFgAcAnGcVzKN8HYNPjsrPW/DllFHO1yj2WtJbypIwwWEkcgcEgAHnpx0rft/HngG1tRbQ+L/D4iAIw2rQsWz1JJckk9yeTSlrFpblfav0ONeTVdS8RfDbWtQ1f7UNTnluPswhQRW7NaOwEZUBioBwd5Yk85HSrFj4m8W3Ph2a5uJru8Fnrt1aX0+j2cXnpBESFKRSbgRkfMBufB45qxEnwahmtnXW/DzC0mM9rHJrivHbOe8cbSlY/XCgAHB7U6wk+E2mW9xDYeLdPgW4keSRl8VSby78uwfz9ylsDJBGe9U32/rVP/NE9En/W/wDmvuLNp4ku/FmuW2j6D4gmtrY6T/aB1KG1j82ZmlKKu2RGVQu07htznjIrB03xZ4z8Rar4f09dYttL+3xajbzyQWKuxltmKCZd5IwxIO3HGCMnPG9PqXwpntLO3XxNoVstkhjt3s9dW2kRTyy+ZHKrEE8kE4J5OaQ6j8Kf7Y07VE8T6LFc6ZGYrPydfEccSnqPLWUIc98g5wM5wKSt+f62DX8v0/4f8DmvGuoat4i+HPiO/l1Zo7fT9SWw+wpbxhZBFPGrO5ILhi2WG1gACBg9a2L/AMTeM9Q1m/fwvp97PHpmpC1MINktrLGoTzDI0kgmD4LEFQB93g81Pqcnwg1i6vJ9Q17w/Kb4qbqIa4qRTspBVniWUIzDA+YjOOM4qwup/CmPUVvbfxLoNtIqLGyW2uLDFIqrtUPEkgR8AADcpwAKI6Wv/T0/y/Ecutv6X9dfLzKmg33jjVU8TTx63b3NzpN9dWltZLYpHFORChjySxZcMc/eOcnPbHQeCNdOqC7tLq/1KTULNYxc2eq2kcFxAzbju/dqqMrdAVyPl6nmsnS9T+FmjwajDY+K9IEepyGW7E3iLzvMc9Wy8pwT3IxnA9BVzS/E/wAN9HuLq4svFuh/aLtgZ559cSeR8Zwu+SRjtGThc4GTgChPS3kvvB7/ADf3HbUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVSA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoAPiP/ySzxX/ANgW8/8ARD10led+PvH3g+8+G3iW1s/Fmhz3E2k3UcUUWpQs8jGFgFUBskknAAroP+Fj+CP+hy8P/wDg0g/+KoA5mz0rQfh78VrieHTrKws/EFmzxTxwqghmhG6SMEdA6YfA4yhNRwT2HgjRrfUtM0eKy1XxVeu7PFpsk7RBleRd0UI3vtUD5Rj5iTkcmrvizV/hl400uGw1vxfobQwXKXKGLVoFbcp6Z3HgglSPQnp1qfXvEvw91+zgin8baNazWsomtbq11a3WW3kAI3KSSOhIIIIIJBBoW34fLf8Ar08wer/rfZf15mND8Q/F9xNo1mNEtbWS+1ObT2ub62ubYS7YmkSaOBwGCEDkFs5BX/aF638UeLtL1bVdM8VzaILmLSfttgbGzl2zSZ2svzy5ba20YGCd4OR0qtfX3gXUdQ0e9u/ilbPcaTP9ojf+1LH99Jt2EuNmPukjC7RyT15qHXPGfw+8UeL9G2+KtLV9Dummnne8WKNl2cRhmIEoL7G+UsBs5wcU9Nv623+/UPP+t72+7Q6rxZrmu+F/hreaysWn3mq2Nr50ytvigJAy20ZZvoCefUVlap4l8W6bY2z3T6Dam7EksM/lyzYURqywiAOryOSX5QkALnHOKk8UeJvAXivw3d6LdePtJtLe8Ty5ntdVtQ5Q9Vy+4AH6Z9CKo3OpeALq60u6f4j2K3Wm2z2gnTVrQNcRPt3K4xjnapygUjHBFJ63/r+tbf1oNWVv6/rqRw+PvFOry+FIdHsNIgPiLSpbtZbqSV/KlRAxUqoHy5Zec55PTHK2nxI1m81iz+yaVNd2UmoNYXENvpF4TFtcxtcC5x5RQMvK4yB/FkEVU0xPh7pV/oNzb/E+2caDbtbWkMmq2JQxt94NhAxyAoyCD8ox3J07HWfAGm6pPcWHxD06CzuJjPJpiava/ZzKTuZx/GuTyQHCk545NXePNfpr+f8Alp/VydbW/rb/AD/roeiUVzf/AAsfwR/0OXh//wAGkH/xVH/Cx/BH/Q5eH/8AwaQf/FVAzpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Sub+I/wDySzxX/wBgW8/9EPR/wsfwR/0OXh//AMGkH/xVYfjXxr4V1nwD4g0zSPEuj3+oXumXNva2lrfxSyzyvEypGiKxLMzEAAAkkgCgDvpEEkbISQGBBI6ivKL/AOH/AIRs/ip4W0yLw3pTWr6ZeeakllG3nMnlBWfK/MwyeTzyfWvWa5u/8Grf+NLLxI2uapDPZI0cNrF5HkhG271IMRYhtoyd2R2IoXxJ/wBbP/MHs/66ow01TU7A6vofgiLT4rbwvFGGivY3czlkMnkoVZRGAuAGIfr045zNY+JWt2en6Jr1umnx6H4gtQtoJ4GMtvdugMSyt5yqYyc5YAYx+NdlqPg61vtUub621C/02S+RY75LNowt2qjAD7kYg4JG5CrY78DEF54C0+8WeE3d1FZyaadNiskSBobaI4BMYaMkNwOpIOBxwMHTX+t7/fpbt+b0v/Xlb7tb9/yo6j4n17QNd8M6dqyabcRaik5vbm2WRCGjiaTEcZJwOByWJPPA7TeF9d8Ta5/ZWrSWlg2h6tbmdVi3JPZAqGj3sWIl3Dg7VXafUc1HH8Noll0F5vEuuXP9hBhbCd7d/MDDawkPk5bKHb1Bx3zzWr4f8JQ+G1Fvp+p6i2nRkm30+WRDFb5zwpCByvJwrMwHYcCq0/r5/wDAt6E62RQ8QeItcs/Hui+H9Lg09bfVLa4k+1XBd3jaMA/6tcAj5l/i55+7jJwbD4geIJrDQ7+7i0zybzWX0a6hiik3GQO6ecjF8KuUzsIY4P3q6rVvB6at4s07XzrGpWlxp0bxwQ2/k+Vh/vkh42YkgDvxgYxznFj+FVrFpVpYJ4k1wR2epNqkT/6Lu88sWyf3GCNzMcY/iPbAEx6X/rX/ACHLZ2/rT/OxDa+KPFIfX9Jv59HGt2V5bw2IjspRHLFKRtlZTMWIPzg4I27D96oLv4ga3D4du/FVvDp82iafeva3Fr5Ti4lRJfKeZJN+1fmyQhU8D73NbMelWuu/ES18Qw295ENMtZbZ3uLeSATSFsLhXVSwUeZhgCP3nB61ZfwFpzXEyi7vE0y4uPtU2kq0f2aSXdvLH5N4ywyVDhSeo5NOPRv+v+HV38/mD6/1/Vnb7vkc9ceNfFbJ4tntbXSIk8NTAmFvNla6h8oSkB8qEfaRztYA8YPWm6z8RtUstQtp7VNPWwlnskW0kR5bmaO42jzSyPiAKWIAdDu2nB5FVNG8P/8ACSeNfG0N+2vWOnXt5GWgNo9vBfxLCkbDfJHnG5SPkZSR6iukv/hrpt9LqBTUtTtIb+5gu3gt5IwiTQ7NjruQnpGowSV46Z5ojb3W9tP0v/XT8h9V6/8AAPOvFg1XU/DPxMOt3Vjf29heRpbRmyKtE4SIoVYuwUAMR93JJJyM4rs77xN4wiv9e0fTE0ibUrDTodRsg1vKUkRi4aFv3gJbKcOMA5+6Kv6x8MtP1iLWom1fVrSLW5ElvI7eSLazKqrkbo2xkIufpxjJzOvhy28N+ILnxXeavrd/M9pHZywi2ScMin5SI4Id5O5iSR/ePYABfZS8vxt/mPrf+t1+lxfDniLUPEM+kz2l3YzWEulpd3hW1dXMkmQgQ+YQgyr5UhiNuM81va1eXOnaDfXlhaNe3NvA8kVsvWVgCQo+prnvDHhptD8NaotgLyzm1C6nuYljZDLArMdioJAUXA52kYBY8V0MNrdzaFHbahcut20IWae3IUh8clTjHX2/CnLXbT/g/wCWxMdHrr/wP89zg7rxrr9z4Evta8M6noWqXOmgSXcP9nzo6AZMiGEzBkcLggMecEYGRjR1bxZrUNve6jops7/Tbe0tjuispZZBJKQWkwkmXRIyH2AbjkDdWpHpGn+GrnUNXvpdS1S71QxwTSm1M7lBu2JsgjACDc3zFe/zNUPg/wAJf2F4JttLjmurKTzDOSkgaSLLZWMkgghV2pjkYWjTV+n/AAV/X/BHt/X9f19xyus+ItZ1i88GyaD4j0e4tb3VWiaa3s3eORlgZvnXzQVwwb5N2R8pJ4wblz8R9WfXCuj6XcX1lDqRsJreLR7tnYK+x5hcgeSApz8nPA+8DxW0PhvpY8iU32om+i1E6k98JI1lmmMflksFQIAU+XCqvqMHmr0Hg+Cz1a6u9P1PUbS3vJDNcafE8ZgkkI5f5kLqTwTtYAnkg5OXp/Xy/wCCv8uieq/rz/4DOOj+Ifij+xX1a5s9Hjjt/EH9kTWqGVy4MoiDLIcbcMc8ocjstS618QPEmiab4uBttLvLzw/JAyy7ZIY3ilXIym5yWU8feAP+zWgfhRanR5tNPibXTDNqQ1R2JtdxnD78/wCoxjeA2MY49Mil1b4VW2sXGtSXHibXY01vyxexRfZQriMYQDMBK4HocnvmktEr/wBaL9bj+030/wCC/wBLE954l8R6hqmr2/hO1sJjopiSaC7Db7yR0DlEcMFiwrDDMGyT0AGS74t28N18IPEYu4I5Nlg8irIobY6jIIz3B5Bq9H4Kig1gapZ61qltdyxRxXrxNDi/CDCtIpjIDY43RhD+mLvibw5D4o8M3Wh3N5d2ltdR+VLJbMnmMndcurDnucZ96T20HF2ab/r+v68udh8Q62niqXQLaTT1gHh9L+1kktnZo5NwTD4kAdeCeNp5xnvWN4X8e+L/ABXcWFnBBollNeaGuprcOk0qljIE2mPcu0ZDD757HPausl8D28t5YXh1fVEurSyawkmR4la6hJB2yYjwDkZBTaR61wuneD49G+J1tomiXHiaw0+10P7GmopBJIpfzTIY/OkiaMDae2ADwCDxT3lb1/8Abn/kTa0b+n/tqf6/ebeg+PdZ13XNBthDY20OqWF40qNC7vBc28gjbDbwGQk9MA4HXninY/ErVjoOk32tSadpsM91dw3mpNZTPbIYZjGqYEn7ouATvdiARjBzXVv4C0xBov8AZlze6Y+iq8du9rIpZ43xvRzIrbg2ASeGzyCDUFh8O7LSdDm0rSNY1i0t52kaX/SVmLeY25+JUcDPPQA/MT1OaG10/rV/18uo+n9dv6/4Bpa14h/sHwTPrlwsd08Fssm22JZJXIAAUgElSSMcE49a4HVPiZ4s0zSdbuItGjulsbdLmG9utMvNOhIZtrRFJVJd1JU5BUMCfu4xXov/AAjWlHwmvhs22dLW2FqISxOIwMAZ65GOvXPNYup/D5dZ8Mz6HqXiXXJ7ebCmVnt/MEYIPl58nBGQDuILcfexnI7cz7AtlcoT674z0fxTo6a9LoI0XVLxrYPbWs3mxEoWiVnaXbliCudvUDj5uMjUNT8XX3jDwg39r6XFY39/dvbxJp0nzRJE+xnPn/MShyMbQCQcHGK6Xxnpkes+Gh4Vf+0Lm8uEiMV4tuy+Wyuv74zIojR1xu2gqTjgc1pal4RsNSm0aUTXNo+isTam2cL8pjMZQ5B4KntgjsRTVl94tbW8jznRtWvfBsXiW60i30+PS4vFwt5rbyWDFJTChKbSFQgsDyGzz0raX4kavd65B/ZOk3F7p8movYPAmkXe6MLI0ZnN1t8kruXlQMgfxZBFXp/hTa3Gm39lJ4l10xahqK6lOQbUMZlIIIPkcDKocf7I987Nl4Ni027nksNX1K3trhzNJZI0XkmUnLSDMe5SW+YqGCk5+Xk0lblSfRL8Ev8AJ/1s3u7dW/zf+a/rfkbL4heKJtF03Vbq00eOO41x9Ilto/NY581oldZCRjDLyChyOfl6Vop4z12Ox8R2866W9/o2oQ2v2xgYLcRyKjeayPIT8gc/KHy2MDGakT4U2sekW+nL4m13ybfUjqaEm13eeX35P7jpuJOPf0wBPN8MrOe81K6k13WPO1C9ivywa3HkTRYCMg8rsoC4bcCBzk80K3X+vh/+2/rYd91/W/8AwDktc8YeItZ8C3LW95Z21zZ+I4NMlnSxlVLmMyRYYRu4ZAd4yNx3AHBGc1u33jXxCml69qmnLpk9t4ZlaG9ieCRXvWjjV5WjbzCIgNxwCJM46jrWtN8ONOn0/U7SXUtSZdRvotRaQyR7op49mHQ7MdY1JDAj0AFTXHgHT55LtUv9QhtNQ51GyjkQxXrbQpZyyFwSAAdjLnvmjp5/raP4fF9/3HXXb9Lv/gfcZp8dTS+KILE3NlpUF3FA9iuo20mb7zArHZMGCBgCy+XgsSAeBWWnj7xIPC1nqUv9lNMviT+x7pVtZAskf2jyd6fvSUbvzuFdfq3g+21mSJLy/vvsEc8c509TGIWZNuwZ2b1UFAcKwySc5BxWXd/C/Sb1LmCfUdWFlPqI1IWkVyIkhn3biyMqhxlucFjg8jFNWuu1/wALr9L/ANbGvL5/8B/rYXQfF91qfiy70m/urGzuIbiRV0ua3kiuTCu4LKrs22UN8rZVQACRkkV2dYH/AAiNvJrtjqd7qF/etpzO9pBcOhSF3BUvkIHY7WK4ZiMds81v0uiDqwrm/Hn/ACLtr/2GtK/9OFvXSVzfjz/kXbX/ALDWlf8Apwt6QHSUUUUAFFFFABRRRQAVzd9/yVPQv+wLqX/o+xrpK5u+/wCSp6F/2BdS/wDR9jQBL418QXnhXwnea3Y6fBqAsozNNDNdGD92ASSpCPlunBAHvWdZeNdQh8W6doHiTR7exm1WCSaymsr43Mb7AC6vujjKnBBHBB9aPis0jfDHW7S2tL28ub21e3ghs7SSd2dlOOEUkD3OB71zmlQDwf4hg1yPTNa1bSdWgWJZ5rS5ur7THA5QrIDMIW25xjhh6EU426/1oEttP62PRV1vSm1Z9LXU7M6iieY9mLhPOVf7xTOQPfFMt/EOi3V7FZ2ur2E1zMrNHBHcozuFJDEKDkgEEH0INeXaR4YW4kt4fFMviWW60u+nvharpsbWkwZn3MJVt9zhkc5jLlznGMgVl+HoJdO8O+BYIfD2r201nr9xPcomi3CeTE3nAM37vgESRj6f7pwLXcHpf+u/9fM9jTX9MvLy607S9T0+61O2Ql7NbpS8Z7b1XLKM45xWf4C8Q3ninwdbatqUEEFzLLMjxwElF2SsgwTyeFHPGfQdK890FLy38T+GNSudE1SxtrNdRjntItKnZbNn+YDeVZ5SxB+cHYx6AdK634RedH8PYbe7sr2ynhubjfFeWkkDfNM7qQHUZBVhyOO3UGhbA/1Ooh1/R7jV5dKt9WsZdRhG6WzS5RpkHqUB3DqOo70kfiLRJr2Gzh1iwkupy4igW6QvIUOG2rnJwQc46V5VZWt0fE3h67uNC1G0tLTVdQ+02SaXK8cAlST52kKs0u8kHcp2fNjHArK0y2fT/CWg29j4e1e0mg8WyXbJFodyhit/Mkw5Aj4XY6DHpkdiALp8vxf9MJaX+f4J/wCX4npPivxyNG13RtL0qfS7qe71KG0vYHucz26SdGEa884PJIxxwa6e+1bTtLe3TU9QtbNrqQQwLcTLGZnPRVyRub2HNeOfZdSj8N+FtMl8Marca1o2vpcXzR2Z2y/NIzzrM2EYPkEndxnBxxXe/E6yurvwvaTWdrPdNZapZ3kkVvEZJDHHMrOVVcliBk4HPFCSsr/zfh7uv5g/i07fjd/8A3k8S6FJ9q8vWtPb7HJ5VztukPkPnG1+flOQeDzxSQa1Y39/Aunazps8TJLuhjkWSSQowBKsH4CnIYbTyRyMc+MeN7C41W78XTSeEtWuoNQu9MlsJjpby58sL5hCgF0OwsMlR3U4J2nqr+w0mx+MGn31p4auEs7jR7pb+e20OUpK0hRlWQrH8zFVcYOSOh5OKS8/P8r/APAD+vxPQLfxDot1exWdrq9hNczKzRwR3KM7hSQxCg5IBBB9CDS2niDRr+8ubSx1exubm05uIYblHeH/AH1Byv414tokM2m+F/BMNv4c1iGey125nuIU0a4jMcbCYAsfL4BEkYz6f7pxd0SzkGr6Hc6t4f1CPTk0S+s7jT/7GmeK1JaNvJOVZ5cgMNxJVyPlHJFNrf5/lf8A4H9WDrb+t7f8E9OufHXhGzkWO88U6Lbuy7lWXUYlJGcZALdMg/lWnFq2nTanJp0N/ayX0cYle1SZTKiHoxTOQD64xXmPhHwVDq3wKtdNbS20zWY7YhJLmyaCaGdJDJGfmUNgOQcjg5PvXYeAru51vRT4i1K0a0u9SC5hcDdEkY27eO24Ow/36dtWu39IV9iH4i+Nl8HeF7y5sLjS31aKAzQWV7c7GlUfeKoPmfHoMfUVvw6gj3oSS/s1xaiWS16Sp/tk7uE7fd/HtXlXi2w1BtB8f6LdaDqF/qOqzG40+eCzeaOePagjXzACqFCp+ViD3AOasGygv/iFrIvPD2sWltqnhqO1uni01wWmySy+aoMbOEKjO4jjbkkYpLVL+ul/z09Snb7v80v+D6Hptr4g0a9sJL6y1exuLSNdz3EVyjxoMkZLA4A4P5Gkg8RaLdaS2q22sWE2nLndeR3SNCMdfnBx+teZTweKL0xrc28+raXo+q2k73b6Y1rdXsMe/chhIBk8tijBlUBudoJrP8c6EdX0jxlq9pod9Pa6tFaJZWp0qYzSXSFt8/klN6fKQu9lBOPTGTT+vl/n+Alvb+v6W56te+J9It9Llu4tX0vAdoInnvUSJpxx5ZfnBzwQASPSsrwp43g1L4eWPiXxPdafpS3BcSO84jhQiRlADOfYfX07Viy28WkePrXVv7BuZdH1DSfIhNpprs1vOzZfzYgu5N6hAWYDGwBiK5Pw7pGuWHhvwrLqFp4g0WysYLu1mWysYrieNpJFZH8kxynYVypIUMPTBOS39ff+en3r5r+vv/y/Rnsd14g0axRHvdWsbdZI/NRpblEDJkDcMnkZI59xTrbW9Kvb6ays9Ts7i6gbbLBFcKzxnGcMoOQcc815Ro/g7SdJ+Ivh6xi0XUr2wj0q7glvNQ0tnDeZIrRpI6xBANvmAKcbQdpAJxXQ+GINS0jxdb6Zpsd3daEyzTsl/prQPprOdwWOfAWRSSRtG5h3bHFOy/P8GwZ6JRRRUjCiiigDm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh66SgDlV8XXuraxf2PhLSoNRTTJvs95dXd4baIS4y0aFY3Z2XIzwBz1q9beKbRNKub7xB5egx21y1vIb+4jRQRjB3Z24OQRz0I+lcn4Ua5+H13rWk63pupTWl3qc19ZX9jYy3aSJKdxVxErMjKePmAB7GrutvfJ400PxHe6beNpFrb3MLQw27XE0UjlNkpijDNyFYcAkA84ycC2Xp+Nr/APAB7v1/D+tTrzq+mi1t7k6haiC5IEEvnrtlz02nOG/CqqeKvD0sdtJHr2mOl3KYbZlvIyJpAcFEOfmbPYc15Je+HDp8mhTz6DezQP4sl1G3hj0uWdrKzYHO4KjeWC+19nB5HGVOG65FPNoHxDS10LWGmvtZt5bQJo1xumVfKyy/u+RmOQ5/H+IZas9/6+H/ADf3A97L+vi/yT+Z7FdeIdFsZjFe6vYW8glWEpLcoh3t91cE/ePYdTUtrrGmX1zdW9jqNpcz2Z23MUM6u0B9HAOV/GvFNRgin034oNp3hrVkbWI4jY40C5ja4bygGIBiBz5mSc98t71c8S2Opa1rd5a6BpupQteeEls4pH02eCIy795iLsgVCUyOSME44PFJdP66X/Swf1+KX63+R63Ya/o+qi4Ol6tY3otWKzm3uUk8kjqG2k7T9aLPX9H1C8FpYatY3VyYhOIYblHcxno+0HO0+vSvPdVsbfXddh1e30W+j0+x0W6s9QhuNKlVrjcE8uFYimZQpDHKhl9DzWP4Sjmsbj4YQDRNWtmsbG4hv2Ok3Eawu6BQJGKADLqTk8dGPBBqkr/16/5L7xXdr/10/wA/wPaqKKKkYUUUUAFc38R/+SWeK/8AsC3n/oh66Sub+I//ACSzxX/2Bbz/ANEPQB0blgjbAC2OATgE/WuG0rxj4u1WPUZIPCWmsNNvHtJok1tjI7Jgkxg24U5B43Mvviu5dgiMxzhRk4BJ/Ida808JeKY9LXxC8+h+I2lvNYnuLWEaFdKZkYKFO5owi5wfvMuO+KS3fp+N1/wQey9f0f8AwDp9I8Y2PiLw9banY3cOmmS6FtLDqKAOkqvteAjeP3meBgnkg4PSsO5+I0d54r1DTtE1zw3DBo5Q3a39z8064zKUdXwnljrlWGeDtxmuPvfDV7pGh6bqOr6Lczavf+LF1qWGyspLtrCIupZS0atghFXOPvHOM4rr/D2rpB458Z3U2nazHbzGCWGR9HugJljhCPs/d/Md3QDluoBFN7X/AK2X+bXyDrb+t2vyF8MeObzxSsGqWmt+GotJnmEZgLM1zA3mYSNiJNrO68jhdpI4euym13SbfVU0y41Syi1CRd6Wj3CLKy+oQnJHB5xXjaqW+GvgqKbw9rLajpWsQySqdDuTLbxrLukYfu8gbSvTr05IIHV6HYQLf6npHinQ765u31ttTtLpbSRo5huDQv5yjajIAF2uwOFxgg1SV9PX9P8AN/d6sHpr/XX/ACX3nYp4s8OS29rPHr+lvDeS+RbSLexlZ5M42Ic4Zs9hzXKf8LRh0n+328WGxsBp2rpp1ssc5/fb1RgxZgOgfLcYAB64zXK3djqtt4buNHg8P6rd3tr4vGoFYbQhHgNz5odJGwjZXjhuD1x1pNQgv76Pxa9vo2r/ADeJrG/QPps6mWCMwh2TK/PgxtwuTgZHBFEEnbz/APtP839wS0uvX/2787I9TsvGfhfUluG07xJpF2ttEZpzBfROIox1dsN8qj1PFaEeo2l1pYv7O9tpLSSPfHdLIHiK/wB7cDgj8a4LxPaXdl4ys73SbWRI/FcA0u9AAVonALpKeeoj84dzwtdP4ytbX/hANVtJLBruD7E8cdrFatOWO3CARqCTzjtxjPaok7Qcv6/rYqKvNL+v63LQ8QaXZ6bbzaprmmAvbC4NwJlijkQAZlUMxwnI53EDI5NaMN1b3Nol1bzxy28iB0mjcMjKRnII4I968Z8ORwQeKPBt/c+HdVjex8MyWt5O+g3O5JlWMKhPlZJwsgHXrgfeGeq+HKeV8GIbTW9MvUFvDPFcWV3p8vmMu5jtETLucFSAAAc9ParqLlu10v8Am1+i+8iOtr/1omdcnibQZJhCmt6c0piacILuMt5YOC+M/dBHJ6U1tcsLvTbW90zWtN+z3E6JFcmRZY5ssAUQhwCx6DBOD2PSvIPDdq1r4e+GdrJ4e1WGbT9Qla9VtFuB5GUkXc58vABZk5/HsSK8/wAytv8ADmtvcQ+Nf7Shk/sC6JS1MilpFbyuAQOQOT6UJLnUfP8AVL8nf5MH8N/62f8Al+J7dca5pNpqcGm3ep2cF9cDMNrLcIssv+6hOT+ArA034n+EdS1K9sl8QaXBNa3f2RFmvY1adtqnKKSCRuYrx1KmsWwsYF1zX9L8U6HfXhv9VXULK5S0kkjmVVQxAyqMRFCmMOy/kawtV0jVW0DxnarpF/JKPEkWpxhLZj50KvA2Y/75wjcLk/Lg4OMqNm1ft+sfyu/uG+tu/wDn+dl956kfEmhh71DrOn7tPIF4v2pM22enmc/J0PXHSozr2nzz2/2PW9M8szSRyIZFdpCiksikONrKRk8NgA8DqPHfH9nc61deMbgeE9XvLbUtPsV0+Y6W7kzRs5P7vHmI21zyVGMEHGRnqtbs9PtviN4H1DSvD91H80z3V1baNKPLWSEonmsI/lO7GQ2CvU4HNCVwlpsdHo/j7RPE+mXFzomt6bEILwW5eaVXBHmbR8oZSN+G2ZPPBwelbl3r2kWGowWF9qtlbXtz/qLaa4RJJf8AdUnJ/CvG7/T7mDwClleeHtUmv7PxWbqMx6XLMUjN4ZGdCqk48s/eHBzjJORW1qul3U2leNtGvtKvby+8Q3Dz6ZMllI0bKYUEW6TbtiKMvRypGMjNHS6/4fSP53f3D62/rd/lb8T0i/8AEOi6W0i6nq9hZtHt3i4uUjK7jhc5IxkggetaIIZQVOQeQR3rxS+0z7Dr3jQPomoXE9x4ahsxdQ6NO4u7kK6vtcRneSWjycnIHX5Tj1DwZJJJ4H0X7RFcQzLZRJLHdQvFIrqoDBlcAg5B69etFlZ/13/y/Em70/rt/n+Bt0UUUhhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN+PP+Rdtf+w1pX/pwt66Sub8ef8AIu2v/Ya0r/04W9AHSUUUUAFFFFABRRRQAVzd9/yVPQv+wLqX/o+xrpK5u+/5KnoX/YF1L/0fY0AdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBT1Owm1CBI4dSu9P2uGdrUR5kXuh3o2AfVcN6EVPaWsNjZw2trGI4IEEcaD+FQMAVLRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/5JZ4r/wCwLef+iHo+w+N/+hh8P/8Aghn/APkyj4j/APJLPFf/AGBbz/0Q9dJQBzf2Hxv/ANDD4f8A/BDP/wDJlH2Hxv8A9DD4f/8ABDP/APJlczZ6VoPw9+K1xPDp1lYWfiCzZ4p44VQQzQjdJGCOgdMPgcZQmo4J7DwRo1vqWmaPFZar4qvXdni02SdogyvIu6KEb32qB8ox8xJyOTR0v/V72/zB72/qx1X2Hxv/ANDD4f8A/BDP/wDJlH2Hxv8A9DD4f/8ABDP/APJlchD8Q/F9xNo1mNEtbWS+1ObT2ub62ubYS7YmkSaOBwGCEDkFs5BX/aF638UeLtL1bVdM8VzaILmLSfttgbGzl2zSZ2svzy5ba20YGCd4OR0p2f8AXpcP6/Gx0P2Hxv8A9DD4f/8ABDP/APJlH2Hxv/0MPh//AMEM/wD8mVD4s1zXfC/w1vNZWLT7zVbG186ZW3xQEgZbaMs30BPPqKytU8S+LdNsbZ7p9BtTdiSWGfy5ZsKI1ZYRAHV5HJL8oSAFzjnFJ6X8gWtvM2/sPjf/AKGHw/8A+CGf/wCTKPsPjf8A6GHw/wD+CGf/AOTK5aHx94p1eXwpDo9hpEB8RaVLdrLdSSv5UqIGKlVA+XLLznPJ6Y5W0+JGs3msWf2TSpruyk1BrC4ht9IvCYtrmNrgXOPKKBl5XGQP4sgiq5Xfl/re35ivpf8ArudR9h8b/wDQw+H/APwQz/8AyZR9h8b/APQw+H//AAQz/wDyZXSUVIzm/sPjf/oYfD//AIIZ/wD5Mo+w+N/+hh8P/wDghn/+TK6SigDm/sPjf/oYfD//AIIZ/wD5Mrn/AB9Z+MV+G3iVrzXdDltxpN0ZY4tFmR2XyWyFY3TBSR0JBx6HpXolc38R/wDklniv/sC3n/oh6AD7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TK6SuM+JOrabBpFvoeq6tbaVFrUht5bi4uEhCQAZlwzEckYQe7ik3YaVy/9h8b/APQw+H//AAQz/wDyZR9h8b/9DD4f/wDBDP8A/Jlcl4M8fQ2Xweu7x549VuPDrNp7vDMGW4KMFibeMjDKUORnqfStDxL4g8b+GfC2u6ncxaLN9htkura5SCQRvz88LR+buyBjEgIBz90VTWtl/X9ISu/U3fsPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MrlvGPi3xJZ3XiDTrG5sII4vDb6rbTC1cyxMDtZSfMwehIOBjI4OOYV8Z61o+i6Vo9s0d1qUekRXryw6JeXKOrAiOLZCzFGO05kZscZC84C6X/rr/kw/r8v/AJJHX/YfG/8A0MPh/wD8EM//AMmUfYfG/wD0MPh//wAEM/8A8mVX1LxTqsHwrl8T2+krb6hFYfa5LDUGeLyiF3OrfLnIAOBgZ45HWsifxr4gsNJ0t9Tisluda2vaNY2F1efZ08gO5eKPLyEMcDaVGDkkY5bVm12Don3/AE/4cux+GfG/9stqF14v0m7Kkm3gl0BxHbZGDs23IJyO7liMnGM1pfYfG/8A0MPh/wD8EM//AMmVwjeJ/Feua94OMwXRWbULyOaG60yZFuPKhYiYI7o4RkJwp+6TyWxitTR/iPrWs6rpz6dpEt1p2p7wgOlXkAtMKTG8lyymN1YgA7R8u7jdQH9f1/XodP8AYfG//Qw+H/8AwQz/APyZUVzH4wsrdp7zxR4bt4Uxukl0SZVXJwMk3mOprmtD+IHiO/s/DV9qEGlxQa1qFxp7wwRyM0Tp5uyQOWAI/dYK7eeoI6DL0fxZ4r0P4b3+vXE+m6pJ/bklu3mQyQlFN00Rbh2D8ldq/LtA6tRZ3t/XT/MHp/Xr/kd99h8b/wDQw+H/APwQz/8AyZR9h8b/APQw+H//AAQz/wDyZWFq3jfWxaeI9W0OHT30/wANzvDc21wjmW78tFeQpIGAjwGIAKvkjtVW+8feI5b7xAulW2lQW2m6NDq1s9wJJXmR1dtjqCgUkIRwTt4PzZwF0v8AP5Wv+Q7O9v63t+bOn+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MqS88Vw2Pw7fxXPA3lJpwvjCDycpu25/HFYy+JfElnr+laZqv8AZjDX7eVrG4t7eQC0mRN+yRTJ+9XH8SlM46DOQ2mm12/r9CU00pLr/X6k8d54jm1aTS4vGnhN9QiXfJaLpEhmRfUp9tyB74q99h8b/wDQw+H/APwQz/8AyZWD8JtPuZfC6X+sPp95Ml7eG2ljsjHLEzXEgkO9nbO4+gXA4O7rVLUvHviWx8N+Kb5DpTXGg6ytmubSTbNCwj6jzch/3v3skcfd54La2/rdL9UP+v6+46v7D43/AOhh8P8A/ghn/wDkyoraPxhe263Fn4o8N3EL52yRaJMytg4OCLzHUVk2fijxlqfibxBp9lY6HHHotwibZppiZ0eIuvzhflblM/KR94c8Gs/RfiF4m12TwnDBZ6Tbf8JBY3Nw07mWTyXi7CMEZHK/xjPP3eMr+vwuB1f2Hxv/ANDD4f8A/BDP/wDJlH2Hxv8A9DD4f/8ABDP/APJlcnb/ABP1G80XS4o4Eh1a7W786WHS7m+iQ283lEiGEl8MTwS2F7knAPbeENavfEHha01HVNMn0u8lDCa1nieNkZWK5CuAwBxkZGcEU7dQ2Kv2Hxv/ANDD4f8A/BDP/wDJlH2Hxv8A9DD4f/8ABDP/APJldJRSA5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TK6SigDm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MrpKKAOb+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkyukooA5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TK6SigDm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MrpKKAOb+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkyukooA5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TK6SigDm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MrpKKAOb+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkyukooA5v7D43/AOhh8P8A/ghn/wDkysPxZaeKotLsX1XWdHubQa1pfmRW2kSwyN/p8GMO1y4HOD905HHHUegVzfjz/kXbX/sNaV/6cLegDpKKKKACiiigAooooAK43xHrelaD8SdAutc1Oz023fSdRjWW8uFhRmM1kQoLEDOATj2NdlXN33/JU9C/7Aupf+j7GgA/4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKqXxr4gvPCvhO81ux0+DUBZRmaaGa6MH7sAklSEfLdOCAPes6y8a6hD4t07QPEmj29jNqsEk1lNZXxuY32AF1fdHGVOCCOCD600rg9Fcuf8LH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFVrDW9KbVn0tdTszqEaeY9oLhPNVf7xTOQPfFMt/EWiXeoJY2usWE946F1t47pGkZQSCQoOSAQRn1FIDM/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KrUj1/R5bpraLVrF51V2aJblCwC43HGc4GRn0yKdpmt6Vrds9xo2p2eoQI21pbS4SVVPoSpIBoAyf8AhY/gj/ocvD//AINIP/iqP+Fj+CP+hy8P/wDg0g/+KrKPxFtT8Qf7Lj1DRn0OPTZrqa/S8DGKSORFZXOdqAb+5J+nfqIfEWiXF5bWlvrFhLc3cP2i3hS6Rnmi670UHLLweRxxTton3/4P+QGZ/wALH8Ef9Dl4f/8ABpB/8VR/wsfwR/0OXh//AMGkH/xVT3vjbw3Y6bqV9JrdhJFpak3YiuUdoT2VgDkMTwAeSaZp3i3S9W03TtTttZ0yO0uIGnkQzq5IC5bDhwBsIO7g9D0pAR/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FVcj8XeG5bGK9i8Q6U9rNP9ninW9jKSS/881bdgt/sjmrcOtaXcarNplvqVnLqEA3S2iTq0sY9WQHI/EUAZH/Cx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVbN/q2naUITqmoWtkJ5BFF9pmWPzHPRV3EZPsKrQeJ9AudSfT7bW9NmvY08x7aO7jaRUwDuKg5AwQc+hoAz/8AhY/gj/ocvD//AINIP/iqP+Fj+CP+hy8P/wDg0g/+Kq7B4t8OXX2f7Nr+lzfalZrfy72NvOCnBK4PzAHg46Gqej+O9A1zWtW02w1K0ebSn2zAXC5IABZgOu1SdpbpnIoAT/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKrSt/EeiXenLf2ms6fPZtIIluYrpGjLk4ChgcZzxio28WeHVtzO2v6WIRP9mMhvI9vm/8APPOfvf7PWgCj/wALH8Ef9Dl4f/8ABpB/8VR/wsfwR/0OXh//AMGkH/xVdE8iRxtJIyqijLMxwAPXNZtr4n0C902bULLXNNuLK3O2a5iu43jjPozA4H40AZ//AAsfwR/0OXh//wAGkH/xVH/Cx/BH/Q5eH/8AwaQf/FVsWmsaZqD3KWGo2l01o2y4WGdXMLej4Pyn2Nc1pPjf+2fiRcaHp82mXmlx6d9qjurO5852cSBCrY+VcHdxyenI6ULV2/ra4PRX/rexd/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KqnqnjSTRfiLDpGrPptjosmmS3hvZ7jYwdZEXDFsKo+f1Ofbvv3PiDRrO3juLvV7CCGWMyxyS3KKroBksCTgjHfpR0T/rdr9A62Mz/hY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqtU67pK6pFprapZC/mTzIrU3Cea6/3gmcke4FJDr+j3Ory6Vb6rYy6jCN0lmlyjTIPUoDuHUdu9AGX/wALH8Ef9Dl4f/8ABpB/8VR/wsfwR/0OXh//AMGkH/xVT6j418OaZp+oXlzrViU05WNyqXKM0ZXGVKg5DZIGOuSPWrmga3Z+I9BtNV02eGeC5jD5hlEiq2OV3DjIOQfcULUHocZ4+8feD7z4beJbWz8WaHPcTaTdRxRRalCzyMYWAVQGySScACug/wCFj+CP+hy8P/8Ag0g/+Ko+I/8AySzxX/2Bbz/0Q9dJQB594s1f4ZeNNLhsNb8X6G0MFylyhi1aBW3Kemdx4IJUj0J6dan17xL8Pdfs4Ip/G2jWs1rKJrW6tdWt1lt5ACNykkjoSCCCCCQQa0F8XXuraxf2PhLSoNRTTJvs95dXd4baIS4y0aFY3Z2XIzwBz1q9beKbRNKub7xB5egx21y1vIb+4jRQRjB3Z24OQRz0I+lHT8fy1/IHvr6fnp+Zxt9feBdR1DR727+KVs9xpM/2iN/7Usf30m3YS42Y+6SMLtHJPXmodc8Z/D7xR4v0bb4q0tX0O6aaed7xYo2XZxGGYgSgvsb5SwGznBxXpB1fTRa29ydQtRBckCCXz12y56bTnDfhVVPFXh6WO2kj17THS7lMNsy3kZE0gOCiHPzNnsOaet/63F0v/VjmvFHibwF4r8N3ei3Xj7SbS3vE8uZ7XVbUOUPVcvuAB+mfQiqNzqXgC6utLun+I9it1pts9oJ01a0DXET7dyuMY52qcoFIxwRXcXXiHRbGYxXur2FvIJVhKS3KId7fdXBP3j2HU1La6xpl9c3VvY6jaXM9mdtzFDOrtAfRwDlfxpf1/X3/AIj/AK/r7jzTTE+HulX+g3Nv8T7ZxoNu1taQyarYlDG33g2EDHICjIIPyjHcnTsdZ8Aabqk9xYfEPToLO4mM8mmJq9r9nMpO5nH8a5PJAcKTnjk12lhr+j6qLg6Xq1jei1YrObe5STySOobaTtP1os9f0fULwWlhq1jdXJiE4hhuUdzGej7Qc7T69Kd3f+vX/giMv/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKrpKKQzm/+Fj+CP+hy8P8A/g0g/wDiqP8AhY/gj/ocvD//AINIP/iq6SigDm/+Fj+CP+hy8P8A/g0g/wDiq5/x94+8H3nw28S2tn4s0Oe4m0m6jiii1KFnkYwsAqgNkkk4AFeiVzfxH/5JZ4r/AOwLef8Aoh6AD/hY/gj/AKHLw/8A+DSD/wCKrFi8R+B4vGE3iBviPp0ryQC3FnJqlmYI0zn5cDeOeT83PfIAA71ywRtgBbHAJwCfrXDaN4w8Xa6+qJZ+GNGVtMvXspRJrso3uqqxK4tTxhh1x9KFvp/XT9Q6f16/oYk6/Da61zWtQvPiJYzw65GIr7T21azW3kULtX7qhwyjo27dwMk1e/tXwDP4bvNE1b4kWWq2l1A1sftesWoaOMjGAUC5Ix95tze9dodf0+1WCPV72y0+8kSMvazXSbkZ8AL1GfmO0HuelTQ61pdxqs2mW+pWcuoQDdLaJOrSxj1ZAcj8RR0sF+p5s0XwzubqS61P4iWuoXEumNpckk+vQLvhbdnKxlVJ+brjqAcZ5qwl18P4Bp8tj8S7W0vrG3FqL6LV7MyTwjGEkVlKEDGRhQRzjGTntbjxf4dtYdRkl1vTz/Zib71UuUZrcf7ag5X2z1qtoHi3T/E+n6Vf6Vqen7L2IyG081ZJS20EoCG4Kn7w2n8Kd3uv63/4IPTR/wBbf5Ixtb8S+Atc8L3WhS+P9KtoLqIwyzQatbGUq33hl9w5BIJx34xVOfVPh9caHpdg3xC05LjScfY9Rj1a0W4jIXbngbDlTggpg9xW34S8YS6p4f1TUvEv2HTBp2oXFpKyznyUWJtu4u+O+eSB9K6WyvrTUrOO7066hu7aUbo5oJA6OPUMODS6X72f+QdbPpdfo/yPP7zVPh9qE2lXN58RLCS80yVpUuhrFqryl08tgwGFAK/3AuO2KTTdV8B6Os0Gm/EqygsWLNBYjVrNorVm5zHkFsAnIVmZR/dxxWr428dL4cuNOtNLuNLnvZtQtre6tp7n99DDLIE3iNeT16kgDrz0rah8Y+GLiwub6DxHpMtpaFVuLhL6IxwknADsGwuT0zT3V/66f5h1t/XX/gnnNpZfDyys9HtovipEYtHvXvrYNqun8yMSTuPl8j5n4/2z6DEt5bfDa78P3eix/Eq2tbK6vjfMkOsWZ2MZPN2ruU4Xf8397tnHFekDxFohupLYaxp/nxIJJIvtSbkUqWDEZyBtBOfQE1xuh/Ey31zV/tEPiDwxDpAvJbNraa7C3RIZljkVt5VvMK5CbRxyGPShXbt/XT/gA9r/ANdf+CVZ7n4dTvdA/EPT0ttQwdStU1a0Ed+20KWk4ypIUZ8soD3FQX5+H19qWsXg+J9rbf2vZLYzQwapYBI4VzhUyhI4Zhkkn5j6DHof/CSaGZruIazp/mWTBLpPtSZt2PQOM/KTjgHFS2Ws6ZqS3DadqNpdrauY7gwTq4hcdVbB+Uj0NLdf1sNXTORs/Efw7t/CMfhy78a6JqNilt9kY3eqWxaSPG3DbSo6cZAHT15qlZ6p4DtJUmk+JVldz28LwWM1xqtmzWKsAD5eFAY4AG6QOeOpyc9BrPxE8MaR4Zn1sazYXdrHIIFaC6R1eU9E3AkA9z6DJ7VrWmrWl/eK1jq2n3Nu9sJljhcO7KTxIGDYKY4+7+Pam222yVZJLsch4T17wJ4R0p9Pt/iNp2oQGV5U+26pZkxl2LNgxhOrMTzn2wKy9Wj+GesPq63HxBsorTWJo57uzg1u2SNpU24cEfOCQigjdjvjODXothr+j6qLg6Xq1jei1YrObe5STySOobaTtP1os9f0fULwWlhq1jdXJiE4hhuUdzGej7Qc7T69KXW49jgdIvfAei3Ws3Nr8ULaSXV1USvPq9k5iKrsRkJXJIUAfPuzjJycmszSLD4faLcaTLafFhGGjxSw2UcmqacVjST74/1WTnA6k4xXsNUrbWtKvNRuNPtNTs5721x59tFcK0kX+8oOV/GgOh5lp1v8OtKsLeGx+J1vHdWs801vqH9rWPnRiVt0ifc2MjNzhlPPTGBjsLTx94HtbdYv+E30OYjJaSXVYCzk9ScMB+AAA7AVpprljYaPJf61rmli2SZka7DrBCnzEBCWdhuHQ88nsOlT3HiDRrTSE1W71axg06QApeS3KLCwPTDk4Oe3NO4dTL/4WP4I/wChy8P/APg0g/8AiqP+Fj+CP+hy8P8A/g0g/wDiq0z4h0UXQtTq9h9oa3+1CL7Sm8w/89MZzs4+90rBu/Gpk8VeGLXQ5NN1DR9aedGvYLjzTujjZsJt+XGQATk9xjvRbWwdLlv/AIWP4I/6HLw//wCDSD/4qj/hY/gj/ocvD/8A4NIP/iq0f+Ek0P8AtC4sBrOnm9tUMk9sLpPMiUDJZlzlQB3NZvh/x/4d8Q+H7jWbbVbKOytpZI5pJLlAIgrsoZyT8gYLuGccEUgF/wCFj+CP+hy8P/8Ag0g/+Ko/4WP4I/6HLw//AODSD/4qtVde0d9Phv01WxazuGCw3AuUMchJwArZwSTxxVXT/GPhjVrprbSvEek306oXaK2vopGCjqcKxOB60AVP+Fj+CP8AocvD/wD4NIP/AIqj/hY/gj/ocvD/AP4NIP8A4qtSLXtIuNFbWLfVbKXTFVna9S4RoQF4Y7wduBg55rkfCvj869aPr9xrPh2Lw8FfzV+0bJ7Jt2EEjlih3AZ5CY4A3daOtgNr/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qtJtYs7m2sbnT9X0/wAi7lURSlxItyp/hjIYAsexGfoawPDnjgXQ1YeKZ9M0l7TWH0y3H2nCykIrKAz43Mdx4AH04zTSu7f10/zDz/rr/kXf+Fj+CP8AocvD/wD4NIP/AIqj/hY/gj/ocvD/AP4NIP8A4qtI+JNDD3qHWdP3aeQLxftSZts9PM5+ToeuOlNm8T6DbWLXtxremxWiymBriS7jWMSA4KFicbgeMdaQGf8A8LH8Ef8AQ5eH/wDwaQf/ABVH/Cx/BH/Q5eH/APwaQf8AxVdGjrIivGwZWGVZTkEetLQBzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVXSUUAc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFV0lFAHN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVdJRQBzf8AwsfwR/0OXh//AMGkH/xVYfizxr4V1fS7Gx0rxLo99dy61pfl29tfxSSPi/gJwqsScAE/QV6BXN+PP+Rdtf8AsNaV/wCnC3oA6SiiigAooooAKKKKACubvv8Akqehf9gXUv8A0fY10lc3ff8AJU9C/wCwLqX/AKPsaAKfxWaRvhjrdpbWl7eXN7avbwQ2dpJO7OynHCKSB7nA965zSoB4P8Qwa5HpmtatpOrQLEs81pc3V9pjgcoVkBmELbc4xww9CK9TqpLqunQPcrNf2sbWcYmuQ8ygwIc4Z+flXg8njg007D30PKtF8IjUrm1sfE8viGS70+/mu1tXsIhZSh3bc3n/AGcblZHO5Gk3HJBHFZ3gu1XWPh/4O0vS9Kuo7iw1P7ZLdCyZIYYVlk3kSY2uXX5NqktzyMCva50N3ZSJBcvCZYyEnh2lkyOGXcCpPcZBHsayvCPheHwd4fj0ezv7y9t4XZomvDGXQMclcoigjJJ5BPPXGKFp+H4Ceq9f1/4c8r0fwq134A1qLSfDstpPF4ie7jgn0x7V5bMzo5SMSIvDRpjaPQA4rW8RaLqfie+8Qaz4Us7y1S60IWTR3NvJZveTCTdt2SBW4QMu4gD5+D1r1moXvLaO8jtZLiJbmVS0cLOA7gdSF6kCl0S7f5W/IOrfd/rf8zy1o5db+IFhe6T4Z1S2tJPDtzp8sk9ibZbdyVKo3mbSQNpA25HPGRkjAk03xBqHh7wTp+k6Hq8N9p2j3dhcTyWxgFrM1usYJZyuV3c7lyCOmSCK93opvVW/r7X/AMkwWjT7f5L/ACR5fLp1prfw9vY7Dwzf2ev2/h+bTBHLZyQbMx/6pWICSAsowU3D3GarWgB8feAr0aFqkTw6TLa3dy2kzDZuRFjWR9nyjcH4YjbnJwDk+s0U+b3r/wBdf82K3uqPb/gf5I8/8NaPqGneJNQ8PNZSxaNY3b6lY3RjxG/nZIiB7lJGkOOwCVjeDfDExv8AR01678Sf2voc8j+S9lFHaFmyHdbhYB5iMGztMhbJ5GRXrNFJOw3rfzOK8eW1xHc2uraTcX9rqllBKkLQaa99DMrlMxSRoCwyVU7gVxgknFY2vx6xpJ8OeKLPSktdUu7VNI1CzgwViMwHlHjgiOXA9lZsV6dWbLo4uNYS+ur66mjiYPBZt5YhicKV3jChycMfvMR3AFJaaP8Are/33f8AVwf9fp9z1OG13TL7w7qkUvhJLyeZktrOXTJ9Naa1vETo3nAfuWAY/Mzbcj7pNZmqaPrkz+N7WzsdQje41m1v0khhX9/bosO8Rs6lHf5G+Ug8jBGCM+vUU03e/wDW6f6B/X5r9Tw3xR4bsZNHfVoLXxNrt1qGq2E0v2/RCHj8qQb2EMduhU+XkFiuGGACateIVe5vPiX9l0PVm/tDSoYbNl0a4/fyCNkYIfL55KfgM9ASPaKKXS39bJfoNaO/p+Ducfq7vefCCby9HudReTTQjadNFLDJJ8oVlKfK4PXgYJxx1rzHxRplzeab4xFzo2ranJqllp7WDf2BKAZE3ghUEZMe0f3zuGevIr36iqcryb7kxVkl2PFfElrqGreIvEEXh7R9SENxodlGqPp01vFciKYvJAGdFUMYm24JHUr1BA6LRZZL/wCMUWsWHh7VLbT59BW2e4uLE2wikWUsFZZNrcAY4B6jtzXpFFK+qfr+N/8AMLXVvT8Lf5HCeJIpNP8AijpOvXOnXl1pqaVcWbSWlo9yySvJGygogLAEK3zYx6kVxmi+Exp3jfwnHqvh2Zhs1IzN/ZrzRW0U8hMEMkqqUGFZxt3YXJ6A8+3UUJ2SXa/43/zG9bnkUPhSW41y80vXLnxFC6awdRso7Gxi+ySKHDREXAgJTaoCFWkBwuBwRUOmWt83i7w1dNouo2MFpq9+JrVNOlMdv5qSYkaVgWfexB3qQg3Y7CvY6KE7K39dvyQS1v5/8H/M8fm07W10fWfDuj219qWlyaJdCD7fprW89lI6gpAspAWYNnBAyQVGWPFekeEpWl8IaV5lvcWzJaRI0dzEY3BCAHKtyOfUCtiii+n9ef8AmD1a+f42/wAjm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh66SkB5v4Ua5+H13rWk63pupTWl3qc19ZX9jYy3aSJKdxVxErMjKePmAB7GrutvfJ400PxHe6beNpFrb3MLQw27XE0UjlNkpijDNyFYcAkA84ycd3RRtby0/Cwd/P/hzw698OHT5NCnn0G9mgfxZLqNvDHpcs7WVmwOdwVG8sF9r7ODyOMqcN1yKebQPiGlroWsNNfazby2gTRrjdMq+Vll/d8jMchz+P8Qz7nRTTsrL+vh/+RB6u7/rd/qeEajBFPpvxQbTvDWrI2sRxGxxoFzG1w3lAMQDEDnzMk575b3q54lsdS1rW7y10DTdSha88JLZxSPps8ERl37zEXZAqEpkckYJxweK9rooWlvL/ACa/UP6/FP8AQ8t1Wxt9d12HV7fRb6PT7HRbqz1CG40qVWuNwTy4ViKZlCkMcqGX0PNY/hKOaxuPhhANE1a2axsbiG/Y6TcRrC7oFAkYoAMupOTx0Y8EGvaqKE7f16/5itp/Xl/kFFFFIYUUUUAFc38R/wDklniv/sC3n/oh66Sub+I//JLPFf8A2Bbz/wBEPQB0bsERmOcKMnAJP5DrXi+ixaTNqHia61uy8Z2zXmsSXNqttYarGksW1NrGJE8s5KkYdc+vGK9pooWjv5W/J/oD1Vv6/rU8s0qyttX+Ml3qN54XuLUXuhwh5LnS38vzxJvw0pTYXC+Xzk8rtBJWs3RPCN9d2dpaahf+JIvEOkC48lXs4orQSOrKZFuFgHmI27djzC2eoyK9looaTVv63b/Ud3dv0/BWPNNF0+1vvBcFo3hy+tPEOmaNLYES2jxqhaPDBZCBHKGZQcqW6g8c1i6AjW/in4d3Evh/VoJrLRXs725bSJhsJjRUV3CcAMJOCeOTwGBPstFVzPmcu/8Awf8ANk20t2/4H+R4hYWurXGjyXNva6/YQ2niq61CcRaYy3DQSBxHJHHPEwkwWBKhSw9M4r0fwJodroulXhsLjVLiK+u3uy+qQrDIXcDcREI49gyOhUHOT3rqKKS0VvK35f5Deru/X8W/1Z4lfWepp4StNHn8Napea5p/iSO+nkisyy3C/aS/nJM2EOUIGNwI6HAFdNLplxYfEibRbe1I0nxGU1SbGMQyQlRMp5x8/wC5HHXLV6PWbYaP9jvpby4vrq/uZAUSS5EY8qMnPlqERRjPcgscDJOKIu39eSX6J/1YHrf+urf6v+tTi4v7R0Xxui6TFf3ml3V7PdXtpeaW5Flw4aaG4C4bcw4j+ZiH4wK55YLzUvhPq1tb6RqwurfXm1D7PNps8UkkJvvOBjV0G87AThcnsRk17PRQna3l+jX+Q3r/AF6/5/118D+INpcazrXiC6HhLWLy1v49MNlOdJeTDRSlpPkwZEPluw5UdGBxkA62v2eo6v4i8ZQ6HpOpeVc2OntEklhLbxXYhkJmiDOoXJQhcE85x0Bx7NRQnYL3dzy7xnZWmveCdW1Pw54f1JL+5ayNyslhNDLIsMyttETgFiq7uVU5xjJwBWR4p0291rxp4oTw/o9/az6p4dS3Fw+nSxRzzByzI0u0LuMeFyT6LnIwPaKKXW/r+KsF3b7vwaf6Hluq2Nvruuw6vb6LfR6fY6LdWeoQ3GlSq1xuCeXCsRTMoUhjlQy+h5rG8KLNp0vwyj/sTV7c2FhcRX5Gj3CCF3jC4c+Xjl1J/I9CDXtdIw3KQc4IxwcU72/r1/zJsv6+X+RStr+LWdHa40ySRRKrqhlieJ0YZGGRwGUg9iAa818D+F2a70NtbuPEZ1bQ4ngktrmyijtBvQq+JlgXzkY4IHmM2cE85r1O1tYbK3WC2jEca5IGc5JOSSTySSSSTySai1G0mvrF4LbULnTpGIxcWqxs64PYSI689OVNGz0/r+rj3VjyTQoPsWgaTFp+kuYLbxJqKx3FraSTjTx5sqKVij45BKgsCq5yRTPCdlqOgDw7e6rpGqzafYf2laXEf9nu8sEklxujm8lEywZARujUgbvTNetaPpFroemrZWIbyw7yMznLSO7Fndj6liT+NXqd7f15WB6/15tnm9xplvoHjDwjfaTot/Fo1tbXloI7e0klaFpWRk3KMsikq3LYC5Gdtcr4Zj1Ow1bwbBqHh3WrQ2eralLKx095ESOcyeWxaMMFBLgHJGME/dwT7lRSTt/XzB6q39bWPHNLtb5vF3hq6Oi6hYw2mr34mtU06Ux2/mpJiRpWBL72IO9SEG7GOBSaBp2rWGi+F5b3SdQFroWrXst/b/ZHZzvMwjkRAN0gXcDlQfvAjODj2Sii7SB63/rv/meGa/4fBvzq39gX01pfeJ7S+tIU0maSSCFVT7RKyBC0W9hkqQGbHSuv8ZadL4Z1rSte8K6fGklwG0m4hgjCDE5zFIQMfdlwT7O1eiVmy6OLjWEvrq+upo4mDwWbeWIYnCld4wocnDH7zEdwBQrJJdP0sl+S/EH1fl+rf5sekdtoPh9Y0jlNvZQBQsMLSuQo7IgLMfYAk15bost3H8N/CUDaDqS3FjqGJ5LjS7kvYnEhEohwpk4YLn5lUtk524r2Gil1uw2VkeEW9hLYWXhhbrQtXlvdO8V3NxJP/Y0rvHbtJIS+6OPaFbdGcLwew+Xi5Na32p+E/GQttI1bzP8AhJItThil02aJ54FkhJaMOo3nEb/KOeBxyM+10U02tf6+z/8AIoJe87v+vi/+SZ4P4/s7nWrrxjcDwnq95balp9iunzHS3cmaNnJ/d48xG2ueSoxgg4yM9V4i0jytf03U7NNW07RrnT5IpW0fSkllSVyhPmwPBI43KoBIXI24OK9Oopf1+gPX+vT/ACMbwjo0Hh7wnYaTZvdvb2kflxG9IMuzJxuwABx2wMDArZoopt3d2JKysFFFFIYUUUUAFFFFABXN+PP+Rdtf+w1pX/pwt66Sub8ef8i7a/8AYa0r/wBOFvQB0lFFFABRRRQAUUUUAFc3ff8AJU9C/wCwLqX/AKPsa6SuN8R6vbaN8SdAuLyO8kRtJ1FALOymunz51keUiVmA46kY6DPIoA1/Fevv4f0yCS3iSa7vLuKytkkbanmSNgFj6AZJxycYrzGbUtb8G+J/iJrEdtpF1qVrpllcyNFE9vDNjzcuUy7bsDGC3OB8w7dj4h1zw34m0htP1G08Som9ZY5YPD+oJJDIp3K6N5HDAjPp65rmb/RvDGprqj3upePJLnVrRLO8uf7DuwZIlzxsFp5eeSM7cjJxjJyLS/8AXb9R6f16/wCR01941urTxRaadd3VhpUNzbwvbvfW0uy9lfqiTBgiMuPuEMzZ4xVC++IGsxaDe+K7OCxl0HT757Wa0aN/tMkaS+U8qybtoOckIUOQPvDPEd5LoWpaXDpuo3vjS6sl8vzoJPDt1i4CYwGItAV5UE7CuTSMPC7TzIo8WJpk9x9qm0lfDt59mkl3byx/0beMsASocKT1HJqtL/13X6X/AOB0lXt939fkOuPiB4itdQ8UzXVlpUel+GpFedUeR5p4WhMg2nAAflOoI5YZ4BqhcS6hY/FrQta8RJpvmNod9MzWEDI6ovlt5bMzEybcnDfKDuPyjvctR4ZhvvEM943i3UYvEIxeWt14cu/LwF2ALstVYYX5eSfXrzVe1sfC8Wpade3t1441J9Mhkt7ZLrRb7aInABRtlspkGFH3yc984GJXlvb9GvzH/X4p/wCYsHxK8TTqZ7XQ/tVvPp0l5G8umXlnFZuih/LkmkQrKGXOGQLkjGMHNTx+O/Ettoeiavrx0jT9M1WGKdr6O0nnS0zGrMkoDjbuJOJC21cYIPUtj/sSHQ7jR4dU8cJYSRGGCH/hH7pvsiEEFUY2hJG0kfOXwOmDg1Ytr3SbLwzZaLZ6n41gjs7Y2sc6+HLkyNH8uAwNmUJAXaDtzgnuc03bW3lb8f8Agf8ABBdL+f6f8E77TbhrvS7W4ea3naWJXMtq26J8jOUPdT2qzXG6N4l8O6DotppWm2HiGO1tIhFEreHdQYgD1Jg5q9/wnmkf8+fiD/wnNQ/+MUO19BK9tTpKK5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YpDOkorm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABigDpKK5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYoA6Siub/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGKAOkorm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABigDpKK5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYoA6Siub/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGKAOkorm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABigDpKK5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYoAPiP/ySzxX/ANgW8/8ARD10led+PvGml3Xw28S28VrrivNpN0imXQL6NATCwG52hCqPUkgDqTXQf8J5pH/Pn4g/8JzUP/jFAHSUVzf/AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFAHSUVzf/AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFAHSUVzf/AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFAHSUVzf/AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFAHSUVzf/AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFAHSUVzf/AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFAHSVzfxH/wCSWeK/+wLef+iHo/4TzSP+fPxB/wCE5qH/AMYrn/H3jTS7r4beJbeK11xXm0m6RTLoF9GgJhYDc7QhVHqSQB1JoA9Eorm/+E80j/nz8Qf+E5qH/wAYo/4TzSP+fPxB/wCE5qH/AMYoA6Siub/4TzSP+fPxB/4Tmof/ABij/hPNI/58/EH/AITmof8AxigDpKK5v/hPNI/58/EH/hOah/8AGKP+E80j/nz8Qf8AhOah/wDGKAOkorm/+E80j/nz8Qf+E5qH/wAYo/4TzSP+fPxB/wCE5qH/AMYoA6Siub/4TzSP+fPxB/4Tmof/ABij/hPNI/58/EH/AITmof8AxigDpKK5v/hPNI/58/EH/hOah/8AGKP+E80j/nz8Qf8AhOah/wDGKAOkorm/+E80j/nz8Qf+E5qH/wAYo/4TzSP+fPxB/wCE5qH/AMYoA6Siub/4TzSP+fPxB/4Tmof/ABij/hPNI/58/EH/AITmof8AxigDpKK5v/hPNI/58/EH/hOah/8AGKP+E80j/nz8Qf8AhOah/wDGKAOkorm/+E80j/nz8Qf+E5qH/wAYo/4TzSP+fPxB/wCE5qH/AMYoA6Siub/4TzSP+fPxB/4Tmof/ABij/hPNI/58/EH/AITmof8AxigDpKK5v/hPNI/58/EH/hOah/8AGKP+E80j/nz8Qf8AhOah/wDGKAOkorm/+E80j/nz8Qf+E5qH/wAYo/4TzSP+fPxB/wCE5qH/AMYoA6Siub/4TzSP+fPxB/4Tmof/ABij/hPNI/58/EH/AITmof8AxigDpKK5v/hPNI/58/EH/hOah/8AGKP+E80j/nz8Qf8AhOah/wDGKAOkorm/+E80j/nz8Qf+E5qH/wAYo/4TzSP+fPxB/wCE5qH/AMYoA6Siub/4TzSP+fPxB/4Tmof/ABij/hPNI/58/EH/AITmof8AxigDpKK5v/hPNI/58/EH/hOah/8AGKP+E80j/nz8Qf8AhOah/wDGKAOkorm/+E80j/nz8Qf+E5qH/wAYo/4TzSP+fPxB/wCE5qH/AMYoA6Siub/4TzSP+fPxB/4Tmof/ABij/hPNI/58/EH/AITmof8AxigDpKK5v/hPNI/58/EH/hOah/8AGKP+E80j/nz8Qf8AhOah/wDGKAOkrm/Hn/Iu2v8A2GtK/wDThb0f8J5pH/Pn4g/8JzUP/jFYfizxbp2p6XY2ltbawksmtaXta50S8t4xi/gPMkkSqOncjJ46mgD0CiiigAooooAKKKKACubvv+Sp6F/2BdS/9H2NdJXN33/JU9C/7Aupf+j7GgDR8ReILDwvoVxq2qyMlvABwgyzsThUUd2JIAHvWSfEfiG2tVvtS8LpDZuyALDqAkuIgzAbpIygUAZydrvjHeq/xQ8Naj4m8IpHomx9RsLyG/t4ZH2rM0TZ2E9ORnGeM4rB8Z6re+K/DcNlo2n+KtL14TxERRRXVosY3r5oadMQuNm7Hzn25oj+v4d/z+4GehT61pdrqkGm3OpWcN/cDMNrJOqyyj/ZQnJ/AVG3iLREvEtH1iwW5kmMCQm6QO0gAJQLnJbBBx15FeZXXhF7rW9V0jXLvxMkVxqKXll9ito5oZgioYy1y0Dujrswd8gzjjOawprQWvhbxLDpvhvVoJJ/FUF3bRwaFcIzQrJE29QIxwAkh/8ArsMuNm1f+tUv1f3Cd0n/AF0f+X4nt0mtaXFq0elS6lZpqMi70s2nUTMvqEzkj3xUa+IdFe4aBNXsGmRXdoxcoWVUxuJGc4GRk9sivMk8NSalrN9ZeIrnxKrNq51O0jtdPjNtMu7fGfP+zlkIXCMryA8EAYIFU9C0e2t/ht4o+zeDZpJv7WuHtrSbS5rdzbySrtZF2o7KEUHYhBIULxSW2vb/AC/z/Dp0p72Xe35/5fidz4s8dR2Pw/v/ABH4QudL1kWmNzrdb4hyAeY85IyPlyPqK69WzGGbAyMmvDtdt9Q/4R/4gRjTdavZtXFm9oyaNMpn/dqDhVT5cbTkNyOM8mvSvGFvf698MdRh0GOb7XdWX7mKRWhkcEAlCGwUJGRg4IzzTekb/wBbCWrRUg8eLffElND0+60m60r+zprl7u3ufNdJY3RSj4+VAN3TJP0770ev6baadYS6prmmFrwAQzrKsUdy2M/uwznPrgM31rzXUjFqnjC11OLwhqzaWfDlzY3SS6Q48ttyFY2jYBnA2kAKGzkYyMkQaXa6lZ/Dvw5fabHrGn65pukiya0uNElmiuScZhkj2hl+ZB84KgAgkkUacq/rrL/Jff1Dd/12X+b/AOB09XvPEGjafc21tf6vY2s93/x7xTXKI03+4Cct17U671zSbC4FvfanZ20zFQI5rhEYljheCc8kgD1JrzWawvltPFtj4i0G6uLrxFChsorW1eeJf9HVBCZFBWPZIGwXKjnIPWodD8MiH4lS29/pMk9yPDVvaTalLpkhgnvEOSxlZNrNgId2f4QM5GAbP+uzdvla3zF0v/W6X63+R1niDx0un+L9D0XSrjS7try++y38f2ndcW2Y2df3a9M7Tyx9ODnjpBrelNqz6Wup2Z1CNPMe0Fwnmqv94pnIHvivI7S31BNN8BWJ8Mas2qaFqYGosLMhcmKQPKJmwjq7EMWDH35wDY0zwqs80Nt4rk8STXWlX0959lXTY3s5gzPuYSrb5kV0c5jLlznGDxQ0lp6/oN7/AC/HU9N/4Sjw+I5pDrmm7LeMyzN9rjxGgYqWY54G4EZPcEVftLy2v7dZ7G5huYW6SQuHU/iOK8m8H+GrST4U2kU2m6lomo219K0dxDpLLc25E7SofLePLJjZwAR0HUcd54Gu9XvPD7y69bJFcfaJAkq2rWpuY8/LK0LfNGx7q3PHbNFt/wCv6/r5J/1/X9f56cWv6PcatLpUGrWMuowruls0uUM0Y9WQHIHI6ikt/EOi3V7FZ2ur2E1zMrNHBHcozuFJDEKDkgEEH0INeTQ20/8Ab2hXd7oGpW9jZ6lqP2uwj0iaZIlljlyxYqzTbyc5X5Pm244FZ+jWtzZeFPBVpZaFq9ldWuuXU0wXRbhPs6MJlV2xHwuJI/w/3Tg6Del/67/5HpHiDx0un+L9D0XSrjS7try++y38f2ndcW2Y2df3a9M7Tyx9ODnjsq8VtLfUE03wFYnwvqzapoWqD+0WFmQuTFIHlEzYR1diGLBj784B9qptJL5/5Cvr8v1YUUUVIwooooAKKKKACiiigDm/iP8A8ks8V/8AYFvP/RD10lc38R/+SWeK/wDsC3n/AKIeukoA5VfF17q2sX9j4S0qDUU0yb7PeXV3eG2iEuMtGhWN2dlyM8Ac9avW3im0TSrm+8QeXoMdtctbyG/uI0UEYwd2duDkEc9CPpXJ+FGufh9d61pOt6bqU1pd6nNfWV/Y2Mt2kiSncVcRKzIynj5gAexq7rb3yeNND8R3um3jaRa29zC0MNu1xNFI5TZKYowzchWHAJAPOMnAtl6fja//AAAe79fw/rU686vpotbe5OoWoguSBBL567Zc9Npzhvwqqnirw9LHbSR69pjpdymG2ZbyMiaQHBRDn5mz2HNeSXvhw6fJoU8+g3s0D+LJdRt4Y9Llnays2BzuCo3lgvtfZweRxlThuuRTzaB8Q0tdC1hpr7WbeW0CaNcbplXyssv7vkZjkOfx/iGWrPf+vh/zf3A97L+vi/yT+Z7FdeIdFsZjFe6vYW8glWEpLcoh3t91cE/ePYdTUtrrGmX1zdW9jqNpcz2Z23MUM6u0B9HAOV/GvFNRgin034oNp3hrVkbWI4jY40C5ja4bygGIBiBz5mSc98t71c8S2Opa1rd5a6BpupQteeEls4pH02eCIy795iLsgVCUyOSME44PFJdP66X/AEsH9fil+t/ket2Gv6PqouDperWN6LVis5t7lJPJI6htpO0/Wiz1/R9QvBaWGrWN1cmITiGG5R3MZ6PtBztPr0rz3VbG313XYdXt9Fvo9PsdFurPUIbjSpVa43BPLhWIpmUKQxyoZfQ81j+Eo5rG4+GEA0TVrZrGxuIb9jpNxGsLugUCRigAy6k5PHRjwQapK/8AXr/kvvFd2v8A10/z/A9qoooqRhRRRQAVzfxH/wCSWeK/+wLef+iHrpK5v4j/APJLPFf/AGBbz/0Q9AHRu6xozuwVVGSxOAB61wT/ABW8Py389vZeItBc/b7e1g/02NjIjBDI4w/IwxUHpuHfpXeuCyMAxUkYDDGR7815tpHhTXJdS0mW78R68F8251CQyWtooR92xAc24IZkkOR7HGOMEfi1/r+kD203L1/418U2OqaRZt4W01TrFxJBaedrEiMuxGfMii2O3Kr0BbBOK6DTNYu7h7dNY+w6Vd7ZjNp3nea7BGwJI5DsymOSSn8Q5GOeb8c3bJ8QPBvl6fqlxHZXks9zNa6bPNHEjwvGpLohX7xHGcgcnAql4rgsk+LtndXWhXl3atol1bXs8OjzXEcu4oUjZkjYPwr8c4zjvR0+/wDBD6/d+Lsd0PE2gtDPKut6cY7aMSzuLuPESEkBmOflGQeTxwae+vaQmjDV31WxXTSu4XpuUEJHrvztx+NeQaJ4dvLf4X+D7q003U9MuNLuT/aQtdNC3qpiXBWOWJvMCs4bAU9yvIrTt9C/4RrWNG1q0h17WNFN9c3V0LmxzPFPNGoWZbaOJGCghwQEyC7HGDmqtq1/X9P+vJf1/X9f8HrPBvjY65pmoXeuS6bZ/Z9VksIWguMxSbdoXDtjeWJ4wBnjiuhg17SLrTZdRttVsZrGEsJbqO5Rooyv3tzg4GO+eleI3GluLMx3fhDVNo8af2hbv/ZLzYtjIC7AIrMowBkEDdkYzg40ry11W81zxLPp9nrlraR+ILa+cw6ayyTQrAI2eFZoikhWQBsYJIXIB4pLWK+X5Rv+b+4NpNeb/OVvyX3nrB8SaGukx6o2taeNPlYLHdm6TynYnAAfOCSeOtPudf0ez+z/AGvVrGD7VnyPNuUXzsDJ25PzYHpXnS+GYLGxfVtI1XxPFeSXj6jHe3OkeYfNMYjdWtUhRgrAjgIpJBII6lmpHxAujWWtw2NzZeIm09bebTI9Ka5sr4M7kRsFBMJOCSSwC7xuJo6/12/z/wCGBa/15/5f8OesA5GRyK5HXfiN4e0PxAmm3evaTA8cE0t0k93GrxlQu1MFgQzbsgEZIBxW/p+qw3k0toUkhvLZEM8LwuoUsP4WYAOucjcuRkEda4rxP4b1nVtW1mSDWtZht51trGOCG3timyRv3uC8JJQBsk7s5DZPAATTvYItbsu6B40v9W8Xadpjrps1jeaH/aIurOUvvkDojAdgoJbuxPHIravvGvhux0vUr+TWrCSHTAftflXKO0RH8LAHIYngA8k1w+uWOqSfEKWwsG1a4uG8MXFhFqs9g6x/aHYOm6WONYgcDqAACMdeKz08LPqfhnUbmA+JptZh0C400WWoWMVtHHuTiNSkEYl+YDaVZh3zzRJ3hddn+crfkvv++or3kpeX5L/N/d93Tr8SY59f8PeTNpQ0HVbCe6lvvtgYwvEoLITwigFgCST0IwMV1V14o0Cy0231C91zTbeyusfZ7mW7jSObPI2sThvwrzpZjL4u+H9xcaLq/k6dpc6zyPpE7CF2iRVzhDtbKOMHBHfqM8/oMGoTaNBYtoGrWUv2fVII7uTSJy6rLMXWFVddiBlKne6kcbRg5FVOyvbz/N/8D/gsiGqTfl+P9f8ADHtV5rukadt/tDVLK13J5i+fcImUyBuGT0yRz7il/tvSjq40oanZ/wBolPMFn9oXzin97ZnOPfFeS+HNHtbjxb4K/tHw1dny/DLWV9JdaNKEEu2MLHI7R7eiyDk4GcfxDMGq2kF7qmq6Jf2bf2L/AMJAuoTXs+lXdwV2FS0fywNCUO0ruMg2qSCvFNxSly37/g7flr+Ak3y39Pyv+eh6vD4u8N3EF5Pb+IdKlisf+PuRL2Nlt+cfOQ3y8gjnHStWGeK5t457eRJYZFDpJGwZXUjIII6g+tedajpU2nfEI6dptrnSPFUaSXPlKNkLwY8wkekkW1eB1FekAYGBwKnpcfWwUUUUhhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/kXbX/sNaV/6cLeukrm/Hn/Iu2v/AGGtK/8AThb0AdJRRRQAUUUUAFFFFABXN33/ACVPQv8AsC6l/wCj7Gukrm77/kqehf8AYF1L/wBH2NAHSUVgeM9QutO8PGSwv4rCeW4ihEzRmR8M4DCNArbpCM7QQRnGeK4jTPGWvyxrolzezx3dx4ik0qLULq3hE8UKweduZUHlmQj5R8uOQSuQRTiubb+tv80D0/r1/wAj0XS/EGla3cX0Gk30V3Jp83kXQiyRHJ3UnoSO+OlaNeISX/iDw3e+LJNM1hGuv+El0+2mubm0R3mjkjhTou1QcMMkLzg4C5yNrW9d8S6d/wAJxBD4imJ8PWseoWshtINz742byX+TBTKHoA2D97jk+zf+tk/1Ha8rf1u0eofaE+2fZtsnmeX5mfKbZjOPv4259s574qWvNLrxR4lPiDWbe31G1iij8NR6paIbPcIZCSG3fNl/unHIAz0OOYdD8Q+Jprzw1FPrS3EmveHpLtvNs4/Lt50WMh1VNrEHecqWwe23pRbR+X/23/yLF1/ry/8AkkemW1wl3brNEsio2cCWJo2645VgCPxFP8xPN8vevmbd2zPOPXHpXlmneLvEl14F8Ma/fy6g1lPBLNql1pVpFLIrhvk3RsrHysbs7BuGByOTUWnSale/EPXdQ0nxVPcKvh60ubaR4Int5N4lwdgUMFyNwAZTk8kjih6Xv0v+v+Qbr+u6X6nrVNeRI2QO6qXbagJxuOCcD1OAT+FeU6TrPiq98I+G9SvfFZV9diiZ4LXT4zcqRG7N5A2MpJOzcXG1QGIIyAM+z1DW/E198OrvUdZvrW5kvL+KYQxwLuaFZVDMpRl3lRg4yOTtx1quVqVn6C5la/kexxXKTTTRIsoaBgrl4mRSSAflJADDB6rkZyOoIqWvLX8a+ILN9etLm8hnuE8SW2k2ky2wRbeKZYznbk5IDnkk5OO3FVPF3ifxd4Wh8S6Zaa0t3Jp+nwajbajd2cbSqryNG0bBAiE5GQ23pkEHrUpXt5/5J/kyuv8AXe35nrtFcdoOqaqnxG1XQtR1Br+3XTre+iZ4UQws7urIu0DK/KCN2SPU1X8S+INR0TxYG1O51DTtDaOJILy2tY5rbzWbDC4JUyJ/DhhtXnk5otqvMm+jOxF9Bm53l4ltjiV5Y2jQfKGyGYAMMHqCQDkdQasV4t4v1bXtS8I+Mra+1qRDpuvWttC1nCkQMLmE7CGDE/6w855I9PlrY1nXvGUmq6ppnhSLVL+50TyY0k22Aiu5GjVybjeyMAQ2B5SrjBPPQJapP+tk/wBSrf1+B6jRXMeMPEV5ofhOC9t0jiurq4trXc+HS3M0ioXPZtu4nrg4FY+rX3ibwx9l0+51lb9NX1WCysr+W3jE9ujKxkLhVWMkbcKdvfkHHLt+dvnp/mLpfyv8v6R39FeR+JvFPi3w5p3i7TrbWEuLjR7a2vLbUrmzjaRo5WZTGyoFTcCuQ23GOqnrVnWvGeu+GfEOq6ZJfrfeZb2D2stxAiraSXE7QscIBlBgMAxJ7FjmhJu1uoPT+v67noEPiLSbnW73R7a9jm1CxjWW5t4wWaJW6ZwOp9OvtV2G7hnhgkVmT7Qu+NJUMbkYzyjAMDjqCMjvXljxazo3xA8WPDrTXd9B4agmgvLy2jJGJJjhkjCKehxwOoznHLNOm1fXPHHgW9m168ilu/Dcl3KiRw+W0n7ktlSnRi3OCDwNpXmiKv8A1/i/+RCWjf8AX8v+Z6vbXKXUbPEsqhXaM+bE0ZypwcBgCRxwRwRyCRUteU+HvF/iHWk0bRbzVPJvdQvtSjn1G2tY1Kx20hVVjVgygn5fvBuAep5qG78XeLreD7AuqW4nsPE8GkTXr2Ss13DJsYHAIVWAfDYHPbbQldpLrb8Wl+bB6Xfa/wCF3+h65RXmqa54p+zeKtOsri71S40jVIYknhigF19neNHfYpVYmddzYyOe4J69d4S1m31zRDc21/cXuyZonN3beRNEy8FJE2rhh9B19KErq/8AWtv8wehuUUUUgOb+I/8AySzxX/2Bbz/0Q9H2Hxv/ANDD4f8A/BDP/wDJlHxH/wCSWeK/+wLef+iHrpKAOb+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTK5mz0rQfh78VrieHTrKws/EFmzxTxwqghmhG6SMEdA6YfA4yhNRwT2HgjRrfUtM0eKy1XxVeu7PFpsk7RBleRd0UI3vtUD5Rj5iTkcmjpf8Aq97f5g97f1Y6r7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMrkIfiH4vuJtGsxolrayX2pzae1zfW1zbCXbE0iTRwOAwQgcgtnIK/7QvW/ijxdperarpniubRBcxaT9tsDY2cu2aTO1l+eXLbW2jAwTvByOlOz/r0uH9fjY6H7D43/wChh8P/APghn/8Akyj7D43/AOhh8P8A/ghn/wDkyofFmua74X+Gt5rKxafearY2vnTK2+KAkDLbRlm+gJ59RWVqniXxbptjbPdPoNqbsSSwz+XLNhRGrLCIA6vI5JflCQAucc4pPS/kC1t5m39h8b/9DD4f/wDBDP8A/JlH2Hxv/wBDD4f/APBDP/8AJlctD4+8U6vL4Uh0ew0iA+ItKlu1lupJX8qVEDFSqgfLll5znk9McrafEjWbzWLP7JpU13ZSag1hcQ2+kXhMW1zG1wLnHlFAy8rjIH8WQRVcrvy/1vb8xX0v/Xc6j7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMrpKKkZzf2Hxv/ANDD4f8A/BDP/wDJlH2Hxv8A9DD4f/8ABDP/APJldJRQBzf2Hxv/ANDD4f8A/BDP/wDJlc/4+s/GK/DbxK15ruhy240m6MscWizI7L5LZCsbpgpI6Eg49D0r0Sub+I//ACSzxX/2Bbz/ANEPQAfYfG//AEMPh/8A8EM//wAmVBJ/wlsTOsvivwyjIyIwbRZRtZzhQf8ATOCSQB611MrFYXZTghSQdpb9ByfoK8UtfEes32sw7tS81L7WBLIB4O1FflgUKCpMhAG6Ncr1UkkngihaysD0Vz0n7D43/wChh8P/APghn/8Akyj7D43/AOhh8P8A/ghn/wDkyuL+LutWV1K+kjxFY6TeaRbrqkKXF4kLT3KtmGMBmGRhXyP9pK2b/wCIF/Po/g7U/DltYz2viK5igke5lcGEupbAVRzjawOSOQODnIFqtO9vv2/G/wDTB6fc392v5W/pGpcjxbZCM3nirwzbiV1jjMuiyrvcnAUZvOSScAUt0ni+xtXub3xT4atoIxl5ZtEmRVHqSbzArgfFmvm/023ufE0Nkbzw34ut7Vr23tio8vKOWVSXZcqQCAxyVrR8eTX2v/BjXdU1dtMubGeNLnS44bUh4U3gozuZHUvtI+6Fxz64DSur+f4NJr8/wH9rl/rdr9DshZeNyMjxF4fI/wCwDP8A/JlL9h8b/wDQw+H/APwQz/8AyZXOeJPiFqmn6lf2nh/Tpr59JEQltk0m7uWu2ZFcossQ2REKw5bdknoByem8TeJn0PQ7K6ht83WoXVvaW8U+VCySsAN/f5QSSPbFG+39X2J9fUZ9h8b/APQw+H//AAQz/wDyZR9h8b/9DD4f/wDBDP8A/JlYF78QNS8M3msaZ4kgtry8sraC5tbiwgkRLhZpfKVTFmR1YP2BbI6c8VXt/iNrUDXVpfaW8s0lxbW+nXsml3OnwTvMxUqyT/NlMZOCcjpiktdhvTf+uptW1l4nXVbuO38T+GWv9qNcINGmaRV52ZH23Kr97A4HXHerv2Hxv/0MPh//AMEM/wD8mVwVrqtz4M8d+OdS1WGzuLsWmnZOn2rxrcSSPIisYwXbOSAcFiQOPSrOofEvxVpukanMujRXP2OW2EV9dadd6dDKsr7CojlBYurFejYIOe2C7bWB6X/rodp9h8b/APQw+H//AAQz/wDyZR9h8b/9DD4f/wDBDP8A/Jlc/qfi7xTY6h4nsFOjmbRtPTU4pTbSlXjYOfKK+YPmzGfnyByPkqp4l+JOs6ZpMWrWcOmw2w023v8A7LOrzzXXmH50Xy2BiVRj94yspJ7YNCV/673/AMmH9fl/mjq/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkyujRtyK3TIzS0g3Ob+w+N/+hh8P/wDghn/+TK5u1+H3jOzknjh8d2n9mzyPI+mPorNDl2LNhzceaASSceZjkjGOK9IooA4iy8L+NrXUpL648X6RfTHcsP2jQGAto2IJjQJcrx8o5bc3A5rT+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMrD8WWniqLS7F9V1nR7m0GtaX5kVtpEsMjf6fBjDtcuBzg/dORxx1HoFc348/5F21/7DWlf+nC3oA6SiiigAooooAKKKKACuN8R6vbaN8SdAuLyO8kRtJ1FALOymunz51keUiVmA46kY6DPIrsqKAOL1rxB4Y8Q2As9W03xFLCsiyrs0HU4nR1OVZXSIMpB7gist08ByWt5bvofiJo724W6mzouq7vOUACVW8vKPgD5lIPvXpFFAHldxo3w3umlebw/wCJTLPKk0066VrCyyugGxmkCBmxgHknnnrzU89p4DupNUe40zxdI2rxiK+JsNa/foOin5eAOnGOCR0JB9NooA8rXSfh+sssg03xmZJbb7I7tba6S0P/ADzyR9326VIth4CSSyePTPGCPYWzWtqy2etgwxN1VSF4Hb8F9Bj1Cij+v6+9gea2kXgaw0WPSbLTPFsFlGrKkcen6yCqkgld2zdtJH3c468cmpppPA8sxlXRPEMDmzFjm10PVIMQrnaoCRDGASARyASAea9Eoo3DY84iHgeHStN06LSPE6W+lOXssaTq++DIwQJPL3bccbSduOMYoiXwJBBaQxaH4iWOyuZLq3X+xNV/dySZ34/d/dbccp93npXo9FO73A84tx4GtjqZTR/E0g1WQS3gn0jVphI4IIcB4yFYYGCuCMDHQU26j8DX2iz6XeaV4qntrllacyaZrDSzbc7Q8pTeyjPCliB6V6TRSA8+0+68H6Zr761aaf4r/tB7dbZ5ptM1ibdGvRSroVOOucZySepJqbUdU8JatcebqGmeJZsyLI8X9i6osUjKABvjEQRwMDhgRxmu7ooA80Fv4C8nVYn0fxRLHrDiS9WXS9YfzHBBDjch2sMDBXBGAOwq1NdeDZ9QhvjpXiaK5hjEXmQaPq0RlQHIWTZGPNGSeH3dT6mvQaKAOQ1HxP4a1bS5dO1LSdbubOZNjwSeGtQKkfTyP/1Vnre+DhpD6bLpnia5t2283Wj6tPIu05XbK8Zddp5GGGD0xXf0UAecXa+B77QptIvNK8UzWlxIJLjfpesGWcjp5kuze4HozEcD0FRPbeApry5urrRvFF1Ld2q2k/2rS9YmWSJfuqVdCOCMg4yDk5ySa9MooA8x+w/D7dM7aH4mknntfsklzJpWrvOYck7BKU3gc4ODyODxxVi3/wCEGtYtNSHR/Ew/suN4bNm0jVmaKNsZTcY8leBgEkDaMYwK9Goov/X9eoHmlpb+A7HSzp9rpHilIPtBukb+zNYMsUrZ3OkpTehOTnaRnJz1qS9HgfULCzs7nSfFHk2U/wBph8rStXjbzs58xmVAzvnncxJznnmvR6KLgec2reCrK8vru203xYtxfyia4kOm6wxZwCAwynykA4BXGBgdhWppPiTw1odl9l0zTfEMUZcyOX8P6lI8jnqzO0JZmPqSTXZUUAc3/wAJ5pH/AD5+IP8AwnNQ/wDjFH/CeaR/z5+IP/Cc1D/4xXSUUAef+NfFllq/gHxBpun6f4gmu7zTLmCCP/hHb9d7vEyqMmEAZJHJOK3P+E80j/nz8Qf+E5qH/wAYrpKKAPPvFl54T8aaXDYa3YeJGhguUuUMXh6/VtynpnyDwQSpHoT061Pr2teHdfs4Ip4PE9rNayia1urXw9frLbyAEblJtyOhIIIIIJBBruqKAPMb59G1HUNHvbvVPG73Gkz/AGiN/wDhHLj99Jt2EuPsePukjC7RyT15qXxLq2i694h8PXb6f4iA0y5e4eVfD9+Mrt4jI8nJBfY2OnyfSvSaKdwOE8Ua3oXivw3d6Ldf8JVaW94nlzPa+HL0OUPVcvbMAD9M+hFUbmfQLq60u6e58YrdabbPaCdPD12GuIn27lcfZcc7VOUCkY4Ir0mikB5Rplj4d0q/0G5t9R8buNBt2trSGTw7cFDG33g2LMMcgKMgg/KMdydOxvtB03VJ7iwm8XwWdxMZ5NMTw9efZzKTuZx/o29cnkgOFJzxya9Eop3d7gc3/wAJ5pH/AD5+IP8AwnNQ/wDjFH/CeaR/z5+IP/Cc1D/4xXSUUgOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKw/Gviyy1fwD4g03T9P8AEE13eaZcwQR/8I7frvd4mVRkwgDJI5JxXoFFAHN/8J5pH/Pn4g/8JzUP/jFZdlrnh6wms5IrfxMzWkMsSb/Dt/8AN5jKzMQLcZYlevua7iigDz/QdX0jQf7RIu/F9/JqE5nkku/Dd0WRyAuVKWi8YCjByAFGK5qz8P8Ah6yjsYotd8fmCwvzqFvA3h2XYkxLEkD7DwDvb5RxzwBXstFG39dtgeqa/rU8bn0Hw/cXNxM2u+Ph9o1JdUdB4cl2/aFwFbmx6AKBt6ccg1NLo/hp/DuqaDHqfjmDS9SuDO9rF4duAsOWLMkebM7VJwce3GMnPr1FGyt/XT/JDvrf+v61Z5stzosWqLqFrf8AjS2uZIkivWi8O3QF9sGA0im0IDY43RhDj6DGnrGveGtc0oWF7Y+IxGjpJE8fh7UA8ToQUdW8jgggH+ea7aigWx5tv8L3FlfxaxH4q1a41CJYZ7y68O3qzFEJKBfLtkVNpJIKgHPPJptzJoGpaE2mazd+NNSIZHhu59AvEmt2QhkZDHaqNwIByQSe+RxXpdFAHlQsPCU13qF3qreM9TudRtUtbiS50S/XcqHKMFjt0UODyGAyDyMZOV1aLRtc8O/2RqmtePJ4/MRzOfDs4lIRgyrxZbcbgDnG44GSRxXqlFAHlNzbaHd3+r3k+r+OWl1exWwuf+KbmA8pc42j7Fwfmfn/AGz6DFX+w/Cx0y6sH1Dx00F5Yx2NwDoFyDIkYIjYkWYwyg44wD/ECea9goo/r+vvD+vy/wAkcvB430mG3jiaDxHKUUKZH8N3+5sdziADP0AqT/hPNI/58/EH/hOah/8AGK6SigNjm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xisjxJ4ktde0+ysNMsNce4fVtOk/e6Fewoqpewu7M7xBVAVWJJI6V3dFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH//Z" /></p><p><strong>Description of selected side effects:</strong></p><p><strong>Immune system disorders</strong><br />Reported suspected hypersensitivity reactions include rash (including reversible scaly rash), pruritus, dyspnoea and very rarely drug fever or angioedema.</p><p><strong>Vascular disorders</strong></p><p>Orthostatic hypertension is more common at very high doses if the initial dose is too high or if doses are increased too rapidly.</p><p><strong>Hepatobiliary disorders</strong></p><p>Signs and symptoms of hepatobiliary disorders are usually reversible on withdrawal of the medicinal product.</p><p><strong>To report any side effect(s):</strong></p><p><strong>Saudi Arabia:</strong></p><table border="1" cellspacing="1" cellpadding="1"><tbody><tr><td>- The National Pharmacovigilance and Drug Safety Center (NPC)<br />- Fax: +966-11-205-7662<br />- SFDA call center 19999<br />- Toll free phone: 8002490000<br />- E-mail: npc.drug@sfda.gov.sa<br />- Website: www.sfda.gov.sa/npc</td></tr></tbody></table><p><strong>Other GCC States:</strong></p><table border="1" cellspacing="1" cellpadding="1"><tbody><tr><td>- Please contact the relevant competent authority.</td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Symptoms and signs: </u></strong></p><p>An extensive cardiovascular effect can be expected, e.g. extensive orthostatic hypotension and at times bradycardia. Oliguric renal failure has been reported after massive overdosage of labetalol orally. In one case, the use of dopamine to increase blood pressure may have aggravated the renal failure.</p><p><strong><u>Treatment: </u></strong></p><p>The patients should be placed in a supine position with the legs elevated.</p><p>Parenteral adrenergic/anticholinergic treatment should be administered as required to improve circulation.</p><p>Haemodialysis removes less than 1% labetalol hydrochloride from circulation.</p><p>Further administration should follow clinical indication or recommendations from the national poison control centre if possible.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Mechanism of action</strong></p><p>Labetalol lowers the blood pressure by blocking peripheral arteriolar alpha-adrenoceptors, thereby reducing the peripheral resistance and by concurrent beta-blockage protecting the heart against reflex sympathetic pressure which would otherwise occur.</p><p><strong>Pharmacodynamic effects</strong></p><p>Cardiac output is not significantly reduced at rest or with moderate exercise. Systolic blood pressure elevation during exercise is reduced, but corresponding changes in diastolic pressure are essentially normal. All of these effects are expected to benefit hypertensive patients.</p><p>In patients with angina pectoris co-existing with hypertension, the reduced peripheral resistance decreases myocardial afterload and oxygen demand. All of these effects are expected to benefit hypertensive patients with concurrent angina.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Pharmacokinetics</strong></u></p><p><strong>Absorption</strong><br />Chemically labetalol consists of 4 stereoisomers with different pharmacodynamic effects. Labetalol is absorbed rapidly from the gastrointestinal system with maximal plasma levels occurring 1-2 hours after oral administration. A significant metabolisation occurs with first passage, leading to a bioavailability of approx. 25%, but the variation is significant. The bioavailability is increased in elderly patients.</p><p><strong>Distribution</strong><br />Approximately 50% of labetalol in the blood is protein bound. In animal studies the amount of labetalol crossing the blood-brain barrier is insignificant. Labetalol crosses the placental barrier and is excreted in human milk.</p><p><br /><strong>Biotransformation</strong></p><p>Labetalol is primarily metabolised by conjugation to inactive glucuronide metabolites.</p><p><strong>Elimination: </strong></p><p>The glucuronide metabolites are excreted in both urine and via bile in faeces. Less than 5% of the labetalol dose is excreted unchanged in the urine and bile. The half-life of labetalol in plasma is around 4 hours.</p><p><u><strong>Special patient populations </strong></u></p><ul><li>Hepatic insufficiency Labetalol undergoes significant but variable first-pass metabolisation when given orally. In a study with 10 patients with histologically proven cirrhosis the exposure to oral labetalol was approx. threefold compared to healthy volunteers. The variation between the subjects, both patients and healthy volunteers, was high (approx. 2..5 fold). Patients with hepatic insufficiency may require lower oral doses of labetalol (see section 4.2 Posology and administration and 4.4 Special warnings and precautions for use.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Carcinogenicity, mutagenicity and teratogenicity</strong></u></p><p>No verification of mutagenic potential was found in in vitro and in vivo tests.</p><p>Labetalol did not exhibit any carcinogenicity in prolonged studies of mice and rats.</p><p>No teratogenicity was observed in rats and rabbits at oral doses of 6 and 4 times the maximal recommended human dose. Foetal resorption was observed in both species at doses close to the maximal recommended dose for humans. A teratologic study carried out with labetalol in rabbits at intravenous doses of up to 1.7 times the maximal recommended human dose revealed no signs of medicine related foetal injury.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lactose, anhydrous<br />Magnesium stearate<br />Microcrystalline cellulose<br />Hypromellose<br />Sodium benzoate (E211)<br />Titanium dioxide (E171)<br />Sunset Yellow (E110)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                100 mg/25Tablet: 2 years
100 mg/100Tablet: 3 years
200 mg/25Tablet: 3 years
200 mg/100Tablet: 3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tablet container (plastic).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aspen Pharma Trading Limited
3016 Lake Drive
Citywest Business Campus
Dublin 24
Ireland
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                07 March 2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>